
<html lang="en"     class="pb-page"  data-request-id="47c21032-3545-4b4a-98a9-b2ec5f7060cb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501535r;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure" /></meta><meta name="dc.Creator" content="Zoran  Rankovic" /></meta><meta name="dc.Description" content="The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins. Designing molecules that can overcome this prote..." /></meta><meta name="Description" content="The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins. Designing molecules that can overcome this prote..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 6, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501535r" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501535r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501535r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501535r" /></link>
        
    
    

<title>CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501535r" /></meta><meta property="og:title" content="CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0020.jpeg" /></meta><meta property="og:description" content="The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins. Designing molecules that can overcome this protection system and achieve optimal concentration at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery. Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochemical properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates. This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most critical physicochemical and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chemistry strategies toward molecules with optimal brain exposure. A summary of modern CNS pharmacokinetic concepts and methods is also provided." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501535r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501535r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501535r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501535r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501535r&amp;href=/doi/10.1021/jm501535r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2584-2608</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500843d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm501915g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zoran++Rankovic">Zoran Rankovic</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Eli Lilly and Company, 893 South Delaware Street, Indianapolis, Indiana 46285, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1 (317) 277-3179; E-mail: <a href="/cdn-cgi/l/email-protection#f381929d989c859a90ac899c81929db39f9a9f9f8add909c9e"><span class="__cf_email__" data-cfemail="9fedfef1f4f0e9f6fcc0e5f0edfef1dff3f6f3f3e6b1fcf0f2">[email protected]</span></a>, <a href="/cdn-cgi/l/email-protection#a4decbd6c5ca8ac9c5cdc8c6cbdce4c3c9c5cdc88ac7cbc9"><span class="__cf_email__" data-cfemail="156f7a67747b3b78747c79777a6d557278747c793b767a78">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501535r&amp;href=/doi/10.1021%2Fjm501535r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2584–2608</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 11, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 October 2014</li><li><span class="item_label"><b>Published</b> online</span>6 January 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501535r" title="DOI URL">https://doi.org/10.1021/jm501535r</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2584%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZoran%2BRankovic%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D6%26contentID%3Djm501535r%26title%3DCNS%2BDrug%2BDesign%253A%2BBalancing%2BPhysicochemical%2BProperties%2Bfor%2BOptimal%2BBrain%2BExposure%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2608%26publicationDate%3DMarch%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501535r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">19254</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">275</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501535r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zoran&quot;,&quot;last_name&quot;:&quot;Rankovic&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;2584-2608&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501535r&quot;},&quot;abstract&quot;:&quot;The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins. Designing molecules that can overcome this protection system and achieve optimal concentration at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery. Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochemical properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates. This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most critical physicochemical and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chemistry strategies toward molecules with optimal brain exposure. A summary of modern CNS pharmacokinetic concepts and methods is also provided.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501535r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501535r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501535r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501535r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501535r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501535r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501535r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501535r&amp;href=/doi/10.1021/jm501535r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501535r" /></input><a href="/doi/pdf/10.1021/jm501535r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26pmid%3D25494650%26genre%3Darticle%26aulast%3DRankovic%26date%3D2015%26atitle%3DCNS%2BDrug%2BDesign%253A%2BBalancing%2BPhysicochemical%2BProperties%2Bfor%2BOptimal%2BBrain%2BExposure%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D6%26spage%3D2584%26epage%3D2608%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jmcmar.2015.58.issue-6/20150326/jmcmar.2015.58.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins. Designing molecules that can overcome this protection system and achieve optimal concentration at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery. Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochemical properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates. This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most critical physicochemical and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chemistry strategies toward molecules with optimal brain exposure. A summary of modern CNS pharmacokinetic concepts and methods is also provided.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Traditionally, the development of medicines for central nervous system (CNS) disorders has been an intense and profitable research activity for the pharmaceutical industry. Despite the recent divestment of research in some areas, such as psychiatric disorders (i.e., depression and schizophrenia),<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> this trend is likely to continue as a result of the acute medical needs and market opportunities created by an increasing human life span. It is estimated that, in the absence of disease-modifying treatments, age-related neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease will be the major drivers of the predicted increase in US health care expenditures from the current ∼15% of gross domestic product (GDP) to ∼29% of GDP in 2040.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Additionally, the brain is a common site of metastases for some of the most prevalent cancers, such as lung and breast cancers,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and is the second leading cause of death in the United States among males younger than 40 years and females younger than 20 years.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Patients who present with metastatic brain cancer have a poor prognosis with a median survival of only 2.5 months,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> which is at least partially a consequence of poor CNS exposure for currently available drugs that were developed to treat systemic disease. Consequently, CNS exposure is increasingly seen as an important requirement in the development of new cancer treatments.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">However, the pressures of medical needs and the incentives of market opportunities are countered by the challenges and complexities of CNS drug discovery. In addition to the difficulties of CNS target validation and clinical translation, designing therapeutic agents that are able to reach and effectively modulate targets in the brain makes CNS research one of the most challenging endeavors in drug discovery. This is largely due to a highly sophisticated protection system that the brain has evolved to preserve its physiological environment and shield itself from external insults and toxins. An important component of this system is the blood–brain barrier (BBB), which lies at the interface between the blood capillaries of the brain and brain tissue.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The BBB has a very complex multicellular organization comprising brain endothelial cells that line the blood vessels and form the brain capillary endothelium as well as surrounding cells, including pericytes, astrocytes, and neurons. The BBB provides a fully autonomous milieu for the cells within the CNS, enabling selective access of required nutrients and hormones while removing waste and diminishing exposure to potentially harmful xenobiotics.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The blood–cerebrospinal fluid barrier (BCSFB) is a similar barrier between the blood capillaries and the cerebrospinal fluid (CSF), which fills the ventricles and bathes the external surface of the brain to provide buoyancy and mechanical protection within the skull.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In brain tissue, the CSF is exchanged with the brain’s interstitial fluid (ISF), which eliminates metabolic waste from the CNS and regulates the chemical environment of the brain (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><div class="NLM_p">Since the density of the capillaries within the brain parenchyma is so high that virtually every neuron is supplied by its own capillary (the combined capillary length in the human brain is 400 miles), it is estimated that the BBB surface area (∼120 square feet) is approximately 5000 times larger than the BCSFB surface area. Consequently, the BBB is thought to have a much greater role than the BCSFB in CNS drug delivery to the brain.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Active transport and passive diffusion through endothelial cells are the two principal mechanisms by which molecules can enter the brain. In contrast to the endothelial cells of capillaries elsewhere in the body, diffusion through the intercellular space between cells (paracellular) is effectively precluded by the presence of the tight junctions that characterize the BBB and BCSFB. For example, the capillary endothelial cell junctions in the brain are sufficiently tight to restrict the movement of ions such as Na<sup>+</sup> and Cl<sup>–</sup> and consequently display much higher transendothelial electrical resistance than peripheral capillaries (>1000 versus <20 ohm/cm<sup>2</sup>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This restrictiveness is thought to protect the brain from fluctuations in ionic composition that may occur, e.g., during a meal or physical activity.</div><div class="NLM_p">The majority of CNS drugs are small molecules that cross the BBB via the transcellular passive diffusion route.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Designing molecules that can achieve optimal concentration at the desired therapeutic target in the brain is a unique and major challenge for medicinal chemists working in CNS drug discovery.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> Tremendous progress has been made in recent years in terms of enabling the development of robust pharmacokinetic-pharmacodynamic (PK/PD) relationships for centrally acting agents as well as in understanding how these relationships are influenced by molecular physicochemical properties. The objective of this Perspective is to review this progress and highlight successful medicinal chemistry strategies toward molecules that can achieve optimal brain exposure via transcellular passive diffusion. Alternative brain delivery systems utilizing BBB active transport are beyond the scope of this Perspective, and the reader is referred to an excellent review of this topic.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p last">At this point, it should also be noted that the term “optimal” is used loosely in this context, since there is no single value or desirable concentration range, but what is considered to be optimal exposure depends on a multitude of variables, including drug potency, mode of action (e.g., agonist vs antagonist), binding kinetics (e.g., fast vs slow dissociation constant or reversible vs irreversible binders), pharmacokinetic properties, and therapeutic index. One could define the optimal brain exposure as a free drug concentration at the site of the intended target expressed in the brain that produces maximum desired and minimum undesired effects (best therapeutic window) over the time course deemed to be suitable for the intended dosing regimen (e.g., once-a-day).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Important CNS Pharmacokinetic Concepts and Parameters</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Achieving a good understanding of the PK and PD relationships in preclinical disease models, which is a critical prerequisite for successful drug discovery programs across all therapeutic areas, is particularly challenging for CNS targets. The existence of the BBB renders classical PK parameters, such as oral bioavailability and plasma concentration, insufficient for assessing drug exposure and time courses in the brain. For a meaningful assessment of CNS drug candidates, additional data and more sophisticated PK methods are required.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Free Drug Hypothesis</h3><div class="NLM_p">The most direct information on drug exposure at the site of action is provided by receptor occupancy (RO) studies. In the clinical setting, brain RO is measured using radiolabeled tracer ligands whose distribution can be determined by noninvasive imaging methods, such as single photon emission computed tomography (SPECT) and positron emission tomography (PET).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In preclinical studies, the tracer distribution is established mainly by scintillation spectroscopy of dissected brain tissue. These studies are characterized by the need for radiolabeled ligands, long turnaround times, and relatively low success rates (particularly for agonists). Therefore, due to technical complexities as well as time and costs involved, RO studies tend to be performed mainly for the most advanced compounds. Consequently, the more easily obtained drug total brain concentration (<i>C</i><sub>b</sub>) and whole brain-to-plasma ratio (<i>K</i><sub>p</sub> = <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>; also referred to as the B/P ratio) have historically been used as the main decision-making drivers in CNS drug discovery.</div><div class="NLM_p">However, recent evidence suggests that relying solely on these parameters is insufficient for adequate understanding of the CNS exposure needed to establish robust PK/PD correlations.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This insufficiency arises from the fact that only a fraction of total drug concentration in the plasma (<i>C</i><sub>p</sub>) and tissues, such as brain (<i>C</i><sub>b</sub>), is unbound from the tissue proteins or lipids and is free to diffuse across biological barriers and tissues to reach the intended therapeutic target (<i>C</i><sub>u,p</sub> = <i>C</i><sub>p</sub> × <i>f</i><sub>u,p</sub> and <i>C</i><sub>u,b</sub> = <i>C</i><sub>b</sub> × <i>f</i><sub>u,b</sub>, respectively), as depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a. Because the unbound plasma and tissue fractions tend to be different, the unbound brain-to-plasma ratio (<i>K</i><sub>p,uu</sub>) is often considerably different from the total brain-to-plasma ratio (<i>K</i><sub>p</sub>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Principal CNS PK parameters and concepts. (a) Schematic representation of bound and unbound drug concentration equilibrium across BBB and brain main compartments: interstitial fluid (ISF), intracellular fluid (ICF), and cerebrospinal fluid (CSF); (b) <i>K</i><sub>p,uu</sub> values significantly lower or higher than 1 indicate active transport across the BBB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The potential for misleading conclusions derived from the reliance on total brain and plasma concentrations is well-exemplified by comparative <i>in vivo</i> PK/PD studies of morphine, <b>1</b>, and one of its active metabolites, morphine-6-glucuronide <b>2</b> (M6G).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Both compounds are thought to exert their centrally mediated analgesic affect through the activation of mu-opioid receptors (MOR) expressed in CNS.</div><div class="NLM_p">Although the two compounds exhibit similar activities <i>in vitro</i> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> their similar <i>in vivo</i> efficacy<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> was unexpected considering the poor total brain/plasma ratio (<i>K</i><sub>p</sub> = 0.05) and much lower rate of BBB permeation, expressed as permeability surface area product (PS = 0.11 μL/min/g), for <b>2</b> compared with those of morphine (<i>K</i><sub>p</sub> = 0.54; PS = 3.5 μL/min/g). In fact, based on the classic concepts of CNS exposure, <b>2</b> should have no <i>in vivo</i> efficacy.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To explain this phenomenon, several hypotheses, such as glucuronide <b>2</b> activation of a new and not yet discovered receptor subtype, have been proposed.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, this apparent paradox could also be explained by considering the unbound (free) rather than total drug concentrations in the brain.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Actually, whereas the <b>2</b> total brain AUC concentration is 4–5-fold lower compared with that of morphine, the drug ISF AUC (unbound) is approximately 4-fold higher than morphine (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), which may explain the similar <i>in vivo</i> efficacy observed for these two compounds.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> These general observations have been confirmed by multiple CNS drug studies reported over the past decade: ISF is the relevant brain compartment for drug pharmacodynamics effect, and ISF drug concentration is not reflected by the total brain concetration.<a onclick="showRef(event, 'ref15 ref23 ref27'); return false;" href="javascript:void(0);" class="ref ref15 ref23 ref27">(15, 23, 27)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Morphine and Morphine-6-glucuronide Paradox Explained by Considering Drug <i>C</i><sub>u,b</sub> Data<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0005.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MOR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">AUC<sub>b</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p</sub></th><th class="colsep0 rowsep0" align="center">ISF AUC<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p,uu</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">(μM/min)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(μM/min)</th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">186</td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">336</td><td class="colsep0 rowsep0" align="left">0.56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">[<sup>3</sup>H]-Naloxone displacement binding assay in MOR-expressing cell membranes.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Total brain AUC concentration in rat, 10 mg/kg (s.c.).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Measured by <i>in vivo</i> transcortical microdialysis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></div></div><div class="NLM_p">It is important to note that the total B/P ratio (<i>K</i><sub>p</sub>) can be misleading, even when comparing structurally similar compounds. For example, a <i>K</i><sub>p</sub> value of 0.04 suggests significantly lower brain penetration for (<i>R</i>)-cetirizine compared with that of its enantiomer, (<i>S</i>)-cetirizine, which has a <i>K</i><sub>p</sub> value of 0.22.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, the unbound drugs in the brain (<i>C</i><sub>u,b</sub>) and plasma (<i>C</i><sub>u,p</sub>) show that (<i>S</i>)- and (<i>R</i>)-cetirizine have very similar, if not identical, effective compound levels in the brain, with <i>K</i><sub>p,uu</sub> (<i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub>) values of 0.17 and 0.14, respectively. The observed <i>K</i><sub>p</sub> enantioselectivity has been rationalized by the lower plasma protein binding (PPB) of (<i>S</i>)-cetirizine (PPB = 50%) compared with that of (<i>R</i>)-cetirizine (PBB = 85%).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">The importance of free drug concentrations is embedded in the central tenet of <i>in vivo</i> pharmacology, the free drug hypothesis, which states that: (1) the free (unbound) drug concentration (<i>C</i><sub>u</sub>) at the site of action is responsible for pharmacological activity <i>in vivo</i> and (2) at steady state and in the absence of active transport, the free drug concentration is the same on both sides of any biomembrane (e.g., the BBB).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Thus, at steady state, one could equate the drug unbound brain concentration (<i>C</i><sub>u,b</sub>) with its experimentally more accessible unbound plasma concentration (<i>C</i><sub>u,p</sub>). The <i>C</i><sub>u,p</sub> could be then used in combination with the drug <i>in vitro</i> potency data to estimate the brain exposure or dose required for <i>in vivo</i> efficacy. However, it is important to note that this assumption is not valid for compounds that<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">•</td><td colspan="5" valign="top" class="paragraph"><p class="last">Display a low rate of passive permeability across the BBB/BCSFB (require a long time to reach equilibrium across membranes).</p></td></tr><tr class="li1"><td valign="top">•</td><td colspan="5" valign="top" class="paragraph"><p class="last">Are actively transported in or out of the brain.</p></td></tr></table></div><div class="NLM_p">In these cases, the disconnect between a compound’s free plasma and brain concentrations (<i>C</i><sub>u,b</sub> ≠ <i>C</i><sub>u,p</sub>) is translated into <i>K</i><sub>p,uu</sub> values, which can be either above or below 1. <i>K</i><sub>p,uu</sub> values below 1 indicate compounds that are subject to active efflux and/or have low passive permeability across the BBB (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This profile is suitable for peripherally active drugs, such as (<i>S</i>)-cetirizine (<i>K</i><sub>p,uu</sub> = 0.22), a second-generation antihistamine that was intentionally designed to minimize brain exposure to avoid sedation and other CNS side effects generally associated with first-generation antihistamines.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, pursuing compounds with low <i>K</i><sub>p,uu</sub> values for CNS targets is less desirable, due not only to the higher peripheral exposure needed to achieve efficacious brain levels and the consequently increased risk of side effects but also to the difficulty with estimating low human <i>C</i><sub>u,b</sub>, which results in low confidence human dose predictions.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a><i>K</i><sub>p,uu</sub> values greater than 1, as exemplified by the first-generation antihistamine diphenhydramine (rat <i>K</i><sub>p,uu</sub> = 5.5), indicate an active uptake process mediated by influx transporters.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Active transport may offer an alternative approach for achieving optimal brain exposure for molecules whose properties are nonconducive to passive BBB penetration, as exemplified by gabapentin or <span class="smallcaps smallerCapital">l</span>-DOPA that are transported via L-type amino acid transporter-1 (LAT1).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> However, intentionally targeting specific transport proteins or transcytosis mechanisms for CNS drug delivery remains challenging, and, although this approach has attracted interest across the pharmaceutical industry and academia, research in this area is still in its infancy.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> A successful small molecule CNS drug candidate typically complies with the free drug hypothesis and displays a ratio of the unbound drug in the brain to the unbound drug in the plasma (<i>K</i><sub>p,uu</sub> value) close to 1.<a onclick="showRef(event, 'ref19 ref35'); return false;" href="javascript:void(0);" class="ref ref19 ref35">(19, 35)</a> With a <i>K</i><sub>p,uu</sub> in mouse of 0.98, the antidepressant venlafaxine is one such example.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p last">To simplify the process and increase the throughput, <i>K</i><sub>p,uu</sub> values are often estimated from single-time-point measurements. This is generally an acceptable approximation; however, one should be aware that such data can be misleading if the selected time point was before the system could reach steady state. In this context, more reliable <i>K</i><sub>p,uu</sub> values are generated using the area under the concentration–time curves (AUCs) for total and unbound concentrations obtained from time course experiments (<i>K</i><sub>p,uu</sub> = AUC<sub>u,b</sub>/AUC<sub>u,p</sub>). Again, AUCs and steady-state concentrations can be used interchangeably in this equation as they measure the same property.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> When making important decisions on the basis of <i>K</i><sub>p,uu</sub> data, it is worth remembering that these values include experimental errors from four separate <i>in vivo</i> and <i>in vitro</i> measurements (total plasma concentrations, total brain concentrations, PPB, and brain tissue binding). For comparing and prioritizing key compounds, one might like to consider generating multiple <i>K</i><sub>p,uu</sub> data points (e.g., <i>n</i> = 2) to increase confidence in the <i>K</i><sub>p,uu</sub> values.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2 Experimental Methods Commonly Used To Measure or Estimate Brain Exposure</h3><div class="NLM_p">Microdialysis is the method of choice for the direct measurement of unbound drug concentrations (<i>C</i><sub>u,b</sub>) within the brain ISF.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This powerful technique enables investigations into the extent as well as the rate of drug delivery to the brain, providing critical parameters for PK/PD modeling. However, similar to RO studies, technical challenges and resource requirements limit its use in drug discovery to more advanced drug candidates.</div><div class="NLM_p">CSF sampling is a less demanding and therefore more widely employed technique for assessing brain exposure during early drug discovery. The CSF is separated from the ISF compartment by only a single layer of ependyma, a cell layer that does not have tight junctions. Due to the very low protein levels in CSF, approximately 0.2 mg/mL compared to 70 mg/mL in plasma, drug CSF concentrations (<i>C</i><sub>CSF</sub>) can be approximated by <i>C</i><sub>u,b</sub>. Indeed, microdialysis studies of brain distribution, as well as PK/PD studies for a range of preclinically and clinically used compounds, suggest that the drug CSF level is generally a good approximation of the brain ISF concentration.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> A comparative study of brain exposure in rats for 39 structurally diverse drugs demonstrated a 3-fold agreement between drugs with respect to <i>K</i><sub>p,uu</sub> (ISF) and <i>K</i><sub>p,uu</sub> (CSF), within a similar rank order.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, one should remember that the CSF approximation fails for compounds that are subject to active efflux or influx (<i>K</i><sub>p,uu</sub> ≪ 1 or ≫ 1), presumably due to the lower active transport capacity of the blood–cerebrospinal fluid barrier compared with that of the blood–brain barrier.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> For example, while the <i>C</i><sub>CSF</sub> significantly overpredicts the <i>C</i><sub>b,u</sub> of highly effluxed drugs, such as loperamide, it underpredicts the <i>C</i><sub>b,u</sub> of actively influxed drugs, such as oxycodone.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">CSF sampling has a high value in CNS translational studies, being the only generally applicable method of obtaining information on free drug concentrations in the human brain.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Studies comparing rat and human CSF data showed that the human <i>K</i><sub>p,uu</sub> (CSF) was, on average, approximately 3-fold higher than the rat <i>K</i><sub>p,uu</sub> (CSF).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Some of the proposed explanations for the observed species difference include the disease state of the patients (e.g., altered BBB function), active transport, kinetic bias due to timing of CSF sampling, and the different sampling site (cisterna magna in the rat vs lumbar puncture in the patients).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In any case, the 3-fold error is generally considered to be of little pharmacokinetic or pharmacodynamic consequence for the prediction of drug concentrations in human CSF on the basis of rat CSF concentrations. However, prediction of rat unbound brain exposure based on rat CSF concentration includes an additional 3-fold error, which results in a cumulative 9-fold error margin in prediction of human <i>C</i><sub>u,b</sub> solely on the basis of rat CSF exposure.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> This may have significant consequences if a drug has a narrow therapeutic window. In order to enhance the predictive power of modeling human <i>C</i><sub>u,b</sub> and related PK/PD relationships on the basis of preclinical data, more complex physiologically based PK (PBPK) algorithms have been developed in recent years, which also incorporate mechanistically relevant <i>in vitro</i> data and integrate drug-dependent physiological and biological parameters, as they vary between species, subjects, age, or disease state.<a onclick="showRef(event, 'ref41 ref70'); return false;" href="javascript:void(0);" class="ref ref41 ref70">(41, 70)</a></div><div class="NLM_p">A more screening-based approach commonly used in early drug discovery due to much higher throughput is the brain homogenate-based estimation of unbound drug concentrations in the brain (<i>C</i><sub>u,b</sub>). This method relies on a combination of the <i>in vitro</i> measured fraction unbound in the brain (<i>f</i><sub>u,b</sub>) and the relatively straightforward <i>in vivo</i> determined brain total concentration (<i>C</i><sub>b</sub>). The <i>f</i><sub>u,b</sub> data are generated in a high-throughput fashion using a simple and elegant method based on the equilibrium dialysis of compounds between brain homogenate and buffer, which is used to calculate the unbound concentration in the brain (<i>C</i><sub>u,b</sub> = <i>f</i><sub>u,b</sub> × <i>C</i><sub>b</sub>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> An alternative to the <i>in vitro</i><i>f</i><sub>u,b</sub> determination method preserves the cellular structure of the brain tissue using brain slices.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In contrast to the brain homogenate method, this approach can capture potential differences between ISF and intracellular fluid (ICF) drug concentrations, as observed for gabapentin.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Since this phenomenon is thought to be relatively rare, generally associated with compounds that are actively transported into tissue, the more elaborate slice method is considered mainly when other techniques fail to explain the PK/PD relationship.</div><div class="NLM_p">It is important to note that due to a very poor correlation the free fraction in plasma (<i>f</i><sub>u,p</sub>) is not a suitable surrogate for <i>f</i><sub>u,b</sub>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> This lack of correlation is mostly a consequence of the very different lipid and protein contents of the two compartments, with plasma having twice as much protein and the brain having 20-fold more lipids.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, the free drug hypothesis infers that at steady state, irrespective of differences in <i>f</i><sub>u,p</sub> and <i>f</i><sub>u,tissue</sub>, the unbound drug concentration in the tissue of interest is mirrored by <i>C</i><sub>u,p</sub>, i.e., <i>C</i><sub>u,plasma</sub> = <i>C</i><sub>u,tissue</sub>. For example, following either single or multiple doses of the antifungal drug fluconazole, similar free drug concentrations are found in a range of body fluids, including plasma, CSF, saliva, breast milk, vaginal secretions, sputum, and prostatic and seminal vesicle fluid.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Species dependence of plasma protein binding is a well-documented phenomenon. Summerfield and colleagues at GlaxoSmithKline reported marked variations on comparing human <i>f</i><sub>u,p</sub> values with rat (<i>R</i><sup>2</sup> = 0.49) and pig (<i>R</i><sup>2</sup> = 0.65) for a set of 21 CNS drugs and PET tracers.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> This is hardly surprising considering the evolutionary divergence in the structure of blood proteins and overall blood content. In contrast, however, Summerfield et al. found good interspecies correlations for <i>f</i><sub>u,b</sub> values among rat, pig, and human (<i>R</i><sup>2</sup> > 0.9; <i>n</i> = 21).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Similarly high degrees of <i>f</i><sub>u,b</sub> correlation were reported by Di et al. at Pfizer for a set of 47 drugs in six different species and in two different strains of rat.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> This evidence supports the commonly accepted practice of using rodent <i>f</i><sub>u,b</sub> values in human PK prediction models. It was suggested that interspecies similarities in <i>f</i><sub>u,b</sub> reflect the conserved brain general morphology across species and mainly nonspecific nature of drug binding to brain lipids, since the brain-lipid content is higher than that in plasma and protein binding within brain tissue is thought to be insignificant.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Therefore, if species differences in brain exposure of passively diffused drugs are observed, then they are likely to be driven by differences in plasma protein binding where the homology varies significantly from one species to another.</div><div class="NLM_p last">Plasma protein and brain tissue binding are clearly very important parameters for understanding drug PK, PD, and safety properties. However, theoretical analyses and experimental observations suggest that these parameters should not be the primary focus of optimization efforts in drug discovery.<a onclick="showRef(event, 'ref30 ref49'); return false;" href="javascript:void(0);" class="ref ref30 ref49">(30, 49)</a> Indeed, high tissue binding is generally not considered to be a liability, as many successful drugs exhibit low <i>f</i><sub>u</sub>, e.g., 24% of all dugs launched between 2003 and 2013 have PPB > 99%, whereas 15 out of 32 the most prescribed CNS drugs have <i>f</i><sub>u,b</sub> < 5%.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> It has also been pointed out that lowering brain tissue binding does not necessarily lead to higher <i>C</i><sub>u,b</sub> and consequently, instead of focusing on <i>f</i><sub>u,p</sub> and <i>f</i><sub>u,b</sub>, discovery teams should place a stronger emphasis on minimizing intrinsic clearance and BBB efflux transport to achieve high <i>C</i><sub>u,p</sub> and <i>C</i><sub>u,b</sub>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> It is worth noting that improved <i>C</i><sub>u,p</sub> and <i>C</i><sub>u,b</sub> levels, especially when achieved by reducing lipophilicity, are often accompanied by increased unbound concentrations (e.g., Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Ultimately, assuming all other properties being equal, one may still prefer drugs with higher <i>f</i><sub>u</sub> levels, which may translate into lower daily dose requirements.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.3 BBB Permeability and Active Transport</h3><div class="NLM_p">A fine interplay between passive membrane permeability and active transport processes at the BBB level, together with plasma/brain tissue binding, is widely recognized as being the primary determinant of drug disposition within the CNS. However, despite decades of experience in culturing brain endothelial cells, there is still no satisfactory <i>in vitro</i> model of the BBB available to date. Culturing primary brain endothelial cells is too difficult for routine applications, whereas immortalized brain endothelial cell lines lack the required junction tightness. Still, useful high-throughput permeability assays have been developed using alternative cell lines, such as Caco2 (heterogeneous human epithelial colorectal adenocarcinoma cells), porcine kidney (LLC-PK1), and the industry favorite MDCK (Madin–Darby canine kidney) cell lines.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Although these cells lines are neither endothelial cells nor do they originate from the brain, the tightness of the monolayer results in permeability values (<i>P</i><sub>app</sub>) that correlate well with <i>in vivo</i> permeation. Due to its significantly lower cost and higher throughput, a parallel artificial membrane permeability assay (PAMPA)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> that lacks transporter proteins can be positioned in a screening flow scheme to remove poorly permeable compounds from testing in the MDCK cell line.</div><div class="NLM_p">Active efflux and poor permeability tend to exert a much greater effect on CNS than peripheral exposure, mainly because the transporters at the BBB are less likely to be saturated, as the drug concentration in the brain blood capillaries is much lower than that in the gut. Consequently, the physicochemical property requirements for brain exposure are generally more stringent. In a comparative study of marketed CNS and non-CNS drugs examined using MDCK assays, 96% of the CNS drugs exhibited passive permeability (<i>P</i><sub>app</sub>) greater than 150 nm/s, whereas only 76% of the non-CNS drugs met this criterion.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> On the basis of these results, a widely quoted <i>P</i><sub>app</sub> > 150–200 nm/s cutoff was suggested for compounds designed for CNS targets. In contrast, a lower threshold value of <i>P</i><sub>app</sub> > 100 nm/s is the generally accepted guideline for achieving good oral bioavailability.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">Limited brain exposure due to active efflux is a common issue for CNS drug discovery programs. Among the transporters known to be expressed in BBB endothelial cells that can affect drug transport in either direction,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> P-glycoprotein (P-gp, or MDR1), an active efflux transporter, is by far the most studied and best understood.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> This large transmembrane glycoprotein, first discovered in mutant cancer cells that appeared to alter membrane permeability for chemotherapeutics, belongs to the ATP-binding cassette transporter superfamily, which uses the energy of ATP hydrolysis to extrude compounds across a lipid membrane (hence named permeability glycoprotein, P-gp).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> This was a ground breaking discovery, providing a rationale for a frequently observed cancer treatment failure due to resistance to multiple chemotherapeutics. Years later, P-gp was found in the brain, expressed at high levels at the luminal face (blood-side) of the brain vascular endothelium, in addition to the endothelial cells of the choroid plexus, where it facilitates transport toward the CSF.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> In fact, P-gp has been found widely expressed in a variety of tissues, including the intestine, liver, kidney, testis, and placenta.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Interestingly, CNS drugs were found to have a significantly lower incidence of P-gp-mediated efflux than non-CNS drugs, suggesting the greater importance of P-gp efflux for CNS therapeutics.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> This is probably because, in contrast to the intestine, drug plasma concentrations at the BBB can rarely reach P-gp saturation levels.</div><div class="NLM_p">In humans, P-gp is encoded by a single gene (MDR1), whereas in rodents, there are two genes, mdr1a and mdr1b. They are both expressed in brain; however, only mdr1a is found at the BBB, whereas mdr1b is expressed in brain parenchyma.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The significant species-dependent substrate recognition divergence is a relatively rare occurrence,<a onclick="showRef(event, 'ref54 ref59'); return false;" href="javascript:void(0);" class="ref ref54 ref59">(54, 59)</a> although compounds that exhibit difference between rodent and human efflux ratios have been observed.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> These observations are consistent with a relatively high primary sequence homology between human and rodent P-gp transporters, also shared with other species, e.g., there is 85–93% sequence homology among human, mouse, rat, dog, and rhesus monkey.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">The continuous research focus on P-gp is a reflection of its apparent role as the main BBB gatekeeper with the broadest substrate specificity. Its molecular recognition promiscuity is better understood since the recent publication of the mouse P-gp apo crystal structure at 3.8 Å resolution, along with two co-crystal structures with the enantiomers of a P-gp inhibitor, which revealed an internal cavity of ∼6000 Å<sup>3</sup> with a very large hydrophobic substrate binding site and two ATP-binding domains.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The crystal structures support a “hydrophobic vacuum cleaner”<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> model whereby the substrate partitioned from the outside of the cell into the membrane bilayer enters the P-gp binding pocket through an open portal at the level of the inner leaflet of the lipid bilayer. With the substrate in place, ATP binds to the two nucleotide binding domains, triggering a large conformational change that presents the substrate to the extracellular space while occluding the cytosolic side, thereby providing unidirectional transport to the outside. ATP hydrolysis and dissociation returns the protein to its inward facing conformation, ready for the next transport cycle. The proposed transport mechanism is also consistent with the observation that increasing passive permeability is often accompanied by a lower likelihood of P-gp efflux.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> It is possible that compounds that rapidly diffuse across the membrane could overwhelm the P-gp efflux process and, to some extent, escape into the cytosol. Therefore, increasing passive permeability can be seen as a potential strategy for addressing the risk of efflux by P-gp.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">Two decades after the discovery of P-gp, another member of the ATP-binding cassette transporter superfamily implicated in cancer multidrug resistance was identified, first in the multidrug-resistant human breast cancer cell line (hence the name breast cancer resistance protein, or BCRP)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and then found widely expressed in tissues including gastrointestinal tract, liver, and kidney, as well as the luminal membrane of the brain capillaries.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Studies using BCRP and the dual P-gp/BCRP knockout mouse point toward BCRP and P-gp having synergistic and potentially compensatory roles in brain exclusion of cancer drugs such as dasatanib<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and sunitinib.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> On the basis of the currently available structure–activity relationship, an amino-heteroraomatic motif is suggested to be an important substrate recognition element for BCRP.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> However, the relative contribution of BCRP to overall drug BBB efflux capacity, and its broader impact on brain exposure of therapeutic agents outside oncology, is still unclear.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> Other well-characterized members of the ABC transporter superfamily, such as multidrug resistant protein 1 (MRP1), MRP4, and MRP5, are also found to be expressed in brain endothelial capillary cells, albeit at lower levels than that of P-gp.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p">Similarly to P-gp, BCRP shares high sequence homology across species, e.g., there is 86% homology between human and rat transporters.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> However, recent quantitative proteomics studies uncovered a significant interspecies difference in the abundance of these two transporters at the BBB, with P-gp being more abundant at the rat and mouse BBB and BCRP being more abundant at the monkey and human BBB.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Consequently, the incorporation of transporter protein abundances into human brain <i>in vivo</i> PK modeling algorithms is considered to be essential for interspecies translational modeling of drugs that are substrates for these two transporters.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> This translational challenge, in addition to driving doses higher than necessary, is one of the reason for a general preference given by CNS drug discovery teams to the development of clinical candidates that are not substrates of active transport. Potential risk of drug–drug interactions (DDI) at the BBB has been another frequently raised concern about drugs that undergo P-gp and/or BCRP efflux,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> although the extent of this risk has been questioned recently. Following evaluation of clinical evidence, the International Transporter Consortium (ITC) concluded that, while increased CNS distribution of efflux transport substrates has been commonly observed in animal models, the overall risk of the BBB active transport-related DDI and consequent safety events is low in humans.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> This was rationalized by the inability of marketed drugs to achieve unbound systemic concentrations sufficient to elicit appreciable changes in CNS drug distribution. Only a few drugs (e.g., cyclosporine, quinine, and quinidine) were found to have potential for P-gp inhibition at therapeutic doses in humans, but, even so, the magnitude of the potential clinical effect would be low (≤2-fold increase in B/P ratio).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">The MDCK cell line is the most favored <i>in vitro</i> assay for assessing P-gp efflux and has provided a large amount of the data reported in the literature. The popularity of this cell line is related to its relatively low background expression of endogenous transporters and stable transfection with human MDR1 or rodent mdr1a transporter (MDR1-MDCK or Mdr1a-MDCK, respectively). The apparent permeability (<i>P</i><sub>app</sub>) for this cell line is determined in both directions, apical-to-basolateral (A–B) and basolateral-to-apical (B–A), to calculate the efflux ratio (ER) defined as the ratio of <i>P</i><sub>app(BA)</sub>/<i>P</i><sub>app(AB)</sub>. ER values greater than 3 are generally used to define P-gp substrates.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The <i>in vivo</i> effect of P-gp efflux can be evaluated using either mdr1a<sup>–/–</sup> knockout mice<a onclick="showRef(event, 'ref35 ref74'); return false;" href="javascript:void(0);" class="ref ref35 ref74">(35, 74)</a> or P-gp inhibitors to create chemical P-gp knockouts, which also enables studies in species beyond mice.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a></div><div class="NLM_p">While <i>in vitro</i> assays offer lower costs and higher throughput than <i>in vivo</i> studies, the complexity of bidirectional assays, such as MDR-1 MDCK, prevents screening a large number of compounds, which is often necessary during the early stages of drug discovery. Therefore, <i>in silico</i> tools can be useful for identifying potential issues related to P-gp efflux and prioritizing the design, synthesis, and testing of compounds. The availability of large <i>in vitro</i> data sets has enabled the development of numerous <i>in silico</i> approaches, ranging from simple rules based on physicochemical properties to more complex quantitative structure–activity relationship (QSAR) models. For example, an analysis of an internal MDR-1 MDCK data set of 2000 compounds at Eli Lilly found that molecules with a topological polar surface area (TPSA) < 60 Å<sup>2</sup> and calculated most-basic p<i>K</i><sub>a</sub> < 8.0 exhibited a much lower likelihood of being P-gp substrates (94%), whereas over 75% of P-gp substrates had TPSA > 60 Å<sup>2</sup> and a calculated p<i>K</i><sub>a</sub> > 8.0. The same data set was used to generate a QSAR model that exhibited a robust prediction profile, with positive prediction values (PPV) and negative prediction values (NPV) over 80%.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">These findings are consistent with a recently proposed rule of 4 that suggests that compounds with molecular weights < 400, total numbers of nitrogen and oxygen atoms < 4, and basic p<i>K</i><sub>a</sub> < 8 are unlikely to be P-gp substrates.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Although a number of CNS-active molecules exceed one of these criteria, the rule of 4 is a useful strategy that researchers can apply to reduce P-gp efflux. Indeed, lowering p<i>K</i><sub>a</sub> and reducing the number of heteroatoms, particularly hydrogen-bond donors (HBD), have proved to be effective medicinal chemistry approaches for reducing P-gp efflux, as will be exemplified below.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">In contrast to efflux, active uptake can have a positive effect on brain exposure, particularly for compounds with poor passive permeability, such as the previously mentioned gabapentin and <span class="smallcaps smallerCapital">l</span>-DOPA.<a onclick="showRef(event, 'ref34 ref79'); return false;" href="javascript:void(0);" class="ref ref34 ref79">(34, 79)</a> However, in such cases, understanding the transport mechanism and how that mechanism is influenced by the compound structure to inform the optimization process presents a significant challenge. Even if a project is successful in delivering a clinical candidate, concerns related to cross-species and interpatient variability are likely to be raised. For these reasons, the generally preferred optimization strategy for overcoming the poor permeability of small molecule drugs is by addressing inherent passive permeability rather than by exploiting active transport.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">3 Physicochemical Properties and Brain Exposure Relationships</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The landmark study by Lipinski et al.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> of the physicochemical properties associated with the oral bioavailability of drugs and advanced clinical candidates, codified in a simple mnemonic known as the rule of 5 (Ro5), was a major milestone in the evolution of medicinal chemistry from a largely trial-and-error effort to the modern scientific endeavor of today that is driven by robust prediction methods. Analogous to the now widely accepted Ro5 in the design of oral drugs, the physicochemical properties needed for brain penetration have been extensively studied by a number of researchers in the attempt to similarly define the characteristics of successful CNS drugs and drug candidates using a variety of approaches. To illustrate the evolution of scientific thought and the current state of the art in this field, a representative selection from this body of work reported in the literature is summarized in chronological order in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and discussed below in more detail.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Evolving CNS Property Space: Summary of Selected Literature Describing the Physicochemical Properties Required for Optimal Brain Exposure<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">data set</th><th class="colsep0 rowsep0" align="center">conclusions and recommendations</th><th class="colsep0 rowsep0" align="center">year, author(s), ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">P-gp ER for 2000 compounds from Eli Lilly collection</td><td class="colsep0 rowsep0">Compounds with TPSA < 60 Å<sup>2</sup> and p<i>K</i><sub>a</sub> < 8 are less likely to be P-gp substrates.</td><td class="colsep0 rowsep0">2013, Desai et al.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Medicinal chemistry literature review</td><td class="colsep0 rowsep0">General guidelines for minimizing P-gp recognition include HBD count < 2 and the TPSA < 90 Å<sup>2</sup> (preferably <70 Å<sup>2</sup>).</td><td class="colsep0 rowsep0">2012, Hitchcock<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">317 CNS and 626 non-CNS oral drugs</td><td class="colsep0 rowsep0">CNS drug design property profile guidelines: TPSA < 76 Å<sup>2</sup> (25–60 Å<sup>2</sup>); at least one N atom; <7 (2–4) linear chains outside of rings; <3 (0–1) HBD; 740–970 Å<sup>3</sup> volume; solvent accessible surface of 460–580 Å<sup>2</sup>.</td><td class="colsep0 rowsep0">2011, Ghose et al.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">119 marketed CNS drugs and 108 Pfizer CNS clinical candidates</td><td class="colsep0 rowsep0">Median values for marketed CNS drugs: MW 305.3 Da; cLogP 2.8; cLogD 1.7; MW 305.3; PSA 44.8 Å<sup>2</sup>; HBD = 1; and p<i>K</i><sub>a</sub> 8.4.</td><td class="colsep0 rowsep0">2010, Wager et al.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">9571 Caco-2 measurements</td><td class="colsep0 rowsep0">Passive permeability is influenced by both MW and LogD: guidelines to achieve >50% chance of high permeability for a given MW: for MW 300–350, AZLogD > 1.1; for MW 350–400, AZLogD > 1.7; for MW 400–450, AZLogD > 3.1; for MW 450–500, AZLogD > 3.4.</td><td class="colsep0 rowsep0">2009, Waring<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">3059 rat CNS LogBB; 1975 P-gp ER; 50 641 PAMPA <i>P</i><sub>app</sub>; and 986 brain tissue binding measurements</td><td class="colsep0 rowsep0">↑ cLogP leads to ↑ brain tissue binding. ↑ cLogP leads to ↑ LogBB.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> For basic, acidic, and zwitterionic molecules, ↑ clogP leads to ↑ permeability. Suggested optimal cLogP is <3. ↑ MW leads to ↓ <i>P</i><sub>app</sub>, ↑ ER, and ↓ LogBB<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> and ↑ brain tissue binding.</td><td class="colsep0 rowsep0">2008, Gleeson<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Mouse <i>C</i><sub>u,b</sub> data for 1000 compounds from Eli Lilly collection</td><td class="colsep0 rowsep0">Compounds with cLogP < 4 and TPSA 40–80 Å<sup>2</sup> are more likely to achieve higher <i>C</i><sub>u,b</sub>.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0">2006, Raub et al.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Medicinal chemistry literature review</td><td class="colsep0 rowsep0">Suggested physicochemical property ranges for increasing the potential for BBB penetration: PSA < 90 Å<sup>2</sup>; HBD < 3; cLogP 2–5; cLogD (pH 7.4) 2–5; MW < 500.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0">2006, Hitchcock and Pennington<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Marketed CNS drugs</td><td class="colsep0 rowsep0">Attributes of a successful CNS drug candidate: MW < 450; cLogP < 5; HBD < 3; HBA < 7; RB < 8; H-bonds < 8; p<i>K</i><sub>a</sub> 7.5–10.5; PSA < 60–70 Å<sup>2</sup>.</td><td class="colsep0 rowsep0">2005, Pajouhesh and Lenz<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">329 launched oral drugs from the period 1983–2002</td><td class="colsep0 rowsep0">CNS drugs have significantly different properties relative to non-CNS drugs. CNS drug properties (mean/median): MW (310/307); O + N (4.32/4); HBA (2.12/2); RB (4.7/4.5).</td><td class="colsep0 rowsep0">2004, Leeson and Davis<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">1000 P-gp measurements</td><td class="colsep0 rowsep0">Proposed cut-offs to avoid P-gp efflux liability: MW < 400; N + O < 4; p<i>K</i><sub>a</sub> < 8.</td><td class="colsep0 rowsep0">2003, Petrauskas et al.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Literature review</td><td class="colsep0 rowsep0">Rule of thumb for brain uptake: compound with O + N < 5 (∼70 Å<sup>2</sup>), or cLogP – (O + N) > 0 has a better chance of brain penetration.<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0">2002, Norinder and Haeberlein<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">48 CNS and 45 non-CNS drugs</td><td class="colsep0 rowsep0">Physicochemical properties of non-CNS drugs differ significantly from CNS drugs, which have ↑ cLogP (CNS mean 3.43); ↑ cLogD (CNS mean 2.08); ↓ HBD (CNS mean 0.67); ↓ PSA (CNS mean 40.5 Å<sup>2</sup>).</td><td class="colsep0 rowsep0">2002, Polli et al.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">776 CNS and 1590 non-CNS oral drugs that reached at least Phase II</td><td class="colsep0 rowsep0">Upper PSA limit for the most of CNS drugs is <60–70 Å<sup>2</sup>; oral drugs do not exceed PSA of 120 Å<sup>2</sup>.</td><td class="colsep0 rowsep0">1999, Kelder et al.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">125 CNS and non-CNS drugs</td><td class="colsep0 rowsep0">PSA can be used as a drugs H-bond capacity descriptor. Improved chance of CNS penetration if MW <450; PSA <90 Å<sup>2</sup>, and LogD 1–4.</td><td class="colsep0 rowsep0">1998, Van der Waterbeemd et al.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Young’s data set</td><td class="colsep0 rowsep0">LogBB<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> can be predicted using LogP alkane/water and calculated molar volume or PSA.</td><td class="colsep0 rowsep0">1992, Van der Waterbeemd and Kansy<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">20 CNS penetrant histamine H<sub>2</sub> antagonists</td><td class="colsep0 rowsep0">LogBB<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> can be increased by ↑ lipophilicity (LogP) or/and reducing hydrogen-bonding capacity.</td><td class="colsep0 rowsep0">1988, Young et al.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">201 barbiturates with preclinical <i>in vivo</i> efficacy data</td><td class="colsep0 rowsep0">LogP is critical for <i>in vivo</i> activity. Found drug <i>in vivo</i> efficacy in a parabolic dependence on LogP. Suggested optimal LogP = 2.</td><td class="colsep0 rowsep0">1971, Hansch et al.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Based on drug unbound (free) blood/brain concentrations.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Based on drug total blood/brain concentrations; MW: molecular weight; PSA: polar surface area; TPSA: topological polar surface area; HBD: hydrogen-bond donors; HBA: hydrogen-bond acceptors; RB: rotatable bonds; ER: efflux ratio; ↑: increased; ↓: decreased.</p></div></div></div><div class="NLM_p">Inevitably, the data set choice greatly influences the conclusions drawn from these analyses, which has spawned much debate in the CNS medicinal chemistry community regarding the best methods for evaluating brain exposure. Many studies have been based on the physicochemical properties of marketed CNS drugs. Consequently, their conclusions reflect not only brain penetration but also the overall ADME and toxicological requirements for a successful CNS drug candidate.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Alternatively, researchers have analyzed large <i>in vitro</i> BBB permeation data sets (e.g., MDR1-MDCK, Caco-2, PAMPA) or <i>in vivo</i> measurements of brain penetration, such as total brain/plasma concentration ratios (<i>K</i><sub>p</sub> or Log BB). It is important to realize that the former approach provides information on the rate of permeation of the BBB, whereas the latter approach provides information on the extent of penetration, which was historically based primarily on the total drug concentration in the brain. Used in isolation, neither technique provides insight into the more relevant brain free drug concentration (<i>C</i><sub>u,b</sub>); therefore, the associated physicochemical guidelines should be interpreted with care.</div><div class="NLM_p">Understanding how physicochemical properties affect each of the parameters discussed above and how they influence each other enables the design of molecules with optimal CNS exposure. Several physicochemical properties have consistently been found to be important in the context of designing molecules for optimal brain exposure, including lipophilicity, as expressed by calculated logarithm of the octanol/water partition coefficient (cLogP) or calculated logarithm of the octanol/water partition coefficient at physiological pH 7.4 (cLogD), the number of hydrogen-bond donors (HBD) and acceptors (HBA), polar surface area (PSA), ionization state (p<i>K</i><sub>a</sub>), rotatable bond (RB) count, and molecular weight (MW).<a onclick="showRef(event, 'ref82 ref83 ref84 ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84 ref85 ref86 ref87">(82-87)</a></div><div class="NLM_p">One of the critical challenges for the medicinal chemist in drug discovery is balancing multiple physicochemical parameters with SAR to address deficits in one property without negatively affecting another. For example, increasing lipophilicity can improve BBB permeability, but it may also negatively impact blood clearance and increase nonspecific binding, leading to an overall reduction in <i>C</i><sub>u,b</sub>. To achieve an optimal balance, one should have a good understanding of how individual physicochemical properties may influence each other as well as the extent of CNS penetration and the rate of permeation. This Perspective presents a synopsis of recent studies published in the medicinal chemistry literature and attempts to capture the most prominent physicochemical guidelines that have been reported as useful aids for decision making during lead optimization. Key physicochemical properties are discussed sequentially, and their impact on CNS exposure is illustrated with literature examples. However, it should be noted that it is not possible to alter one parameter in isolation, which may confound the interpretation of the controlling factor mitigating CNS exposure. Therefore, the categorization applied here is best regarded as a mnemonic rather than as a rigorous classification.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.1 Lipophilicity</h3><div class="NLM_p">Lipophilicity is generally regarded to be one of the most important, if not the most important, physicochemical properties, which is critical to control for ultimate success in drug discovery and development. Increasing ligand lipophilicity often results in improved <i>in vitro</i> potency, which makes it a relatively straightforward and tempting optimization strategy. However, it is now widely accepted that increased lipophilicity is also accompanied by increased risk of poor solubility and metabolic stability, as well as a greater probability of nonspecific, off-target activities with related toxicological outcomes.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><div class="NLM_p">Lipophilicity was the first molecular descriptor to be identified as an important determinant of CNS exposure, including both the rate and extent of drug distribution into the brain. In the 1960s, Hansch et al.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> initiated the field of quantitative structure–activity relationships (QSAR) and, in their early work, demonstrated that the hypnotic activity of around 200 barbiturates depended almost entirely on their lipophilic character, as defined by their octanol–water partition coefficient (LogP).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> To minimize the metabolism and side effects, cLogP values of ∼2 were suggested to be the most optimal, although it was recognized that a higher lipohilicity may be required to achieve greater CNS efficacy. These observations were later supported by comparative studies of marketed CNS and non-CNS drugs reported by Van de Waterbeemd et al.,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> who also introduced a more physiologically relevant lipophilicity indicator: the pH-dependent octanol–water distribution coefficient (LogD). This analysis showed that a good correlation exists between LogD and brain exposure expressed by LogBB, and cLogD values in the range of 1–4 were proposed for optimal LogBB. In comparison, the median cLogD for marketed CNS drugs is 1.7.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p">Since both <i>in vitro</i> potency and total brain levels are driven mainly by lipophilicity, many CNS drug discovery programs have ended up on a “lipid escalator” with little prospect of success.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> As discussed earlier, the drug discovery reliance on LogBB (based on total brain and plasma concentrations) and its correlation with <i>in vivo</i> efficacy, as well as its general pharmacological relevance, have been questioned in recent years.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref22">(16-20, 22)</a> In contrast, a good correlation has been found between nonspecific brain tissue binding and cLogP in an analysis of over 3000 diverse compounds from GlaxoSmithKline.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> This finding suggests that the higher LogBB values observed for more lipophilic compounds are a consequence of increased nonspecific brain tissue binding, which is unlikely to translate into a therapeutic effect. Importantly, this study also uncovered a negative correlation between <i>f</i><sub>u,b</sub> and LogP, which suggests that reducing lipophilicity would be an effective strategy for improving free drug concentrations in the brain and achieving the desired therapeutic profile.</div><div class="NLM_p">This strategy was adopted by Johnson et al. in their efforts to identify selective muscarinic M<sub>1</sub> agonists for the treatment of the cognitive deficits associated with schizophrenia and Alzheimer’s disease (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> During the course of the program, a potent and moderately lipophilic oxindole <b>3</b> was identified (cLogP = 3.5). Despite a high total B/P ratio (rat <i>K</i><sub>p</sub> = 5.7), its brain unbound drug concentration was very low (<i>C</i><sub>u,b</sub> = 2.5 nM), a consequence of higher brain tissue vs plasma protein binding (<i>f</i><sub>u,b</sub> = 6% vs <i>f</i><sub>u,p</sub> = 20%) and high plasma clearance (Cl = 85 mL/min/kg).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. M1 Agonists: Reducing Lipophilicity To Improve <i>C</i><sub>u,b</sub><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0006.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">M<sub>1</sub></th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">Cl<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p</sub></th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u,b</sub></th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u,p</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>u,b</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>u,p</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p,uu</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(mL/min/kg)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(%)</th><th class="colsep0 rowsep0" align="center">(%)</th><th class="colsep0 rowsep0" align="center">(nM)</th><th class="colsep0 rowsep0" align="center">(nM)</th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">168</td><td class="colsep0 rowsep0" align="left">378</td><td class="colsep0 rowsep0" align="left">0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">261</td><td class="colsep0 rowsep0" align="left">265</td><td class="colsep0 rowsep0" align="left">0.98</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">3 mg/kg p.o. (rat).</p></div></div></div><div class="NLM_p">To improve metabolic stability and <i>C</i><sub>u,b</sub>, a series of analogues with reduced lipophilicity was synthesized, which led to the discovery of benzoxazolinone <b>4</b> (cLogP = 1.5). Despite the reduced <i>K</i><sub>p</sub> compared with that of the parent compound <b>3</b> (0.8 vs 5.7, respectively), <b>4</b> displayed a much improved brain free concentration (<i>C</i><sub>u,b</sub> = 168 vs 2.5 nM for <b>3</b>), presumably a result of combined improvements in metabolic stability (Cl = 11 mL/min/kg) and brain free fraction (<i>f</i><sub>u,b</sub> = 36%). However, an over 2-fold difference between the <i>C</i><sub>u,b</sub> and <i>C</i><sub>u,p</sub> values (<i>K</i><sub>p,uu</sub> = 0.44) suggested that <b>4</b> undergoes active efflux, possibly by P-gp, which prevented its further progression. This result led the authors to target additional analogues with a cLogP at ∼1.5 but reduced H-bond acceptor capacity, which was thought to be associated with P-gp recognition. This strategy resulted in the identification of nitrile analogue <b>5</b> (cLogP = 1.5), which, as a P-gp nonsubstrate (<i>K</i><sub>p,uu</sub> = 0.98), achieved an almost 2-fold higher <i>C</i><sub>u,b</sub> compared with that of <b>4</b> (261 and 168 nM, respectively), despite of its slightly higher clearance in rat (Cl = 23 mL/min/kg). Compound <b>5</b> was examined further in PD studies and exhibited a robust pro-cognitive effect in preclinical models at a 1 mg/kg dose.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><div class="NLM_p">The optimization of a series of neurokinin-3 (NK<sub>3</sub>) receptor antagonists reported by Smith et al. at GlaxoSmithKline is another example that highlights the importance of controlling lipophilicity and looking beyond total brain levels to successfully prosecute CNS optimization programs (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Following the first round of optimization of a lead quinolone series, the authors selected two analogues, <b>6</b> and <b>7</b>, to examine further in an <i>ex vivo</i> NK<sub>3</sub> receptor occupancy study in gerbils, which was selected as a suitable species due to its close receptor homology to the human NK<sub>3</sub>. <i>Ex vivo</i> receptor occupancy (RO) was determined using a homogenate binding technique and the cortical tissue harvested following a 1 h pretreatment time. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, despite the higher whole brain exposure observed for compound <b>6</b>, its receptor occupancy at 30 mg/kg i.p. was similar to the occupancy observed for compound <b>7</b> at 10 mg/kg p.o. Equilibrium dialysis measurements of the brain tissue binding revealed a ∼5-fold lower unbound fraction for <b>6</b> (cLogP = 6.8) compared with that of the less lipophilic analogue <b>7</b> (cLogP = 4.5). This difference, together with the slightly higher affinity of <b>7</b> for the NK<sub>3</sub> receptor, offsets the over 40-fold lower total brain concentration of <b>7</b> compared with that of <b>6</b> (118 nM vs 5011 nM), which results in RO levels that predict equivalent efficacy <i>in vivo</i>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. NK<sub>3</sub> Antagonists: Total Brain Concentration (<i>C</i><sub>b</sub>) Does Not Correlate with Measured Receptor Occupancy (RO)<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0007.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">hNK<sub>3</sub></th><th class="colsep0 rowsep0" align="center">dose<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b</sub></th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u,b</sub></th><th class="colsep0 rowsep0" align="center">RO<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(pKi)</th><th class="colsep0 rowsep0" align="center">(route)</th><th class="colsep0 rowsep0" align="center">(nM)</th><th class="colsep0 rowsep0" align="center">(%)</th><th class="colsep0 rowsep0" align="center">(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left">30 (ip)</td><td class="colsep0 rowsep0" align="left">5011</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">10 (po)</td><td class="colsep0 rowsep0" align="left">118</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">61</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Gerbil.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">RO (%) obtained from brain homogenate binding experiment (gerbil).</p></div></div></div><div class="NLM_p">In addition to the extent of drug distribution into the brain, as discussed above, lipophilicity also affects the rate of drug distribution into the brain (BBB permeation). For example, an analysis of over 50 000 data points from a PAMPA assay at GlaxoSmithKline showed that increased LogP is associated with increased passive permeability of molecules containing ionizable groups, such as acidic, basic, or zwitterion groups. Interestingly, no such linear correlation was observed for neutral molecules.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Consistent with these findings, Waring’s analysis of a large Caco-2 data set at AstraZeneca indicated that LogD is a better permeability predictor than LogP.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> He also demonstrated that, in addition to LogD, molecular size also must be considered. As MW increases, LogD must also increase to maintain a 50% probability of high permeability. For instance, a 300–350 Da compound requires a cLogD > 1.1, but a 450–500 Da compound requires a cLogD > 3.4.<a onclick="showRef(event, 'ref84 ref98'); return false;" href="javascript:void(0);" class="ref ref84 ref98">(84, 98)</a></div><div class="NLM_p last">Because permeability is a principal prerequisite for CNS penetration, it is tempting to optimize compounds for a very high permeability using the rapid <i>in vitro</i> screens described above. However, if offset by other parameters (e.g., no active efflux, low plasma clearance, or high <i>f</i><sub>u,b</sub>), even low-to-moderate permeability may suffice. Therefore, optimization efforts should focus on improving <i>K</i><sub>p,uu</sub> and <i>C</i><sub>u,b</sub> since these two parameters have a much greater impact on the desired pharmacological efficacy.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The significance of <i>K</i><sub>p,uu</sub> is well-reflected by the fact that among CNS-active drugs it varies by a factor of up to 150-fold, whereas the range for log B/P ratios (<i>K</i><sub>p</sub>) differs by up to 2000-fold, and for BBB permeability, it spans an even larger range of up to 20 000-fold differences.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> High permeability is more critical for acute treatments that need fast-acting drugs, e.g., anesthetics or analgesics for acute pain. It is of lesser importance for chronic administration schedules, where even poor permeants can elicit significant pharmacological effects, as seen for morphine-6-glucuronide <b>2</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.2 Hydrogen Bonding</h3><div class="NLM_p">In the context of CNS drug design, H-bonding capacity is probably the most critical physicochemical property due to its effect on a multitude of properties related to brain exposure. Studies using artificial membranes (PAMPA) suggest that increased H-bonding potential is associated with lower passive permeability.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This is related to the desolvation of the associated hydrogen-bound water molecules that is required for membrane permeability as well as lipid solubility. This effect is often further exaggerated in biological membranes, where an increased H-bonding potential also increases the risk of P-gp recogition.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In addition to the rate of permeation, the extent of unbound brain exposure has also been found to be dominated by H-bonding capacity, e.g., removal of two HBAs can lead to a 2-fold increase in <i>K</i><sub>p,uu</sub>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> These findings are consistent with molecular property analyses showing that CNS drugs have significantly lower numbers of H-bond donors (HBD)<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and H-bond acceptors (HBA)<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> compared with that of non-CNS drugs. Consequently, the reduction of H-bond donors and acceptors is often a successful strategy for optimizing the targeting of the CNS. Pajouhesh and Lenz proposed the following frequently quoted guidelines for successful CNS drug candidates: H-bond donors < 3, H-bond acceptors < 7, and total H-bonds < 8.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p">In many cases, a simple HBD/HBA count could be used to successfully differentiate chemotypes for the relative likelihood of P-gp recognition. However, because not all HBDs and HBAs are equal in terms of the strength of the H-bond they that they can form,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> incorporating relative H-bond strength into molecular design can be an effective strategy to reduce P-gp efflux. According to a global model based on Abraham’s HBD and HBA strength parameters, α and β, respectively,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> compounds with β < 1.7, MW < 400, and the most basic p<i>K</i><sub>a</sub> < 8 are likely to be nonsubstrates.<a onclick="showRef(event, 'ref62 ref78'); return false;" href="javascript:void(0);" class="ref ref62 ref78">(62, 78)</a> For example, a set of B<sub>1</sub> receptor (BK<sub>1</sub>R) antagonists reported by Kuduk et al.,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> which differ only in the substitution at the terminal amide group, were found to have similar BK<sub>1</sub>R potencies and the same HBD/HBA count and acceptable passive permeability while exhibiting a range of ERs (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. B<sub>1</sub>R Antagonists: Lowering HBA Strength To Reduce P-gp ER<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0008.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">B<sub>1</sub>R</th><th class="colsep0 rowsep0" align="center">HBA<sup>(O atom)</sup></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">ER</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">strength<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">(nm/sec)</th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">2.12</td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="left">8.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">–CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">1.63</td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">–CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.39</td><td class="colsep0 rowsep0" align="left">280</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">–CF<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.35</td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">1.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Desai et al.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">MDR1-MDCK: passive apparent permeability coefficient with P-gp inhibited.</p></div></div></div><div class="NLM_p">Clearly, the effect of a fluorine substitution in BK<sub>1</sub>R on the ER could not be explained by HBD/HBA count or PSA because these values are the same for all analogues. There is also very little difference in their permeabilities, <i>P</i><sub>app</sub> 210–310 nm/s. To explain the observed difference in ER, the authors proposed that the strong electron-withdrawing effect of fluorine substitution makes the amide carbonyl group a poorer HBA with consequently reduced P-gp recognition.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> This hypothesis has been supported by a quantum mechanical HBD/HBA strength calculation reported by Desai et al.,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> which found that the HBA strength of the terminal amide carbonyl group dropped approximately 10-fold, from 2.1 to 1.3 (the values are in log scale), as the number of fluorine molecules increased across compounds <b>8</b>–<b>11</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_p">A reduction in HBD capacity is one of the most frequently reported medicinal chemistry strategies for improving brain exposure. For example, this strategy was employed by Hu and colleagues at Amgen while optimizing the CNS exposure of a benzimidazole series of PDE10A inhibitors that they were developing for the treatment of schizophrenia (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PDE10A Inhibitors: Reducing HBD Capacity To Improve Brain Exposure<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0009.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">PDE10A</th><th class="colsep0 rowsep0" align="center">HBD</th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Cl<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">F<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">RO<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(L/h/kg)</th><th class="colsep0 rowsep0" align="center">(%)</th><th class="colsep0 rowsep0" align="center">(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">76.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">11.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">21.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.07</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">57.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">MDR1-MDCK.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Fed male Sprague–Dawley rats; dose: 5 mg/kg p.o.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Dose: 10 mg/kg.</p></div></div></div><div class="NLM_p">One of the initial leads in the program was compound <b>12</b>, a potent and selective PDE10A inhibitor (IC<sub>50</sub> = 92 nM), which was also a strong P-gp substrate with an efflux ratio (ER) in the MDR1-MDCK assay of 76.7. Early SAR investigations indicated that the piperidine alcohol moiety in <b>12</b> is not critical for potency and can be replaced by groups lacking HBDs. In fact, a morpholine analogue, <b>13</b>, displayed almost 2 orders of magnitude higher potency (IC<sub>50</sub> = 1.1 nM) with one HBD less than <b>12</b> and with a reduced ER of 11.1. Encouraged by these initial results, the authors further pursued the HBD-reduction strategy, which led to the identification of benzothiazole <b>14</b>, a slightly less potent PDE10A inhibitor (IC<sub>50</sub> = 4.3 nM), but with the P-gp efflux reduced to an acceptable 2.4 ER. Because a co-crystal structure of the HTS hit (<b>12</b>) bound to PDE10A suggested that the NH linker was not essential, the authors decided to replace it with a carbonyl group to further reduce the HBD count while maintaining the observed planarity of the phenyl and the benzimidazole rings. The resulting keto analogue <b>15</b> not only retained the low nanomolar PDE10A potency but also exhibited a low efflux ratio of 0.9. The modest target engagement achieved by this compound at 10 mg/kg (RO = 21%) and 30 mg/kg (RO = 55%) in rats (p.o.) was attributed to its poor systemic exposure, which was related to the oxidative metabolism of the morpholine ring. Optimization around that region of the molecule led to the identification of piperazine analogue <b>16</b>, which had a superior ADME profile and 57% RO at 10 mg/kg (p.o.).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_p">A slightly greater impact on the ER of the carbonyl group in <b>15</b> compared with that of the benzothiazole in <b>14</b> could be rationalized by a masking effect of an intramolecular hydrogen bonding (IMHB) between the carbonyl group and the last remaining HBD in <b>15</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Indeed, the introduction of an IMHB motif can be an attractive alternative to the complete removal of HBD. When a hydrogen-bond donor and acceptor are on the same molecule in close proximity, an equilibrium may exist between closed conformations where an intramolecular hydrogen bond is formed and open conformations where the polar groups are exposed to solvent.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The closed forms, masking the polarity from the environment, are likely to be more lipophilic and may consequently display higher membrane permeability, whereas the open forms are more water-soluble.</div><div class="NLM_p">The incorporation or reposition of an existing HBA in a molecule to enable intramolecular H-bond formation is a widely employed property optimization strategy, particularly when the HBD is required for target activity.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> By practically removing polar HBD and HBA groups from the molecular environment, the formation of an IMHB can result in increased lipophilicity, which, in turn, may improve passive permeability as well as impair P-gp recognition, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Intramolecular H-Bond (IMHB) Improves <i>P</i><sub>app</sub> and ER<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0010.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">HBD</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">2<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">177</td><td class="colsep0 rowsep0" align="left">1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Includes one intramolecular H-bond.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Apparent AB permeability in the MDR1-MDCK assay.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">BA/AB permeability ratio in the MDR1-MDCK assay.</p></div></div></div><div class="NLM_p">One important consideration when designing an IMHB is the equilibrium between the open (polar) conformations and the closed (nonpolar) conformation, which is needed to achieve optimally balanced molecular solubility and permeability properties. For example, to improve aqueous solubility, one could consider introducing steric constraints or altering ring size in the closed form to shift the equilibrium toward the open, more water-soluble conformation. An elegant analysis of the Cambridge Structural Database (CSD) and the Protein Data Bank (PDB) by Kuhn and co-workers suggested a relatively high propensity for intramolecular hydrogen bonds to form five- to eight-membered rings.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> By far the highest frequency motif was found to have planar, six-membered rings stabilized by conjugation with a π-system. A number of less explored topologies have also been identified, including weaker six-membered ring hydrogen bonds containing one sp<sup>3</sup> center and nonplanar seven- and eight-membered ring topologies.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">One of the first reported intentional uses of an IMHB designed to improve CNS exposure was in the optimization of a series of NK<sub>1</sub> receptor antagonists described by Ashwood et al.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The initial lead <b>19</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>) displayed a desired pharmacological profile with an oral bioavailability of 60% in dogs and a half-life of greater than 6 h; however, it also exhibited poor solubility (<2 mg/L) and a modest total brain–plasma ratio in rat (<i>K</i><sub>p</sub> = 0.6). The authors reasoned that the inclusion of an HBA at the amide alpha-carbon could potentially lead to the formation of an IMHB with one of the neighboring N–H’s from the urethane or amide groups. They hoped that the resulting compounds would display improved permeability due to the effective removal of an HBD and HBA in the IMHB as well as increased aqueous solubility. While the inclusion of an NMe<sub>2</sub> group in <b>20</b> did not affect NK<sub>1</sub> potency, it did produce a desirable profile with improved solubility and total brain exposure, despite reduced total plasma AUC, which ultimately resulted in a greatly improved <i>K</i><sub>p</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Since <i>K</i><sub>p,uu</sub> values were not reported, it is difficult to establish to what extent the improved total brain exposure of compound <b>20</b> was driven by the nonspecific tissue binding. However, a significantly higher efficacy of compound <b>20</b> in the centrally mediated gerbil foot tapping paradigm with minimum effective dose (MED) of 1 mg/kg is indicative of its superior free brain exposure when compared to that of parent compound <b>19</b> (MED = 30 mg/kg).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. NK<sub>1</sub> Receptor Antagonists: Rationally Designed IMHB To Improve Brain Exposure<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0011.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">NK<sub>1</sub></th><th class="colsep0 rowsep0" align="center">HBD</th><th class="colsep0 rowsep0" align="center">PSA</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–1h</sub><a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p</sub><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">MED<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(ng h/g)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">3<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Includes one IMHB.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Dose 0.5 mg/kg, i.v. (rat).</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last"><i>K</i><sub>p,uu</sub> values were not reported.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Substance P induced foot tapping in the gerbil.</p></div></div></div><div class="NLM_p">The enhanced efficacy of <b>20</b> was rationalized by a combination of improved solubility and reduced HBD count by IMHB. The presence of an IMHB between the NMe<sub>2</sub> and the amide hydrogen, forming a six-membered ring, has been substantiated by variable-temperature nuclear magnetic resonance (NMR) spectroscopy studies.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Although it is likely to be protonated at physiological pH conditions, the amine can pass through lipophilic cell membranes only in its unprotonated form, in which the observed IMHB would increase apparent molecular lipophilicity and consequently cell membrane permeability. A similar amide NH → N<sub>3</sub>R IMHB and its impact on molecular properties such as lipophilicity and permeability have been described more recently by Over and colleagues at AstraZeneca.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><div class="NLM_p">There is a scaffold-dependent limit to which molecular polarity can be increased with the addition of a polar HBA before showing a deleterious effect on membrane penetration, presumably due to a high water desolvation penalty. This issue could potentially be avoided by considering an intramolecular halogen bond, the existence of which has been supported by X-ray crystallography evidence.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Although considerably weaker than classical O···H and N···H H-bonds, an improved property profile has been associated with molecules containing an intramolecular halogen bond. This approach was effectively leveraged by researchers at Amgen in their efforts to decrease P-gp recognition in a hydroxyethylamine series of β-amyloid cleaving enzyme-1 (BACE-1) inhibitors represented by pyridine <b>21</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. BACE-1 Inhibitors: Introducing Intramolecular Halogen Bond To Mask a HBD and Reduce P-gp ER<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0012.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1</th><th class="colsep0 rowsep0" align="center">HBD</th><th class="colsep0 rowsep0" align="center">PSA</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">26.1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">96.4</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">48.4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">96.4</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">33.2</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">96.4</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">MDR1-MDCK cell line.</p></div></div></div><div class="NLM_p">BACE-1, an intensely pursued target in the quest for a disease-modifying treatment for Alzheimer’s disease, is an aspartic protease with a characteristically polar and relatively shallow substrate binding site.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Consequently, BACE-1 inhibitors are large molecules that are generally characterized by a high PSA and HBD/HBA count, which presents a considerable drug discovery challenge in terms of delivering potent inhibitors with optimal brain exposure capable of achieving the desired <i>in vivo</i> efficacy. Pyridine <b>21</b>, one of the early leads in Amgen’s BACE-1 effort, was prototypical; it displayed high <i>in vitro</i> potency (IC<sub>50</sub> = 26.1 nM) as well as moderate permeability and a very high efflux ratio of 49 in a human MDR1-MDCK assay. As discussed earlier, reducing the number of HBDs would be a sensible mitigation strategy for P-gp efflux, except that both the SAR and crystallographic data indicate that all three HBDs in <b>21</b> are critical for binding to BACE-1. In such situations, HBD masking should be considered, and when PSA is already high (as in this case), introduction of intramolecular hydrogen bonding may be the preferred option. Gratifyingly, the incorporation of a fluorine atom into position 2 of the pyridine ring to engage in halogen bonding and mask the amide N–H was successful; analogue <b>23</b> exhibited an ER that was an order of magnitude lower than that of the parent compound <b>21</b> (ER = 4 vs 49, respectively). Interestingly, 5<i>-</i>fluoropyridine derivative <b>22</b>, a regioisomer of <b>21</b> that lacks an appropriately positioned fluorine atom to mask the amide N–H, displayed a high potential for efflux (ER = 35). This finding supports the intramolecular halogen bond hypothesis as a rationale for the reduced efflux rate observed for compound <b>23</b>.</div><div class="NLM_p">Most commonly used computational methods for the calculation of physicochemical properties are independent of molecular conformation; consequently, they do not account for the potential existence of internal hydrogen bonds. Therefore, researchers should be cautious when relying only on calculated properties, such as cLogP and PSA. Significant discrepancies between the calculated and experimental properties for molecules with intramolecular hydrogen bonds could account for the unexpectedly good <i>in vivo</i> pharmacokinetics displayed by molecules that reside in the Beyond Rule of 5 (BRo5) property space.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><div class="NLM_p">To experimentally confirm the existence of intramolecular hydrogen bonds, <sup>1</sup>H NMR temperature dependency in lipophilic solvents, such as deuterated chloroform or toluene, is often employed. An exchangeable proton that is involved in a hydrogen-bond interaction is more deshielded (higher δ chemical shift value) than a similar, exchangeable proton that is not hydrogen bonded.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The temperature coefficient (TC) value determined in these experiments corresponds to the slope of the line obtained by plotting the chemical shift versus the temperature of the experiment; this value is generally negative, and compounds containing intramolecular hydrogen bonds exhibit a less negative TC than compounds unable to form an IMHB.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p last">Shalaeva et al.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> described an experimental method to characterize the intramolecular hydrogen-bond capacity using ΔlogP, which is defined as the difference in a compound’s distribution between a protic (octanol) and an aprotic (toluene) solvent. A potential advantage of the ΔlogP over the NMR method is that it uses a physiologically more relevant environment that is conducive to IMHB formation. However, similar to the NMR method, the ΔlogP technique is low-throughput and too laborious for a more extensive evaluation of the impact of intramolecular hydrogen bonds during the early stages of the drug discovery process. Recently, several high-throughput methods for intramolecular hydrogen-bond detection have been reported, including chromatographic methods such as supercritical fluid chromatography, as described by Goetz et al.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> This technique correlates chromatographic retention with the exposed polarity of a molecule; molecules that can form an intramolecular hydrogen bond can hide their polarity and therefore exhibit lower retention than structurally similar compounds that cannot form an intramolecular hydrogen bond.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">3.3 Polar Surface Area</h3><div class="NLM_p">The polar surface area (PSA) of a molecule is generally defined as the surface area (Å<sup>2</sup>) over all polar atoms, primarily oxygen and nitrogen, including their attached hydrogens. There are at least three different calculation approaches, each producing considerably different results. The most commonly reported method is the topological polar surface area (TPSA), which is the simplest and therefore the fastest calculation method derived from the 2D atomic connectivity and is independent of molecular conformation. The TPSA is often calculated by the atom-based method, which correlates closely with the total hydrogen-bond count, the sum of hydrogen-bond donors and acceptors.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> A more complex PSA method accounts for the PSA dependence on the conformation and is based on the molecular van der Waals surface of a three-dimensional (3D) conformation. In a simpler version, the method utilizes a single low-energy conformer of the molecule to calculate the PSA, whereas a more sophisticated dynamic PSA calculation includes the Boltzmann weighted average of all conformers within 2.5 kcal mol<sup>–1</sup> of the lowest energy conformer found during a conformational search.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Yet another method calculates the solvent accessible surface area (SASA) by enclosing the water dimension radius of 1.4 Å over a 3D conformation to estimate the polar surface area.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div><div class="NLM_p">Often described as a surrogate measure of hydrogen-bonding capacity and molecular polarity, the PSA is a commonly used metric during the optimization of a drug’s ability to permeate cell membranes. Molecules with a PSA > 140 Å<sup>2</sup> generally have poor gut permeability, leading to low oral bioavailability.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> However, reflecting the differences in the gut and BBB permeability as well as plasma and brain tissue binding, PSA values for CNS penetrant compounds tend to be considerably lower. A comparative analysis of marketed CNS and non-CNS drug properties led van de Waterbeemd et al. to propose PSA < 90 Å<sup>2</sup> as a cutoff for optimal CNS exposure.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> On the basis of a similar analysis of a different data set, Kelder et al. suggested an even more stringent cutoff of <60–70 Å<sup>2</sup>.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p">The optimization efforts around a series of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors described by researchers at AstraZeneca provide a good illustration of the impact of the PSA on brain exposure.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> One of early leads in this series, thiazole <b>24</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>), displayed moderate <i>in vitro</i> potency (h11β-HSD1 IC<sub>50</sub> = 69 nM) and favorable physicochemical properties (e.g., PSA = 61 Å<sup>2</sup>; LogD<sub>7.4</sub> = 2.0), which were translated into modest oral bioavailability and high CNS penetration in rat (F = 12%; <i>K</i><sub>p,uu</sub> = 0.9). Further optimization efforts led to the discovery of tetrahydrofuryl analogues such as <b>25</b> and <b>26</b> with improved <i>in vitro</i> potency and rat pharmacokinetic properties when compared to those of lead compound <b>24</b>. However, these improvements came at the price of increased PSA, which ultimately impacted the compounds’ CNS penetration. Compound <b>25</b> with PSA of 84 Å<sup>2</sup> showed <i>K</i><sub>p,uu</sub> of 0.7, whereas <b>26</b> with PSA = 93 Å had <i>K</i><sub>p,uu</sub> further reduced to 0.4. This trend continued with sulfone analogue <b>27</b> (PSA = 111 Å<sup>2</sup>), which maintained good oral bioavailability (F = 65%) but had brain exposure at the very limits of analytical detection, with <i>K</i><sub>p,uu</sub> value estimated to be as low as 0.03.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. 11β-HSD1 Inhibitors: Increasing PSA Leads to Reduced <i>K</i><sub>p,uu</sub> Values<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0013.gif" alt="" id="fx9" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">h11β-HSD1</th><th class="colsep0 rowsep0" align="center">PSA</th><th class="colsep0 rowsep0" align="center">LogD<sub>7.4</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p,uu</sub><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">F<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">(Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">MeO–</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">cPr(1-CN)CH<sub>2</sub>O–</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">93</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">486</td><td class="colsep0 rowsep0" align="left">111</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">65</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">Oral bioavailability in male Han Wistar rat at 1 h, 30 mg/kg.</p></div></div></div><div class="NLM_p">Interestingly, despite the reduced CNS penetration, compound <b>26</b> (<i>K</i><sub>p,uu</sub> = 0.4) achieved a free brain concentration 20-fold over its IC<sub>50</sub> at a relatively low dose of 20 mg/kg (p.o.). Because it exhibited the most balanced oral bioavailability and brain exposure in the series, compound <b>26</b> was progressed further into preclinical target validation studies to assess the impact of 11β-HSD1 inhibition on body weight and glucose levels in rat.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><div class="NLM_p">Another example illustrating the influence of PSA on CNS exposure is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>. Again, the observed poor CNS properties of lead molecule <b>28</b> (ER = 5.8; <i>K</i><sub>p</sub> = 0.1) from an Indane series of <i>R</i>-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid (AMPA) receptor potentiators were attributed to the compound’s high PSA (109.1 Å<sup>2</sup>), a consequence of containing two sulphonamide groups.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Because modifications to the Indane sulphonamide were not tolerated, the PSA optimization efforts were focused on finding alternatives to the less restrictive phenyl sulphonamide moiety. One of the earlier analogues resulting from this study was <i>N</i>-methylated analogue <b>29</b>, which, consistent with a reduced HBD count, had a lower ER and improved brain exposure (ER = 3.2 and <i>K</i><sub>p</sub> = 0.4).</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. AMPA Positive Allosteric Modulators: Reducing PSA To Improve Brain Exposure<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0014.gif" alt="" id="fx10" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">AMPA<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">PSA</th><th class="colsep0 rowsep0" align="center">HBD</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p</sub><a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">(Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">109.1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">100.3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">67.4</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last">FLIPR-based hGluA<sub>2</sub> flip isoform assay.</p></div><div class="footnote" id="t11fn2"><sup>b</sup><p class="last">Efflux ratio in the MDR1-MDCK.</p></div><div class="footnote" id="t11fn3"><sup>c</sup><p class="last">Brain–blood AUC<sub>0–<i>t</i></sub> ratio (rat).</p></div></div></div><div class="NLM_p last">Seeking further improvements, the authors explored a range of PSA-lowering heterocyclic replacements. This investigation led to the discovery of pyridine analogue <b>30</b>, which retained the AMPA potency and cLogP of the parent bis-sulphonamide but significantly reduced the PSA to 67.4 Å<sup>2</sup> compared with 109.1 Å<sup>2</sup> for <b>28</b>. Accordingly, compound <b>30</b> was not a P-gp substrate (ER = 1.1) and exhibited good passive permeability and good brain exposure (<i>K</i><sub>p</sub> = 2.1). On the basis of its favorable overall PK and PD properties, including its efficacy and safety margin in preclinical models, <b>30</b> advanced to clinical development for the treatment of cognitive impairment in schizophrenia.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">3.4 p<i>K</i><sub>a</sub> and Ionization State</h3><div class="NLM_p">The majority of CNS drugs contain a basic center. Wager at al. found that a median p<i>K</i><sub>a</sub> value for marketed CNS drugs and Pfizer CNS clinical candidates was 8.4.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> There are two schools of thought as to whether this fact reflects an inherent benefit of compound basicity for brain exposure or is merely due to bias in the data set resulting from the fact that many currently prescribed CNS drugs target monoamine receptors or transporters, which ligand pharmacophores contain basic centers. Pajouhesh and Lenz proposed that the optimal p<i>K</i><sub>a</sub> range for CNS drugs is 7.5–10.5.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Although the lower limit of this range would currently be considered overly conservative, the upper limit is consistent with more recent analyses of P-gp substrate liability (<i>vide infra</i>).<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> In a review of P-gp data for 1000 compounds, Petrauskas proposed a cutoff of p<i>K</i><sub>a</sub> < 8 for compounds designed to avoid possible P-gp interactions.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Controlling p<i>K</i><sub>a</sub> was an approach adopted by McDonald et al. at Bristol-Myers Squibb to improve CNS penetration in a quinolone series of α7 nicotinic acetylcholine receptors (nAChR) agonists that they were developing as a potential treatment for the cognitive deficits associated with schizophrenia.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> One of their early leads, quinuclidine <b>31</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>), exhibited very poor brain penetration in rats (<i>K</i><sub>p</sub> < 0.002), despite its good permeability as measured in a PAMPA assay (<i>P</i><sub>app</sub> = 900 nm/s). Follow-up experiments revealed that all of the tested quinuclidine analogues in this series exhibited very high efflux ratios in a bidirectional Caco-2 assay, suggesting transporter-mediated efflux.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. α7 nAChR Agonists: Controlling p<i>K</i><sub>a</sub> To Improve Permeability<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0015.gif" alt="" id="fx11" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">α7 nAChR</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub></th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub><a class="ref internalNav" href="#t12fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p</sub><a class="ref internalNav" href="#t12fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> μM</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(nm/s)</th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">10.1</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">900</td><td class="colsep0 rowsep0" align="left"><0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">5.80</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">380</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">8.1</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">550</td><td class="colsep0 rowsep0" align="left">0.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup>a</sup><p class="last">Caco-2 <i>P</i><sub>app(BA)</sub>/<i>P</i><sub>app(AB)</sub>.</p></div><div class="footnote" id="t12fn2"><sup>b</sup><p class="last">PAMPA, pH 7.4.</p></div><div class="footnote" id="t12fn3"><sup>c</sup><p class="last">Rat, 30 min.</p></div></div></div><div class="NLM_p">To test the hypothesis that the observed high ER was related to the quinuclidine high basicity (p<i>K</i><sub>a</sub> = 10.1), the authors explored a series of quinolone analogues containing amine groups with reduced p<i>K</i><sub>a</sub>, such as 4-fluoroquinuclidine <b>32</b> (p<i>K</i><sub>a</sub> = 7.6). Confirming the hypothesis, the less basic compound <b>32</b> displayed significantly reduced efflux (ER = 0.6), although the drop in basicity was also accompanied by a substantial loss in α7 activity (EC<sub>50</sub> = 5.8 μM). Gratifyingly, the slightly more basic morpholine analogue <b>33</b> (p<i>K</i><sub>a</sub> = 8.1) retained α7 potency (EC<sub>50</sub> = 260 nM) while displaying near unity ER in the Caco-2 assay, achieving a <i>K</i><sub>p</sub> value of 0.9 in rats at 10 mg/kg dose (no concomitant improvement in <i>C</i><sub>u,b</sub> was reported).<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><div class="NLM_p">A research group at Novartis employed a similar approach in their efforts to improve the CNS exposure in a series of BACE-1 inhibitors represented by macrocyclic ethanol amine <b>34</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> This initial lead compound was a potent and selective BACE-1 inhibitor; however, it also displayed poor permeability and high efflux in the MDR1-MDCK cell line (<i>P</i><sub>app</sub> = 1.4 × 10<sup>–6</sup> cm/s; ER = 23). The p<i>K</i><sub>a</sub>-lowering strategy adopted to address these issues required modifications around the ethanolamine group (p<i>K</i><sub>a</sub> = 8.5), a critical pharmacophoric element involved in a direct interaction with the catalytic aspartates in the enzyme binding site (Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a>).</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. BACE-1 Inhibitors: Reducing p<i>K</i><sub>a</sub> To Improve <i>P</i><sub>app</sub> and Brain Penetration<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0016.gif" alt="" id="fx12" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub><a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b</sub></th><th class="colsep0 rowsep0" align="center">Aβ40<a class="ref internalNav" href="#t13fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> nM</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(μM)</th><th class="colsep0 rowsep0" align="center">(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">72</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>a</sup><p class="last">MDR1-MDCK.</p></div><div class="footnote" id="t13fn2"><sup>b</sup><p class="last">APP51/16 tg mouse; dose: 60 μmol/kg.</p></div></div></div><div class="NLM_p">Indeed, insertion of small fluorinated alkyl groups such as CHF<sub>2</sub> and CF<sub>3</sub> into the benzylic position next to the amine resulted in improved passive permeability and reduced P-gp efflux (data not shown).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Unfortunately, these changes were also accompanied by a complete loss of activity, presumably due to the amine p<i>K</i><sub>a</sub> now being too low for a productive interaction with the catalytic aspartates. A search toward a more tempered p<i>K</i><sub>a</sub> effect led the authors to the design of cyclopropane analogue <b>35</b> (p<i>K</i><sub>a</sub> = 7.3), which displayed significantly improved passive permeability and reduced ER values (<i>P</i><sub>app</sub> = 4 × 10<sup>–6</sup> cm/s; ER = 3.5) while retaining high BACE-1 potency. Consequently, this compound showed higher concentrations in the brain (0.32 μM) and a significantly greater reduction in brain levels of Aβ40 (72%) when compared to that of parent benzylamine <b>34</b> (<i>C</i><sub>b</sub> = 0.04 μM; Aβ40 = 7%). Unfortunately, the introduction of the cyclopropyl group into the ethanolamine motif led to the loss of selectivity over the closely related aspartyl proteases cathepsin D and E, which prevented this series from progressing further.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p">Contrary to amines, carboxylic acids are generally associated with poor brain exposure due to a combination of multiple factors, including high plasma protein binding, poor passive permeability, and P-gp recognition.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This trend was first observed in studies related to terfenadine (<b>36</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), a first-generation antihistamine discontinued in 1997 due to instances of <i>torsades de pointes</i>, a polymorphic ventricular tachycardia that can persist and possibly degenerate into a life-threatening ventricular fibrillation.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Terfenadine and its main metabolite, fexofenadine.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cardiac arrhythmia was later associated with a block of a cardiac potassium channel, a product of the human ether-á-go-go related gene (hERG). It was subsequently found that its principle metabolite, carboxylate <b>37</b>, accounts not only for most of terfenadine’s therapeutic effect but also produced significantly less of the CNS side effects such as sedation as well as a greatly improved selectivity over hERG.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> On the basis of these findings, the metabolite was subsequently marketed as fexofenadine, the progenitor of the second generation antihistamines that are characterized by a lack of the central side effects intrinsic to the prior generation. The improved CNS side-effect profile of fexofenadine has been attributed to its low brain exposure. Terfenadine has a high passive permeability (<i>P</i><sub>app</sub> = 28.5 × 10<sup>–6</sup> cm/s) and does not exhibit markedly different brain uptakes in wild type and mdr1 KO mice. In contrast, zwitterionic fexofenadine has low passive permeability (<i>P</i><sub>app</sub> = 6.6 × 10<sup>–6</sup> cm/s) and <i>in vivo</i> efflux ratio of ∼50, as indicated by the mdr1 KO studies.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122, 123)</a></div><div class="NLM_p">Although zwitterions are generally associated with poor CNS exposure, examples of brain-penetrant zwitterionic molecules have been reported in the literature, such as a series of melanin-concentrating hormone receptor-1 (MCHR-1) antagonists described by Mihalic and colleagues at Amgen.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Progress in this intensely pursued research field toward the treatment of obesity and mood disorders has been severely hampered by an extensive MCHR-1 and hERG pharmacophore overlap and consequent cardiovascular risks.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Inevitably, achieving sufficient selectivity over hERG was one of the major challenges faced by the Amgen group, too. An initial lead in their series, compound <b>38</b>, was a potent MCHR-1 antagonist with good brain exposure and overall ADME profile and demonstrated efficacy in reducing food consumption in mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a>). However, this compound was subsequently found to be a potent hERG blocker, which ultimately prevented its further development. In order to address this issue, the authors considered incorporation of a carboxylic group into the molecule, a strategy commonly employed to improve selectivity over hERG ever since the terfenadine–fexofenadine example was reported.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. MCHR-1 Antagonists: Zwitterions Can Be Brain-Penetrant<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0017.gif" alt="" id="fx13" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MCHR-1</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Cl<a class="ref internalNav" href="#t14fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>CSF</sub>/<i>C</i><sub>p</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">(L/h/kg)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">0.55</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup>a</sup><p class="last">Rb<sup>+</sup> efflux.</p></div><div class="footnote" id="t14fn2"><sup>b</sup><p class="last">APP51/16 tg mouse; dose: 60 μmol/kg.</p></div></div></div><div class="NLM_p last">The hERG evolved, as a potassium cation channel, to stabilize positive charge within its central cavity, which not only may explain why many hERG blockers contain basic amine groups but also rationalize the fact that the presence of a functionality that is negatively charged at physiological pH, such as a carboxylic group, is often detrimental to hERG binding. Indeed, while the replacement of the tetrahydropyran in <b>38</b> with a cyclohexyl carboxyl group in <b>39</b> did not affect MCHR-1 potency, it resulted in the near complete elimination of hERG potency (IC<sub>50</sub> > 5 μM). Importantly, compound <b>39</b> (AMG 076) displayed sufficient CNS exposure (<i>C</i><sub>CSF</sub>/<i>C</i><sub>p</sub> = 0.21; 10 mg/kg, p.o.) to produce robust <i>in vivo</i> efficacy in mouse models of obesity (<i>C</i><sub>CSF</sub>/<i>C</i><sub>p</sub> = 0.21; 10 mg/kg, p.o.) and was advanced into the clinic.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> A similar zwitterion approach to improve general selectivity profile was successfully employed in the design of brain-penetrant dual H<sub>1</sub>/5-HT<sub>2A</sub> antagonists that advanced into the clinical development for the treatment of sleep disorders.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">3.5 Molecular Flexibility and Rotational Bonds</h3><div class="NLM_p">Veber and colleagues at GlaxoSmithKline highlighted the importance of molecular flexibility, as measured by the number of rotational bonds (RB), for predicting rat oral bioavailability and permeation rates in an artificial membrane permeation assay.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> They showed that increased molecular flexibility exerted a negative effect on passive permeation. Consistent with the supposition that such effects would have a more profound influence at the BBB, Leeson and Davis demonstrated that the average rotational bond count of oral CNS drugs (mean 4.7, median 4.5) within a data set of oral drugs (1983–2002 NCE list) was reduced relative to the global average across all therapeutic areas (mean 6.4, median 6).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> This finding led to the proposed guideline of a rotatable bond count < 8 as an attribute of a successful CNS drug candidate.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p">The inverse agonist of growth hormone secretagogue receptor type 1a (GSH-R1) <b>40</b> reported by scientists at AstraZeneca was characterized by several physicochemical parameters lying outside the range usually associated with good CNS exposure, including high MW (621.2 Da) and PSA (132 Å<sup>2</sup>) and eight rotatable bonds (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Therefore, it was no surprise to find that compound <b>40</b> showed no detectable levels in the brain, despite good oral exposure in rats (F = 50%). This result was attributed to a combination of poor permeability and high efflux ratio in the MDR1-MDCK assay, 0.5 × 10<sup>–6</sup> cm/s and 69, respectively.</div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. GSH-R1 Antagonists: Reducing Molecular Flexibility (RB count) To Improve Brain Exposure<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0018.gif" alt="" id="fx14" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">GHS-R1a</th><th class="colsep0 rowsep0" align="center">RB</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">cp<i>K</i><sub>a</sub></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub><a class="ref internalNav" href="#t15fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t15fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>p,uu</sub><a class="ref internalNav" href="#t15fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">free brain</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">count</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(basic)</th><th class="colsep0 rowsep0" align="center">(10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">multiple<a class="ref internalNav" href="#t15fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left"><0.03<a class="ref internalNav" href="#t15fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">8.1</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.42<a class="ref internalNav" href="#t15fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t15fn1"><div class="footnote" id="t15fn1"><sup>a</sup><p class="last">A-B MDR1-MDCK.</p></div><div class="footnote" id="t15fn2"><sup>b</sup><p class="last">6 h post p.o. dose in rat.</p></div><div class="footnote" id="t15fn3"><sup>c</sup><p class="last">Dose: 100 mg/kg.</p></div><div class="footnote" id="t15fn4"><sup>d</sup><p class="last">Dose: 50 mg/kg.</p></div><div class="footnote" id="t15fn5"><sup>e</sup><p class="last"><i>C</i><sub>u,b</sub>/IC<sub>50</sub> (GHS-R1a).</p></div></div></div><div class="NLM_p">The authors noted that a single-crystal structure of <b>40</b> confirmed the existence of an internal hydrogen bond between the urea NH and the amide CO groups, as marked in Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>. It was reasoned that this intramolecular H-bond effectively masks the physicochemical parameters driven by the acylurea portion of the molecule, e.g., polarity, number of hydrogen-bond donors and acceptors, and RB count. With these considerations in mind, the authors focused their optimization efforts on the flexible side chain region of the molecule to further reduce the number of RBs. This strategy led to the discovery of piperidine <b>41</b>, whose physicochemical properties, other than RB count, remained largely unchanged from those of the parent compound <b>40</b>. Gratifyingly, this physicochemical profile did translate into significantly improved MDR1-MDCK permeability and efflux, which ultimately resulted in greatly improved <i>K</i><sub>p,uu</sub> (0.4) and a free brain exposure multiple of 0.4 (<i>C</i><sub>b,u</sub> divided by IC<sub>50</sub> GHS-R1a) in rat at 50 mg/kg. The authors were interested in inverse agonists or antagonists of GSH-R1 as a potential approach to the treatment of obesity; these two compounds enabled them to demonstrate that CNS exposure was necessary to obtain reduced food intake in mice.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><div class="NLM_p">Johnson and colleagues at Pfizer recently described their efforts towards CNS-penetrant inhibitors of anaplastic lymphoma kinase (ALK) for the treatment of nonsmall cell lung carcinoma (NSCLC).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> NSCLC commonly metastasises in the brain where the current standards of care have only limited effectiveness.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> For example, a sample taken at steady state from a single patient at the recommended 250 mg twice daily (bid) dose of crizotinib <b>42</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), approved by FDA in 2011, showed a CSF to free plasma ratio of 0.03 (Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a>).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. A structure of ALK inhibitor crizotinib, <b>42</b>, co-crystallized with the ALK kinase domain, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2">2XP2</a> (the protein is omitted for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The lack of CNS exposure can be explained by the compound’s high efflux ratio, as measured in the MDR1-MDCK assay. Although early optimization efforts produced leads with improved overall properties, as represented by compound <b>43</b>, these improvements were considered to be inadequate, and the team looked for an alternative design approach. Interestingly, the structures of several of these new leads co-crystallized with the ALK kinase domain all showed a typical U-shaped binding conformation, similar to the one observed for <b>42</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), with the aryl and pirazol groups in close proximity.</div><div class="NLM_table-wrap" id="tbl16"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 16. ALK Inhibitors: Macrocyclic Analogues Displayed Improved Brain Exposure<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0019.gif" alt="" id="fx15" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">ALK</th><th class="colsep0 rowsep0" align="center">RB</th><th class="colsep0 rowsep0" align="center">PSA</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub><a class="ref internalNav" href="#t16fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">ER</th><th class="colsep0 rowsep0" align="center">AUC</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">count</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">CSF/<i>C</i><sub>u,b</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="left">44.5</td><td class="colsep0 rowsep0" align="left">0.03<a class="ref internalNav" href="#t16fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">18.8</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">28.8</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.31<a class="ref internalNav" href="#t16fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t16fn1"><div class="footnote" id="t16fn1"><sup>a</sup><p class="last">A–B MDR1-MDCK.</p></div><div class="footnote" id="t16fn2"><sup>b</sup><p class="last">Human.</p></div><div class="footnote" id="t16fn3"><sup>c</sup><p class="last">Rat.</p></div></div></div><div class="NLM_p last">This observation prompted the authors to consider the synthesis of macrocyclic analogues using the existing amide functionality to connect the two proximal regions of the acyclic template. The macrocycles were expected to reinforce the binding conformation and consequently display improved potency and selectivity profile. In addition, due to the significant reduction in number of RBs and increased buried surface area, the macrocyclics were also anticipated to show improved BBB permeability properties. Indeed, dramatic improvements in all key parameters were observed upon the implementation of this strategy. Amide macrocycle <b>44</b> showed over 20-fold higher ALK potency relative to that of acyclic analogue <b>43</b> as well as improved permeability and reduced efflux ratio in the MDR1-MDCK assay. Importantly, the AUC ratios of CSF to free plasma of 0.31 suggested that compound <b>44</b> is distributed into the CNS. There have been a number of similarly successful examples reported in the literature; consequently, macrocyclization as an approach to improving the molecular properties of drugs has been receiving ever increasing attention in recent years.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">3.6 Molecular Weight</h3><div class="NLM_p last">CNS drugs tend to be smaller than non-CNS therapeutics. The mean MW of CNS drugs launched between 1983 and 2002 was 310 Da, whereas the mean MW for oral therapeutics (including CNS drugs) was 377 Da.<a onclick="showRef(event, 'ref82 ref87'); return false;" href="javascript:void(0);" class="ref ref82 ref87">(82, 87)</a> Levin proposed, on the basis of brain capillary permeability measurements in anesthetized rats, that there was a MW cutoff for passive brain permeability somewhere between MW 400–657 Da.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Moreover, following an analysis of CNS versus non-CNS drugs, Van de Waterbeemd proposed that the value should be MW < 450 Da.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Waring suggested that the molecular size and LogD are the most critical parameters for predicting permeability in Caco2 cell line: larger molecules require higher LogD to have a chance of high permeability.<a onclick="showRef(event, 'ref84 ref98'); return false;" href="javascript:void(0);" class="ref ref84 ref98">(84, 98)</a> Of course, molecular weight reduction often has coincidental beneficial effects on other parameters, such as rotatable bonds, PSA, and cLogP, which are, as discussed earlier, frequently employed CNS optimizations strategies in their own right. This approach is typically initiated by deletion studies carried out early in hit optimization to establish minimum pharmacophore, which is then optimized while closely monitoring the ligand binding efficiency (LE).<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">4 Multiparameter Optimization Approaches</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As discussed earlier, a good understanding of the general risks and benefits associated with individual physicochemical parameters and their interplay in the context of molecular pharmacokinetic and pharmacodynamics properties is a critical aspect of modern CNS drug design. However, often no single physicochemical parameter can be used to fully explain or predict the intricate pharmacokinetic properties related to brain exposure; rather, more complex multivariate models that interrogate multiple descriptors simultaneously are required.</div><div class="NLM_p">Waring et al. demonstrated that LogD and MW together predict cell permeability better than LogD alone.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Similar dependencies of BBB permeability on LogD and MW as well as on the PSA and HBD and HBA counts have been reported by other researchers.<a onclick="showRef(event, 'ref133 ref134 ref135'); return false;" href="javascript:void(0);" class="ref ref133 ref134 ref135">(133-135)</a> To simplify the visualization of the multivariate property space and facilitate applications in drug design, there has been a growing interest in the development of scoring functions that combine multiple parameters into a single value. For example, ligand efficiency (LE = −1.4 log (<i>K</i><sub>i</sub> [M])/number of heavy atoms),<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> lipophilic ligand efficiency (LLE = −log (<i>K</i><sub>i</sub> [M]) – cLogD),<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> and ligand efficiency-dependent lipophilicity (LELP = cLogP/LE)<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> are recently introduced scoring functions that normalize the size and lipophilicity contributions to drug potency. While all three efficiency parameters demonstrated utility in hit and lead optimization, only LELP, the multivariate scoring function that combines potency, MW, and cLogP, was found to be able to distinguish marketed drugs from clinical candidates and leads.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Wager et al. reported no significant difference in LE and LLE between 119 CNS drugs and a set of Pfizer’s 108 CNS clinical candidates.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The authors reasoned that, given the higher MW and cLogP values associated with the candidate set, the average potency of the compounds in this set must be higher than in the drug set. While the higher MW and cLogP may have contributed to increased potency and favorable LE and LLE values, these properties were also associated with less favorable ADME profiles found in the candidate set. In contrast to LE and LLE, the LELP analysis was able to distinguish drugs from candidates, showing a statistical difference between median LELP values of drugs (5.9) and candidates (7.0).<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Similarly, a comparative analysis of a wider range of compounds at different stages of drug discovery, as well as marketed drugs, showed that LELP outperformed LLE for risk assessments related to ADME and safety properties, further supporting the greater predictive power of multivariate scoring functions.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p">Wager and colleagues at Pfizer have recently reported an extension of the multiparameter scoring approach into a method designed specifically for CNS drug discovery, termed CNS multiparameter optimization (MPO).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> To assess probability of success, the CNS MPO method utilizes six fundamental molecular parameters: cLogP, cLogD, MW, TPSA, HBD count, and p<i>K</i><sub>a</sub> of the most basic center. Importantly, instead of hard cutoffs, this algorithm constructs desirability scores (0–1) for each of the six properties and composes an overall desirability score using summation, ranging from 0 (undesirable) to 6 (highly desirable). Indeed, an increasing CNS MPO desirability score was shown to align with greater chance of identifying compounds with the desired attributes such as increased passive permeability, reduced P-gp-mediated efflux, and reduced intrinsic clearance of the unbound drug. CNS MPO scores ≥ 4, as calculated for the majority of CNS active drugs (74%), can be used as a potential reference point when evaluating design ideas.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">In order to further assess the general utility of the CNS MPO algorithm, the author of this Perspective was interested in investigating if the resulting desirability scores could be used to enhance chances of identifying compounds that could achieve high unbound concentrations in the brain (<i>C</i><sub>u,b</sub>). This is a particularly challenging test, since <i>C</i><sub>u,b</sub> is one of the most complex pharmacokinetic parameters, as it is influenced by a multitude of <i>in vivo</i> variables, including fraction unbound in the brain, passive permeability, active efflux, and metabolic stability.</div><div class="NLM_p">For this purpose, the CNS MPO scores were calculated using the published algorithm<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> for a diverse set of 616 compounds from Lilly’s database with experimental <i>C</i><sub>u,b</sub> data. The <i>C</i><sub>u,b</sub> values were generated from total brain concentrations measured in the mouse (brain harvested 5 min after a single i.v. dose of 2.17 μmol/kg) and <i>f</i><sub>u,b</sub> obtained from the LC/MS analysis of the brain homogenate, as previously reported.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The compounds were classified, on the basis of their <i>C</i><sub>u,b</sub> levels, as low (<i>C</i><sub>u,b</sub> < 10 nM; 44% of the total) and high (<i>C</i><sub>u,b</sub> > 10 nM; 56%). This is an arbitrary classification cutoff used for the purpose of this particular exercise, since the compounds in this set originated from many different programs for which preferred range of the <i>C</i><sub>u,b</sub> values would differ greatly. The analysis showed that, at least for this set, the likelihood of finding compounds with high <i>C</i><sub>u,b</sub> values progressively increases as the CNS MPO desirability score increases (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). For example, 100% of compounds with low CNS MPO scores (≤2) had low <i>C</i><sub>u,b</sub> values, whereas 81% of compounds with CNS MPO score > 5 had <i>C</i><sub>u,b</sub> values classified as high. Although there is still room for improvement, this is a remarkable result considering the challenge presented by the intrinsic complexity of this important pharmacokinetic end point. In contrast, an analysis of the same data set using a single physicochemical parameter, such as cLogD, showed no meaningful alignment, except to note that 86% of the most lipohilic compounds (cLogD > 5) were in the low <i>C</i><sub>u,b</sub> group (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Distribution of brain unbound concentrations (<i>C</i><sub>u,b</sub>) in mouse for a diverse set of 616 compounds from Eli Lilly’s collection as a function of: (a) CNS MPO score (1–6) and (b) cLogD (Chemaxon). Pie charts are colored according to <i>C</i><sub>u,b</sub> levels: red, low (<i>C</i><sub>u,b</sub> < 10 nM); green, high (<i>C</i><sub>u,b</sub> > 10 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It is therefore not surprising that over recent years MPO methods have been steadily gaining wider acceptance in drug discovery,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> with their application to the prospective design of new compounds being particularly appealing. Machine learning algorithms designed to differentiate CNS from non-CNS penetrating compounds on the basis of their substructure fingerprints have also been reported in recent years.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> However, these approaches are based on molecular descriptors and fingerprint patterns that are less intuitive and difficult for medicinal chemists to translate into optimization hypotheses and desired structural modifications, which may limit their application in prospective design. These algorithms may prove to be more effective when used to select or prioritize structures, for example, to prioritize design ideas for synthesis, to select compounds for focused screening, to triage high-throughput screening (HTS) hits, or to evaluate structures from the patent literature. The MPO algorithms may also prove to be useful in this context.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">5 Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The existence of the blood–brain barrier presents a unique and major challenge in CNS drug discovery.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> This challenge can be addressed effectively and successfully only with a good understanding of structure–brain exposure built on reliable and meaningful data. Therefore, it is important to note the large body of evidence described in the literature indicates that total brain concentration (<i>C</i><sub>b</sub>), which is still commonly reported as a measure of brain exposure, is actually a measure of nonspecific binding to brain tissue rather than a pharmacologically relevant concentration. The reliance on drug total brain levels is often misleading, which inevitably and unnecessarily leads to large and highly lipophilic molecules. It is now unambiguously clear that the unbound brain concentration (<i>C</i><sub>u,b</sub>) is a better measure of drug concentration at the target site and, ultimately, <i>in vivo</i> drug efficacy.</div><div class="NLM_p">As discussed earlier, receptor occupancy (RO) is the most direct measure of target engagement, but the time and cost associated with the required ligand radiolabeling prevent its wider and more impactful application in drug discovery. However, the need for a radiolabeled ligand can be circumvented by a method recently described by scientists at Eli Lilly. They used nonradiolabeled tracers in combination with high-performance liquid chromatography and mass spectrometry (LC/MS) to measure the ROs of several antipsychotics at dopamine D<sub>2</sub> and serotonin 5-HT<sub>2A</sub> receptors.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> This method has a potential for a major impact on CNS drug discovery. By eliminating the need for radiolabeled ligands, it enables a routine measurement of <i>in vivo</i> RO, which should result in a better understanding of structure–brain exposure at early stages in drug discovery and a more effective execution of hit and lead optimization efforts toward successful drug candidates. Similarly, PET ligand discovery efforts, which focus on radioligand optimization, could also greatly benefit from the LC/MS method. In addition, an elegant extension of the LC/MS detection approach recently reported by Need and colleagues at Eli Lilly demonstrated the possibility of obtaining reliable RO data simultaneously against multiple targets, thereby establishing ligand selectivity <i>in vivo</i> within a single experiment.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><div class="NLM_p">One of the emerging challenges in CNS drug discovery is related to the increasing evidence that mechanisms leading to a failing, more permeable BBB are at the core of the underlying pathology of CNS diseases, such as Alzheimer’s disease, multiple sclerosis, ischemic stroke, and injury due to brain trauma.<a onclick="showRef(event, 'ref11 ref142'); return false;" href="javascript:void(0);" class="ref ref11 ref142">(11, 142)</a> A better understanding of these mechanisms is required to help design more relevant preclinical disease models and therapeutic agents. There is also emerging evidence that the BBB can be altered in certain preclinical models, which may present considerable difficulties when establishing drug PK/PD relationships. For example, a significant increase in P-gp expression has been observed in carrageenan-induced inflammatory hyperalgesia in the rat, resulting in decreased CNS penetration of morphine and the consequent attenuation of morphine-induced antinociception.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Therefore, it is good research practice to use tissues collected from <i>in vivo</i> PD experiments for PK studies whenever possible, particularly for the key compounds on which important program decisions are to be made.</div><div class="NLM_p">One of the fundamental challenges for medicinal chemists working on CNS targets is that the existence of the BBB reduces the size of the CNS drug physicochemical property space compared with the space available to oral drugs designed for peripheral targets. Generally, CNS drugs are smaller, more lipophilic, and have fewer hydrogen-bond donors and lower PSA compared with those of non-CNS drugs.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The median values derived from an analysis of marketed CNS drugs offer useful guidance when defining the desirable CNS candidate profile: cLogP = 2.8, cLogD = 1.7, HBD = 1, TPSA = 44.8 Å<sup>2</sup>, p<i>K</i><sub>a</sub> = 8.4, RB = 4.5, and MW = 305.3 Da.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Obviously, these numbers are median values, and there are many marketed drugs with properties at either end of the range. Furthermore, the current CNS pharmacopeia is heavily dominated by drugs that modulate monoamine GPCRs, transporters, and ion channels, many of which were developed for the treatment of psychiatric disorders such as schizophrenia and depression, e.g., out of 118 drugs included in the analysis described above,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> 34 are aminergic GPCR ligands, 24 are ion channel blockers, and 11 are aminergic transporter inhibitors. This situation is likely to change, as CNS drug discovery efforts across the pharmaceutical industry have been rapidly refocusing toward emerging CNS therapeutic areas, such as neurodegeneration and oncology. Consequently, there are ever increasing numbers of non-traditional CNS targets currently being evaluated in the clinic, many of which are characterized by larger and more polar ligands, such as proteases, kinases, and phosphodiesterases.<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144, 145)</a> It will be interesting to see how the median values of CNS drug properties change as these new approaches begin delivering drugs to the market.</div><div class="NLM_p">Regardless, lipophilicity is likely to continue to be seen as the most critical physicochemical parameter and a robust predictor of clinical success across all therapeutic areas.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The essentially unchanging overall lipophilicity distribution in oral drugs over the past 40 years reflects the importance of balancing the impact of this property on the potency, pharmacokinetic, and safety profiles.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> It is well-documented that increased lipophilicity is often accompanied not only by increased potency but also increased probability of reduced solubility and plasma free fraction as well as increased metabolic and toxicity liabilities.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> For example, an analysis of the physicochemical properties and <i>in vivo</i> safety data relationships for 245 preclinical compounds at Pfizer showed a significantly higher risk of safety events for basic nitrogen containing compounds with PS < 75 Å<sup>2</sup> and cLogP > 3.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> The inferred high-risk property profile significantly overlaps with the CNS drug property space, as described above, which further emphasizes the challenges associated with CNS drug discovery. With judicious selection of lead compounds and controlling lipophilicity during optimization by an effective use of efficiency parameters (LE, LLE, and LELP), medicinal chemists have an opportunity and responsibility to improve success rates in the clinic.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><div class="NLM_p">In contrast to lipophilicity, molecular descriptors related to hydrogen bonding are often found to be the dominant parameters impacting unbound drug brain concentrations. This is most likely a consequence of an additive combination of the two detrimental effects generally associated with hydrogen bonding, namely, poor passive permeability and increased risk of interactions with efflux transporters. An analysis of how oral drug properties have changed over time showed that the mean value of HBD count is constant, similar to cLogP and PSA, suggesting that HBD is one of the most critical physicochemical properties, i.e., more important than HBA count.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Indeed, reducing the HBD count is one of the most frequently reported strategies that was successfully used in the optimization of brain exposure. An alternative strategy, which may be particularly attractive when HBDs are required for target activity, is the introduction of a suitably positioned HBA group to form an intramolecular H-bond. When increasing the PSA is undesirable, one could consider the incorporation of a halogen atom instead of HBA. Although considerably weaker than classical O···H and N···H H-bonds, improved property profiles have been reported in molecules that contain an intramolecular halogen bond.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div><div class="NLM_p">Another important molecular property to consider in CNS drug discovery is aqueous solubility, which is at least in part a composite reflection of the physicochemical properties discussed earlier, as well as some of the more recently introduced structural descriptors such as carbon sp<sup>3</sup> fraction (Fsp<sup>3</sup> = number of sp<sup>3</sup>-hybridized carbons/total carbon count)<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> and aromatic ring count.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Alelyunas and colleagues at AstraZeneca reported that only 7 out of 98 marketed CNS drugs displayed measured solubility < 10 μM in pH 7.4 buffer.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Interestingly, most of them were associated with significant safety issues for which they were either withdrawn or given a black box warning. The great majority of the CNS drugs in this set proved to be highly soluble compounds, with 85% displaying solubility > 100 μM. The authors indicated that one could relate poor solubility with higher safety risks on the basis of its strong correlation with increased lipophilicity. It was suggested that compounds having solubility < 1 μM are unlikely to become CNS drugs, while advancing compounds with solubility < 10 μM would still bear high developability risks. The authors also pointed out a high risk of being outperformed by a competitor when advancing a poorly soluble compound. Improving solubility is one of the common objectives for fast follow-up programs. It is, therefore, tempting to consider aqueous solubility as one of the potential predictors of clinical success.</div><div class="NLM_p">The majority of drugs bind to their targets by forming reversible noncovalent interactions, e.g., hydrogen bonds and hydrophobic interactions. For such agents, PK/PD relationships are usually well-understood in terms of equilibrium binding affinities (<i>K</i><sub>d</sub>) for their primary target relative to steady-state free plasma concentrations. However, in recent years, there has been a renewed and growing interest in the design of covalently bound inhibitors,<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> even for targets outside oncology indications that are historically associated with this approach, including CNS-related indications such as schizophrenia<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> and pain.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Several covalent irreversible inhibitors for CNS disorders have already been available on the market for many years (e.g., vigabatrin, selegiline, disulfiram), suggesting that this can be a safe and effective CNS drug discovery approach. Potential advantages of covalent inhibition include high potency and ligand efficiency, especially for less-druggable targets, which may translate to reduced dose and the associated body burden of the parent drug and its metabolites.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Due to nonequilibrium binding kinetics, covalent inhibitors of protein targets that regenerate slowly tend to display much longer pharmacodynamic half-lives than their pharmacokinetic half-lives.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> For irreversible binders, free drug concentrations at the target coverage levels are generally needed only until the covalent interaction takes place, which often occurs relatively quickly (30 min to 1 h).<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Consequently, this approach deemphasizes the need for compounds with long half-lives and high, prolonged systemic drug loads.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> However, this potentially attractive aspect of the covalent binding approach may not be fully realized in CNS drug discovery for compounds with poor BBB penetration (e.g., <i>K</i><sub>puu</sub> < 1) that may require prolonged and high systemic exposure in order to achieve optimal target coverage in the brain. Hence, to minimize the risk of nonspecific irreversible tissue binding when pursuing covalent binders for CNS targets, while potentially compromising on drug half-life, one would be well-advised to focus, just as in reversible ligand programs, on designing compounds exhibiting physicochemical parameters conducive to good brain penetration properties, e.g., high <i>P</i><sub>app</sub> and no active efflux.</div><div class="NLM_p">Many covalent inhibitors display high protein binding,<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> which, as discussed earlier,<a onclick="showRef(event, 'ref30 ref49'); return false;" href="javascript:void(0);" class="ref ref30 ref49">(30, 49)</a> is not a liability per se, especially if most of the binding is reversible. The above-mentioned advantages of covalent irreversible inhibitors are critically balanced with the risk of idiosyncratic toxicity or immune-mediated hypersensitivity that may arise from nonspecific covalent binding.<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153, 154)</a> In this context, it is important to focus such drug discovery efforts on covalent binders with high specificity for the desired target(s) and with minimum off target nonspecific covalent tissue binding. To achieve this, one may focus on designing molecules with high reversible binding affinities, and containing chemically less reactive groups (warheads) in which covalent binding is a secondary and final interaction with the desired target, that occurs only when the warhead is in a close proximity to the nucleophilic residue in the binding site. To potentially minimize the risks associated with irreversible binders, one may consider alternative approaches such as covalent reversible inhibition with slow <i>K</i><sub>off</sub> (e.g., rivastigmine) or arguably a more challenging prodrug approach (e.g., selegiline).<a onclick="showRef(event, 'ref150 ref151 ref155'); return false;" href="javascript:void(0);" class="ref ref150 ref151 ref155">(150, 151, 155)</a> In any case, a good aspirational goal for all drug discovery efforts has been provided by an observation that idiosyncratic toxicity is very rare among drugs administered at doses below 10 mg, regardless of the mode of action.<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156, 157)</a></div><div class="NLM_p last">It is estimated that 98% of systemically administered small molecules, as well as nearly all biological therapeutics, i.e., recombinant proteins or gene-based medicines, are unable to cross the BBB.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Enabling brain exposure for at least some of these molecules is the ultimate goal of the brain delivery systems.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Great progress has been made in recent years, particularly with some of the shuttle-mediated approaches that have proved to be successful in improving the CNS exposure of some of the small molecules synonymous with poor brain permeability, such as taxol.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> However, further developments are needed for this approach to become a more robust mainstream technology with a general applicability. Until then, fine-tuning physicochemical properties for optimal brain exposure will remain a staple of CNS drug discovery.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/jm501535r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Calculated physicochemical properties and CNS MPO scores for a diverse set of compounds with experimentally obtained <i>C</i><sub>u,b</sub> values (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501535r/suppl_file/jm501535r_si_001.pdf">jm501535r_si_001.pdf (735.3 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501535r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zoran Rankovic</span> - <span class="hlFld-Affiliation affiliation">Eli Lilly
and Company, 893 South
Delaware Street, Indianapolis, Indiana 46285, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a2d0c3ccc9cdd4cbc1fdd8cdd0c3cce2cecbcecedb8cc1cdcf82d8cdd0c3cc8ccfc3cbcec0cddae2c5cfc3cbce8cc1cdcf"><span class="__cf_email__" data-cfemail="a1d3c0cfcaced7c8c2fedbced3c0cfe1cdc8cdcdd88fc2cecc">[email protected]</span> <span class="__cf_email__" data-cfemail="fe84918c9f90d0939f97929c9186be99939f9792d09d9193">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The author declares no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Zoran Rankovic</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=BIO-d1630e5197-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zoran Rankovic</b> is a Research Fellow at Eli Lilly Headquarters, Indianapolis, Indiana, US. Before joining Eli Lilly in 2011, he was a medicinal chemistry director at Merck, Schering-Plough, and Organon UK. He started his industrial career at Organon in 1995, the same year he earned his Ph.D. in organic chemistry from the University of Leeds (UK), under the guidance of Professor Ronald Grigg. During his career, Zoran has been fortunate to be able to contribute to and lead teams that delivered multiple clinical candidates for a range of CNS disorders, including neurodegenerative, psychiatric, and pain indications. He is an author and coinventor on over 70 patents, scientific publications, and book chapters and an editor of two books on drug discovery topics.</p></figure></div><div class="ack" id="ACK-d1630e5202-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The author thanks Jibo Wang for constructing the MPO algorithm and Jeffrey J. Alberts and Mark G. Bures for helpful discussions and critical evaluations of the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35"> Abbrevations</h2><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">SLC</td><td class="NLM_def"><p class="first last">solute carrier class</p></td></tr><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP-binding cassette</p></td></tr><tr><td class="NLM_term">MRP</td><td class="NLM_def"><p class="first last">multidrug-resistance protein</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BCSFB</td><td class="NLM_def"><p class="first last">blood–cerebrospinal fluid barrier</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β-peptide</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">LLC-PK</td><td class="NLM_def"><p class="first last">pig-kidney-derived epithelial</p></td></tr><tr><td class="NLM_term">A–B</td><td class="NLM_def"><p class="first last">apical-to-basal</p></td></tr><tr><td class="NLM_term">B–A</td><td class="NLM_def"><p class="first last">basal-to-apical</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">logP</td><td class="NLM_def"><p class="first last">logarithm of the octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">cLogP</td><td class="NLM_def"><p class="first last">calculated LogP</p></td></tr><tr><td class="NLM_term">logD</td><td class="NLM_def"><p class="first last">logarithm of the octanol/water distribution coefficient at a given pH</p></td></tr><tr><td class="NLM_term">cLogD</td><td class="NLM_def"><p class="first last">calculated LogD</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen-bond donors</p></td></tr><tr><td class="NLM_term">HBA</td><td class="NLM_def"><p class="first last">hydrogen-bond acceptors</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">RB</td><td class="NLM_def"><p class="first last">rotatable bonds</p></td></tr><tr><td class="NLM_term">B/P</td><td class="NLM_def"><p class="first last">brain-to-plasma ratio</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-á-go-go related gene</p></td></tr><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knockout</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-amyloid cleaving enzyme</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">per oral</p></td></tr><tr><td class="NLM_term">s.c.</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">LELP</td><td class="NLM_def"><p class="first last">ligand efficiency-dependent lipophilicity</p></td></tr><tr><td class="NLM_term">LAT1</td><td class="NLM_def"><p class="first last">L-type amino acid transporter-1</p></td></tr><tr><td class="NLM_term">RO</td><td class="NLM_def"><p class="first last">receptor occupancy</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 158 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Chandler, D. J.</span><span> </span><span class="NLM_article-title">Something’s got to give: psychiatric disease on the rise and novel drug development on the decline</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=202-206&author=D.+J.+Chandler&title=Something%E2%80%99s+got+to+give%3A+psychiatric+disease+on+the+rise+and+novel+drug+development+on+the+decline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChandler%26aufirst%3DD.%2BJ.%26atitle%3DSomething%25E2%2580%2599s%2520got%2520to%2520give%253A%2520psychiatric%2520disease%2520on%2520the%2520rise%2520and%2520novel%2520drug%2520development%2520on%2520the%2520decline%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D202%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>Forecasting Health Care Costs; <span class="NLM_publisher-name">National Bureau of Economic Research</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>; <a href="http://www.nber.org/aginghealth/2008no4/w14361.html" class="extLink">http://www.nber.org/aginghealth/2008no4/w14361.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Forecasting+Health+Care+Costs%3B+National+Bureau+of+Economic+Research%3A+Cambridge%2C+MA%3B+http%3A%2F%2Fwww.nber.org%2Faginghealth%2F2008no4%2Fw14361.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DForecasting%2520Health%2520Care%2520Costs%26pub%3DNational%2520Bureau%2520of%2520Economic%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Barnholtz-Sloan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigneau, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, R. E.</span><span> </span><span class="NLM_article-title">Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1200%2FJCO.2004.12.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15254054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2865-2872&author=J.+S.+Barnholtz-Sloanauthor=A.+E.+Sloanauthor=F.+G.+Davisauthor=F.+D.+Vigneauauthor=P.+Laiauthor=R.+E.+Sawaya&title=Incidence+proportions+of+brain+metastases+in+patients+diagnosed+%281973+to+2001%29+in+the+metropolitan+detroit+cancer+surveillance+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System</span></div><div class="casAuthors">Barnholtz-Sloan Jill S; Sloan Andrew E; Davis Faith G; Vigneau Fawn D; Lai Ping; Sawaya Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2865-72</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Population-based estimates of the incidence of brain metastases are not generally available.  The purpose of this study was to calculate population-based incidence proportions (IPs) of brain metastases from single primary lung, melanoma, breast, renal, or colorectal cancer.  PATIENTS AND METHODS:  Patients diagnosed with single primary lung, melanoma, breast, renal, or colorectal cancer (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System (MDCSS) were used for analysis.  IP of brain metastases by primary site and variable of interest (race, sex, age at diagnosis of primary cancer, and Surveillance, Epidemiology, and End Results [SEER] stage of primary cancer) was calculated with 95% CIs.  RESULTS:  Total IP percentage (IP%) of brain metastases was 9.6% for all primary sites combined, and highest for lung (19.9%), followed by melanoma (6.9%), renal (6.5%), breast (5.1%), and colorectal (1.8%) cancers.  Racial differences were seen with African Americans demonstrating higher IP% of brain metastases compared with other racial groups for most primary sites.  IP% was significantly higher for female patients with lung cancer, and significantly higher for male patients with melanoma.  The highest IP% of brain metastases occurred at different ages at diagnoses: age 40 to 49 years for primary lung cancer; age 50 to 59 years for primary melanoma, renal, or colorectal cancers; and age 20 to 39 for primary breast cancer.  IP% significantly increased as SEER stage of primary cancer advanced for all primary sites.  CONCLUSION:  Total IP% of brain metastases was lower than previously reported, and it varied by primary site, race, sex, age at diagnosis of primary cancer, and SEER stage of primary cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1FltY_UquSCCEBeYuoi7AfW6udTcc2eZNtYg6rTCC4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D&md5=76fa82deca39e5aced5f3d98735be3d0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.12.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.12.149%26sid%3Dliteratum%253Aachs%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%2BS.%26aulast%3DSloan%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DF.%2BG.%26aulast%3DVigneau%26aufirst%3DF.%2BD.%26aulast%3DLai%26aufirst%3DP.%26aulast%3DSawaya%26aufirst%3DR.%2BE.%26atitle%3DIncidence%2520proportions%2520of%2520brain%2520metastases%2520in%2520patients%2520diagnosed%2520%25281973%2520to%25202001%2529%2520in%2520the%2520metropolitan%2520detroit%2520cancer%2520surveillance%2520system%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2865%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistics</span> <span class="citation_source-journal">Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><div class="note"><p class="first last">2014</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.3322%2Fcaac.21208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=24399786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=9-29&author=R.+Siegelauthor=J.+Maauthor=Z.+Zouauthor=A.+Jemal&title=Cancer+statistics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2014</span></div><div class="casAuthors">Siegel Rebecca; Ma Jiemin; Zou Zhaohui; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics.  A total of 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014.  During the most recent 5 years for which there are data (2006-2010), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.4% per year in women.  The combined cancer death rate (deaths per 100,000 population) has been continuously declining for 2 decades, from a peak of 215.1 in 1991 to 171.8 in 2010.  This 20% decline translates to the avoidance of approximately 1,340,400 cancer deaths (952,700 among men and 387,700 among women) during this time period.  The magnitude of the decline in cancer death rates from 1991 to 2010 varies substantially by age, race, and sex, ranging from no decline among white women aged 80 years and older to a 55% decline among black men aged 40 years to 49 years.  Notably, black men experienced the largest drop within every 10-year age group.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-53QNNisGn5agfuraLLzSfW6udTcc2eb4FCmuholCqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D&md5=2aa85d07bbfc7838e1d0e6bf94ce6c46</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21208%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%26jtitle%3DCancer%2520J.%2520Clin.%26date%3D2014%26volume%3D64%26spage%3D9%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Nguyen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, L. M.</span><span> </span><span class="NLM_article-title">Brain metastases</span> <span class="citation_source-journal">Neurol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.ncl.2007.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17964030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2snjvFygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1173-1192&author=T.+D.+Nguyenauthor=L.+M.+DeAngelis&title=Brain+metastases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metastases</span></div><div class="casAuthors">Nguyen Teri D; DeAngelis Lisa M</div><div class="citationInfo"><span class="NLM_cas:title">Neurologic clinics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1173-92, x-xi</span>
        ISSN:<span class="NLM_cas:issn">0733-8619</span>.
    </div><div class="casAbstract">Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression.  Supportive therapies include steroids and antiseizure medications.  Definitive treatments include radiation therapy, surgery, and chemotherapy.  The optimal choice of treatment and overall prognosis largely depend on patient characteristics and the extent and distribution of disease.  Delaying or decreasing neurologic cause of death and disability are important therapeutic goals for this population.  While better definitive strategies are investigated, physicians must remember to optimize the use of supportive therapies to ameliorate symptoms and maintain quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSYt-AmUO_aF1C8OJBvdfbfW6udTcc2eb4FCmuholCqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snjvFygtg%253D%253D&md5=a16350bd3ec9d4488bee98cd27c8cd77</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ncl.2007.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ncl.2007.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26aulast%3DDeAngelis%26aufirst%3DL.%2BM.%26atitle%3DBrain%2520metastases%26jtitle%3DNeurol.%2520Clin.%26date%3D2007%26volume%3D25%26spage%3D1173%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and cros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4720</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.-L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-Amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28metheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+cros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-Amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520cros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">The blood-brain barrier: bottleneck in brain drug development</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1602%2Fneurorx.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15717053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=3-14&author=W.+M.+Pardridge&title=The+blood-brain+barrier%3A+bottleneck+in+brain+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The blood-brain barrier: bottleneck in brain drug development</span></div><div class="casAuthors">Pardridge William M</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">The blood-brain barrier (BBB) is formed by the brain capillary endothelium and excludes from the brain approximately 100% of large-molecule neurotherapeutics and more than 98% of all small-molecule drugs.  Despite the importance of the BBB to the neurotherapeutics mission, the BBB receives insufficient attention in either academic neuroscience or industry programs.  The combination of so little effort in developing solutions to the BBB problem, and the minimal BBB transport of the majority of all potential CNS drugs, leads predictably to the present situation in neurotherapeutics, which is that there are few effective treatments for the majority of CNS disorders.  This situation can be reversed by an accelerated effort to develop a knowledge base in the fundamental transport properties of the BBB, and the molecular and cellular biology of the brain capillary endothelium.  This provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D9y3lHz94U-GfW6udTcc2eYghyH4DHRabrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D&md5=88e326d840c4ab0f4e55da8a2ffd513c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DThe%2520blood-brain%2520barrier%253A%2520bottleneck%2520in%2520brain%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D3%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Shen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artru, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkison, K. K.</span><span> </span><span class="NLM_article-title">Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.addr.2004.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15381336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslOhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1825-1827&author=D.+D.+Shenauthor=A.+A.+Artruauthor=K.+K.+Adkison&title=Principles+and+applicability+of+CSF+sampling+for+the+assessment+of+CNS+drug+delivery+and+pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics</span></div><div class="casAuthors">Shen, Danny D.; Artru, Alan A.; Adkison, Kimberly K.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1825-1857</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Cerebrospinal fluid (CSF) concns. are used as a surrogate measure of central nervous system (CNS) availability of drugs.  Systemically administered drugs can reach CSF either directly via passage across the choroid plexus, or indirectly by passage across the blood-brain barrier (BBB) followed by diffusion/convection transport from the interstitial fluid (ISF) to CSF.  This review focuses on the physiol. and pharmacokinetic variables that must be considered in the interpretation of the CSF-to-plasma concn. gradient.  A survey of the literature suggests that the equilibrated CSF-to-unbound plasma concn. ratio reflects the balance between drug permeability across the blood-CNS barriers and the sink action of CSF turnover.  As lipophilicity and membrane permeability increase, the CSF-to-plasma unbound concn. ratio rises from well below 1 toward unity.  Deviations are noted in that lipophilic drugs highly bound to CSF proteins had ratio exceeding unity, and lipophilic drugs that were efflux transporter substrates exhibited ratios well less than unity.  Drug concn. gradients have been obsd. between drug in the ISF and CSF, the direction of which depends on the CSF sink action and drug permeability/transport across the BBB and choroid plexus.  Despite the complexity of CSF pharmacokinetics, for some drugs a rapid kinetic equil. exists between the CSF and biophase, such that CSF concn. can serve as a proximate ref. for detailed investigation of factors affecting the intrinsic pharmacodynamics of a centrally acting drug.  The applicability and limitations of CSF sampling for assessing the CNS availability and concn.-effect relationship of drug candidates with varying physicochem. properties during drug discovery and development is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Nkcnqy8t3rVg90H21EOLACvtfcHk0lj3WxbZaCziFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslOhsrg%253D&md5=e16fbe5043d36b99261b7eea0d3972ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DArtru%26aufirst%3DA.%2BA.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26atitle%3DPrinciples%2520and%2520applicability%2520of%2520CSF%2520sampling%2520for%2520the%2520assessment%2520of%2520CNS%2520drug%2520delivery%2520and%2520pharmacodynamics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1825%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Martin, I.</span><span> </span><span class="NLM_article-title">Prediction of blood–brain barrier penetration: are we missing the point?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=161-162&author=I.+Martin&title=Prediction+of+blood%E2%80%93brain+barrier+penetration%3A+are+we+missing+the+point%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26atitle%3DPrediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%253A%2520are%2520we%2520missing%2520the%2520point%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D161%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Giacomini, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillgren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmaster, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Membrane transporters in drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=20190787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-236&author=K.+M.+Giacominiauthor=S.-M.+Huangauthor=D.+J.+Tweedieauthor=L.+Z.+Benetauthor=K.+L.+R.+Brouwerauthor=X.+Chuauthor=A.+Dahlinauthor=R.+Eversauthor=V.+Fischerauthor=K.+M.+Hillgrenauthor=K.+A.+Hoffmasterauthor=T.+Ishikawaauthor=D.+Kepplerauthor=R.+B.+Kimauthor=C.+A.+Leeauthor=M.+Niemiauthor=J.+W.+Polliauthor=Y.+Sugiyamaauthor=P.+W.+Swaanauthor=J.+A.+Wareauthor=S.+H.+Wrightauthor=S.+W.+Yeeauthor=M.+J.+Zamek-Gliszczynskiauthor=L.+Zhang&title=Membrane+transporters+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transporters in drug development</span></div><div class="casAuthors">Giacomini, Kathleen M.; Huang, Shiew-Mei; Tweedie, Donald J.; Benet, Leslie Z.; Brouwer, Kim L. R.; Chu, Xiaoyan; Dahlin, Amber; Evers, Raymond; Fischer, Volker; Hillgren, Kathleen M.; Hoffmaster, Keith A.; Ishikawa, Toshihisa; Keppler, Dietrich; Kim, Richard B.; Lee, Caroline A.; Niemi, Mikko; Polli, Joseph W.; Sugiyama, Yuicchi; Swaan, Peter W.; Ware, Joseph A.; Wright, Stephen H.; Wah Yee, Sook; Zamek-Gliszczynski, Maciej J.; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-236</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs.  This presents several key questions for drug development, including which transporters are clin. important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters.  In addn., what criteria should trigger follow-up clin. studies, and which clin. studies should be conducted if needed.  In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clin. studies on the currently recognized most important drug transporter interactions.  The recommendations are generally intended to support clin. development and filing of a new drug application.  Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clin. trial enrollment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metab. and excretion properties of the drug mol., and information required for drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiBIf0gk93W7Vg90H21EOLACvtfcHk0lj3WxbZaCziFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D&md5=89d9ce746284c1814fb01cd9b9a72027</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3028%26sid%3Dliteratum%253Aachs%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%2BR.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DDahlin%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHillgren%26aufirst%3DK.%2BM.%26aulast%3DHoffmaster%26aufirst%3DK.%2BA.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DNiemi%26aufirst%3DM.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DWare%26aufirst%3DJ.%2BA.%26aulast%3DWright%26aufirst%3DS.%2BH.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMembrane%2520transporters%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Abbott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönnbäck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, L.</span><span> </span><span class="NLM_article-title">Astrocyte–endothelial interactions at the blood–brain barrier</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrn1824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16371949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlaktbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=41-53&author=N.+J.+Abbottauthor=L.+R%C3%B6nnb%C3%A4ckauthor=L.+Hansson&title=Astrocyte%E2%80%93endothelial+interactions+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Astrocyte-endothelial interactions at the blood-brain barrier</span></div><div class="casAuthors">Abbott, N. Joan; Roennbaeck, Lars; Hansson, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-53</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier, which is formed by the endothelial cells that line cerebral microvessels, has an important role in maintaining a precisely regulated microenvironment for reliable neuronal signaling.  At present, there is great interest in the assocn. of brain microvessels, astrocytes and neurons to form functional neurovascular units, and recent studies have highlighted the importance of brain endothelial cells in this modular organization.  Here, we explore specific interactions between the brain endothelium, astrocytes, and neurons that may regulate blood-brain barrier function.  An understanding of how these interactions are disturbed in pathol. conditions could lead to the development of new protective and restorative therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpmeWESRRQSbVg90H21EOLACvtfcHk0ljpeNUBxj9ySw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlaktbjP&md5=831bcfddad8af8122f7139d525c96356</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrn1824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1824%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DR%25C3%25B6nnb%25C3%25A4ck%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DL.%26atitle%3DAstrocyte%25E2%2580%2593endothelial%2520interactions%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D41%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecker, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennernas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugano, K.</span><span> </span><span class="NLM_article-title">Evidence-based approach to assess passive diffusion and carrier-mediated drug transport</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.drudis.2012.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=22507594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlWisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=905-912&author=L.+Diauthor=P.+Arturssonauthor=A.+Avdeefauthor=G.+F.+Eckerauthor=B.+Fallerauthor=H.+Fischerauthor=J.+B.+Houstonauthor=M.+Kansyauthor=E.+H.+Kernsauthor=S.+D.+Kramerauthor=H.+Lennernasauthor=K.+Sugano&title=Evidence-based+approach+to+assess+passive+diffusion+and+carrier-mediated+drug+transport"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence-based approach to assess passive diffusion and carrier-mediated drug transport</span></div><div class="casAuthors">Di, Li; Artursson, Per; Avdeef, Alex; Ecker, Gerhard F.; Faller, Bernard; Fischer, Holger; Houston, J. Brian; Kansy, Manfred; Kerns, Edward H.; Kramer, Stefanie D.; Lennernas, Hans; Sugano, Kiyohiko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">905-912</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Evidence supporting the action of passive diffusion and carrier-mediated (CM) transport in drug bioavailability and disposition is discussed to refute the recently proposed theory that drug transport is CM-only and that new transporters will be discovered that possess transport characteristics ascribed to passive diffusion.  Misconceptions and faulty speculations are addressed to provide reliable guidance on choosing appropriate tools for drug design and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxroQ5Hx-CarVg90H21EOLACvtfcHk0ljpeNUBxj9ySw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlWisrg%253D&md5=a16c61888f55b82f03c1115b95fc4b94</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DKramer%26aufirst%3DS.%2BD.%26aulast%3DLennernas%26aufirst%3DH.%26aulast%3DSugano%26aufirst%3DK.%26atitle%3DEvidence-based%2520approach%2520to%2520assess%2520passive%2520diffusion%2520and%2520carrier-mediated%2520drug%2520transport%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D905%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing CNS drugs for optimal brain exposure</span>. In  <span class="citation_source-book">Blood–Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Di, L.; Kerns, E. H.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1002%2F9781118788523.ch18" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Rankovicauthor=L.+Di&author=E.+H.+Kerns&title=Blood%E2%80%93Brain+Barrier+in+Drug+Discovery%3A+Optimizing+Brain+Exposure+of+CNS+Drugs+and+Minimizing+Brain+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F9781118788523.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118788523.ch18%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520CNS%2520drugs%2520for%2520optimal%2520brain%2520exposure%26btitle%3DBlood%25E2%2580%2593Brain%2520Barrier%2520in%2520Drug%2520Discovery%253A%2520Optimizing%2520Brain%2520Exposure%2520of%2520CNS%2520Drugs%2520and%2520Minimizing%2520Brain%2520Side%2520Effects%26aulast%3DDi%26aufirst%3DL.%26pub%3DWiley%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rankovic, Z.; Bingham, M.</span><span> </span><span class="NLM_article-title">Medicinal chemistry challenges in CNS drug discovery</span>. In  <span class="citation_source-book">Drug Discovery for Psychiatric Disorders</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Rankovic, Z.; Bingham, M.; Nestler, E.; Hargreaves, R.</span>, Eds.; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=465-509&author=Z.+Rankovic&author=M.+Binghamauthor=Z.+Rankovic&author=M.+Bingham&author=E.+Nestler&author=R.+Hargreaves&title=Drug+Discovery+for+Psychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DMedicinal%2520chemistry%2520challenges%2520in%2520CNS%2520drug%2520discovery%26btitle%3DDrug%2520Discovery%2520for%2520Psychiatric%2520Disorders%26aulast%3DRankovic%26aufirst%3DZ.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2013%26spage%3D465%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Malakoutikhah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giralt, E.</span><span> </span><span class="NLM_article-title">Shuttle-mediated drug delivery to the brain</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">7998</span><span class="NLM_x">–</span> <span class="NLM_lpage">8014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=7998-8014&author=M.+Malakoutikhahauthor=M.+Teixidauthor=E.+Giralt&title=Shuttle-mediated+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalakoutikhah%26aufirst%3DM.%26aulast%3DTeixid%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DShuttle-mediated%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D7998%26epage%3D8014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Strategies to optimize brain penetration in drug discovery</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=505-512&author=X.+Liuauthor=C.+Chen&title=Strategies+to+optimize+brain+penetration+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DStrategies%2520to%2520optimize%2520brain%2520penetration%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26spage%3D505%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deusen, J. V.</span><span> </span><span class="NLM_article-title">Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood–brain barrier permeability, plasma protein binding, and brain tissue binding</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">1254</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.104.079319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15743928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslektbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=1254-1262&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrognaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+Nelsonauthor=M.+A.+Szewcauthor=J.+V.+Deusen&title=Use+of+a+physiologically+based+pharmacokinetic+model+to+study+the+time+to+reach+brain+equilibrium%3A+an+experimental+analysis+of+the+role+of+blood%E2%80%93brain+barrier+permeability%2C+plasma+protein+binding%2C+and+brain+tissue+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: An experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffery</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1254-1262</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed (1) to examine the effects of blood-brain barrier (BBB) permeability [quantified as permeability-surface area product (PS)], unbound fraction in plasma (fu,plasma), and brain tissue (fu,brain) on the time to reach equil. between brain and plasma and (2) to investigate the drug discovery strategies to design and select compds. that can rapidly penetrate the BBB and distribute to the site of action.  The pharmacokinetics of seven model compds.: caffeine, CP-141938 (methoxy-3-[(2-phenyl-piperadinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), fluoxetine, NFPS [N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine], propranolol, theobromine, and theophylline in rat brain and plasma after s.c. administration were studied.  The in vivo log PS and log fu,brain calcd. using a physiol. based pharmacokinetic model correlates with in situ log PS (R2 = 0.83) and in vitro log fu,brain (R2 = 0.69), where the in situ PS and in vitro fu,brain was detd. using in situ brain perfusion and equil. dialysis using brain homogenate, resp.  The time to achieve brain equil. can be quantitated with a proposed parameter, intrinsic brain equil. half-life [t1/2eq,in = VbIn2/(PS · fu,brain)], where Vb is the physiol. vol. of brain.  The in vivo log t1/2eq,in does not correlate with in situ log PS (R2 < 0.01) but correlates inversely with log(PS · fu,brain) (R2 = 0.85).  The present study demonstrates that rapid brain equilibration requires a combination of high BBB permeability and low brain tissue binding.  A high BBB permeability alone cannot guarantee a rapid equilibration.  The strategy to select compds. with rapid brain equilibration in drug discovery should identify compds. with high BBB permeability and low nonspecific binding in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv5KbqnWflVbVg90H21EOLACvtfcHk0ljgbf68tT273g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslektbs%253D&md5=544d4bff8b1460321f1941018ac8b5f5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.079319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.079319%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DDeusen%26aufirst%3DJ.%2BV.%26atitle%3DUse%2520of%2520a%2520physiologically%2520based%2520pharmacokinetic%2520model%2520to%2520study%2520the%2520time%2520to%2520reach%2520brain%2520equilibrium%253A%2520an%2520experimental%2520analysis%2520of%2520the%2520role%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%252C%2520plasma%2520protein%2520binding%252C%2520and%2520brain%2520tissue%2520binding%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D1254%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=54-61&author=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cecchelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renftel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehouck, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenart, L.</span><span> </span><span class="NLM_article-title">Modelling of the blood–brain barrier in drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=50-661&author=R.+Cecchelliauthor=V.+Berezowskiauthor=S.+Lundquistauthor=M.+Culotauthor=M.+Renftelauthor=M.-P.+Dehouckauthor=L.+Fenart&title=Modelling+of+the+blood%E2%80%93brain+barrier+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DBerezowski%26aufirst%3DV.%26aulast%3DLundquist%26aufirst%3DS.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DRenftel%26aufirst%3DM.%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DFenart%26aufirst%3DL.%26atitle%3DModelling%2520of%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D50%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+Debartoloauthor=D.+A.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0ljgbf68tT273g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDebartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Markus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, F.</span><span> </span><span class="NLM_article-title">Positron emission tomography in CNS drug discovery and drug monitoring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9232</span><span class="NLM_x">–</span> <span class="NLM_lpage">9258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9232-9258&author=P.+Markusauthor=I.+Vernalekenauthor=F.+Roesch&title=Positron+emission+tomography+in+CNS+drug+discovery+and+drug+monitoring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkus%26aufirst%3DP.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DRoesch%26aufirst%3DF.%26atitle%3DPositron%2520emission%2520tomography%2520in%2520CNS%2520drug%2520discovery%2520and%2520drug%2520monitoring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9232%26epage%3D9258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0lgo6G3TLsyopw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1997&pages=768-771&author=D.+Wuauthor=Y.-S.+Kangauthor=U.+Bickelauthor=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+permeability+to+morphine-6-glucuronide+is+markedly+reduced+compared+with+morphine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DY.-S.%26aulast%3DBickel%26aufirst%3DU.%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520permeability%2520to%2520morphine-6-glucuronide%2520is%2520markedly%2520reduced%2520compared%2520with%2520morphine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D26%26spage%3D768%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Frolich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dees, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paetz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaev, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenk, M. H.</span><span> </span><span class="NLM_article-title">Distinct pharmacological properties of morphine metabolites at Gi-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=1248-1254&author=N.+Frolichauthor=C.+Deesauthor=C.+Paetzauthor=X.+Renauthor=M.+J.+Lohseauthor=V.+O.+Nikolaevauthor=M.+H.+Zenk&title=Distinct+pharmacological+properties+of+morphine+metabolites+at+Gi-protein+and+%CE%B2-arrestin+signaling+pathways+activated+by+the+human+%CE%BC-opioid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolich%26aufirst%3DN.%26aulast%3DDees%26aufirst%3DC.%26aulast%3DPaetz%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DZenk%26aufirst%3DM.%2BH.%26atitle%3DDistinct%2520pharmacological%2520properties%2520of%2520morphine%2520metabolites%2520at%2520Gi-protein%2520and%2520%25CE%25B2-arrestin%2520signaling%2520pathways%2520activated%2520by%2520the%2520human%2520%25CE%25BC-opioid%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D1248%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Paul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standiffer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inturrisi, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of morphine 6-b-glucuronidase, a very potent morphine metabolite</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=477-483&author=D.+Paulauthor=K.+M.+Standifferauthor=C.+E.+Inturrisiauthor=G.+W.+Pasternak&title=Pharmacological+characterization+of+morphine+6-b-glucuronidase%2C+a+very+potent+morphine+metabolite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DStandiffer%26aufirst%3DK.%2BM.%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DPharmacological%2520characterization%2520of%2520morphine%25206-b-glucuronidase%252C%2520a%2520very%2520potent%2520morphine%2520metabolite%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D251%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Reichel, A.</span><span> </span><span class="NLM_article-title">Addressing central nervous system (CNS) penetration in drug discovery: Basics and implications of the evolving new concept</span> <span class="citation_source-journal">Chem. Biodivers.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2030</span><span class="NLM_x">–</span> <span class="NLM_lpage">2049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=2030-2049&author=A.+Reichel&title=Addressing+central+nervous+system+%28CNS%29+penetration+in+drug+discovery%3A+Basics+and+implications+of+the+evolving+new+concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DAddressing%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetration%2520in%2520drug%2520discovery%253A%2520Basics%2520and%2520implications%2520of%2520the%2520evolving%2520new%2520concept%26jtitle%3DChem.%2520Biodivers.%26date%3D2009%26volume%3D6%26spage%3D2030%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Stain-Texier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandouk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span> </span><span class="NLM_article-title">Elevated concentrations of morphine 6-beta-<span class="smallcaps smallerCapital">d</span>-glucuronide in brain extracellular fluid despite low blood–brain barrier permeability</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fsj.bjp.0702873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=10556926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXntFCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=917-924&author=F.+Stain-Texierauthor=G.+Boschiauthor=P.+Sandoukauthor=J.+M.+Scherrmann&title=Elevated+concentrations+of+morphine+6-beta-d-glucuronide+in+brain+extracellular+fluid+despite+low+blood%E2%80%93brain+barrier+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood - brain barrier permeability</span></div><div class="casAuthors">Stain-Texier, Frederique; Boschi, Gabrielle; Sandouk, Pierre; Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">917-924</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">This study was done to find out how morphine 6-beta-D-glucuronide (M6G) induces more potent central analgesia than morphine, despite its poor blood-brain barrier (BBB) permeability.  The brain uptake and disposition of these compds. were investigated in plasma and in various brain compartments: extracellular fluid (ECF), intracellular space (ICS) and cerebrospinal fluid (CSF).  Morphine or M6G was given to rats at 10 mg kg-1 s.c.  Transcortical microdialysis was used to assess their distributions in the brain ECF.  Conventional tissue homogenization was used to det. the distribution in the cortex and whole brain.  These two procedures were combined to est. drug distribution in the brain ICS.  The blood and CSF pharmacokinetics were also detd.  Plasma concn. data for M6G were much higher than those of morphine, with Cmax and AUC 4-5 times more higher, Tmax shorter, and VZf-1 (vol. of distribution) and CL f-1 (clearance) 4-6 times lower.  The concns. of the compds. in various brain compartments also differed: AUC values for M6G were lower than those of morphine in tissue and CSF and higher in brain ECF.  AUC values in brain show that morphine levels were four times higher in ICS than in ECF, whereas M6G levels were 125 higher in ECF than in ICS.  Morphine entered brain cells, whereas M6G was almost exclusively extracellular.  This high extracellular concn., coupled with extremely slow diffusion into the CSF, indicates that M6G was predominantly trapped in the extracellular fluid and therefore durably available to bind at opioid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4m4joGsaYsLVg90H21EOLACvtfcHk0lgo6G3TLsyopw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFCiu7g%253D&md5=5c21b08e2b1099a8fe5b3e5b32ae0d39</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702873%26sid%3Dliteratum%253Aachs%26aulast%3DStain-Texier%26aufirst%3DF.%26aulast%3DBoschi%26aufirst%3DG.%26aulast%3DSandouk%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DElevated%2520concentrations%2520of%2520morphine%25206-beta-d-glucuronide%2520in%2520brain%2520extracellular%2520fluid%2520despite%2520low%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D917%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massingham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. N.</span><span> </span><span class="NLM_article-title">Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1002%2Fbdd.509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16791848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=291-297&author=A.+Guptaauthor=M.+Hammarlund-Udenaesauthor=P.+Chatelainauthor=R.+Massinghamauthor=E.+N.+Jonsson&title=Stereoselective+pharmacokinetics+of+cetirizine+in+the+guinea+pig%3A+role+of+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding</span></div><div class="casAuthors">Gupta, Anubha; Hammarlund-Udenaes, Margareta; Chatelain, Pierre; Massingham, Roy; Jonsson, E. Niclas</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Purpose. To characterize the pharmacokinetics of cetirizine enantiomers in the guinea pig including protein binding in both the guinea pig and human plasma.  Methods. Plasma concns. of cetirizine enantiomers in the guinea pig were detd. using a LC-MS/MS method after a short i.v. infusion (1, 2 and 4 mg/kg) of racemic cetirizine.  Protein binding was detd. using an in vitro equil. dialysis technique.  A pharmacokinetic model was developed using NONMEM and the differences in pharmacokinetic parameters of levocetirizine and dextrocetirizine were estd.  Results. The plasma concn. time data of both the enantiomers were best described by a three-compartment pharmacokinetics model.  The clearance (CL) of levocetirizine and dextrocetirizine was 1.2 and 2.7 mL/min, resp., and the vol. of distribution at steady state (Vss) was 457 mL and 996 mL, resp.  The fraction unbound (fu) in guinea pig plasma for levocetirizine and dextrocetirizine was 7-10% and 16-21% while in human plasma, it was 8% and 12%, resp.  The factor describing the difference in the pharmacokinetic parameters of the cetirizine enantiomers was estd. to be 2.26.  Conclusions. Cetirizine pharmacokinetics is stereoselective in the guinea pig.  For levocetirizine, fu, CL and Vss were half those of dextrocetirizine, indicating that protein binding is an important factor affecting the pharmacokinetics of cetirizine.  The effect of protein binding on the pharmacokinetics of the cetirizine enantiomers could be extrapolated to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGT69fkPBFHrVg90H21EOLACvtfcHk0lgo6G3TLsyopw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGlsrjF&md5=5294005f5f2b7f326e2f00330e8bc18d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbdd.509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.509%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DP.%26aulast%3DMassingham%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%2BN.%26atitle%3DStereoselective%2520pharmacokinetics%2520of%2520cetirizine%2520in%2520the%2520guinea%2520pig%253A%2520role%2520of%2520protein%2520binding%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2006%26volume%3D27%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0lhjF_-wr6kfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughman, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, K.H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mote, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salisbury, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tippin, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span> </span><span class="NLM_article-title">P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2082</span><span class="NLM_x">–</span> <span class="NLM_lpage">2089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2082-2089&author=J.+W.+Polliauthor=T.+M.+Baughmanauthor=J.+E.+Humphreysauthor=K.H.+Jordanauthor=A.+L.+Moteauthor=J.+A.+Salisburyauthor=T.+K.+Tippinauthor=C.+J.+Serabjit-Singh&title=P-glycoprotein+influences+the+brain+concentrations+of+cetirizine+%28Zyrtec%29%2C+a+second-generation+non-sedating+antihistamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBaughman%26aufirst%3DT.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DJordan%26aufirst%3DK.H.%26aulast%3DMote%26aufirst%3DA.%2BL.%26aulast%3DSalisbury%26aufirst%3DJ.%2BA.%26aulast%3DTippin%26aufirst%3DT.%2BK.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26atitle%3DP-glycoprotein%2520influences%2520the%2520brain%2520concentrations%2520of%2520cetirizine%2520%2528Zyrtec%2529%252C%2520a%2520second-generation%2520non-sedating%2520antihistamine%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2082%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Simon, F. E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, K. J.</span><span> </span><span class="NLM_article-title">H1 antihistamines: current status and future directions</span> <span class="citation_source-journal">World Allergy Organ. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1186%2F1939-4551-1-9-145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=145-155&author=F.+E.+R.+Simonauthor=K.+J.+Simons&title=H1+antihistamines%3A+current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2F1939-4551-1-9-145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1939-4551-1-9-145%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DF.%2BE.%2BR.%26aulast%3DSimons%26aufirst%3DK.%2BJ.%26atitle%3DH1%2520antihistamines%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DWorld%2520Allergy%2520Organ.%2520J.%26date%3D2008%26volume%3D1%26spage%3D145%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sadiq, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjoerkman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlundudenaes, M.</span><span> </span><span class="NLM_article-title">Diphenhydramine active uptake at the blood–brain barrier and its interaction with oxycodone <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3912</span><span class="NLM_x">–</span> <span class="NLM_lpage">3923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=3912-3923&author=M.+W.+Sadiqauthor=A.+Borgsauthor=T.+Okuraauthor=K.+Shimomuraauthor=S.+Katoauthor=Y.+Deguchiauthor=B.+Janssonauthor=S.+Bjoerkmanauthor=T.+Terasakiauthor=M.+Hammarlundudenaes&title=Diphenhydramine+active+uptake+at+the+blood%E2%80%93brain+barrier+and+its+interaction+with+oxycodone+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadiq%26aufirst%3DM.%2BW.%26aulast%3DBorgs%26aufirst%3DA.%26aulast%3DOkura%26aufirst%3DT.%26aulast%3DShimomura%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DJansson%26aufirst%3DB.%26aulast%3DBjoerkman%26aufirst%3DS.%26aulast%3DTerasaki%26aufirst%3DT.%26aulast%3DHammarlundudenaes%26aufirst%3DM.%26atitle%3DDiphenhydramine%2520active%2520uptake%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520its%2520interaction%2520with%2520oxycodone%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D3912%26epage%3D3923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kageyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimohama, S.</span><span> </span><span class="NLM_article-title">The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">879</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FS0006-8993%2800%2902758-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=11011012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslyjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=879&publication_year=2000&pages=115-121&author=T.+Kageyamaauthor=M.+Nakamuraauthor=A.+Matsuoauthor=Y.+Yamasakiauthor=Y.+Takakuraauthor=M.+Hashidaauthor=Y.+Kanaiauthor=M.+Naitoauthor=T.+Tsuruoauthor=N.+Minatoauthor=S.+Shimohama&title=The+4F2hc%2FLAT1+complex+transports+L-DOPA+across+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The 4F2hc/LAT1 complex transports l-DOPA across the blood-brain barrier</span></div><div class="casAuthors">Kageyama, T.; Nakamura, M.; Matsuo, A.; Yamasaki, Y.; Takakura, Y.; Hashida, M.; Kanai, Y.; Naito, M.; Tsuruo, T.; Minato, N.; Shimohama, S.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">879</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">115-121</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">L-DOPA is transported across the blood-brain barrier (BBB) by an amino acid transporter, system L.  Recently, it has been demonstrated that system L consists of two subunits, 4F2hc and either LAT1 or LAT2. 4F2hc/LAT1 and 4F2hc/LAT2 show different transport characteristics, while their distribution in the brain has not been detd.  To clarify whether 4F2hc/LAT1 participates in l-DOPA transport across the BBB, we first examd. the expression of 4F2hc/LAT1 in the mouse brain capillary endothelial cell line, MBEC4, as an in vitro BBB model.  Northern hybridization and immunoblotting revealed that both 4F2hc and LAT1 are expressed and form a heterodimer in MBEC4 cells.  To confirm whether 4F2hc/LAT1 acts as system L to transport l-DOPA, we characterized l-DOPA uptake into the cells.  The uptake process was time-dependent, temp.-sensitive, and Na+-independent.  Neutral amino acids with bulky side chains and a bicyclic amino acid, 2-aminobicyclo-[2,2,1]-heptane-2-carboxylic acid (BCH), inhibited l-DOPA uptake into MBEC4 cells to a great extent, while an acidic amino acid, basic amino acids, and glycine had no effect.  Other neutral amino acids, such as alanine, asparagine, glutamine, serine, and threonine inhibited l-DOPA uptake by 40-70% at most.  These characteristics are more compatible with those of 4F2hc/LAT1, rather than those of 4F2hc/LAT2.  Finally, immunohistochem. with anti-LAT1 antibody demonstrated that LAT1 is predominantly expressed in the microvessels of the central nervous system.  This is the first report showing that the 4F2hc/LAT1 complex participates in l-DOPA transport across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE3IFZUc76ybVg90H21EOLACvtfcHk0lhjF_-wr6kfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslyjsLs%253D&md5=08b982ef604a9fe2889d94d53440c101</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902758-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902758-X%26sid%3Dliteratum%253Aachs%26aulast%3DKageyama%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMatsuo%26aufirst%3DA.%26aulast%3DYamasaki%26aufirst%3DY.%26aulast%3DTakakura%26aufirst%3DY.%26aulast%3DHashida%26aufirst%3DM.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DMinato%26aufirst%3DN.%26aulast%3DShimohama%26aufirst%3DS.%26atitle%3DThe%25204F2hc%252FLAT1%2520complex%2520transports%2520L-DOPA%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D879%26spage%3D115%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Doran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasman, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahematpura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raunig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasgar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span> </span><span class="NLM_article-title">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=165-174&author=A.+Doranauthor=R.+S.+Obachauthor=B.+J.+Smithauthor=N.+A.+Hoseaauthor=S.+Beckerauthor=E.+Callegariauthor=C.+Chenauthor=X.+Chenauthor=E.+Chooauthor=J.+Cianfrognaauthor=L.+M.+Coxauthor=J.+P.+Gibbsauthor=M.+A.+Gibbsauthor=H.+Hatchauthor=C.+E.+Hopauthor=I.+N.+Kasmanauthor=J.+LaPerleauthor=J.+Liuauthor=X.+Liuauthor=M.+Logmanauthor=D.+Maclinauthor=F.+M.+Nedzaauthor=F.+Nelsonauthor=E.+Olsonauthor=S.+Rahematpuraauthor=D.+Raunigauthor=S.+Rogersauthor=K.+Schmidtauthor=D.+K.+Spracklinauthor=M.+Szewcauthor=M.+Troutmanauthor=E.+Tsengauthor=M.+Tuauthor=J.+W.+Van+Deusenauthor=K.+Venkatakrishnanauthor=G.+Walensauthor=E.+Q.+Wangauthor=D.+Wongauthor=A.+S.+Yasgarauthor=C.+Zhang&title=The+impact+of+P-glycoprotein+on+the+disposition+of+drugs+targeted+for+indications+of+the+central+nervous+system%3A+evaluation+using+the+MDR1A%2F1B+knockout+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%2BM.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DGibbs%26aufirst%3DM.%2BA.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DKasman%26aufirst%3DI.%2BN.%26aulast%3DLaPerle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DRahematpura%26aufirst%3DS.%26aulast%3DRaunig%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DSzewc%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%2BW.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DWalens%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DYasgar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520impact%2520of%2520P-glycoprotein%2520on%2520the%2520disposition%2520of%2520drugs%2520targeted%2520for%2520indications%2520of%2520the%2520central%2520nervous%2520system%253A%2520evaluation%2520using%2520the%2520MDR1A%252F1B%2520knockout%2520mouse%2520model%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friden</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syvnen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span> </span><span class="NLM_article-title">On the rate and extent of drug delivery to the brain</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1737</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2Fs11095-007-9502-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18058202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1737-1750&author=M.+Hammarlund-Udenaesauthor=+Fridenauthor=M.+S.+Syvnenauthor=A.+Gupta&title=On+the+rate+and+extent+of+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">On The Rate and Extent of Drug Delivery to the Brain</span></div><div class="casAuthors">Hammarlund-Udenaes, Margareta; Friden, Markus; Syvaenen, Stina; Gupta, Anubha</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1737-1750</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  To define and differentiate relevant aspects of blood-brain barrier transport and distribution in order to aid research methodol. in brain drug delivery.  Pharmacokinetic parameters relative to the rate and extent of brain drug delivery are described and illustrated with relevant data, with special emphasis on the unbound, pharmacol. active drug mol.  Drug delivery to the brain can be comprehensively described using three parameters: K p,uu (concn. ratio of unbound drug in brain to blood), CLin (permeability clearance into the brain), and V u,brain (intra-brain distribution).  The permeability of the blood-brain barrier is less relevant to drug action within the CNS than the extent of drug delivery, as most drugs are administered on a continuous (repeated) basis.  K p,uu can differ between CNS-active drugs by a factor of up to 150-fold.  This range is much smaller than that for log BB ratios (K p), which can differ by up to at least 2000-fold, or for BBB permeabilities, which span an even larger range (up to at least 20,000-fold difference).  Methods that measure the three parameters K p,uu, CLin, and V u,brain can give clin. valuable ests. of brain drug delivery in early drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkysWU99T_hbVg90H21EOLACvtfcHk0liuTkWor_kQEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D&md5=20f106a980c4949b78ead8c00cb5db41</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs11095-007-9502-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-007-9502-2%26sid%3Dliteratum%253Aachs%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DFriden%26aulast%3DSyvnen%26aufirst%3DM.%2BS.%26aulast%3DGupta%26aufirst%3DA.%26atitle%3DOn%2520the%2520rate%2520and%2520extent%2520of%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26spage%3D1737%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnaraj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patsalos, P. N.</span><span> </span><span class="NLM_article-title">The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus)</span> <span class="citation_source-journal">Seizure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">574</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.seizure.2004.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15519917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2crkvVOqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=574-581&author=X.+Wangauthor=N.+Ratnarajauthor=P.+N.+Patsalos&title=The+pharmacokinetic+inter-relationship+of+tiagabine+in+blood%2C+cerebrospinal+fluid+and+brain+extracellular+fluid+%28frontal+cortex+and+hippocampus%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus)</span></div><div class="casAuthors">Wang Xiaolan; Ratnaraj Neville; Patsalos Philip N</div><div class="citationInfo"><span class="NLM_cas:title">Seizure</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">574-81</span>
        ISSN:<span class="NLM_cas:issn">1059-1311</span>.
    </div><div class="casAbstract">PURPOSE:  Tiagabine is a unique antiepileptic drug with a novel mechanism of action.  Whilst some limited data are available as to the peripheral blood pharmacokinetics of tiagabine, data regarding the kinetics of tiagabine in the central brain compartment are very limited.  We therefore sought to investigate serum, cerebrospinal fluid (CSF) and frontal cortex and hippocampal extracellular fluid (ECF) kinetic inter-relationship of tiagabine in a freely moving rat model.  METHODS:  Adult male rats were implanted with either a jugular vein catheter and a cisterna magna catheter for blood and CSF sampling, respectively, or a blood catheter and a microdialysis probe in the hippocampus and frontal cortex (for ECF sampling).  Tiagabine was administered intraperitoneal (i.p.) at 20 or 40 mg/kg and blood, CSF and ECF were collected at timed intervals for the measurement of tiagabine concentrations by high performance liquid chromatography.  RESULTS:  Tiagabine concentrations in blood and CSF rose linearly and dose-dependently and time to maximum concentration (Tmax) was 15 and 29 min, respectively.  Mean CSF/serum tiagabine concentration ratios (range, 0.008-0.01) were much smaller than the mean free/total tiagabine concentration ratios in serum (0.045 +/- 0.003).  Entry of tiagabine into brain ECF (frontal cortex and hippocampus) was rapid with Tmax values of 31-46 min.  Distribution of tiagabine in brain was not brain region specific with values in the frontal cortex and hippocampus being indistinguishable.  Whilst elimination from CSF was comparable to that of serum, half-life (t(1/2)) values in ECF were three times longer.  CONCLUSIONS:  Tiagabine is associated with linear kinetic characteristics and with rapid brain penetration.  However, CSF concentrations are not reflective of free non-protein-bound concentrations in serum.  The observation that tiagabine elimination from the brain is threefold slower than that seen in blood, may explain as to the relatively long duration of action of tiagabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrouhM9sT0mdy3lHz94U-GfW6udTcc2eZ9UuIFKbDaVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crkvVOqsw%253D%253D&md5=233a864b5f0bbe2d4b2f6d87162f29a5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.seizure.2004.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.seizure.2004.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRatnaraj%26aufirst%3DN.%26aulast%3DPatsalos%26aufirst%3DP.%2BN.%26atitle%3DThe%2520pharmacokinetic%2520inter-relationship%2520of%2520tiagabine%2520in%2520blood%252C%2520cerebrospinal%2520fluid%2520and%2520brain%2520extracellular%2520fluid%2520%2528frontal%2520cortex%2520and%2520hippocampus%2529%26jtitle%3DSeizure%26date%3D2004%26volume%3D13%26spage%3D574%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerndal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6233</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901036q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6233&author=M.+Fridenauthor=S.+Winiwarterauthor=G.+Jerndalauthor=O.+Bengtssonauthor=H.+Wanauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaesauthor=M.+Antonsson&title=Structure%E2%80%93brain+exposure+relationships+in+rat+and+human+using+a+novel+data+set+of+unbound+drug+concentrations+in+brain+interstitial+and+cerebrospinal+fluids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm901036q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901036q%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DJerndal%26aufirst%3DG.%26aulast%3DBengtsson%26aufirst%3DO.%26aulast%3DWan%26aufirst%3DH.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DAntonsson%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%2520in%2520rat%2520and%2520human%2520using%2520a%2520novel%2520data%2520set%2520of%2520unbound%2520drug%2520concentrations%2520in%2520brain%2520interstitial%2520and%2520cerebrospinal%2520fluids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kodaira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusuhara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of the impact of active efflux by P-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.111.180398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21934030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=935-944&author=H.+Kodairaauthor=H.+Kusuharaauthor=T.+Fujitaauthor=J.+Ushikiauthor=E.+Fuseauthor=Y.+Sugiyama&title=Quantitative+evaluation+of+the+impact+of+active+efflux+by+P-glycoprotein+and+breast+cancer+resistance+protein+at+the+blood-brain+barrier+on+the+predictability+of+the+unbound+concentrations+of+drugs+in+the+brain+using+cerebrospinal+fluid+concentration+as+a+surrogate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of the impact of active efflux by P-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span></div><div class="casAuthors">Kodaira, Hiroshi; Kusuhara, Hiroyuki; Fujita, Takuya; Ushiki, Junko; Fuse, Eiichi; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">935-944</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study investigated the impact of the active efflux mediated by P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp) at the blood-brain barrier (BBB) on the predictability of the unbound brain concn. (Cu,brain) by the concn. in the cerebrospinal fluid (CSF) (Cu,CSF) in rats.  Cu,brain is obtained as the product of the total brain concn. and unbound fraction in the brain (fu,brain) detd. in vitro in brain slices.  Twenty-five compds., including P-gp and/or Bcrp substrates, were given a const. i.v. infusion, and their plasma, brain, and CSF concns. were detd.  P-gp and/or Bcrp substrates, such as verapamil, loperamide, flavopiridol, genistein, quinidine, dantrolene, daidzein, cimetidine, and pefloxacin, showed a higher CSF-to-brain unbound concn. ratio (Kp,uu,CSF/brain) compared with non-P-gp and non-Bcrp substrates.  Kp,uu,CSF/brain values of P-gp-specific (quinidine and verapamil) and Bcrp-specific (daidzein and genistein) substrates were significantly decreased in Mdr1a/1b(-/-) and Bcrp(-/-) mice, resp.  Furthermore, consistent with the contribution of P-gp and Bcrp to the net efflux at the BBB, Kp,uu,CSF/brain values of the common substrates (flavopiridol and erlotinib) were markedly decreased in Mdr1a/1b(-/-)/Bcrp(-/-) mice, but only moderately or weakly in Mdr1a/1b(-/-) mice and negligibly in Bcrp(-/-) mice.  In conclusion, predictability of Cu,brain by Cu,CSF decreases along with the net transport activities by P-gp and Bcrp at the BBB.  Cu,CSF of non-P-gp and non-Bcrp substrates can be a reliable surrogate of Cu,brain for lipophilic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6e2OeGRsyrVg90H21EOLACvtfcHk0lhErxbea-lTOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D&md5=36a778b164943b101534146120fc6cdf</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180398%26sid%3Dliteratum%253Aachs%26aulast%3DKodaira%26aufirst%3DH.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DQuantitative%2520evaluation%2520of%2520the%2520impact%2520of%2520active%2520efflux%2520by%2520P-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520at%2520the%2520blood-brain%2520barrier%2520on%2520the%2520predictability%2520of%2520the%2520unbound%2520concentrations%2520of%2520drugs%2520in%2520the%2520brain%2520using%2520cerebrospinal%2520fluid%2520concentration%2520as%2520a%2520surrogate%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D935%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">De Lange, E. C. M.</span><span> </span><span class="NLM_article-title">Utility of CSF in translational neuroscience</span> <span class="citation_source-journal">J. Pharmacokinet. Pharmacodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2Fs10928-013-9301-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=23400635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BC3sznsVKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=315-326&author=E.+C.+M.+De+Lange&title=Utility+of+CSF+in+translational+neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of CSF in translational neuroscience</span></div><div class="casAuthors">de Lange Elizabeth C M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacokinetics and pharmacodynamics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human cerebrospinal fluid (CSF) sampling is of high value as the only general applicable methodology to obtain information on free drug concentrations in individual human brain.  As the ultimate interest is in the free drug concentration at the CNS target site, the question is what CSF concentrations may tell us in that respect.  Studies have been performed in rats and other animals for which concentrations in brain extracellular fluid (brain ECF) as a target site for many drugs, have been compared to (cisterna magna) CSF concentrations, at presumed steady state conditions,.  The data indicated that CSF drug concentrations provided a rather good indication of, but not a reliable measure for predicting brain ECF concentrations.  Furthermore, comparing rat with human CSF concentrations, human CSF concentrations tend to be higher and display much more variability.  However, this comparison of CSF concentrations cannot be a direct one, as humans probably had a disease for which CSF was collected in the first place, while the rats were healthy.  In order to be able to more accurately predict human brain ECF concentrations, understanding of the complexity of the CNS in terms of intrabrain pharmacokinetic relationships and the influence of CNS disorders on brain pharmacokinetics needs to be increased.  This can be achieved by expanding a currently existing preclinically derived physiologically based pharmacokinetic model for brain distribution.  This model has been shown to successfully predict data obtained for human lumbar CSF concentrations of acetaminophen which renders trust in the model prediction of human brain ECF concentrations.  This model should further evolute by inclusion of influences of drug properties, fluid flows, transporter functionalities and different disease conditions.  Finally the model should include measures of target site engagement and CNS effects, to ultimately learn about concentrations that best predict particular target site concentrations, via human CSF concentrations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTi9WqlS0U7bsjl5L8hwNX0fW6udTcc2eZE4ynIDjuIaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sznsVKlug%253D%253D&md5=283a3121ccb261617d4d2896012e0dc7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs10928-013-9301-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10928-013-9301-9%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLange%26aufirst%3DE.%2BC.%2BM.%26atitle%3DUtility%2520of%2520CSF%2520in%2520translational%2520neuroscience%26jtitle%3DJ.%2520Pharmacokinet.%2520Pharmacodyn.%26date%3D2013%26volume%3D40%26spage%3D315%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Westerhout, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danhof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lange, E. C. M.</span><span> </span><span class="NLM_article-title">Preclinical prediction of human brain target site concentrations: Considerations and extrapolating to the clinical setting</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3577</span><span class="NLM_x">–</span> <span class="NLM_lpage">3593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=3577-3593&author=J.+Westerhoutauthor=M.+Danhofauthor=E.+C.+M.+De+Lange&title=Preclinical+prediction+of+human+brain+target+site+concentrations%3A+Considerations+and+extrapolating+to+the+clinical+setting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWesterhout%26aufirst%3DJ.%26aulast%3DDanhof%26aufirst%3DM.%26aulast%3DDe%2BLange%26aufirst%3DE.%2BC.%2BM.%26atitle%3DPreclinical%2520prediction%2520of%2520human%2520brain%2520target%2520site%2520concentrations%253A%2520Considerations%2520and%2520extrapolating%2520to%2520the%2520clinical%2520setting%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D3577%26epage%3D3593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehngren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrçm, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunek, A.</span><span> </span><span class="NLM_article-title">High-throughput screening of drug–brain tissue binding and in silico prediction for assessment of central nervous system drug delivery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070375w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4606-4615&author=H.+Wanauthor=M.+Rehngrenauthor=F.+Giordanettoauthor=F.+Bergstr%C3%A7mauthor=A.+Tunek&title=High-throughput+screening+of+drug%E2%80%93brain+tissue+binding+and+in+silico+prediction+for+assessment+of+central+nervous+system+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm070375w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070375w%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DRehngren%26aufirst%3DM.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DBergstr%25C3%25A7m%26aufirst%3DF.%26aulast%3DTunek%26aufirst%3DA.%26atitle%3DHigh-throughput%2520screening%2520of%2520drug%25E2%2580%2593brain%2520tissue%2520binding%2520and%2520in%2520silico%2520prediction%2520for%2520assessment%2520of%2520central%2520nervous%2520system%2520drug%2520delivery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1711</span><span class="NLM_x">–</span> <span class="NLM_lpage">1719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1711-1719&author=M.+Fridenauthor=A.+Guptaauthor=M.+Antonssonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=In+vitro+methods+for+estimating+unbound+drug+concentrations+in+the+brain+interstitial+and+intracellular+fluids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520methods%2520for%2520estimating%2520unbound%2520drug%2520concentrations%2520in%2520the%2520brain%2520interstitial%2520and%2520intracellular%2520fluids%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1711%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Nattaauthor=H.+van+Yeoauthor=O.+Vilenskiauthor=P.+Wellerauthor=P.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0liQS8aICIZXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNatta%26aufirst%3DK.%26aulast%3Dvan%2BYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DWorboys%26aufirst%3DP.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Debruyne, D.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.2165%2F00003088-199733010-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9250423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXltlShsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1997&pages=52-77&author=D.+Debruyne&title=Clinical+pharmacokinetics+of+fluconazole+in+superficial+and+systemic+mycoses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses</span></div><div class="casAuthors">Debruyne, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-77</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis</span>)
        </div><div class="casAbstract">The bis triazole agent fluconazole is used widely in the treatment of superficial and deep mycoses.  A single oral dose of fluconazole 150mg gives a mean long term clin. cure rate of 84±5% and is considered a valuable alternative to other topical antifungal drugs for vaginal candidiasis.  A clin. cure rate of 90.4% for oropharyngeal candidiasis was obtained with 100mg daily for a min. of 14 days; however, as for the other azoles the rate of relapse was large (40%) in immunocompromised patients.  A daily dose of 100mg for at last 3 wk gave satisfying outcomes for esophageal candidiasis.  Most patients (71 to 86%) with signs and symptoms of urinary tract candidiasis show beneficial clin. results when given oral fluconazole 50mg for several weeks.  Fluconazole 50 to 150mg given for weeks or months results in over 90% clin. cure or improvement for cutaneous mycosis including tinea, pityriasis, cryptococcosis and candidiasis.  Prolonged (6 to 12 mo) fluconazole 150mg once a week is needed to treat onychomycosis successfully.  Higher oral doses (200 to 400mg daily) for long periods are generally used to treat deep mycoses such as meningitis, ophthalmitis, pneumonia, hepatosplenic mycosis and endocarditis.  Fluconazole is effective for treating the fungal peritonitis which can complicate continuous ambulatory peritoneal dialysis (CAPD).  A regimen of 50mg i.p. or 100mg orally was used in these patients with impaired renal function.  The dosage schedules used to treat disseminated fungal infections due to systemic mycoses with different or multiple foci of infections vary widely, with doses of 50 to 400mg given orally or i.v. for between 1 wk and several months.  The most recent clin. reports have investigated the use of prophylaxis with fluconazole 100 to 400mg daily, in immunocompromised patients.  Fluconazole is found in body fluids such as vaginal secretions, breast milk, saliva, sputum and cerebrospinal fluid at concns. comparable with those detd. in blood after single or multiple doses.  There is an excellent linear plasma concn.-dose relationship, but the mycol. and clin. responses do not appear to be well correlated with the dose.  A total max. daily dose of 1600mg is recommended to avoid neurol. toxicity.  Data from pharmacokinetic studies conducted in patients, mainly those with AIDS, and using a 1-compartment model give very const. parameters similar to those obtained in healthy individuals.  Bioavailability, measured in HIV-pos. patients and those with AIDS, exceeded 93% for tablets, suspension and suppositories.  The time to reach peak plasma concns. (tmax) was 2.4 to 3.7 h.  The peak plasma drug concn. (Cmax) obtained after a 100mg oral dose was 2 mg/L.  Areas under the concn.-time curve (AUC) obtained in different studies all correlate well with the dose (r = 0.926).  The AUC detd. after 200 and 25mg suppositories were similarly well correlated.  Hypochlorhydria does not affect the absorption of fluconazole, neither does food intake, race (Japanese or Caucasian) or gastrointestinal resection.  Binding to plasma protein is low (11.14%) and is increased to 23% in cancer patients.  Fluconazole is rapidly distributed to the tissue, where it accumulates.  Tissues fall into 1 of 4 groups of increasing drug concn.: blood, bone and brain have the lowest concns., and spleen has the highest.  The vol. of distribution (Vd) remains stable at 46.3±7.9L and is considered to be an "invariant" parameter across species.  Fluconazole is poorly metabolized and is mainly eliminated unchanged in the urine.  The percentage of the dose recovered in the urine in 48 h is close to 60%.  Concns. in the urine are high and the half-life (t 1/2) is long (37.2±5.5h) in patients, mainly those with AIDS, which is not significantly different from the t 1/2 (31.4±4.7 h) in healthy individuals.  The mean total clearance is 1.073±0.473 L/h and renal clearance is 72% of the total clearance.  The pharmacokinetics of fluconazole are different in infants (larger Vd and shorter t 1/2) so that the fluconazole dosage must be adjusted accordingly.  Absorption is rapid and nearly complete, but i.v. administration is preferred for neonates.  The Cmax and AUC0→∞ vary linearly with the dose, and tmax is 1 to 2 h.  The mean Vd is 1.15±0.52 L/kg; it is largest in neonates and decreases in young adult to a value similar to that in adults.  The mean t 1/2 is very long (71±417 h) in premature and neonates and is correlated with age during the first weeks of life.  It stabilizes to around 21.2±5.1 h during the first years of life, shorter than in adults.  Renal clearance is 65±5% of total clearance.  T 1/2 increases with decreasing renal function in renal disease.  It is 124.6 to 98.1 h in patients with end-stage renal failure and the dose must be decreased by 50% or the interval between doses extended 2- to 3-fold.  In patients on CAPD the t 1/2 (79±7 h) is intermediate between those reported in patients with or without renal disease and a 150mg dose is needed in a single dialyzate bag every 48 h.  The t 1/2 does not change in hemodialysis purification mode and the dose given at the end of dialysis need not be changed.  Fluconazole increases the concns. of glipizide, glyburide, midazolam, nortriptyline, phenytoin, rifabutin, tacrolimus, tolbutamide and cyclosporin at doses over 200mg daily.  Cimetidine and rifampicin (rifampin) decrease the concns. of fluconazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-RWZ8YrWnXLVg90H21EOLACvtfcHk0liQS8aICIZXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltlShsbg%253D&md5=3f62b9b5ea79c4d8ca6b28ba26da215f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2165%2F00003088-199733010-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199733010-00005%26sid%3Dliteratum%253Aachs%26aulast%3DDebruyne%26aufirst%3DD.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520fluconazole%2520in%2520superficial%2520and%2520systemic%2520mycoses%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1997%26volume%3D33%26spage%3D52%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Summerfield, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osuna, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffo, A. D.</span><span> </span><span class="NLM_article-title">Toward an improved prediction of human <i>in vivo</i> brain penetration</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">–</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1518-1535&author=S.+G.+Summerfieldauthor=A.+J.+Lucasauthor=R.+A.+Porterauthor=P.+Jeffreyauthor=R.+N.+Gunnauthor=K.+R.+Readauthor=A.+J.+Stevensauthor=A.+C.+Metcalfauthor=M.+C.+Osunaauthor=P.+J.+Kilfordauthor=J.+Passchierauthor=A.+D.+Ruffo&title=Toward+an+improved+prediction+of+human+in+vivo+brain+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DLucas%26aufirst%3DA.%2BJ.%26aulast%3DPorter%26aufirst%3DR.%2BA.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRead%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DMetcalf%26aufirst%3DA.%2BC.%26aulast%3DOsuna%26aufirst%3DM.%2BC.%26aulast%3DKilford%26aufirst%3DP.%2BJ.%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DRuffo%26aufirst%3DA.%2BD.%26atitle%3DToward%2520an%2520improved%2520prediction%2520of%2520human%2520in%2520vivo%2520brain%2520penetration%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D1518%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0liQS8aICIZXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summerfield, S. G.</span><span> </span><span class="NLM_article-title">Challenges for blood–brain barrier (BBB) screening</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=1135-1151&author=P.+Jeffreyauthor=S.+G.+Summerfield&title=Challenges+for+blood%E2%80%93brain+barrier+%28BBB%29+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26atitle%3DChallenges%2520for%2520blood%25E2%2580%2593brain%2520barrier%2520%2528BBB%2529%2520screening%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26spage%3D1135%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0liNA8xBHRRkhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Garberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindmark, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabondzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanimirovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeberg, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oesterberg, T.</span><span> </span><span class="NLM_article-title"><i>In-vitro</i> models for the blood brain barrier</span> <span class="citation_source-journal">Toxicol. In Vitro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=299-334&author=P.+Garbergauthor=M.+Ballauthor=N.+Borgauthor=R.+Cecchelliauthor=L.+Fenartauthor=R.+D.+Hurstauthor=T.+Lindmarkauthor=A.+Mabondzoauthor=J.+E.+Nilssonauthor=T.+J.+Raubauthor=D.+Stanimirovicauthor=T.+Terasakiauthor=J.+O.+Oebergauthor=T.+Oesterberg&title=In-vitro+models+for+the+blood+brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarberg%26aufirst%3DP.%26aulast%3DBall%26aufirst%3DM.%26aulast%3DBorg%26aufirst%3DN.%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DFenart%26aufirst%3DL.%26aulast%3DHurst%26aufirst%3DR.%2BD.%26aulast%3DLindmark%26aufirst%3DT.%26aulast%3DMabondzo%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DJ.%2BE.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DStanimirovic%26aufirst%3DD.%26aulast%3DTerasaki%26aufirst%3DT.%26aulast%3DOeberg%26aufirst%3DJ.%2BO.%26aulast%3DOesterberg%26aufirst%3DT.%26atitle%3DIn-vitro%2520models%2520for%2520the%2520blood%2520brain%2520barrier%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2005%26volume%3D19%26spage%3D299%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0liNA8xBHRRkhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chenauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0liNA8xBHRRkhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DChen%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Giacomini, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillgren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmaster, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Membrane transporters in drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=20190787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-236&author=K.+M.+Giacominiauthor=S.-M.+Huangauthor=D.+J.+Tweedieauthor=L.+Z.+Benetauthor=K.+L.+R.+Brouwerauthor=X.+Chuauthor=A.+Dahlinauthor=R.+Eversauthor=V.+Fischerauthor=K.+M.+Hillgrenauthor=K.+A.+Hoffmasterauthor=T.+Ishikawaauthor=D.+Kepplerauthor=R.+B.+Kimauthor=C.+A.+Leeauthor=M.+Niemiauthor=J.+W.+Polliauthor=Y.+Sugiyamaauthor=P.+W.+Swaanauthor=J.+A.+Wareauthor=S.+H.+Wrightauthor=S.+W.+Yeeauthor=M.+J.+Zamek-Gliszczynskiauthor=L.+Zhang&title=Membrane+transporters+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transporters in drug development</span></div><div class="casAuthors">Giacomini, Kathleen M.; Huang, Shiew-Mei; Tweedie, Donald J.; Benet, Leslie Z.; Brouwer, Kim L. R.; Chu, Xiaoyan; Dahlin, Amber; Evers, Raymond; Fischer, Volker; Hillgren, Kathleen M.; Hoffmaster, Keith A.; Ishikawa, Toshihisa; Keppler, Dietrich; Kim, Richard B.; Lee, Caroline A.; Niemi, Mikko; Polli, Joseph W.; Sugiyama, Yuicchi; Swaan, Peter W.; Ware, Joseph A.; Wright, Stephen H.; Wah Yee, Sook; Zamek-Gliszczynski, Maciej J.; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-236</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs.  This presents several key questions for drug development, including which transporters are clin. important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters.  In addn., what criteria should trigger follow-up clin. studies, and which clin. studies should be conducted if needed.  In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clin. studies on the currently recognized most important drug transporter interactions.  The recommendations are generally intended to support clin. development and filing of a new drug application.  Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clin. trial enrollment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metab. and excretion properties of the drug mol., and information required for drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiBIf0gk93W7Vg90H21EOLACvtfcHk0liD3MiCVlf8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D&md5=89d9ce746284c1814fb01cd9b9a72027</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnrd3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3028%26sid%3Dliteratum%253Aachs%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%2BR.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DDahlin%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHillgren%26aufirst%3DK.%2BM.%26aulast%3DHoffmaster%26aufirst%3DK.%2BA.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DNiemi%26aufirst%3DM.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DWare%26aufirst%3DJ.%2BA.%26aulast%3DWright%26aufirst%3DS.%2BH.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMembrane%2520transporters%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">The P-glycoprotein efflux pump: how does it transport drugs?</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2Fs002329900305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9425600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1997&pages=161-175&author=F.+J.+Sharom&title=The+P-glycoprotein+efflux+pump%3A+how+does+it+transport+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The P-glycoprotein efflux pump: how does it transport drugs?</span></div><div class="casAuthors">Sharom, F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-175</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">A review, with 118 refs.  P-glycoprotein (Pgp) is an atypical translocating ATPase, with low affinity for ATP and high constitutive ATPase activity.  Pgp also has an unusually broad specificity for hydrophobic substrates, including many chemotherapeutic drugs.  Transport studies in reconstituted systems indicate that drug transport requires ATP hydrolysis and is active, generating a drug concn. gradient.  Binding of drugs and ATP to Pgp induces conformational changes in the protein, and the drug binding site is conformationally coupled to nucleotide-binding domains.  Evidence accumulated to date suggest that the transporter interact directly with nonpolar substrate within the membrane environment, and may act as drug flippase, moving drug from the inner to outer leaflet of the bilayer.  Chemosensitizers that block the action of Pgp are proposed to act as alternative substrates, but their high rate of spontaneous flip-flop across the membrane results in futile cycling of the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpduTsyKNWuPrVg90H21EOLACvtfcHk0liD3MiCVlf8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D&md5=52fb1ef5b0a0772eeda2ee1c474ae374</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs002329900305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900305%26sid%3Dliteratum%253Aachs%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520P-glycoprotein%2520efflux%2520pump%253A%2520how%2520does%2520it%2520transport%2520drugs%253F%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1997%26volume%3D160%26spage%3D161%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casals, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittman-Grauer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biedler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertino, J. R.</span><span> </span><span class="NLM_article-title">Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=695-698&author=C.+Cordon-Cardoauthor=J.+P.+O%E2%80%99Brienauthor=D.+Casalsauthor=L.+Rittman-Grauerauthor=J.+L.+Biedlerauthor=M.+R.+Melamedauthor=J.+R.+Bertino&title=Multidrug-resistance+gene+%28P-glycoprotein%29+is+expressed+by+endothelial+cells+at+blood-brain+barrier+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BP.%26aulast%3DCasals%26aufirst%3DD.%26aulast%3DRittman-Grauer%26aufirst%3DL.%26aulast%3DBiedler%26aufirst%3DJ.%2BL.%26aulast%3DMelamed%26aufirst%3DM.%2BR.%26aulast%3DBertino%26aufirst%3DJ.%2BR.%26atitle%3DMultidrug-resistance%2520gene%2520%2528P-glycoprotein%2529%2520is%2520expressed%2520by%2520endothelial%2520cells%2520at%2520blood-brain%2520barrier%2520sites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D695%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Doan, M. K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=M.+K.+M.+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein-mediated+efflux+differentiate+central+nervous+system+%28CNS%29+and+non-CNS+marketed+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Doan, Kelly M. Mahar; Humphreys, Joan E.; Webster, Lindsey O.; Wring, Stephen A.; Shampine, Larry J.; Serabjit-Singh, Cosette J.; Adkison, Kimberly K.; Polli, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-1037</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to det. whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochem. properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compds. for drug development.  Apparent permeability (Papp) and Pgp substrate profiles for 93 CNS and non-CNS drugs were detd. by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were pos. in the calcein-AM assay when tested at 100 μM.  The CNS drug set (of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (of 45, 42.2%).  Anal. of 18 physicochem. properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer pos. charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group, properties that enhance membrane permeability.  This study on a large, diverse set of marketed compds. clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochem. properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B → A/A → B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2qUc-kS0MC7Vg90H21EOLACvtfcHk0liD3MiCVlf8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlamtLg%253D&md5=bcac11a02278360d6d6ad48718f0d5be</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DM.%2BK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein-mediated%2520efflux%2520differentiate%2520central%2520nervous%2520system%2520%2528CNS%2529%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jodoin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagenais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghrabi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Drug transport to the brain: Key roles for the efflux pump P-glycoprotein in the blood–brain barrier</span> <span class="citation_source-journal">Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2002&pages=339-348&author=M.+Demeuleauthor=A.+Reginaauthor=J.+Jodoinauthor=A.+Laplanteauthor=C.+Dagenaisauthor=F.+Bertheletauthor=A.+Moghrabiauthor=R.+Beliveau&title=Drug+transport+to+the+brain%3A+Key+roles+for+the+efflux+pump+P-glycoprotein+in+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DJodoin%26aufirst%3DJ.%26aulast%3DLaplante%26aufirst%3DA.%26aulast%3DDagenais%26aufirst%3DC.%26aulast%3DBerthelet%26aufirst%3DF.%26aulast%3DMoghrabi%26aufirst%3DA.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DDrug%2520transport%2520to%2520the%2520brain%253A%2520Key%2520roles%2520for%2520the%2520efflux%2520pump%2520P-glycoprotein%2520in%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2002%26volume%3D38%26spage%3D339%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lgtIdYhWzebXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Hsiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasongko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankoff, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Verapamil P-glycoprotein transport across the rat blood–brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.105.097931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16415090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=704-710&author=P.+Hsiaoauthor=L.+Sasongkoauthor=J.+M.+Linkauthor=D.+A.+Mankoffauthor=M.+Muziauthor=A.+C.+Collierauthor=J.+D.+Unadkat&title=Verapamil+P-glycoprotein+transport+across+the+rat+blood%E2%80%93brain+barrier%3A+cyclosporine%2C+a+concentration+inhibition+analysis%2C+and+comparison+with+human+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Verapamil p-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data</span></div><div class="casAuthors">Hsiao, Peng; Sasongko, Lucy; Link, Jeanne M.; Mankoff, David A.; Muzi, Mark; Collier, Ann C.; Unadkat, Jashvant D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">704-710</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">To predict the magnitude of P-glycoprotein (P-gp)-based drug interactions at the human blood-brain barrier (BBB), rodent studies are routinely conducted where P-gp is chem. inhibited.  For such studies to be predictive of interactions at the human BBB, the plasma concn. of the P-gp inhibitor must be comparable with that obsd. in the clinic.  Therefore, we detd. the in vivo EC50 of P-gp inhibition at the rat BBB using verapamil as a model P-gp substrate and cyclosporine A (CsA) as the model P-gp inhibitor.  Under isoflurane anesthesia, male Sprague-Dawley rats were administered i.v. CsA to achieve pseudo steady-state CsA blood concns. ranging from 0 to ∼12 μM.  Then, an i.v. tracer dose of [3H]verapamil was administered, and 20 min after verapamil administration, the animals were sacrificed for detn. of blood, plasma, and brain 3H radioactivity by scintillation counting.  The percentage increase in the brain/blood 3H radioactivity (relative to 0 μM CsA) was described by the Hill equation with Emax, 1290%; EC50, 7.2 μM; and γ, 3.8.  Previously, using [11C]verapamil, we have shown that the human brain/blood 11C radioactivity was increased by 79% at 2.8 μM CsA blood concn.  At an equiv. CsA blood concn., the rat brain/blood 3H radioactivity was increased by a remarkably similar extent of 75%.  This is the first time that an in vivo CsA EC50 of P-gp inhibition at the rat BBB has been detd. and the magnitude of such inhibition was compared between the rat and the human BBB at the same blood CsA concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZB-ViPTeAabVg90H21EOLACvtfcHk0lgtIdYhWzebXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamurg%253D&md5=a61944c26815e07bdbd08a5bd94927ed</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097931%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DP.%26aulast%3DSasongko%26aufirst%3DL.%26aulast%3DLink%26aufirst%3DJ.%2BM.%26aulast%3DMankoff%26aufirst%3DD.%2BA.%26aulast%3DMuzi%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DVerapamil%2520P-glycoprotein%2520transport%2520across%2520the%2520rat%2520blood%25E2%2580%2593brain%2520barrier%253A%2520cyclosporine%252C%2520a%2520concentration%2520inhibition%2520analysis%252C%2520and%2520comparison%2520with%2520human%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D704%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Aller, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittaboina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbatsch, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span> </span><span class="NLM_article-title">Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">1718</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1126%2Fscience.1168750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19325113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1718-1722&author=S.+G.+Allerauthor=J.+Yuauthor=A.+Wardauthor=Y.+Wengauthor=S.+Chittaboinaauthor=R.+Zhuoauthor=P.+M.+Harrellauthor=Y.+T.+Trinhauthor=Q.+Zhangauthor=I.+L.+Urbatschauthor=G.+Chang&title=Structure+of+P-glycoprotein+reveals+a+molecular+basis+for+poly-specific+drug+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span></div><div class="casAuthors">Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5922</span>),
    <span class="NLM_cas:pages">1718-1722</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chem. unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers.  Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors.  The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of ~6000 angstroms cubed with a 30 angstrom sepn. of the two nucleotide-binding domains.  Two addnl. P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and arom. interactions.  Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry.  The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2EUmR-iQyaLVg90H21EOLACvtfcHk0lhwAOmyTpTfDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D&md5=66c7398b0257e6c05161a1afbecdafb1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168750%26sid%3Dliteratum%253Aachs%26aulast%3DAller%26aufirst%3DS.%2BG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChittaboina%26aufirst%3DS.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DP.%2BM.%26aulast%3DTrinh%26aufirst%3DY.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DChang%26aufirst%3DG.%26atitle%3DStructure%2520of%2520P-glycoprotein%2520reveals%2520a%2520molecular%2520basis%2520for%2520poly-specific%2520drug%2520binding%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D1718%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Desai, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, M.-J.</span><span> </span><span class="NLM_article-title">How hydrogen bonds impact P-glycoprotein transport and permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6540</span><span class="NLM_x">–</span> <span class="NLM_lpage">6548</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.bmcl.2012.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=23006604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6540-6548&author=P.+V.+Desaiauthor=T.+J.+Raubauthor=M.-J.+Blanco&title=How+hydrogen+bonds+impact+P-glycoprotein+transport+and+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">How hydrogen bonds impact P-glycoprotein transport and permeability</span></div><div class="casAuthors">Desai, Prashant V.; Raub, Thomas J.; Blanco, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6540-6548</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The requirement to cross a biol. membrane can be a complex process esp. if multidrug transporters such as P-gp must be considered.  Drug partitioning into the lipid membrane and efflux by P-gp are tightly coupled processes wherein H-bonding interactions play a key role.  All H-bond donors and acceptors are not equal in terms of the strength of the H-bonds that they form, hence it is important to consider their relative strength.  Using various examples from literature, we illustrate the benefits of considering the relative strengths of individual H-bonds and introducing intramol. H-bonds to increase membrane permeability and/or decrease P-gp efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxB3oN1ILz7LVg90H21EOLACvtfcHk0lhwAOmyTpTfDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO&md5=a27f286d4349eec6f76b745b19ccf84f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DP.%2BV.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DBlanco%26aufirst%3DM.-J.%26atitle%3DHow%2520hydrogen%2520bonds%2520impact%2520P-glycoprotein%2520transport%2520and%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6540%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Raub, T. J.; Lutzke, B. S.; Andrus, P. K.; Sawada, G. A.; Staton, B. A.</span><span> </span><span class="NLM_article-title">Early preclinical evaluation of brain exposure in support of hit identification and lead optimization</span>. In  <span class="citation_source-book">Optimizing the ‘Drug-Like’ Properties of Leads in Drug Discovery</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Borchardt, R. T.; Kerns, E. H.; Hageman, M. J.; Thakker, D. R.; Stevens, J. L.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2F978-0-387-44961-6_16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=355-410&author=T.+J.+Raub&author=B.+S.+Lutzke&author=P.+K.+Andrus&author=G.+A.+Sawada&author=B.+A.+Statonauthor=R.+T.+Borchardt&author=E.+H.+Kerns&author=M.+J.+Hageman&author=D.+R.+Thakker&author=J.+L.+Stevens&title=Optimizing+the+%E2%80%98Drug-Like%E2%80%99+Properties+of+Leads+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-44961-6_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-44961-6_16%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DEarly%2520preclinical%2520evaluation%2520of%2520brain%2520exposure%2520in%2520support%2520of%2520hit%2520identification%2520and%2520lead%2520optimization%26btitle%3DOptimizing%2520the%2520%25E2%2580%2598Drug-Like%25E2%2580%2599%2520Properties%2520of%2520Leads%2520in%2520Drug%2520Discovery%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26pub%3DSpringer%26date%3D2006%26spage%3D355%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Doyle, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abruzzo, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span> </span><span class="NLM_article-title">A multidrug resistance transporter from human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15665</span><span class="NLM_x">–</span> <span class="NLM_lpage">15670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+multidrug+resistance+transporter+from+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0lhwAOmyTpTfDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520multidrug%2520resistance%2520transporter%2520from%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Eisenblatter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galla, H. J.</span><span> </span><span class="NLM_article-title">A new multidrug resistance protein at the blood-brain barrier</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2002&pages=1273-1278&author=T.+Eisenblatterauthor=H.+J.+Galla&title=A+new+multidrug+resistance+protein+at+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisenblatter%26aufirst%3DT.%26aulast%3DGalla%26aufirst%3DH.%2BJ.%26atitle%3DA%2520new%2520multidrug%2520resistance%2520protein%2520at%2520the%2520blood-brain%2520barrier%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D293%26spage%3D1273%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, W. F.</span><span> </span><span class="NLM_article-title">P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.109.154781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19491323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyitL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=956-63&author=Y.+Chenauthor=S.+Agarwalauthor=N.+M.+Shaikauthor=C.+Chenauthor=Z.+Yangauthor=W.+F.+Elmquist&title=P-glycoprotein+and+breast+cancer+resistance+protein+influence+brain+distribution+of+dasatinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib</span></div><div class="casAuthors">Chen, Ying; Agarwal, Sagar; Shaik, Naveed M.; Chen, Cliff; Yang, Zheng; Elmquist, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">956-963</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The novel tyrosine kinase inhibitor dasatinib (Sprycel; BMS-354825) is approved for use in imatinib (Gleevec; STI 571)-resistant or -intolerant chronic myelogenous leukemia and may be useful for other tumors in the central nervous system (CNS).  The objective of this study was to investigate the role of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in modulating the CNS penetration of dasatinib.  Results from the in vitro studies indicate that cellular delivery of dasatinib is significantly limited by active efflux due to both P-gp and BCRP.  Permeability studies indicated greater permeability in the basolateral-to-apical direction than in the apical-to-basolateral direction due to active efflux by P-gp or BCRP.  Selective inhibitors of P-gp and BCRP, such as (R)-4-((1aR,6R,10bS)-1,2-difluoro-1,1a,6,10b-tetrahydrodibenzo-(a,e)cyclopropa(c) cycloheptan-6-yl)-α-((5-quinoloyloxy)methyl)-1-piperazineethanol, trihydrochloride (zosuquidar; LY335979) and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12α-octahydropyrazino1',2':1,6pryrido3,4-bindol-3-yl)-propionic acid tert-Bu ester (Ko143), were able to restore the intracellular accumulation and abolish the directionality in net flux of dasatinib.  In vivo brain distribution studies showed that the CNS distribution of dasatinib is limited, with the brain-to-plasma concn. ratios less than 0.12 in wild-type mice, which increased approx. 8-fold in Mdr1a/b(-/-) Bcrp1(-/-) mice.  Dasatinib brain distribution was significantly increased in Mdr1a/b(-/-) mice and when wild-type mice were pretreated with LY335979.  Simultaneous inhibition of P-gp and BCRP by elacridar [N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide] (GF120918) resulted in a 5-fold increase in brain concn.  These in vitro and in vivo studies demonstrate that dasatinib is a substrate for the important efflux transporters p-glycoprotein and BCRP.  These transport systems play a significant role in limiting the CNS delivery of dasatinib and may have direct implications in the treatment of primary and metastatic brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7uWzd3Qm6q7Vg90H21EOLACvtfcHk0liIzK_rdosejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyitL3F&md5=2b43bf0468e6fea3a5aae1f84b3fb69d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.154781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.154781%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DShaik%26aufirst%3DN.%2BM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DP-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520influence%2520brain%2520distribution%2520of%2520dasatinib%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D956%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Tang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lankheet, N. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrand, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijnen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1002%2Fijc.26000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21351087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOmsrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2012&pages=223-233&author=S.+C.+Tangauthor=J.+C.+Lagasauthor=N.+A.+G.+Lankheetauthor=B.+Pollerauthor=M.+J.+Hillebrandauthor=H.+Rosingauthor=J.+H.+Beijnenauthor=A.+H.+Schinkel&title=Brain+accumulation+of+sunitinib+is+restricted+by+P-glycoprotein+%28ABCB1%29+and+breast+cancer+resistance+protein+%28ABCG2%29+and+can+be+enhanced+by+oral+elacridar+and+sunitinib+coadministration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration</span></div><div class="casAuthors">Tang, Seng Chuan; Lagas, Jurjen S.; Lankheet, Nienke A. G.; Poller, Birk; Hillebrand, Michel J.; Rosing, Hilde; Beijnen, Jos H.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-233</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Sunitinib is an orally active, multitargeted tyrosine kinase inhibitor which has been used for the treatment of metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors.  We aimed to investigate the in vivo roles of the ATP-binding cassette drug efflux transporters ABCB1 and ABCG2 in plasma pharmacokinetics and brain accumulation of oral sunitinib, and the feasibility of improving sunitinib kinetics using oral coadministration of the dual ABCB1/ABCG2 inhibitor elacridar.  We used in vitro transport assays and Abcb1a/1b-/-, Abcg2-/- and Abcb1a/1b/Abcg2-/- mice to study the roles of ABCB1 and ABCG2 in sunitinib disposition.  In vitro, sunitinib was a good substrate of murine (mu)ABCG2 and a moderate substrate of human (hu)ABCB1 and huABCG2.  In vivo, the systemic exposure of sunitinib after oral dosing (10 mg kg-1) was unchanged when muABCB1 and/or muABCG2 were absent.  Brain accumulation of sunitinib was markedly (23-fold) increased in Abcb1a/b/Abcg2-/- mice, but only slightly (2.3-fold) in Abcb1a/b-/- mice, and not in Abcg2-/- mice.  Importantly, a clin. realistic coadministration of oral elacridar and oral sunitinib to wild-type mice resulted in markedly increased sunitinib brain accumulation, equaling levels in Abcb1a/1b/Abcg2-/- mice.  This indicates complete inhibition of the blood-brain barrier (BBB) transporters.  High-dose i.v. sunitinib could sat. BBB muABCG2, but not muABCB1A, illustrating a dose-dependent relative impact of the BBB transporters.  Brain accumulation of sunitinib is effectively restricted by both muABCB1 and muABCG2 activity.  Complete inhibition of both transporters, leading to markedly increased brain accumulation of sunitinib, is feasible and safe with a clin. realistic oral elacridar/sunitinib coadministration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9Na4B5yH0LVg90H21EOLACvtfcHk0liIzK_rdosejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOmsrjP&md5=47fee810fd84296c9b1598fd8e80acf7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fijc.26000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.26000%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%2BC.%26aulast%3DLagas%26aufirst%3DJ.%2BC.%26aulast%3DLankheet%26aufirst%3DN.%2BA.%2BG.%26aulast%3DPoller%26aufirst%3DB.%26aulast%3DHillebrand%26aufirst%3DM.%2BJ.%26aulast%3DRosing%26aufirst%3DH.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DBrain%2520accumulation%2520of%2520sunitinib%2520is%2520restricted%2520by%2520P-glycoprotein%2520%2528ABCB1%2529%2520and%2520breast%2520cancer%2520resistance%2520protein%2520%2528ABCG2%2529%2520and%2520can%2520be%2520enhanced%2520by%2520oral%2520elacridar%2520and%2520sunitinib%2520coadministration%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D130%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span> </span><span class="NLM_article-title">Breast cancer resistance protein interacts with various compounds <i>in vitro</i>, but plays a minor role in substrate efflux at the blood–brain barrier</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1251-1258&author=R.+Zhaoauthor=T.+J.+Raubauthor=G.+A.+Sawadaauthor=S.+C.+Kasperauthor=J.+A.+Baconauthor=A.+S.+Bridgesauthor=G.+M.+Pollack&title=Breast+cancer+resistance+protein+interacts+with+various+compounds+in+vitro%2C+but+plays+a+minor+role+in+substrate+efflux+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DSawada%26aufirst%3DG.%2BA.%26aulast%3DKasper%26aufirst%3DS.%2BC.%26aulast%3DBacon%26aufirst%3DJ.%2BA.%26aulast%3DBridges%26aufirst%3DA.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DBreast%2520cancer%2520resistance%2520protein%2520interacts%2520with%2520various%2520compounds%2520in%2520vitro%252C%2520but%2520plays%2520a%2520minor%2520role%2520in%2520substrate%2520efflux%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1251%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Giri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakoshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, W. F.</span><span> </span><span class="NLM_article-title">Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1476</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=1476-1484&author=N.+Giriauthor=N.+Shaikauthor=G.+Panauthor=T.+Terasakiauthor=C.+Mukaiauthor=S.+Kitagakiauthor=N.+Miyakoshiauthor=W.+F.+Elmquist&title=Investigation+of+the+role+of+breast+cancer+resistance+protein+%28Bcrp%2FAbcg2%29+on+pharmacokinetics+and+central+nervous+system+penetration+of+abacavir+and+zidovudine+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiri%26aufirst%3DN.%26aulast%3DShaik%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DTerasaki%26aufirst%3DT.%26aulast%3DMukai%26aufirst%3DC.%26aulast%3DKitagaki%26aufirst%3DS.%26aulast%3DMiyakoshi%26aufirst%3DN.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DInvestigation%2520of%2520the%2520role%2520of%2520breast%2520cancer%2520resistance%2520protein%2520%2528Bcrp%252FAbcg2%2529%2520on%2520pharmacokinetics%2520and%2520central%2520nervous%2520system%2520penetration%2520of%2520abacavir%2520and%2520zidovudine%2520in%2520the%2520mouse%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D1476%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Ball, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzom, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decleves, X.</span><span> </span><span class="NLM_article-title">Physiologically based pharmacokinetic modelling of drug penetration across the blood–brain barrier—Towards a mechanistic IVIVE-based approach</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=913-932&author=K.+Ballauthor=F.+Bouzomauthor=J.-M.+Scherrmannauthor=B.+Waltherauthor=X.+Decleves&title=Physiologically+based+pharmacokinetic+modelling+of+drug+penetration+across+the+blood%E2%80%93brain+barrier%E2%80%94Towards+a+mechanistic+IVIVE-based+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBall%26aufirst%3DK.%26aulast%3DBouzom%26aufirst%3DF.%26aulast%3DScherrmann%26aufirst%3DJ.-M.%26aulast%3DWalther%26aufirst%3DB.%26aulast%3DDecleves%26aufirst%3DX.%26atitle%3DPhysiologically%2520based%2520pharmacokinetic%2520modelling%2520of%2520drug%2520penetration%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%25E2%2580%2594Towards%2520a%2520mechanistic%2520IVIVE-based%2520approach%26jtitle%3DAAPS%2520J.%26date%3D2013%26volume%3D15%26spage%3D913%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Ball, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzom, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decleves, X.</span><span> </span><span class="NLM_article-title">Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an <i>in vitro</i>–<i>in vivo</i> scaling methodology for the blood–brain barrier permeability of two transporter substrates, morphine and oxycodone</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">4277</span><span class="NLM_x">–</span> <span class="NLM_lpage">4292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=4277-4292&author=K.+Ballauthor=F.+Bouzomauthor=J.-M.+Scherrmannauthor=B.+Waltherauthor=X.+Decleves&title=Development+of+a+physiologically+based+pharmacokinetic+model+for+the+rat+central+nervous+system+and+determination+of+an+in+vitro%E2%80%93in+vivo+scaling+methodology+for+the+blood%E2%80%93brain+barrier+permeability+of+two+transporter+substrates%2C+morphine+and+oxycodone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBall%26aufirst%3DK.%26aulast%3DBouzom%26aufirst%3DF.%26aulast%3DScherrmann%26aufirst%3DJ.-M.%26aulast%3DWalther%26aufirst%3DB.%26aulast%3DDecleves%26aufirst%3DX.%26atitle%3DDevelopment%2520of%2520a%2520physiologically%2520based%2520pharmacokinetic%2520model%2520for%2520the%2520rat%2520central%2520nervous%2520system%2520and%2520determination%2520of%2520an%2520in%2520vitro%25E2%2580%2593in%2520vivo%2520scaling%2520methodology%2520for%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%2520of%2520two%2520transporter%2520substrates%252C%2520morphine%2520and%2520oxycodone%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D4277%26epage%3D4292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Eyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Drug interactions at the blood–brain barrier: fact or fantasy?</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.pharmthera.2009.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19393264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ahsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=80-104&author=S.+Eyalauthor=P.+Hsiaoauthor=J.+D.+Unadkat&title=Drug+interactions+at+the+blood%E2%80%93brain+barrier%3A+fact+or+fantasy%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interactions at the blood-brain barrier: Fact or fantasy?</span></div><div class="casAuthors">Eyal, Sara; Hsiao, Peng; Unadkat, Jashvant D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-104</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  There is considerable interest in the therapeutic and adverse outcomes of drug interactions at the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB).  These include altered efficacy of drugs used in the treatment of CNS disorders, such as AIDS dementia and malignant tumors, and enhanced neurotoxicity of drugs that normally penetrate poorly into the brain.  BBB- and BCSFB-mediated interactions are possible because these interfaces are not only passive anatomical barriers, but are also dynamic in that they express a variety of influx and efflux transporters and drug metabolizing enzymes.  Based on studies in rodents, it has been widely postulated that efflux transporters play an important role at the human BBB in terms of drug delivery.  Furthermore, it is assumed that chem. inhibition of transporters or their genetic ablation in rodents is predictive of the magnitude of interaction to be expected at the human BBB.  However, studies in humans challenge this well-established paradigm and claim that such drug interactions will be lesser in magnitude but yet may be clin. significant.  This review focuses on current known mechanisms of drug interactions at the blood-brain and blood-CSF barriers and the potential impact of such interactions in humans.  We also explore whether such drug interactions can be predicted from preclin. studies.  Defining the mechanisms and the impact of drug-drug interactions at the BBB is important for improving efficacy of drugs used in the treatment of CNS disorders while minimizing their toxicity as well as minimizing neurotoxicity of non-CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotLboooAs_BrVg90H21EOLACvtfcHk0lhCzrcDGIS6gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ahsb0%253D&md5=29866ee9b51e99a5fd1833ef680ea7d8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2009.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2009.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DEyal%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DP.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DDrug%2520interactions%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%253A%2520fact%2520or%2520fantasy%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2009%26volume%3D123%26spage%3D80%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdet, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span> </span><span class="NLM_article-title">Why clinical modulation of efflux transport at the human blood–brain barrier is unlikely: the ITC evidence-based position</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fclpt.2013.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=23588303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVOrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=80-94&author=J.+C.+Kalvassauthor=J.+W.+Polliauthor=D.+L.+Bourdetauthor=B.+Fengauthor=S.-M.+Huangauthor=X.+Liuauthor=Q.+R.+Smithauthor=L.+K.+Zhangauthor=M.+J.+Zamek-Gliszczynski&title=Why+clinical+modulation+of+efflux+transport+at+the+human+blood%E2%80%93brain+barrier+is+unlikely%3A+the+ITC+evidence-based+position"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Why Clinical Modulation of Efflux Transport at the Human Blood-Brain Barrier Is Unlikely: The ITC Evidence-Based Position</span></div><div class="casAuthors">Kalvass, J. C.; Polli, J. W.; Bourdet, D. L.; Feng, B.; Huang, S.-M.; Liu, X.; Smith, Q. R.; Zhang, L. K.; Zamek-Gliszczynski, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-94</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Drug interactions due to efflux transport inhibition at the blood-brain barrier (BBB) have been receiving increasing scrutiny because of the theor. possibility of adverse central nervous system (CNS) effects identified in preclin. studies.  In this review, evidence from pharmacokinetic, pharmacodynamic, imaging, pharmacogenetic, and pharmacovigilance studies, along with drug safety reports, is presented supporting a low probability of modulating transporters at the human BBB by currently marketed drugs.  Clin. Pharmacol. & Therapeutics (2013); 94 1, 80-94. doi:10.1038/clpt.2013.34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfxdzZMTG6_7Vg90H21EOLACvtfcHk0lhCzrcDGIS6gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVOrtbY%253D&md5=c106f689e1c83f58eb6d0dbc527cf0fa</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2013.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2013.34%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBourdet%26aufirst%3DD.%2BL.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26aulast%3DZhang%26aufirst%3DL.%2BK.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26atitle%3DWhy%2520clinical%2520modulation%2520of%2520efflux%2520transport%2520at%2520the%2520human%2520blood%25E2%2580%2593brain%2520barrier%2520is%2520unlikely%253A%2520the%2520ITC%2520evidence-based%2520position%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2013%26volume%3D94%26spage%3D80%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deemter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voordouw, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spits, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlmans, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fibbe, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span> </span><span class="NLM_article-title">Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">4028</span><span class="NLM_x">–</span> <span class="NLM_lpage">4033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1073%2Fpnas.94.8.4028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9108099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXis1akurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4028-4033&author=A.+H.+Schinkelauthor=U.+Mayerauthor=E.+Wagenaarauthor=C.+A.+A.+M.+Molauthor=L.+van+Deemterauthor=J.+J.+M.+Smitauthor=M.+A.+van+der+Valkauthor=A.+C.+Voordouwauthor=H.+Spitsauthor=O.+van+Tellingenauthor=J.+M.+Zijlmansauthor=W.+E.+Fibbeauthor=P.+Borst&title=Normal+viability+and+altered+pharmacokinetics+in+mice+lacking+mdr1-type+%28drug-transporting%29+P-glycoproteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins</span></div><div class="casAuthors">Schinkel, Alfred H.; Mayer, Ulrich; Wagenaar, Els; Mol, Carla A. A. M.; van Deemter, Liesbeth; Smit, Jaap J. M.; van der Valk, Martin A.; Voordouw, Arie C.; Spits, Hergen; van Tellingen, Olaf; Zijlmans, J. Mark J. M.; Fibbe, Willem E.; Borst, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4028-4033</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mdr1-type P-glycoproteins (P-gps) confer multidrug resistance to cancer cells by active extrusion of a wide range of drugs from the cell.  To study their physiol. roles, the authors have generated mice genetically deficient in the mdr1b gene [mdr1b (-/-) mice] and in both the mdr1a and mdr1b genes [mdr1a/1b (-/-) mice].  In spite of the host of functions speculatively attributed to the mdr1-type P-gps, the authors found no physiol. abnormalities in either strain.  Viability, fertility, and a range of histol., hematol., serum-chem., and immunol. parameters were not abnormal in mdr1a/1b (-/-) mice.  The high level of mdr1b P-gp normally present in the pregnant uterus did not protect fetuses from a drug (digoxin) in the bloodstream of the mother, although the protein did reduce drug accumulation in the mother, although the protein did reduce drug accumulation in the adrenal gland and ovaries.  Pharmacol., mdr1a/1b (-/-) mice behaved similarly to the previously analyzed mdr1a (-/-) mice, displaying, for instance, increased brain penetration and reduced elimination of digoxin.  However, both mdr1a and mdr1b P-gps contributed to the extrusion of rhodamine from hematopoietic progenitor cells, suggesting a potential role for the endogenous mdr1-type P-gps in protection of bone marrow against cytotoxic anticancer drugs.  This, and the normal viability of mdr1a/1b (-/-) mice, has implications for the use of P-gp-blocking agents in cancer and other chemotherapy.  Mdr1a/1b (-/-) mice should provide a useful model system to further test the pharmacol. roles of the drug-transporting P-gps and to analyze the specificity and effectivity of P-gp-blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtwe5hHz5m7Vg90H21EOLACvtfcHk0ljVvhxAUw-Mug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1akurk%253D&md5=37f9d88768c8eab633618eabb7f19eee</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.8.4028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.8.4028%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DMayer%26aufirst%3DU.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DMol%26aufirst%3DC.%2BA.%2BA.%2BM.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DSmit%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DM.%2BA.%26aulast%3DVoordouw%26aufirst%3DA.%2BC.%26aulast%3DSpits%26aufirst%3DH.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DZijlmans%26aufirst%3DJ.%2BM.%26aulast%3DFibbe%26aufirst%3DW.%2BE.%26aulast%3DBorst%26aufirst%3DP.%26atitle%3DNormal%2520viability%2520and%2520altered%2520pharmacokinetics%2520in%2520mice%2520lacking%2520mdr1-type%2520%2528drug-transporting%2529%2520P-glycoproteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D4028%26epage%3D4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span> </span><span class="NLM_article-title">Development of a P-glycoprotein knockout model in rodents to define species differences in its functional effect at the blood–brain barrier</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1944</span><span class="NLM_x">–</span> <span class="NLM_lpage">1953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1944-1953&author=L.+Cutlerauthor=C.+Howesauthor=N.+J.+Deeksauthor=T.+L.+Buckauthor=P.+Jeffrey&title=Development+of+a+P-glycoprotein+knockout+model+in+rodents+to+define+species+differences+in+its+functional+effect+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DBuck%26aufirst%3DT.%2BL.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520a%2520P-glycoprotein%2520knockout%2520model%2520in%2520rodents%2520to%2520define%2520species%2520differences%2520in%2520its%2520functional%2520effect%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D1944%26epage%3D1953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Syvanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornum, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langstrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Species differences in blood–brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=635-643&author=S.+Syvanenauthor=O.+Lindheauthor=M.+Palnerauthor=B.+R.+Kornumauthor=O.+Rahmanauthor=B.+Langstromauthor=G.+M.+Knudsenauthor=M.+Hammarlund-Udenaes&title=Species+differences+in+blood%E2%80%93brain+barrier+transport+of+three+positron+emission+tomography+radioligands+with+emphasis+on+P-glycoprotein+transport"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSyvanen%26aufirst%3DS.%26aulast%3DLindhe%26aufirst%3DO.%26aulast%3DPalner%26aufirst%3DM.%26aulast%3DKornum%26aufirst%3DB.%2BR.%26aulast%3DRahman%26aufirst%3DO.%26aulast%3DLangstrom%26aufirst%3DB.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DSpecies%2520differences%2520in%2520blood%25E2%2580%2593brain%2520barrier%2520transport%2520of%2520three%2520positron%2520emission%2520tomography%2520radioligands%2520with%2520emphasis%2520on%2520P-glycoprotein%2520transport%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D635%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Desai, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span> </span><span class="NLM_article-title">Integration of <i>in silico</i> and <i>in vitro</i> tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1249</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp300555n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1249-1261&author=P.+V.+Desaiauthor=G.+A.+Sawadaauthor=I.+A.+Watsonauthor=T.+J.+Raub&title=Integration+of+in+silico+and+in+vitro+tools+for+scaffold+optimization+during+drug+discovery%3A+predicting+P-glycoprotein+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Integration of in Silico and in Vitro Tools for Scaffold Optimization during Drug Discovery: Predicting P-Glycoprotein Efflux</span></div><div class="casAuthors">Desai, Prashant V.; Sawada, Geri A.; Watson, Ian A.; Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1249-1261</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In silico tools are regularly utilized for designing and prioritizing compds. to address challenges related to drug metab. and pharmacokinetics (DMPK) during the process of drug discovery.  P-Glycoprotein (P-gp) is a member of the ATP-binding cassette (ABC) transporters with broad substrate specificity that plays a significant role in absorption and distribution of drugs that are P-gp substrates.  As a result, screening for P-gp transport has now become routine in the drug discovery process.  Typically, bidirectional permeability assays are employed to assess in vitro P-gp efflux.  In this article, we use P-gp as an example to illustrate a well-validated methodol. to effectively integrate in silico and in vitro tools to identify and resolve key barriers during the early stages of drug discovery.  A detailed account of development and application of in silico tools such as simple guidelines based on physicochem. properties and more complex quant. structure-activity relationship (QSAR) models is provided.  The tools were developed based on structurally diverse data for more than 2000 compds. generated using a robust P-gp substrate assay over the past several years.  Anal. of physicochem. properties revealed a significantly lower proportion (<10%) of P-gp substrates among the compds. with topol. polar surface area (TPSA) <60 Å2 and the most basic cpKa <8.  In contrast, this proportion of substrates was greater than 75% for compds. with TPSA >60 Å2 and the most basic cpKa >8.  Among the various QSAR models evaluated to predict P-gp efflux, the Bagging model provided optimum prediction performance for prospective validation based on chronol. test sets.  Four sequential versions of the model were built with increasing nos. of compds. to train the models as new data became available.  Except for the first version with the smallest training set, the QSAR models exhibited robust prediction profiles with pos. prediction values (PPV) and neg. prediction values (NPV) exceeding 80%.  The QSAR model demonstrated better concordance with the manual P-gp substrate assay than an automated P-gp substrate screen.  The in silico and the in vitro tools have been effectively integrated during early stages of drug discovery to resolve P-gp-related challenges exemplified by several case studies.  Key learning based on our experience with P-gp can be widely applicable across other DMPK-related challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Q5Y8HssxH7Vg90H21EOLACvtfcHk0ljVvhxAUw-Mug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aju7o%253D&md5=3bd5239b80270c0f4ed85dffb86704ed</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fmp300555n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300555n%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DP.%2BV.%26aulast%3DSawada%26aufirst%3DG.%2BA.%26aulast%3DWatson%26aufirst%3DI.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DIntegration%2520of%2520in%2520silico%2520and%2520in%2520vitro%2520tools%2520for%2520scaffold%2520optimization%2520during%2520drug%2520discovery%253A%2520predicting%2520P-glycoprotein%2520efflux%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1249%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Didziapetris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Japertas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrauskas, A.</span><span> </span><span class="NLM_article-title">Classification analysis of P-glycoprotein substrate specificity</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1080%2F10611860310001648248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15203928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=391-406&author=R.+Didziapetrisauthor=P.+Japertasauthor=A.+Avdeefauthor=A.+Petrauskas&title=Classification+analysis+of+P-glycoprotein+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Classification Analysis of P-Glycoprotein Substrate Specificity</span></div><div class="casAuthors">Didziapetris, Remigijus; Japertas, Pranas; Avdeef, Alex; Petrauskas, Alanas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">391-406</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Prediction of P-glycoprotein substrate specificity (SPGP) can be viewed as a constituent part of a compd.'s "pharmaceutical profiling" in drug design.  This task is difficult to achieve due to several factors that raised many contradictory opinions: (i) the disparity between the SPGP values obtained in different assays, (ii) the confusion between Pgp substrates and inhibitors, (iii) the confusion between lipophilicity and amphiphilicity of Pgp substrates, and (iv) the dilemma of describing class-specific relationships when Pgp has no binding sites of high ligand specificity.  In this work, the authors compiled SPGP data for 1000 compds.  All data were represented in a binary format, assigning SPGP = 1 for substrates and SPGP = 0 for nonsubstrates.  Each value was ranked according to the reliability of exptl. assay.  Two data sets were considered.  Set 1 included 220 compds. with SPGP from polarized transport across MDR1 transfected cell monolayers.  Set 2 included the entire list of 1000 compds., with SPGP values of generally lower reliability.  Both sets were analyzed using a stepwise classification structure-activity relationship (C-SAR) method, leading to derivation of simple rules for crude estn. of SPGP values.  The obtained rules are based on the following factors: (i) compd.'s size expressed through molar wt. or vol., (ii) H-accepting given by the Abraham's β (that can be crudely approximated by the sum of O and N atoms), and (iii) ionization given by the acid and base pKa values.  Very roughly, SPGP can be estd. by the "rule of fours".  Compds. with (N + O) ≥ 8, MW > 400 and acid pKa > 4 are likely to be Pgp substrates, whereas compds. with (N+O) ≤ 4, MW < 400 and base pKa < 8 are likely to be nonsubstrates.  The obtained results support the view that Pgp functioning can be compared to a complex "mini-pharmacokinetic" system with fuzzy specificity.  This system can be described by a probabilistic version of Abraham's solvation equation, suggesting a certain similarity between Pgp transport and chromatog. retention.  The chromatog. model does not work in the case of "marginal" compds. with properties close to the "global" physicochem. cut-offs.  In the latter case various class-specific rules must be considered.  These can be assocd. with the "amphiphilicity" and "biol. similarity" of compds.  The definition of class-specific effects entails construction of the knowledge base that can be very useful in ADME profiling of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsvKJmruZ7RLVg90H21EOLACvtfcHk0ljVvhxAUw-Mug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D&md5=5b7ea95eb2d9faded5645481c1330f03</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1080%2F10611860310001648248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860310001648248%26sid%3Dliteratum%253Aachs%26aulast%3DDidziapetris%26aufirst%3DR.%26aulast%3DJapertas%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DPetrauskas%26aufirst%3DA.%26atitle%3DClassification%2520analysis%2520of%2520P-glycoprotein%2520substrate%2520specificity%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2003%26volume%3D11%26spage%3D391%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Del Amo, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yliperttula, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.ejps.2008.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18656534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyltrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=161-174&author=E.+M.+Del+Amoauthor=A.+Urttiauthor=M.+Yliperttula&title=Pharmacokinetic+role+of+L-type+amino+acid+transporters+LAT1+and+LAT2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2</span></div><div class="casAuthors">del Amo, Eva M.; Urtti, Arto; Yliperttula, Marjo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  LAT1 and LAT2 are heterodimeric large amino acid transporters that are expressed in various tissues, including the intestinal wall, blood-brain barrier, and kidney.  These transporters consist of membrane spanning light chain and heavy chain, and they act as 1:1 exchangers in concert with other amino acid transporters.  Only a few drugs (less than 10) are substrates of LAT1 and LAT2, including -DOPA, alpha-methyldopa, melphalan, and gabapentin.  The mechanisms and substrates have been mostly elucidated using mammalian cells and Xenopus oocytes.  The in vivo relevance of LAT1 and LAT2 in pharmacokinetics is obscure, because contradictory findings have been reported.  It is difficult to make quant. pharmacokinetic conclusions about LAT1 and LAT2.  This is due to the possible involvement of other transporters (including cross-linked heterodimers of light chain with different heavy chains, other overlapping transporters, for example TAT1), competing endogenous amino acids, and satn. phenomena.  This review presents the current functional knowledge on LAT1 and LAT2 with emphasis on their potential involvement in pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvc4C-d6d6X7Vg90H21EOLACvtfcHk0liVJSJ2-vfJCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyltrzP&md5=31f6073e1bc3ff74b78773373ba6a9e9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2008.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2008.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BAmo%26aufirst%3DE.%2BM.%26aulast%3DUrtti%26aufirst%3DA.%26aulast%3DYliperttula%26aufirst%3DM.%26atitle%3DPharmacokinetic%2520role%2520of%2520L-type%2520amino%2520acid%2520transporters%2520LAT1%2520and%2520LAT2%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D35%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Del. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0liVJSJ2-vfJCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Del.%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0liVJSJ2-vfJCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, <i>in vitro</i> ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0liv33oLiPv3Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-439&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liv33oLiPv3Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Defining optimum lipophilicity and molecular weight ranges for drug candidates—molecular weight dependent lower logD limits based on permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2844</span><span class="NLM_x">–</span> <span class="NLM_lpage">2851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2844-2851&author=M.+J.+Waring&title=Defining+optimum+lipophilicity+and+molecular+weight+ranges+for+drug+candidates%E2%80%94molecular+weight+dependent+lower+logD+limits+based+on+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DDefining%2520optimum%2520lipophilicity%2520and%2520molecular%2520weight%2520ranges%2520for%2520drug%2520candidates%25E2%2580%2594molecular%2520weight%2520dependent%2520lower%2520logD%2520limits%2520based%2520on%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2844%26epage%3D2851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0liv33oLiPv3Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eY8tcpslA6fpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span> </span><span class="NLM_article-title">Time-related differences in the physical property profiles of oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6338</span><span class="NLM_x">–</span> <span class="NLM_lpage">6348</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049717d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6338-6348&author=P.+D.+Leesonauthor=A.+M.+Davis&title=Time-related+differences+in+the+physical+property+profiles+of+oral+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Time-Related Differences in the Physical Property Profiles of Oral Drugs</span></div><div class="casAuthors">Leeson, Paul D.; Davis, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6338-6348</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparisons of the calcd. physicochem. properties of oral drugs launched prior to 1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of lipophilicity, percent polar surface area and H-bond donor count are the same, suggesting that these are the most important oral drug-like phys. properties.  In contrast, mean values of mol. wt. and the nos. of O + N atoms, H-bond acceptors, and rotatable bonds and rings have increased in 1983-2002 drugs (by 13-29%).  Anal. of the 1983-2002 oral drugs by therapy area shows that anti-infectives and nervous system drugs have the most extreme phys. property profiles.  Cardiovascular drugs show increasing mol. wt. with year of publication, primarily a consequence of focusing on clin. proven mechanisms, with limited chem. diversity.  Drug classes other than anti-infectives show comparable distributions of lipophilicity, suggesting that this property in oral drugs is important irresp. of the drug's target.  The results suggest that the balance between polar and nonpolar drug properties is an important, unchanging feature of oral drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtNkiWH6Bl6bVg90H21EOLACvtfcHk0lhfIG0wvfAVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D&md5=edd5cceab1ccfe3542cb4df180e3c160</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm049717d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049717d%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26atitle%3DTime-related%2520differences%2520in%2520the%2520physical%2520property%2520profiles%2520of%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6338%26epage%3D6348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Norinder, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeberlein, M.</span><span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood–brain distribution</span> <span class="citation_source-journal">Adv. Drug Deliv. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood%E2%80%93brain+distribution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood%25E2%2580%2593brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayada, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbressine, L. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploemen, J.-P.</span><span> </span><span class="NLM_article-title">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1514</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1023%2FA%3A1015040217741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=10554091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=1514-1519&author=J.+Kelderauthor=P.+D.+J.+Grootenhuisauthor=D.+M.+Bayadaauthor=L.+P.+C.+Delbressineauthor=J.-P.+Ploemen&title=Polar+molecular+surface+as+a+dominating+determinant+for+oral+absorption+and+brain+penetration+of+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span></div><div class="casAuthors">Kelder, Jan; Grootenhuis, Peter D. J.; Bayada, Denis M.; Delbressine, Leon P. C.; Ploemen, Jan-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Purpose: To study oral absorption and brain penetration as a function of polar mol. surface area.  Methods: Measured brain penetration data of 45 drug mols. were investigated.  The dynamic polar surface areas were calcd. and correlated with the brain penetration data.  Also the static polar surface areas of 776 orally administered CNS drugs that have reached at least Phase II efficacy studies were calcd.  The same was done for a series of 1590 orally administered non-CNS drugs that have reached at least Phase II efficacy studies.  Results: A linear relationship between brain penetration and dynamic polar surface area (A2) was found (n = 45, R = 0.917, F1,43 = 229).  Brain penetration decreases with increasing polar surface area.  A clear difference between the distribution of the polar surface area of the 776 CNS and 1590 non-CNS drugs was found.  It was deduced that orally active drugs that are transported passively by the transcellular route should not exceed a polar surface area of about 120 A2.  They can be tailored to brain penetration by decreasing the polar surface to <60-70 A2.  This conclusion is supported by the inverse linear relationship between exptl. brain penetration data and the dynamic polar surface area of 45 drug mols.  Conclusions: The polar mol. surface area is a dominating determinant for oral absorption and brain penetration of drugs that are transported by the transcellular route.  This property should be considered in the early phase of drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmc3v7TzWM4LVg90H21EOLACvtfcHk0lhfIG0wvfAVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D&md5=868fe1e9491dd3b8b92b326d28ee48f9</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015040217741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015040217741%26sid%3Dliteratum%253Aachs%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26aulast%3DBayada%26aufirst%3DD.%2BM.%26aulast%3DDelbressine%26aufirst%3DL.%2BP.%2BC.%26aulast%3DPloemen%26aufirst%3DJ.-P.%26atitle%3DPolar%2520molecular%2520surface%2520as%2520a%2520dominating%2520determinant%2520for%2520oral%2520absorption%2520and%2520brain%2520penetration%2520of%2520drugs%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D1514%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camenisch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chretien, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raevsky, O. A.</span><span> </span><span class="NLM_article-title">Estimation of blood–brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.3109%2F10611869808997889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9886238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=151-165&author=H.+Van+de+Waterbeemdauthor=G.+Camenischauthor=G.+Folkersauthor=J.+R.+Chretienauthor=O.+A.+Raevsky&title=Estimation+of+blood%E2%80%93brain+barrier+crossing+of+drugs+using+molecular+size+and+shape%2C+and+H-bonding+descriptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span></div><div class="casAuthors">Van de Waterbeemd, Han; Camenisch, Gian; Folkers, Gerd; Chretien, Jacques R.; Raevsky, Oleg A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-165</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The influence of physicochem. properties, including lipophilicity, H-bonding capacity and mol. size and shape descriptors on brain uptake has been investigated using a selection of marketed CNS and CNS-inactive drugs.  It is demonstrated that the polar surface area of a drug can be used as a suitable descriptor for the drugs' H-bonding potential.  A combination of a H-bonding and a mol. size descriptor, i.e., the major components of lipophilicity and permeability, avoiding knowledge of distribution coeffs., is proposed to est. brain penetration potential of new drug candidates.  Previously reported exptl. surface activity data appear to be strongly correlated to mol. size of the drug compds.  Present anal. offers a modern basis for property-based design and targeting of CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0yCKmlzsa37Vg90H21EOLACvtfcHk0lhfIG0wvfAVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D&md5=9106ff6aa0755ff76fd0634822857d4a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3109%2F10611869808997889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611869808997889%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DChretien%26aufirst%3DJ.%2BR.%26aulast%3DRaevsky%26aufirst%3DO.%2BA.%26atitle%3DEstimation%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520crossing%2520of%2520drugs%2520using%2520molecular%2520size%2520and%2520shape%252C%2520and%2520H-bonding%2520descriptors%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D1998%26volume%3D6%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span> </span><span class="NLM_article-title">Hydrogen-bonding capacity and brain penetration</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1992&pages=299-303&author=H.+Van+de+Waterbeemdauthor=M.+Kansy&title=Hydrogen-bonding+capacity+and+brain+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DKansy%26aufirst%3DM.%26atitle%3DHydrogen-bonding%2520capacity%2520and%2520brain%2520penetration%26jtitle%3DChimia%26date%3D1992%26volume%3D46%26spage%3D299%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Young, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sore, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, T. J.</span><span> </span><span class="NLM_article-title">Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H<sub>2</sub> receptor histamine antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00398a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaL1cXpsVChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=656-671&author=R.+C.+Youngauthor=R.+C.+Mitchellauthor=T.+H.+Brownauthor=C.+R.+Ganellinauthor=R.+Griffithsauthor=M.+Jonesauthor=K.+K.+Ranaauthor=D.+Saundersauthor=I.+R.+Smithauthor=N.+E.+Soreauthor=T.+J.+Wilks&title=Development+of+a+new+physicochemical+model+for+brain+penetration+and+its+application+to+the+design+of+centrally+acting+H2+receptor+histamine+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists</span></div><div class="casAuthors">Young, Rodney C.; Mitchell, Robert C.; Brown, Thomas H.; Ganellin, C. Robin; Griffiths, Robin; Jones, Martin; Rana, Kishore K.; Saunders, David; Smith, Ian R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-71</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A rational approach to the design of centrally acting agents is presented, based initially upon a comparison of the physicochem. properties of three typical histamine H2 receptor antagonists which do not readily cross the blood-brain barrier with those of the three brain-penetrating drugs clonidine, mepyramine, and imipramine.  A good correlation was found between the logarithms of the equil. brain/blood concn. ratios in the rat and the partition parameter, Δ log P, defined as log P (1-octanol/water) - log P (cyclohexane/water), which suggests that brain penetration might be improved by reducing overall hydrogen-bonding ability.  This model has been employed as a guide in the design of novel brain-penetrating H2 antagonists by the systematic structural modification of representatives of different structural types of H2 antagonists.  Although marked increases in brain penetration among congeners of cimetidine, ranitidine, and tiotidine were achieved, no compd. was found with an acceptable combination of H2 antagonist activity (-log KB in the guinea pig atrium > 7.0) and brain penetration (steady-state brain/blood concn. ratio > 1.0).  Conversely, structural modification of N-[3-[m-(piperidinylmethyl)phenoxy]propyl]acetamide led to several potent, novel compds. which readily cross the blood-brain barrier.  One of these, zolantidine (SK&F 95282), whose -log KB is 7.46 and steady-state brain/blood ratio is 1.4, has been identified for use in studying histaminergic H2 receptor mechanisms in brain.  Comparison of Δ log P values with the logarithms of the brain/blood ratios for 20 structurally diverse compds. for which data became available confirms a highly significant correlation and supports the general validity of this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6PLz9CeYbs7Vg90H21EOLACvtfcHk0liPi0-HjMWySA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXpsVChtA%253D%253D&md5=668f7ad2d17fc57312ed5753f6f9c40a</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm00398a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00398a028%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BC.%26aulast%3DMitchell%26aufirst%3DR.%2BC.%26aulast%3DBrown%26aufirst%3DT.%2BH.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DGriffiths%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DRana%26aufirst%3DK.%2BK.%26aulast%3DSaunders%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DI.%2BR.%26aulast%3DSore%26aufirst%3DN.%2BE.%26aulast%3DWilks%26aufirst%3DT.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520new%2520physicochemical%2520model%2520for%2520brain%2520penetration%2520and%2520its%2520application%2520to%2520the%2520design%2520of%2520centrally%2520acting%2520H2%2520receptor%2520histamine%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D656%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, D. L.</span><span> </span><span class="NLM_article-title">Parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1968&pages=1-11&author=C.+Hanschauthor=A.+R.+Stewardauthor=S.+M.+Andersonauthor=D.+L.+Bentley&title=Parabolic+dependence+of+drug+action+upon+lipophilic+character+as+revealed+by+a+study+of+hypnotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DSteward%26aufirst%3DA.%2BR.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DBentley%26aufirst%3DD.%2BL.%26atitle%3DParabolic%2520dependence%2520of%2520drug%2520action%2520upon%2520lipophilic%2520character%2520as%2520revealed%2520by%2520a%2520study%2520of%2520hypnotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1968%26volume%3D1%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0liPi0-HjMWySA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Leo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, D.</span><span> </span><span class="NLM_article-title">Partition coefficients and their uses</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60274a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaE38XivVansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1971&pages=525-616&author=A.+Leoauthor=C.+Hanschauthor=D.+Elkins&title=Partition+coefficients+and+their+uses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Partition coefficients and their uses</span></div><div class="casAuthors">Leo, Albert; Hansch, Corwin; Elkins, David</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-616</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with 519 refs. includes discussion of:  thermodynamics of partitioning systems, energy requirements for phase transfer, exptl. methods, linear free-energy relations among systems, and uses of partition measurements (countercurrent distribution, equil. detns., dissoln. and partitioning rate of drugs, liq. ion-exchange media and ion-selective electrodes, emulsion systems, hydrophobic bonding ability).  An extensive tabulation of partitioning data is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ7MM8VxGt8LVg90H21EOLACvtfcHk0liPi0-HjMWySA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XivVansw%253D%253D&md5=7dc3aa11e7b4feb2f6087842b251f809</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fcr60274a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60274a001%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DElkins%26aufirst%3DD.%26atitle%3DPartition%2520coefficients%2520and%2520their%2520uses%26jtitle%3DChem.%2520Rev.%26date%3D1971%26volume%3D71%26spage%3D525%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Johnson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzya, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudhar, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murkitt, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartlon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, F.</span><span> </span><span class="NLM_article-title">The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5434</span><span class="NLM_x">–</span> <span class="NLM_lpage">5438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5434-5438&author=D.+J.+Johnsonauthor=I.+T.+Forbesauthor=S.+P.+Watsonauthor=V.+Garzyaauthor=G.+I.+Stevensonauthor=G.+R.+Walkerauthor=H.+S.+Mudharauthor=S.+J.+Flynnauthor=P.+A.+Wymanauthor=P.+W.+Smithauthor=G.+S.+Murkittauthor=A.+J.+Lucasauthor=C.+R.+Mookherjeeauthor=J.+M.+Watsonauthor=J.+E.+Gartlonauthor=A.+M.+Bradfordauthor=F.+Brown&title=The+discovery+of+a+series+of+N-substituted+3-%284-piperidinyl%29-1%2C3-benzoxazolinones+and+oxindoles+as+highly+brain+penetrant%2C+selective+muscarinic+M1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BJ.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26aulast%3DGarzya%26aufirst%3DV.%26aulast%3DStevenson%26aufirst%3DG.%2BI.%26aulast%3DWalker%26aufirst%3DG.%2BR.%26aulast%3DMudhar%26aufirst%3DH.%2BS.%26aulast%3DFlynn%26aufirst%3DS.%2BJ.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DMurkitt%26aufirst%3DG.%2BS.%26aulast%3DLucas%26aufirst%3DA.%2BJ.%26aulast%3DMookherjee%26aufirst%3DC.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DGartlon%26aufirst%3DJ.%2BE.%26aulast%3DBradford%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DF.%26atitle%3DThe%2520discovery%2520of%2520a%2520series%2520of%2520N-substituted%25203-%25284-piperidinyl%2529-1%252C3-benzoxazolinones%2520and%2520oxindoles%2520as%2520highly%2520brain%2520penetrant%252C%2520selective%2520muscarinic%2520M1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5434%26epage%3D5438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafinowska, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coggon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murkitt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Searle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">New quinoline NK3 receptor antagonists with CNS activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=837-840&author=P.+W.+Smithauthor=P.+A.+Wymanauthor=P.+Lovellauthor=C.+Goodacreauthor=H.+T.+Serafinowskaauthor=A.+Vongauthor=F.+Harringtonauthor=S.+Flynnauthor=D.+M.+Bradleyauthor=R.+Porterauthor=S.+Coggonauthor=G.+Murkittauthor=K.+Searleauthor=D.+R.+Thomasauthor=J.+M.+Watsonauthor=W.+Martinauthor=Z.+Wuauthor=L.+A.+Dawson&title=New+quinoline+NK3+receptor+antagonists+with+CNS+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26aulast%3DLovell%26aufirst%3DP.%26aulast%3DGoodacre%26aufirst%3DC.%26aulast%3DSerafinowska%26aufirst%3DH.%2BT.%26aulast%3DVong%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DF.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBradley%26aufirst%3DD.%2BM.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DCoggon%26aufirst%3DS.%26aulast%3DMurkitt%26aufirst%3DG.%26aulast%3DSearle%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DNew%2520quinoline%2520NK3%2520receptor%2520antagonists%2520with%2520CNS%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D837%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Martin, Y. C.</span><span> </span><span class="NLM_article-title">A bioavailability score</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3164</span><span class="NLM_x">–</span> <span class="NLM_lpage">3170</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2nt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3164-3170&author=Y.+C.+Martin&title=A+bioavailability+score"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A Bioavailability Score</span></div><div class="casAuthors">Martin, Yvonne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3164-3170</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Responding to a demonstrated need for scientists to forecast the permeability and bioavailability (F) properties of compds. before their purchase, synthesis, or advanced testing, the authors have developed a score that assigns the probability that a compd. will have F > 10% in the rat.  Neither the rule-of-five, log P, log D, nor the combination of the no. of rotatable bonds and polar surface area successfully categorized compds.  Instead, different properties govern the bioavailability of compds. depending on their predominant charge at biol. pH.  The fraction of anions with >10% F falls from 85% if the polar surface area (PSA) is ≤ 75 Å2, to 56% if 75 < PSA < 150 Å2, to 11% if PSA is ≥ 150 Å2.  On the other hand, whereas 55% of the neutral, zwitterionic, or cationic compds. that pass the rule-of-five have >10% F, only 17% of those that fail have > 10% F.  This same categorization distinguishes compds. that are poorly permeable from those that are permeable in Caco-2 cells.  Further validation is provided with human bioavailability values from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXWIgR8hRzC7Vg90H21EOLACvtfcHk0lidCvUgFwLzvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2nt7k%253D&md5=aeed812cf4ab717896170c232e170c46</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm0492002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492002%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DY.%2BC.%26atitle%3DA%2520bioavailability%2520score%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3164%26epage%3D3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Abraham, M. H.</span><span> </span><span class="NLM_article-title">Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1039%2Fcs9932200073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK3sXktlGjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=73-83&author=M.+H.+Abraham&title=Scales+of+solute+hydrogen-bonding%3A+their+construction+and+application+to+physicochemical+and+biochemical+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes</span></div><div class="casAuthors">Abraham, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    </div><div class="casAbstract">A review with no refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptfSZN252ExLVg90H21EOLACvtfcHk0lidCvUgFwLzvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktlGjt7s%253D&md5=bdeb33e66746bc875a6765f685bbc6fb</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1039%2Fcs9932200073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcs9932200073%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26atitle%3DScales%2520of%2520solute%2520hydrogen-bonding%253A%2520their%2520construction%2520and%2520application%2520to%2520physicochemical%2520and%2520biochemical%2520processes%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D1993%26volume%3D22%26spage%3D73%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirripa, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span> </span><span class="NLM_article-title">Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061094b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=272-282&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=R.+K.+Changauthor=M.+R.+Woodauthor=K.+M.+Schirripaauthor=J.+J.+Kimauthor=J.+M.+Waiauthor=R.+M.+DiPardoauthor=K.+L.+Murphyauthor=R.+W.+Ransomauthor=C.+M.+Harrellauthor=D.+R.+Reissauthor=M.+A.+Holahanauthor=J.+Cookauthor=J.+F.+Hessauthor=N.+Sainauthor=M.+O.+Urbanauthor=C.+Tangauthor=T.+Prueksaritanontauthor=D.+J.+Pettiboneauthor=M.+G.+Bock&title=Development+of+orally+bioavailable+and+CNS+penetrant+biphenylaminocyclopropane+carboxamide+bradykinin+B1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm061094b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061094b%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DSchirripa%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DWai%26aufirst%3DJ.%2BM.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26aulast%3DSain%26aufirst%3DN.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DBock%26aufirst%3DM.%2BG.%26atitle%3DDevelopment%2520of%2520orally%2520bioavailable%2520and%2520CNS%2520penetrant%2520biphenylaminocyclopropane%2520carboxamide%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D272%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmait, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester-Zeiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biorn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span> </span><span class="NLM_article-title">Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8781</span><span class="NLM_x">–</span> <span class="NLM_lpage">8792</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401234w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8781-8792&author=E.+Huauthor=R.+K.+Kunzauthor=N.+Chenauthor=S.+Rumfeltauthor=A.+Siegmundauthor=K.+Andrewsauthor=S.+Chmaitauthor=S.+Zhaoauthor=C.+Davisauthor=H.+Chenauthor=D.+Lester-Zeinerauthor=J.+Maauthor=C.+Biornauthor=J.+Shiauthor=A.+Porterauthor=J.+Treanorauthor=J.+R.+Allen&title=Design%2C+optimization%2C+and+biological+evaluation+of+novel+keto-benzimidazoles+as+potent+and+selective+inhibitors+of+phosphodiesterase+10A+%28PDE10A%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm401234w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401234w%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DAndrews%26aufirst%3DK.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DBiorn%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DDesign%252C%2520optimization%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520keto-benzimidazoles%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8781%26epage%3D8792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lia0MU5WDvLgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Rafi, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hearn, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedantham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Predicting and improving the membrane permeability of peptidic small molecules</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3163</span><span class="NLM_x">–</span> <span class="NLM_lpage">3169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201634q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Ogtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3163-3169&author=S.+B.+Rafiauthor=B.+R.+Hearnauthor=P.+Vedanthamauthor=M.+P.+Jacobsonauthor=A.+R.+Renslo&title=Predicting+and+improving+the+membrane+permeability+of+peptidic+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and Improving the Membrane Permeability of Peptidic Small Molecules</span></div><div class="casAuthors">Rafi, Salma B.; Hearn, Brian R.; Vedantham, Punitha; Jacobson, Matthew P.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3163-3169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluate exptl. and computationally the membrane permeability of matched sets of peptidic small mols. bearing natural or bioisosteric unnatural amino acids.  We find that the intentional introduction of hydrogen bond acceptor-donor pairs in such mols. can improve membrane permeability while retaining or improving other favorable drug-like properties.  We employ an all-atom force field based method to calc. changes in free energy assocd. with the transfer of the peptidic mols. from water to membrane.  This computational method correctly predicts rank order exptl. permeability trends within congeneric series and is much more predictive than calcns. (e.g., clogP) that do not consider three-dimensional conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAMuvF4vQFrVg90H21EOLACvtfcHk0lia0MU5WDvLgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Ogtrg%253D&md5=a517000b38fb76198d38beac165d2d99</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm201634q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201634q%26sid%3Dliteratum%253Aachs%26aulast%3DRafi%26aufirst%3DS.%2BB.%26aulast%3DHearn%26aufirst%3DB.%2BR.%26aulast%3DVedantham%26aufirst%3DP.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DPredicting%2520and%2520improving%2520the%2520membrane%2520permeability%2520of%2520peptidic%2520small%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3163%26epage%3D3169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien-Larose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span> </span><span class="NLM_article-title">Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK1 receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2276</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010825z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2276-2285&author=V.+A.+Ashwoodauthor=M.+J.+Fieldauthor=D.+C.+Horwellauthor=C.+Julien-Laroseauthor=R.+A.+Lewthwaiteauthor=S.+McClearyauthor=M.+C.+Pritchardauthor=J.+Raphyauthor=L.+Singh&title=Utilization+of+an+intramolecular+hydrogen+bond+to+increase+the+CNS+penetration+of+an+NK1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fjm010825z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010825z%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DField%26aufirst%3DM.%2BJ.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DJulien-Larose%26aufirst%3DC.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DPritchard%26aufirst%3DM.%2BC.%26aulast%3DRaphy%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26atitle%3DUtilization%2520of%2520an%2520intramolecular%2520hydrogen%2520bond%2520to%2520increase%2520the%2520CNS%2520penetration%2520of%2520an%2520NK1%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2276%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Over, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grönberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgendorf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellisson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M. W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvall, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span> </span><span class="NLM_article-title">Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2746</span><span class="NLM_x">–</span> <span class="NLM_lpage">2754</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500059t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2746-2754&author=B.+Overauthor=P.+McCarrenauthor=P.+Arturssonauthor=M.+Foleyauthor=F.+Giordanettoauthor=G.+Gr%C3%B6nbergauthor=C.+Hilgendorfauthor=M.+D.+Leeauthor=P.+Matssonauthor=G.+Muncipintoauthor=M.+Pellissonauthor=M.+W.+D.+Perryauthor=R.+Svenssonauthor=J.+R.+Duvallauthor=J.+Kihlberg&title=Impact+of+stereospecific+intramolecular+hydrogen+bonding+on+cell+permeability+and+physicochemical+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Stereospecific Intramolecular Hydrogen Bonding on Cell Permeability and Physicochemical Properties</span></div><div class="casAuthors">Over, Bjoern; McCarren, Patrick; Artursson, Per; Foley, Michael; Giordanetto, Fabrizio; Groenberg, Gunnar; Hilgendorf, Constanze; Lee, Maurice D.; Matsson, Paer; Muncipinto, Giovanni; Pellisson, Melanie; Perry, Matthew W. D.; Svensson, Richard; Duvall, Jeremy R.; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2746-2754</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Profiling of eight stereoisomeric T. cruzi growth inhibitors revealed vastly different in vitro properties such as soly., lipophilicity, pKa, and cell permeability for two sets of four stereoisomers.  Using computational chem. and NMR spectroscopy, we identified the formation of an intramol. NH→NR3 hydrogen bond in the set of stereoisomers displaying lower soly., higher lipophilicity, and higher cell permeability.  The intramol. hydrogen bond resulted in a significant pKa difference that accounts for the other structure-property relationships.  Application of this knowledge could be of particular value to maintain the delicate balance of size, soly., and lipophilicity required for cell penetration and oral administration for chem. probes or therapeutics with properties at, or beyond, Lipinski's rule of 5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR_VAbJqqxirVg90H21EOLACvtfcHk0licpXayYXPE0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKiurg%253D&md5=4227f825b82f5d17fab3f0de43806a5d</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm500059t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500059t%26sid%3Dliteratum%253Aachs%26aulast%3DOver%26aufirst%3DB.%26aulast%3DMcCarren%26aufirst%3DP.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DFoley%26aufirst%3DM.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DGr%25C3%25B6nberg%26aufirst%3DG.%26aulast%3DHilgendorf%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BD.%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DPellisson%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DSvensson%26aufirst%3DR.%26aulast%3DDuvall%26aufirst%3DJ.%2BR.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520stereospecific%2520intramolecular%2520hydrogen%2520bonding%2520on%2520cell%2520permeability%2520and%2520physicochemical%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2746%26epage%3D2754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Hennig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Leon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Cornejo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, L.</span><span> </span><span class="NLM_article-title">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.jfluchem.2009.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2009&pages=453-460&author=L.+Hennigauthor=K.+Ayala-Leonauthor=J.+Angulo-Cornejoauthor=R.+Richterauthor=L.+Beyer&title=Fluorine+hydrogen+short+contacts+and+hydrogen+bonds+in+substituted+benzamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span></div><div class="casAuthors">Hennig, Lothar; Ayala-Leon, Ketty; Angulo-Cornejo, Jorge; Richter, Rainer; Beyer, Lothar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ten Fluorine substituted benzamides were synthesized and studied by spectroscopic methods (NMR, IR, MS) and x-ray structure anal.  The configuration of these compds. strongly depends on solvent, temp. and substitution pattern.  Unexpectedly, some of these compds. form weak intramol. hydrogen bonds/short N-H···F-C contacts in CDCl3 soln. and in the solid state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO1miRde9jnbVg90H21EOLACvtfcHk0licpXayYXPE0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D&md5=2abb3e0d14e81fe2adda68b51bd6b6b8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2009.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2009.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DAyala-Leon%26aufirst%3DK.%26aulast%3DAngulo-Cornejo%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DL.%26atitle%3DFluorine%2520hydrogen%2520short%2520contacts%2520and%2520hydrogen%2520bonds%2520in%2520substituted%2520benzamides%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2009%26volume%3D130%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9009</span><span class="NLM_x">–</span> <span class="NLM_lpage">9024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9009-9024&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+hydroxyethylamine+containing+%CE%B2-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+%CE%B2-amyloid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520hydroxyethylamine%2520containing%2520%25CE%25B2-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9009%26epage%3D9024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4156</span><span class="NLM_x">–</span> <span class="NLM_lpage">4180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Alex, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Baxter, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, M. P.</span><span> </span><span class="NLM_article-title">Temperature dependence of <sup>1</sup>H chemical shifts in proteins</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1023%2FA%3A1018334207887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9255942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXltFCktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=359-369&author=N.+J.+Baxterauthor=M.+P.+Williamson&title=Temperature+dependence+of+1H+chemical+shifts+in+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Temperature dependence of 1H chemical shifts in proteins</span></div><div class="casAuthors">Baxter, Nicola J.; Williamson, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer</span>)
        </div><div class="casAbstract">Temp. coeffs. have been measured by 2D NMR methods for the amide and CαH proton chem. shifts in two globular proteins, bovine pancreatic trypsin inhibitor and hen egg-white lysozyme.  The temp.-dependent changes in chem. shift are generally linear up to about 15° below the global denaturation temp., and the derived coeffs. span a range of roughly -16 to +2 ppb/K for amide protons and -4 to +3 ppb/K for CαH.  The temp. coeffs. can be rationalized by the assumption that heating causes increases in thermal motion in the protein.  Precise calcns. of temp. coeffs. derived from protein coordinates are not possible, since chem. shifts are sensitive to small changes in at. coordinates.  Amide temp. coeffs. correlate well with the location of hydrogen bonds as detd. by crystallog.  It is concluded that a combined use of both temp. coeffs. and exchange rates produces a far more reliable indicator of hydrogen bonding than either alone.  If an amide proton exchanges slowly and has a temp. coeff. more pos. than -4.5 ppb/K, it is hydrogen bonded, while if it exchanges rapidly and has a temp. coeff. more neg. than -4.5 ppb/K, it is not hydrogen bonded.  The previously obsd. unreliability of temp. coeffs. as measures of hydrogen bonding in peptides may arise from losses of peptide secondary structure on heating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr05sDHtiqi5LVg90H21EOLACvtfcHk0lhPEVFCNKnm1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltFCktbo%253D&md5=3e6a19a161d0172703abde67a908774c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018334207887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018334207887%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DN.%2BJ.%26aulast%3DWilliamson%26aufirst%3DM.%2BP.%26atitle%3DTemperature%2520dependence%2520of%25201H%2520chemical%2520shifts%2520in%2520proteins%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1997%26volume%3D9%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Tardia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolfa, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiatordi, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DAlberga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzariti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span> </span><span class="NLM_article-title">Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6403</span><span class="NLM_x">–</span> <span class="NLM_lpage">6418</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500697c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6403-6418&author=P.+Tardiaauthor=A.+Stefanachiauthor=M.+Nisoauthor=D.+A.+Stolfaauthor=G.+F.+Mangiatordiauthor=D.+DAlbergaauthor=O.+Nicolottiauthor=G.+Lattanziauthor=A.+Carottiauthor=F.+Leonettiauthor=R.+Perroneauthor=F.+Berardiauthor=A.+Azzaritiauthor=N.+A.+Colabufoauthor=S.+Cellamare&title=Trimethoxybenzanilide-based+P-glycoprotein+modulators%3A+an+interesting+case+of+lipophilicity+tuning+by+intramolecular+hydrogen+bonding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm500697c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500697c%26sid%3Dliteratum%253Aachs%26aulast%3DTardia%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DDAlberga%26aufirst%3DD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLattanzi%26aufirst%3DG.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DAzzariti%26aufirst%3DA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DCellamare%26aufirst%3DS.%26atitle%3DTrimethoxybenzanilide-based%2520P-glycoprotein%2520modulators%253A%2520an%2520interesting%2520case%2520of%2520lipophilicity%2520tuning%2520by%2520intramolecular%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6403%26epage%3D6418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Shalaeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalamanchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. J.</span><span> </span><span class="NLM_article-title">Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4870</span><span class="NLM_x">–</span> <span class="NLM_lpage">4879</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301850m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4870-4879&author=M.+Shalaevaauthor=G.+Caronauthor=Y.+A.+Abramovauthor=T.+N.+O%E2%80%99Connellauthor=M.+S.+Plummerauthor=G.+Yalamanchiauthor=K.+A.+Farleyauthor=G.+H.+Goetzauthor=L.+Philippeauthor=M.+J.+Shapiro&title=Integrating+intramolecular+hydrogen+bonding+%28IMHB%29+considerations+in+drug+discovery+using+%CE%94logP+as+a+tool"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm301850m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301850m%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DT.%2BN.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DYalamanchi%26aufirst%3DG.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3DIntegrating%2520intramolecular%2520hydrogen%2520bonding%2520%2528IMHB%2529%2520considerations%2520in%2520drug%2520discovery%2520using%2520%25CE%2594logP%2520as%2520a%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4870%26epage%3D4879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Goetz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciabola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. J.</span><span> </span><span class="NLM_article-title">High throughput method for the indirect detection of intramolecular hydrogen bonding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2920</span><span class="NLM_x">–</span> <span class="NLM_lpage">2929</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401859b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2iurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2920-2929&author=H.+Goetzauthor=W.+Farrellauthor=M.+Shalaevaauthor=S.+Sciabolaauthor=D.+Andersonauthor=J.+Yanauthor=L.+Philippeauthor=M.+J.+Shapiro&title=High+throughput+method+for+the+indirect+detection+of+intramolecular+hydrogen+bonding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">High Throughput Method for the Indirect Detection of Intramolecular Hydrogen Bonding</span></div><div class="casAuthors">Goetz, Gilles H.; Farrell, William; Shalaeva, Marina; Sciabola, Simone; Anderson, Dennis; Yan, Jiangli; Philippe, Laurence; Shapiro, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2920-2929</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A supercrit. fluid chromatog. method was developed for the detection of intramol. hydrogen bonds in pharmaceutically relevant mols.  The identification of compds. likely to form intramol. hydrogen bonds is an important drug design consideration given the correlation of intramol. hydrogen bonding with increased membrane permeability.  The technique described here correlates chromatog. retention with the exposed polarity of a mol.  Mols. that can form an intramol. hydrogen bond can hide their polarity and therefore exhibit lower retention than similar compds. that cannot.  By use of a pairwise anal. strategy, intramol. hydrogen bonds are identified within a test set of compds. with diverse topologies.  The chromatog. results are confirmed by NMR chem. shift and temp. coeff. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmIBznjNPRbVg90H21EOLACvtfcHk0lhPEVFCNKnm1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2iurY%253D&md5=14eb39ae2abe2830c634ff1e642af520</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm401859b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401859b%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DH.%26aulast%3DFarrell%26aufirst%3DW.%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3DHigh%2520throughput%2520method%2520for%2520the%2520indirect%2520detection%2520of%2520intramolecular%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2920%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lh7Jk6-Rq-Crg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Palm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungell, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strandlund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Correlation of drug absorption with molecular surface properties</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1021%2Fjs950285r" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=8926580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=32-39&author=K.+Palmauthor=K.+Luthmanauthor=A.+L.+Ungellauthor=G.+Strandlundauthor=P.+Artursson&title=Correlation+of+drug+absorption+with+molecular+surface+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Drug Absorption with Molecular Surface Properties</span></div><div class="casAuthors">Palm, Katrin; Luthman, Kristina; Ungell, Anna-Lena; Strandlund, Gert; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-9</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The correlation between dynamic surface properties of drug mols. and drug absorption in two common in vitro models of the intestinal wall (Caco-2 monolayers and rat intestinal segments) has been investigated.  A homologous series of β-adrenoreceptor antagonists were used as model compds.  Dynamic mol. surface properties, considering all low-energy conformations, of the compds. were calcd.  The flexibility of the mols. was studied by mol. mechanics calcns. (MM2) and the van der Waals' (vdW) and water accessible surface areas were calcd. and averaged according to a Boltzmann distribution.  Excellent correlations were obtained between the dynamic polar vdW surface areas and cell permeabilities in Caco-2 cells and rat ileum (r2 = 0.99 and 0.92, resp.).  These correlations were stronger than those between calcd. octanol/buffer partition coeffs. (log Doct,7.4) and permeability (r2 = 0.80 and 0.73, resp.).  Moreover, the calcd. log Doct,7.4 values failed to rank the permeability coeffs. through Caco-2 monolayers and rat ileum in the correct order.  The results indicate that dynamic polar surface area is a promising alternative model for the prediction of oral drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLOYEAamFQdrVg90H21EOLACvtfcHk0lh7Jk6-Rq-Crg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGkt7Y%253D&md5=ed1c2dc15492941a8084653907c57d0c</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjs950285r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs950285r%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DUngell%26aufirst%3DA.%2BL.%26aulast%3DStrandlund%26aufirst%3DG.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DCorrelation%2520of%2520drug%2520absorption%2520with%2520molecular%2520surface%2520properties%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1996%26volume%3D85%26spage%3D32%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Richmond, T. J. T.</span><span> </span><span class="NLM_article-title">Solvent accessible surface area and excluded volume in proteins</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=1984&pages=63-89&author=T.+J.+T.+Richmond&title=Solvent+accessible+surface+area+and+excluded+volume+in+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DT.%2BJ.%2BT.%26atitle%3DSolvent%2520accessible%2520surface%2520area%2520and%2520excluded%2520volume%2520in%2520proteins%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1984%26volume%3D178%26spage%3D63%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Goldberg, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Schoolmeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swales, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, M. J.</span><span> </span><span class="NLM_article-title">Optimization of brain penetrant 11β-hydroxysteroid dehydrogenase type I inhibitors and <i>in vivo</i> testing in diet-induced obese mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4016729" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=970-986&author=F.+W.+Goldbergauthor=A.+G.+Dossetterauthor=J.+S.+Scottauthor=R.+Robbauthor=S.+Boydauthor=S.+D.+Groombridgeauthor=P.+D.+Kemmittauthor=T.+Sjogrenauthor=P.+M.+Gutierrezauthor=J.+De+Schoolmeesterauthor=J.+G.+Swalesauthor=A.+W.+Turnbullauthor=M.+J.+Wild&title=Optimization+of+brain+penetrant+11%CE%B2-hydroxysteroid+dehydrogenase+type+I+inhibitors+and+in+vivo+testing+in+diet-induced+obese+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm4016729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4016729%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DRobb%26aufirst%3DR.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DDe%2BSchoolmeester%26aufirst%3DJ.%26aulast%3DSwales%26aufirst%3DJ.%2BG.%26aulast%3DTurnbull%26aufirst%3DA.%2BW.%26aulast%3DWild%26aufirst%3DM.%2BJ.%26atitle%3DOptimization%2520of%2520brain%2520penetrant%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%2520I%2520inhibitors%2520and%2520in%2520vivo%2520testing%2520in%2520diet-induced%2520obese%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D970%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1<i>H</i>-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5801</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5801-5812&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=D.+Andreottiauthor=S.+Ballantineauthor=B.+D.+Baxauthor=A.+J.+Harrisauthor=A.+J.+Harkerauthor=J.+Lundauthor=R.+Melarangeauthor=A.+Mingardiauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=M.+Neveauthor=B.+Oliosiauthor=R.+Profetaauthor=K.+J.+Smithauthor=P.+W.+Smithauthor=S.+Spadaauthor=K.+M.+Thewlisauthor=S.+P.+Yusaf&title=Discovery+of+N-%5B%282S%29-5-%286-fluoro-3-pyridinyl%29-2%2C3-dihydro-1H-inden-2-yl%5D-2-propanesulfonamide%2C+a+novel+clinical+AMPA+receptor+positive+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm1005429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005429%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarker%26aufirst%3DA.%2BJ.%26aulast%3DLund%26aufirst%3DJ.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNeve%26aufirst%3DM.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DProfeta%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DSpada%26aufirst%3DS.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25282S%2529-5-%25286-fluoro-3-pyridinyl%2529-2%252C3-dihydro-1H-inden-2-yl%255D-2-propanesulfonamide%252C%2520a%2520novel%2520clinical%2520AMPA%2520receptor%2520positive%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5801%26epage%3D5812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">McDonald, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zusi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post-Munson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertekap, R. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworetzky, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1684</span><span class="NLM_x">–</span> <span class="NLM_lpage">1688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1684-1688&author=I.+M.+McDonaldauthor=R.+A.+Mateauthor=F.+C.+Zusiauthor=H.+Huangauthor=D.+J.+Post-Munsonauthor=M.+A.+Ferranteauthor=L.+Gallagherauthor=R.+L.+Bertekapauthor=R.+J.+Knoxauthor=B.+J.+Robertsonauthor=D.+G.+Hardenauthor=D.+G.+Morganauthor=N.+J.+Lodgeauthor=S.+I.+Dworetzkyauthor=R.+E.+Olsonauthor=J.+E.+Macor&title=Discovery+of+a+novel+series+of+quinolone+%CE%B17+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DI.%2BM.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DZusi%26aufirst%3DF.%2BC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DFerrante%26aufirst%3DM.%2BA.%26aulast%3DGallagher%26aufirst%3DL.%26aulast%3DBertekap%26aufirst%3DR.%2BL.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DRobertson%26aufirst%3DB.%2BJ.%26aulast%3DHarden%26aufirst%3DD.%2BG.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DDworetzky%26aufirst%3DS.%2BI.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520quinolone%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1684%26epage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Lerchner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintelnot-Blomley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaton, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paganetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span> </span><span class="NLM_article-title">Macrocyclic BACE-1 inhibitors acutely reduce Aβ in brain after po application</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=603-607&author=A.+Lerchnerauthor=R.+Machauerauthor=C.+Betschartauthor=S.+Veenstraauthor=H.+Rueegerauthor=C.+McCarthyauthor=M.+Tintelnot-Blomleyauthor=A.-L.+Jatonauthor=S.+Rabeauthor=S.+Desrayaudauthor=A.+Enzauthor=M.+Staufenbielauthor=P.+Paganettiauthor=J.-M.+Rondeauauthor=U.+Neumann&title=Macrocyclic+BACE-1+inhibitors+acutely+reduce+A%CE%B2+in+brain+after+po+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerchner%26aufirst%3DA.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBetschart%26aufirst%3DC.%26aulast%3DVeenstra%26aufirst%3DS.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DJaton%26aufirst%3DA.-L.%26aulast%3DRabe%26aufirst%3DS.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DPaganetti%26aufirst%3DP.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DMacrocyclic%2520BACE-1%2520inhibitors%2520acutely%2520reduce%2520A%25CE%25B2%2520in%2520brain%2520after%2520po%2520application%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D603%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Rampe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wible, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dage, R. C.</span><span> </span><span class="NLM_article-title">Effects of terfenadine and its metabolites on a delayed rectifier K1 channel cloned from human heart</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=1240-1245&author=D.+Rampeauthor=B.+Wibleauthor=A.+M.+Brownauthor=R.+C.+Dage&title=Effects+of+terfenadine+and+its+metabolites+on+a+delayed+rectifier+K1+channel+cloned+from+human+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRampe%26aufirst%3DD.%26aulast%3DWible%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DDage%26aufirst%3DR.%2BC.%26atitle%3DEffects%2520of%2520terfenadine%2520and%2520its%2520metabolites%2520on%2520a%2520delayed%2520rectifier%2520K1%2520channel%2520cloned%2520from%2520human%2520heart%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D44%26spage%3D1240%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Doan, M. K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkison, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2004&pages=92-98&author=M.+K.+M.+Doanauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=K.+H.+Jordanauthor=J.+P.+Bishopauthor=J.+Kratzauthor=E.+Yangauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkisonauthor=J.+W.+Polli&title=Steady-state+brain+concentrations+of+antihistamines+in+rats%3A+interplay+of+membrane+permeability%2C+P-glycoprotein+efflux+and+plasma+protein+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DM.%2BK.%2BM.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DJordan%26aufirst%3DK.%2BH.%26aulast%3DBishop%26aufirst%3DJ.%2BP.%26aulast%3DKratz%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DSteady-state%2520brain%2520concentrations%2520of%2520antihistamines%2520in%2520rats%253A%2520interplay%2520of%2520membrane%2520permeability%252C%2520P-glycoprotein%2520efflux%2520and%2520plasma%2520protein%2520binding%26jtitle%3DPharmacology%26date%3D2004%26volume%3D72%26spage%3D92%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanni, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span> </span><span class="NLM_article-title">Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=529-535&author=R.+Zhaoauthor=J.+C.+Kalvassauthor=S.+B.+Yanniauthor=A.+S.+Bridgesauthor=G.+M.+Pollack&title=Fexofenadine+brain+exposure+and+the+influence+of+blood-brain+barrier+P-glycoprotein+after+fexofenadine+and+terfenadine+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DYanni%26aufirst%3DS.%2BB.%26aulast%3DBridges%26aufirst%3DA.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DFexofenadine%2520brain%2520exposure%2520and%2520the%2520influence%2520of%2520blood-brain%2520barrier%2520P-glycoprotein%2520after%2520fexofenadine%2520and%2520terfenadine%2520administration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D529%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Mihalic, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3781-3785&author=J.+T.+Mihalicauthor=F.+Fanauthor=X.+Chenauthor=X.+Chenauthor=Y.+Fuauthor=A.+Motaniauthor=L.+Liangauthor=M.+Lindstromauthor=L.+Tangauthor=L.-L.+Chenauthor=J.+Jaenauthor=K.+Daiauthor=L.+Li&title=Discovery+of+a+novel+melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonist+with+reduced+hERG+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalic%26aufirst%3DJ.%2BT.%26aulast%3DFan%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DMotani%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.-L.%26aulast%3DJaen%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonist%2520with%2520reduced%2520hERG%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3781%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Hogberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasmal, P. K.</span><span> </span><span class="NLM_article-title">Melanin concentrating hormone receptor 1 (MCHR1) antagonists—still a viable approach for obesity treatment?</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6039</span><span class="NLM_x">–</span> <span class="NLM_lpage">6047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6039-6047&author=T.+Hogbergauthor=T.+Frimurerauthor=P.+K.+Sasmal&title=Melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonists%E2%80%94still+a+viable+approach+for+obesity+treatment%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHogberg%26aufirst%3DT.%26aulast%3DFrimurer%26aufirst%3DT.%26aulast%3DSasmal%26aufirst%3DP.%2BK.%26atitle%3DMelanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonists%25E2%2580%2594still%2520a%2520viable%2520approach%2520for%2520obesity%2520treatment%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6039%26epage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5050</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5050&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lhybhZktypFJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Gianotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglioni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal-Cin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fratte, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korajac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovric, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rast, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roscic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smehil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togninelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigglesworth, M. J.</span><span> </span><span class="NLM_article-title">Novel spirotetracyclic zwitterionic dual H1/5-HT2A receptor antagonists for the treatment of sleep disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7778</span><span class="NLM_x">–</span> <span class="NLM_lpage">7795</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100856p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7778-7795&author=M.+Gianottiauthor=M.+Bottaauthor=S.+Broughauthor=R.+Carlettiauthor=E.+Castiglioniauthor=C.+Cortiauthor=M.+Dal-Cinauthor=S.+D.+Fratteauthor=D.+Korajacauthor=M.+Lovricauthor=G.+Merloauthor=M.+Mesicauthor=F.+Pavoneauthor=L.+Piccoliauthor=S.+Rastauthor=M.+Roscicauthor=A.+Savaauthor=M.+Smehilauthor=L.+Stasiauthor=A.+Togninelliauthor=M.+J.+Wigglesworth&title=Novel+spirotetracyclic+zwitterionic+dual+H1%2F5-HT2A+receptor+antagonists+for+the+treatment+of+sleep+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm100856p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100856p%26sid%3Dliteratum%253Aachs%26aulast%3DGianotti%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBrough%26aufirst%3DS.%26aulast%3DCarletti%26aufirst%3DR.%26aulast%3DCastiglioni%26aufirst%3DE.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DDal-Cin%26aufirst%3DM.%26aulast%3DFratte%26aufirst%3DS.%2BD.%26aulast%3DKorajac%26aufirst%3DD.%26aulast%3DLovric%26aufirst%3DM.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DMesic%26aufirst%3DM.%26aulast%3DPavone%26aufirst%3DF.%26aulast%3DPiccoli%26aufirst%3DL.%26aulast%3DRast%26aufirst%3DS.%26aulast%3DRoscic%26aufirst%3DM.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DSmehil%26aufirst%3DM.%26aulast%3DStasi%26aufirst%3DL.%26aulast%3DTogninelli%26aufirst%3DA.%26aulast%3DWigglesworth%26aufirst%3DM.%2BJ.%26atitle%3DNovel%2520spirotetracyclic%2520zwitterionic%2520dual%2520H1%252F5-HT2A%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520sleep%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7778%26epage%3D7795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span> </span><span class="NLM_article-title">Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6128</span><span class="NLM_x">–</span> <span class="NLM_lpage">6140</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500610n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6128-6140&author=W.+McCoullauthor=P.+Bartonauthor=A.+J.+H.+Brownauthor=S.+S.+Bowkerauthor=J.+Cameronauthor=D.+S.+Clarkeauthor=R.+D.+M.+Daviesauthor=A.+G.+Dossetterauthor=A.+Ertanauthor=M.+Fenwickauthor=C.+Greenauthor=J.+L.+Holmesauthor=N.+Martinauthor=D.+Mastersauthor=J.+E.+Mooreauthor=N.+J.+Newcombeauthor=C.+Newtonauthor=H.+Pointonauthor=G.+R.+Robbauthor=C.+Sheldonauthor=S.+Stokesauthor=D.+Morgan&title=Identification%2C+optimization%2C+and+pharmacology+of+acylurea+GHS-R1a+inverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm500610n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500610n%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DBowker%26aufirst%3DS.%2BS.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavies%26aufirst%3DR.%2BD.%2BM.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DFenwick%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSheldon%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DIdentification%252C%2520optimization%252C%2520and%2520pharmacology%2520of%2520acylurea%2520GHS-R1a%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6128%26epage%3D6140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span> </span><span class="NLM_article-title">CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1200%2FJCO.2010.34.1313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=443-445&author=D.+B.+Costaauthor=S.+Kobayashiauthor=S.+S.+Pandyaauthor=W.+L.+Yeoauthor=Z.+Shenauthor=W.+Tanauthor=K.+D.+Wilner&title=CSF+concentration+of+the+anaplastic+lymphoma+kinase+inhibitor+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.34.1313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.34.1313%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DS.%2BS.%26aulast%3DYeo%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26atitle%3DCSF%2520concentration%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520inhibitor%2520crizotinib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D443%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Marsault, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span> </span><span class="NLM_article-title">Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lgZjPKudq7oKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Levin, V. A.</span><span> </span><span class="NLM_article-title">Relationship of octanol/water partition coefficients to rat brain capillary permeability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00180a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=682-684&author=V.+A.+Levin&title=Relationship+of+octanol%2Fwater+partition+coefficients+to+rat+brain+capillary+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm00180a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00180a022%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DV.%2BA.%26atitle%3DRelationship%2520of%2520octanol%252Fwater%2520partition%2520coefficients%2520to%2520rat%2520brain%2520capillary%2520permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D682%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eat-MXg9AUZY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Bergstrom, C. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strafford, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazorova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Absorption classification of oral drugs based on molecular surface properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020986i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=558-570&author=C.+A.+S.+Bergstromauthor=M.+Straffordauthor=L.+Lazorovaauthor=A.+Avdeefauthor=K.+Luthmanauthor=P.+Artursson&title=Absorption+classification+of+oral+drugs+based+on+molecular+surface+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm020986i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020986i%26sid%3Dliteratum%253Aachs%26aulast%3DBergstrom%26aufirst%3DC.%2BA.%2BS.%26aulast%3DStrafford%26aufirst%3DM.%26aulast%3DLazorova%26aufirst%3DL.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DAbsorption%2520classification%2520of%2520oral%2520drugs%2520based%2520on%2520molecular%2520surface%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D558%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Tantishaiyakul, V.</span><span> </span><span class="NLM_article-title">Prediction of Caco-2 cell permeability using partial least square multivariate analysis</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=407-411&author=V.+Tantishaiyakul&title=Prediction+of+Caco-2+cell+permeability+using+partial+least+square+multivariate+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTantishaiyakul%26aufirst%3DV.%26atitle%3DPrediction%2520of%2520Caco-2%2520cell%2520permeability%2520using%2520partial%2520least%2520square%2520multivariate%2520analysis%26jtitle%3DPharmazie%26date%3D2001%26volume%3D56%26spage%3D407%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Egan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span> </span><span class="NLM_article-title">Prediction of drug absorption using multivariate statistics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3867</span><span class="NLM_x">–</span> <span class="NLM_lpage">3877</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000292e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3867-3877&author=W.+J.+Eganauthor=K.+M.+Merzauthor=J.+J.+Baldwin&title=Prediction+of+drug+absorption+using+multivariate+statistics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Absorption Using Multivariate Statistics</span></div><div class="casAuthors">Egan, William J.; Merz, Kenneth M. Jr.; Baldwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3867-3877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Literature data on compds. both well- and poorly-absorbed in humans were used to build a statistical pattern recognition model of passive intestinal absorption.  Robust outlier detection was utilized to analyze the well-absorbed compds., some of which were intermingled with the poorly-absorbed compds. in the model space.  Outliers were identified as being actively transported.  The descriptors chosen for inclusion in the model were PSA and AlogP98, based on consideration of the phys. processes involved in membrane permeability and the interrelationships and redundancies between available descriptors.  These descriptors are quite straightforward for a medicinal chemist to interpret, enhancing the utility of the model.  Mol. wt., while often used in passive absorption models, was shown to be superfluous, as it is already a component of both PSA and AlogP98.  Extensive validation of the model on hundreds of known orally delivered drugs, "drug-like" mols., and Pharmacopeia, Inc. compds., which had been assayed for Caco-2 cell permeability, demonstrated a good rate of successful predictions (74-92%, depending on the dataset and exact criterion used).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZF9e_GNz8LVg90H21EOLACvtfcHk0liNzz-72MjCdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D&md5=44f909ad1fd6187840921e7f07497b4e</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm000292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000292e%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DW.%2BJ.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520drug%2520absorption%2520using%2520multivariate%2520statistics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3867%26epage%3D3877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2eat-MXg9AUZY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Tarcsay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0liNzz-72MjCdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Nicolaou, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span> </span><span class="NLM_article-title">Multi-objective optimization methods in drug design</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=427-435&author=C.+A.+Nicolaouauthor=N.+Brown&title=Multi-objective+optimization+methods+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DC.%2BA.%26aulast%3DBrown%26aufirst%3DN.%26atitle%3DMulti-objective%2520optimization%2520methods%2520in%2520drug%2520design%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2013%26volume%3D10%26spage%3D427%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span> </span><span class="NLM_article-title">Estimation of ADME properties with substructure pattern recognition</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100104j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFektLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1034-1041&author=J.+Shenauthor=F.+Chengauthor=Y.+Xuauthor=W.+Liauthor=Y.+Tang&title=Estimation+of+ADME+properties+with+substructure+pattern+recognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of ADME Properties with Substructure Pattern Recognition</span></div><div class="casAuthors">Shen, Jie; Cheng, Feixiong; Xu, You; Li, Weihua; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1034-1041</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past decade, absorption, distribution, metab., and excretion (ADME) property evaluation has become one of the most important issues in the process of drug discovery and development.  Since in vivo and in vitro evaluations are costly and laborious, in silico techniques had been widely used to est. ADME properties of chem. compds.  Traditional prediction methods usually try to build a functional relationship between a set of mol. descriptors and a given ADME property.  Although traditional methods have been successfully used in many cases, the accuracy and efficiency of mol. descriptors must be concerned.  Herein, we report a new classification method based on substructure pattern recognition, in which each mol. is represented as a substructure pattern fingerprint based on a predefined substructure dictionary, and then a support vector machine (SVM) algorithm is applied to build the prediction model.  Therefore, a direct connection between substructures and mol. properties is built.  The most important substructure patterns can be identified via the information gain anal., which could help to interpret the models from a medicinal chem. perspective.  Afterward, this method was verified with two data sets, one for blood-brain barrier (BBB) penetration and the other for human intestinal absorption (HIA).  The results demonstrated that the overall predictive accuracies of the best HIA model for the training and test sets were 98.5 and 98.8%, and the overall predictive accuracies of the best BBB model for the training and test sets were 98.8 and 98.4%, which confirmed the reliability of our method.  In the addnl. validations, the predictive accuracies were 94 and 69.5% for the HIA and the BBB models, resp.  Moreover, some of the representative key substructure patterns which significantly correlated with the HIA and BBB penetration properties were also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEzrJIPuAKLrVg90H21EOLACvtfcHk0lgjTTYY5nK0Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFektLs%253D&md5=db97701246ad6ffa35915307bf101e44</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fci100104j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100104j%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DEstimation%2520of%2520ADME%2520properties%2520with%2520substructure%2520pattern%2520recognition%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1034%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Chernet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Need, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phebus, L. A.</span><span> </span><span class="NLM_article-title">Use of LC/MS to assess brain tracer distribution in preclinical, <i>in vivo</i> receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2005&pages=340-346&author=E.+Chernetauthor=L.+J.+Martinauthor=D.+Liauthor=A.+B.+Needauthor=V.+N.+Barthauthor=K.+S.+Rashauthor=L.+A.+Phebus&title=Use+of+LC%2FMS+to+assess+brain+tracer+distribution+in+preclinical%2C+in+vivo+receptor+occupancy+studies%3A+dopamine+D2%2C+serotonin+2A+and+NK-1+receptors+as+examples"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChernet%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DNeed%26aufirst%3DA.%2BB.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26atitle%3DUse%2520of%2520LC%252FMS%2520to%2520assess%2520brain%2520tracer%2520distribution%2520in%2520preclinical%252C%2520in%2520vivo%2520receptor%2520occupancy%2520studies%253A%2520dopamine%2520D2%252C%2520serotonin%25202A%2520and%2520NK-1%2520receptors%2520as%2520examples%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D78%26spage%3D340%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Need, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitch, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phebus, L. A.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=1389-1396&author=A.+B.+Needauthor=J.+H.+McKinzieauthor=C.+H.+Mitchauthor=M.+A.+Statnickauthor=L.+A.+Phebus&title=In+vivo+rat+brain+opioid+receptor+binding+of+LY255582+assessed+with+a+novel+method+using+LC%2FMS%2FMS+and+the+administration+of+three+tracers+simultaneously"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeed%26aufirst%3DA.%2BB.%26aulast%3DMcKinzie%26aufirst%3DJ.%2BH.%26aulast%3DMitch%26aufirst%3DC.%2BH.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26atitle%3DIn%2520vivo%2520rat%2520brain%2520opioid%2520receptor%2520binding%2520of%2520LY255582%2520assessed%2520with%2520a%2520novel%2520method%2520using%2520LC%252FMS%252FMS%2520and%2520the%2520administration%2520of%2520three%2520tracers%2520simultaneously%26jtitle%3DLife%2520Sci.%26date%3D2007%26volume%3D81%26spage%3D1389%26epage%3D1396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Hawkins, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">The blood–brain barrier/neurovascular unit in health and disease</span> <span class="citation_source-journal">Am. Soc. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=173-185&author=B.+T.+Hawkinsauthor=T.+P.+Davis&title=The+blood%E2%80%93brain+barrier%2Fneurovascular+unit+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DB.%2BT.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%252Fneurovascular%2520unit%2520in%2520health%2520and%2520disease%26jtitle%3DAm.%2520Soc.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D57%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Seelbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egleton, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1111%2Fj.1471-4159.2007.04644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17697052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1677-1690&author=M.+J.+Seelbachauthor=T.+A.+Brooksauthor=R.+D.+Egletonauthor=T.+P.+Davis&title=Peripheral+inflammatory+hyperalgesia+modulates+morphine+delivery+to+the+brain%3A+a+role+for+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein</span></div><div class="casAuthors">Seelbach, Melissa J.; Brooks, Tracy A.; Egleton, Richard D.; Davis, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1677-1690</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">P-glycoprotein (Pgp, ABCB1) is a crit. efflux transporter at the blood-brain barrier (BBB) where its luminal location and substrate promiscuity limit the brain distribution of numerous therapeutics.  Moreover, Pgp is known to confer multi-drug resistance in cancer chemotherapy and brain diseases, such as epilepsy, and is highly regulated by inflammatory mediators.  The involvement of inflammatory processes in neuropathol. states has led us to investigate the effects of peripheral inflammatory hyperalgesia on transport properties at the BBB.  In the present study, we examd. the effects of λ-carrageenan-induced inflammatory pain (CIP) on brain endothelium regulation of Pgp.  Western blot anal. of enriched brain microvessel fractions showed increased Pgp expression 3 h post-CIP.  In situ brain perfusion studies paralleled these findings with decreased brain uptake of the Pgp substrate and opiate analgesic, [3H] morphine.  Cyclosporin A-mediated inhibition of Pgp enhanced the uptake of morphine in λ-carrageenan and control animals.  This indicates that the CIP induced decrease in morphine transport was the result of an increase in Pgp activity at the BBB.  Furthermore, antinociception studies showed decreased morphine analgesia following CIP.  The observation that CIP modulates Pgp at the BBB in vivo is crit. to understanding BBB regulation during inflammatory disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgcmw0KrITRrVg90H21EOLACvtfcHk0lgjTTYY5nK0Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7jM&md5=119fd4b1d49f1c3e69f4a59d346a3ddf</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04644.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeelbach%26aufirst%3DM.%2BJ.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26aulast%3DEgleton%26aufirst%3DR.%2BD.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DPeripheral%2520inflammatory%2520hyperalgesia%2520modulates%2520morphine%2520delivery%2520to%2520the%2520brain%253A%2520a%2520role%2520for%2520P-glycoprotein%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D102%26spage%3D1677%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Vieth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durst, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hipskind, P. A.</span><span> </span><span class="NLM_article-title">Characteristic physical properties and structural fragments of marketed oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030267j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=224-232&author=M.+Viethauthor=M.+G.+Siegelauthor=R.+E.+Higgsauthor=I.+A.+Watsonauthor=D.+H.+Robertsonauthor=K.+A.+Savinauthor=G.+L.+Durstauthor=P.+A.+Hipskind&title=Characteristic+physical+properties+and+structural+fragments+of+marketed+oral+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjm030267j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030267j%26sid%3Dliteratum%253Aachs%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DM.%2BG.%26aulast%3DHiggs%26aufirst%3DR.%2BE.%26aulast%3DWatson%26aufirst%3DI.%2BA.%26aulast%3DRobertson%26aufirst%3DD.%2BH.%26aulast%3DSavin%26aufirst%3DK.%2BA.%26aulast%3DDurst%26aufirst%3DG.%2BL.%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26atitle%3DCharacteristic%2520physical%2520properties%2520and%2520structural%2520fragments%2520of%2520marketed%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D224%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2969</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0512185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2969-2978&author=R.+Morphy&title=The+influence+of+target+family+and+functional+activity+on+the+physicochemical+properties+of+pre-clinical+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">The Influence of Target Family and Functional Activity on the Physicochemical Properties of Pre-Clinical Compounds</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2969-2978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The target families of greatest interest in drug discovery can be differentiated on the basis of the physicochem. properties of their preclin. ligands.  The ligands for peptidergic targets, such as peptide G protein-coupled receptors (GPCRs) and integrin receptors, possess significantly higher median property values than those for aminergic targets, such as monoamine transporters and GPCRs.  The ligands for peptide GPCRs were found to be less efficient, in terms of their binding energy per unit of mol. wt. or lipophilicity, than ligands for monoamine GPCRs.  The changes in the property values during the optimization process were found to vary only slightly across the target families, with the main determinant of the drug-likeness of the optimized compds. being the profile of the starting compds.  Agonists for monoamine GPCRs, opioid receptors and ion channels were typically smaller and less lipophilic than the antagonists, but there was no difference between the agonists and the antagonists for peptide GPCRs and nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EegclZUHNbVg90H21EOLACvtfcHk0lgK1QoNKrOPDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D&md5=fcf63bff570d58d56492b46ddecb5eb1</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm0512185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512185%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%2520target%2520family%2520and%2520functional%2520activity%2520on%2520the%2520physicochemical%2520properties%2520of%2520pre-clinical%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2969%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, R. V. D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, E. H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with <i>in vivo</i> toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+D.+E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+H.+T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lgK1QoNKrOPDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DEllsworth%26aufirst%3DR.%2BV.%2BD.%2BE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DKrieger-Burke%26aufirst%3DE.%2BH.%2BT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgK1QoNKrOPDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Ritchie1, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchie1author=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie1%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Alelyunas, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empfield, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi-Kilby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span> </span><span class="NLM_article-title">Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7312</span><span class="NLM_x">–</span> <span class="NLM_lpage">7316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7312-7316&author=Y.+W.+Alelyunasauthor=J.+R.+Empfieldauthor=D.+McCarthyauthor=R.+C.+Spreenauthor=K.+Buiauthor=L.+Pelosi-Kilbyauthor=C.+Shen&title=Experimental+solubility+profiling+of+marketed+CNS+drugs%2C+exploring+solubility+limit+of+CNS+discovery+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlelyunas%26aufirst%3DY.%2BW.%26aulast%3DEmpfield%26aufirst%3DJ.%2BR.%26aulast%3DMcCarthy%26aufirst%3DD.%26aulast%3DSpreen%26aufirst%3DR.%2BC.%26aulast%3DBui%26aufirst%3DK.%26aulast%3DPelosi-Kilby%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26atitle%3DExperimental%2520solubility%2520profiling%2520of%2520marketed%2520CNS%2520drugs%252C%2520exploring%2520solubility%2520limit%2520of%2520CNS%2520discovery%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7312%26epage%3D7316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Noe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span> </span><span class="NLM_article-title">Targeted covalent enzyme inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FB978-0-12-396492-2.00027-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=413-439&author=M.+C.+Noeauthor=A.+M.+Gilbert&title=Targeted+covalent+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted covalent enzyme inhibitors</span></div><div class="casAuthors">Noe, Mark C.; Gilbert, Adam M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">413-439</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Selective covalent modification of a biomol. target can offer several important advantages in drug discovery.  The purpose of this report is to broadly detail targeted covalent inhibitor approaches across a variety of enzyme families which were published over the past 5 years.  Covalent modification of essential enzyme cofactors as a design strategy and the development of covalent probes to enable chem. biol. studies are beyond the scope of this review.  Tis review will be divided into several sections based on reactivity of the electrophilic species (producing functionally irreversible or reversible covalent assocn. with the target protein), and type of nucleophile with which the electrophile is known to assoc. in its biol. context (sulfur, oxygen, or nitrogen).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp04K2rcDR5rVg90H21EOLACvtfcHk0lhdhObW3Z9yqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7jK&md5=4957a32f394ad591702a4316ffe9c8df</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00027-8%26sid%3Dliteratum%253Aachs%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26atitle%3DTargeted%2520covalent%2520enzyme%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D413%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Dounay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechle, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evdokimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salafia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuyten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Discovery of brain-penetrant, irreversible kynurenine aminotransferase II inhibitors for schizophrenia</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200204m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=187-192&author=A.+B.+Dounayauthor=M.+Andersonauthor=B.+M.+Bechleauthor=B.+M.+Campbellauthor=M.+M.+Claffeyauthor=A.+Evdokimovauthor=E.+Evrardauthor=K.+R.+Fonsecaauthor=X.+Ganauthor=S.+Ghoshauthor=M.+M.+Haywardauthor=W.+Hornerauthor=J.-Y.+Kimauthor=L.+A.+McAllisterauthor=J.+Panditauthor=V.+Paradisauthor=V.+D.+Parikhauthor=M.+R.+Reeseauthor=S.+Rongauthor=M.+A.+Salafiaauthor=K.+Schuytenauthor=C.+A.+Strickauthor=J.+B.+Tuttleauthor=J.+Valentineauthor=H.+Wangauthor=L.+E.+Zawadzkeauthor=P.+R.+Verhoest&title=Discovery+of+brain-penetrant%2C+irreversible+kynurenine+aminotransferase+II+inhibitors+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fml200204m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200204m%26sid%3Dliteratum%253Aachs%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DCampbell%26aufirst%3DB.%2BM.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DEvdokimov%26aufirst%3DA.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGan%26aufirst%3DX.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DHorner%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DParadis%26aufirst%3DV.%26aulast%3DParikh%26aufirst%3DV.%2BD.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DRong%26aufirst%3DS.%26aulast%3DSalafia%26aufirst%3DM.%2BA.%26aulast%3DSchuyten%26aufirst%3DK.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DValentine%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDiscovery%2520of%2520brain-penetrant%252C%2520irreversible%2520kynurenine%2520aminotransferase%2520II%2520inhibitors%2520for%2520schizophrenia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0lg0x945JrjniA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Covalent modifiers: an orthogonal approach to drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1231-1246&author=M.+H.+Potashmanauthor=M.+E.+Duggan&title=Covalent+modifiers%3A+an+orthogonal+approach+to+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: An Orthogonal Approach to Drug Design</span></div><div class="casAuthors">Potashman, Michele H.; Duggan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1231-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this article we review a variety of examples in which therapeutic targets are covalently bound by small-mol. drugs or by compds. in advanced clin. development.  The covalent interactions can be either reversible or irreversible, depending on the reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BO6g9_F717Vg90H21EOLACvtfcHk0lg0x945JrjniA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D&md5=f8380d5a1cdd8638ad2a1e0405d25267</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008597%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DCovalent%2520modifiers%253A%2520an%2520orthogonal%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1231%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Moghaddam, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apuy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span> </span><span class="NLM_article-title">A proposed screening paradigm for discovery of covalent inhibitor drugs</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.2174%2F1872312808666140317151735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=24628405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGqur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=19-30&author=M.+F.+Moghaddamauthor=Y.+Tangauthor=Z.+O%E2%80%99Brienauthor=S.+J.+Richardsonauthor=M.+Bacoldauthor=P.+Chaturvediauthor=J.+Apuyauthor=A.+Kulkarni&title=A+proposed+screening+paradigm+for+discovery+of+covalent+inhibitor+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs</span></div><div class="casAuthors">Moghaddam, Mehran F.; Tang, Yang; O'Brien, Zhihong; Richardson, Samantha J.; Bacolod, Maria; Chaturedi, Prasoon; Apuy, Julius; Kulkarni, Ashutosh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-30</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The in vitro and in vivo preclin. ADME properties of 10 clin. late stage or marketed covalent inhibitors were evaluated in order to define advancement criteria for discovery of future drugs in this arena.  Our studies revealed the following: After incubating with S9 fractions for 30 min, the rat and human in vitro stability for these compds. ranged from 1% to 100%.  The blood stability ranged from 30% to 100%.  There was a broad range of CYP inhibition with prevalence for time-dependent inhibition of at least one enzyme.  The Caco-2 permeability (A→B) ranged from negligible (0.6 x 10-6 cm/s) to highly permeable (31 x 10-6 cm/s) and the efflux ratio also varied widely (0.2-30).  Most of the compds. were highly protein bound in both rat and human with binding ≥ 90%.  Rat plasma clearance for the 10 compds. ranged from slow (11 mL/min/kg) to very rapid (350 mL/min/kg).  The Vss ranged from low (0.67 L/kg) to very high (115 L/kg).  MRT's also ranged from short (0.5 h) to long (7.4 h).  The oral exposures also showed a very broad range with Cmax's ranging from 0.01-77 μM and exposure levels ranging from 0.03-106 μM.hr.  In conclusion, the wide range in in vitro and in vivo ADME data makes these particular ADME assays non-discriminatory in the selection of promising compds.  In our opinion, non-traditional assays such as target mass modification, target confirmation by amino acid sequencing, cellular target occupancy, and target turnover rate data in combination with the pharmacokinetic profiles are the crit. considerations for progression of irreversible compds. in early discovery. ; <b>Biog.</b>: Mehran Moghaddam, PhD, is.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobrQbTwxt6f7Vg90H21EOLACvtfcHk0lg0x945JrjniA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGqur%252FF&md5=97ff5ba47e9547cbae3e5d10ec35112e</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.2174%2F1872312808666140317151735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1872312808666140317151735%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DBacold%26aufirst%3DM.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DApuy%26aufirst%3DJ.%26aulast%3DKulkarni%26aufirst%3DA.%26atitle%3DA%2520proposed%2520screening%2520paradigm%2520for%2520discovery%2520of%2520covalent%2520inhibitor%2520drugs%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2014%26volume%3D8%26spage%3D19%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Johansson, M. H.</span><span> </span><span class="NLM_article-title">Reversible michael additions: covalent inhibitors and prodrugs</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=22625413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1330-1344&author=M.+H.+Johansson&title=Reversible+michael+additions%3A+covalent+inhibitors+and+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible Michael additions: covalent inhibitors and prodrugs</span></div><div class="casAuthors">Johansson, Martin H.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1330-1344</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Covalent inhibition is an efficient mol. mechanism for inhibiting enzymes or modulating the function of proteins and is found in the action of many drugs and biol. active natural products.  However, it is has been less appreciated that the formation of covalent bonds can be reversible or irreversible.  This review focuses on biol. active compds. that are Michael acceptors and how the reversible nature of the Michael addn. reaction influences biol. activity and how this can be exploited in designing prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9X1yh9k4q-7Vg90H21EOLACvtfcHk0liT13puNSrMPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jJ&md5=f90694162e39fe57915e888bbadbd2bb</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DM.%2BH.%26atitle%3DReversible%2520michael%2520additions%253A%2520covalent%2520inhibitors%2520and%2520prodrugs%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1330%26epage%3D1344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Uetrecht, J. P.</span><span> </span><span class="NLM_article-title">New concepts in immunology relevant to idiosyncratic drug reactions: the “danger hypothesis” and innate immune system</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx980249i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=387-395&author=J.+P.+Uetrecht&title=New+concepts+in+immunology+relevant+to+idiosyncratic+drug+reactions%3A+the+%E2%80%9Cdanger+hypothesis%E2%80%9D+and+innate+immune+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Ftx980249i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx980249i%26sid%3Dliteratum%253Aachs%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26atitle%3DNew%2520concepts%2520in%2520immunology%2520relevant%2520to%2520idiosyncratic%2520drug%2520reactions%253A%2520the%2520%25E2%2580%259Cdanger%2520hypothesis%25E2%2580%259D%2520and%2520innate%2520immune%2520system%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1999%26volume%3D12%26spage%3D387%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, O.</span><span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0liT13puNSrMPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span> </span><span class="NLM_article-title">Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fbjp.2008.260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18574456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=185-197&author=A.+Reginaauthor=M.+Demeuleauthor=C.+Cheauthor=I.+Lavalleeauthor=J.+Poirierauthor=R.+Gabathulerauthor=R.+Beliveauauthor=J.+P.+Castaigne&title=Antitumour+activity+of+ANG1005%2C+a+conjugate+between+paclitaxel+and+the+new+brain+delivery+vector+Angiopep-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2</span></div><div class="casAuthors">Regina, A.; Demeule, M.; Che, C.; Lavallee, I.; Poirier, J.; Gabathuler, R.; Beliveau, R.; Castaigne, J-P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-197</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Paclitaxel is highly efficacious in the treatment of breast, head and neck, non-small cell lung cancers and ovarian carcinoma.  For malignant gliomas, paclitaxel is prevented from reaching its target by the presence of the efflux pump P-glycoprotein (P-gp) at the blood-brain barrier.  We investigated the utilization of a new drug delivery system to increase brain delivery of paclitaxel.  Exptl. approach: Paclitaxel mols. were conjugated to a brain peptide vector, Angiopep-2, to provide a paclitaxel-Angiopep-2 conjugate named ANG1005.  We detd. the brain uptake capacity, intracellular effects and antitumor properties of ANG1005 in vitro against human tumor cell lines and in vivo in human xenografts.  We then detd. ANG1005 activity on brain tumors with intracerebral human tumor models in nude mice.  Key results: We show by in situ brain perfusion that ANG1005 enters the brain to a greater extent than paclitaxel and bypasses the P-gp.  ANG1005 has an antineoplastic potency similar to that of paclitaxel against human cancer cell lines.  We also demonstrate that ANG1005 caused a more potent inhibition of human tumor xenografts than paclitaxel.  Finally, ANG1005 administration led to a significant increase in the survival of mice with intracerebral implantation of U87 MG glioblastoma cells or NCI-H460 lung carcinoma cells.  Conclusions and implications: These results demonstrate the antitumor potential of a new drug, ANG1005, and establish that conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf7gdI2T8jHbVg90H21EOLACvtfcHk0liT13puNSrMPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N&md5=3c86b5d1a64c5754d439dfa787f16637</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.260%26sid%3Dliteratum%253Aachs%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DLavallee%26aufirst%3DI.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26atitle%3DAntitumour%2520activity%2520of%2520ANG1005%252C%2520a%2520conjugate%2520between%2520paclitaxel%2520and%2520the%2520new%2520brain%2520delivery%2520vector%2520Angiopep-2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D185%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 275 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicky Hwang, Liren Sun, Daisy Noe, Patrick Y. S. Lam, Tianlun Zhou, Timothy M. Block, <span class="NLM_string-name hlFld-ContribAuthor">Yanming Du</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatoselective Dihydroquinolizinone Bis-acids for HBsAg mRNA Degradation. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1130-1136. <a href="https://doi.org/10.1021/acsmedchemlett.1c00228" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00228%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHepatoselective%252BDihydroquinolizinone%252BBis-acids%252Bfor%252BHBsAg%252BmRNA%252BDegradation%26aulast%3DHwang%26aufirst%3DNicky%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19042021%26date%3D16062021%26date%3D22062021%26volume%3D12%26issue%3D7%26spage%3D1130%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Meng Tian, Rui Xing, Juan Guan, Bingxue Yang, Xin Zhao, Juanjuan Yang, Changyou Zhan, <span class="NLM_string-name hlFld-ContribAuthor">Shiyi Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A Nanoantidote Alleviates Glioblastoma Chemotoxicity without Efficacy Compromise. </span><span class="cited-content_cbyCitation_journal-name">Nano Letters</span><span> <strong>2021,</strong> <em>21 </em>
                                    (12)
                                     , 5158-5166. <a href="https://doi.org/10.1021/acs.nanolett.1c01201" title="DOI URL">https://doi.org/10.1021/acs.nanolett.1c01201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.nanolett.1c01201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.nanolett.1c01201%26sid%3Dliteratum%253Aachs%26jtitle%3DNano%2520Letters%26atitle%3DA%252BNanoantidote%252BAlleviates%252BGlioblastoma%252BChemotoxicity%252Bwithout%252BEfficacy%252BCompromise%26aulast%3DTian%26aufirst%3DMeng%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25032021%26date%3D31052021%26date%3D07062021%26volume%3D21%26issue%3D12%26spage%3D5158%26epage%3D5166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Melissa Mejia-Gutierrez, Bryan D. Vásquez-Paz, Leonardo Fierro, <span class="NLM_string-name hlFld-ContribAuthor">Julio R. Maza</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Repositioning of Dopamine Modulators with Possible Application to Schizophrenia: Pharmacophore Mapping, Molecular Docking and Molecular Dynamics Analysis. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (23)
                                     , 14748-14764. <a href="https://doi.org/10.1021/acsomega.0c05984" title="DOI URL">https://doi.org/10.1021/acsomega.0c05984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c05984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c05984%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DIn%252BSilico%252BRepositioning%252Bof%252BDopamine%252BModulators%252Bwith%252BPossible%252BApplication%252Bto%252BSchizophrenia%25253A%252BPharmacophore%252BMapping%25252C%252BMolecular%252BDocking%252Band%252BMolecular%252BDynamics%252BAnalysis%26aulast%3DMejia-Gutierrez%26aufirst%3DMelissa%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09122020%26date%3D30032021%26date%3D01062021%26volume%3D6%26issue%3D23%26spage%3D14748%26epage%3D14764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emily Murrell, Junchao Tong, David Smil, Taira Kiyota, Ahmed M. Aman, Methvin B. Isaac, Iain D. G. Watson, <span class="NLM_string-name hlFld-ContribAuthor">Neil Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Leveraging Open Science Drug Development for PET: Preliminary Neuroimaging of 11C-Labeled ALK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 846-850. <a href="https://doi.org/10.1021/acsmedchemlett.1c00127" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00127%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLeveraging%252BOpen%252BScience%252BDrug%252BDevelopment%252Bfor%252BPET%25253A%252BPreliminary%252BNeuroimaging%252Bof%252B11C-Labeled%252BALK2%252BInhibitors%26aulast%3DMurrell%26aufirst%3DEmily%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D02032021%26date%3D21042021%26date%3D23042021%26volume%3D12%26issue%3D5%26spage%3D846%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amanda Van de Poël, Leticia Toledo-Sherman, Perla Breccia, Roger Cachope, Jennifer R. Bate, Ivan Angulo-Herrera, Grant Wishart, Kim L. Matthews, Sarah L. Martin, Marcus Peacock, Amy Barnard, Helen C. Cox, Graham Jones, George McAllister, Huw Vater, William Esmieu, Cole Clissold, Marieke Lamers, Philip Leonard, Rebecca E. Jarvis, Wesley Blackaby, Maria Eznarriaga, Ovadia Lazari, Dawn Yates, Mark Rose, Sung-Wook Jang, Ignacio Muñoz-Sanjuan, <span class="NLM_string-name hlFld-ContribAuthor">Celia Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5018-5036. <a href="https://doi.org/10.1021/acs.jmedchem.1c00114" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BExploration%252Bof%252BSelectivity%252Bfor%252BATM%252BInhibitors%252Bin%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DAmanda%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D30032021%26volume%3D64%26issue%3D8%26spage%3D5018%26epage%3D5036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuji Koriyama, Akihiro Hori, Hisanori Ito, Shuji Yonezawa, Yoshiyasu Baba, Norihiko Tanimoto, Tatsuhiko Ueno, Shiho Yamamoto, Takahiko Yamamoto, Naoya Asada, Kenji Morimoto, Shunsuke Einaru, Katsunori Sakai, Takushi Kanazu, Akihiro Matsuda, Yoshitaka Yamaguchi, Takuya Oguma, Maarten Timmers, Luc Tritsmans, Ken-ichi Kusakabe, Akira Kato, <span class="NLM_string-name hlFld-ContribAuthor">Gaku Sakaguchi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1873-1888. <a href="https://doi.org/10.1021/acs.jmedchem.0c01917" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01917%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAtabecestat%252B%252528JNJ-54861911%252529%25253A%252BA%252BThiazine-Based%252B%2525CE%2525B2-Amyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252BInhibitor%252BAdvanced%252Bto%252Bthe%252BPhase%252B2b%25252F3%252BEARLY%252BClinical%252BTrial%26aulast%3DKoriyama%26aufirst%3DYuji%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05112020%26date%3D15022021%26volume%3D64%26issue%3D4%26spage%3D1873%26epage%3D1888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elena Lenci, Lorenzo Calugi, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Occurrence of Morpholine in Central Nervous System Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 378-390. <a href="https://doi.org/10.1021/acschemneuro.0c00729" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00729%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DOccurrence%252Bof%252BMorpholine%252Bin%252BCentral%252BNervous%252BSystem%252BDrug%252BDiscovery%26aulast%3DLenci%26aufirst%3DElena%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13112020%26date%3D11012021%26date%3D18012021%26volume%3D12%26issue%3D3%26spage%3D378%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Katherine J. Schultz, Sean M. Colby, Vivian S. Lin, Aaron T. Wright, <span class="NLM_string-name hlFld-ContribAuthor">Ryan S. Renslow</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand- and Structure-Based Analysis of Deep Learning-Generated Potential α2a Adrenoceptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (1)
                                     , 481-492. <a href="https://doi.org/10.1021/acs.jcim.0c01019" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DLigand-%252Band%252BStructure-Based%252BAnalysis%252Bof%252BDeep%252BLearning-Generated%252BPotential%252B%2525CE%2525B12a%252BAdrenoceptor%252BAgonists%26aulast%3DSchultz%26aufirst%3DKatherine%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28082020%26date%3D06012021%26volume%3D61%26issue%3D1%26spage%3D481%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Satish N. Dighe, Mangapathiraju Tippana, Suzannah van Akker, <span class="NLM_string-name hlFld-ContribAuthor">Trudi A. Collet</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (48)
                                     , 30971-30979. <a href="https://doi.org/10.1021/acsomega.0c03848" title="DOI URL">https://doi.org/10.1021/acsomega.0c03848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c03848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c03848%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DStructure-Based%252BScaffold%252BRepurposing%252Btoward%252Bthe%252BDiscovery%252Bof%252BNovel%252BCholinesterase%252BInhibitors%26aulast%3DDighe%26aufirst%3DSatish%2BN.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10082020%26date%3D12112020%26date%3D24112020%26volume%3D5%26issue%3D48%26spage%3D30971%26epage%3D30979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">William Mahy, Nicky J. Willis, Yuguang Zhao, Hannah L. Woodward, Fredrik Svensson, James Sipthorp, Luca Vecchia, Reinis R. Ruza, James Hillier, Svend Kjær, Sarah Frew, Amy Monaghan, Magda Bictash, Patricia C. Salinas, Paul Whiting, Jean-Paul Vincent, E. Yvonne Jones, <span class="NLM_string-name hlFld-ContribAuthor">Paul V. Fish</span>. </span><span class="cited-content_cbyCitation_article-title">5-Phenyl-1,3,4-oxadiazol-2(3H)-ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12942-12956. <a href="https://doi.org/10.1021/acs.jmedchem.0c01391" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01391%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Phenyl-1%25252C3%25252C4-oxadiazol-2%2525283H%252529-ones%252BAre%252BPotent%252BInhibitors%252Bof%252BNotum%252BCarboxylesterase%252BActivity%252BIdentified%252Bby%252Bthe%252BOptimization%252Bof%252Ba%252BCrystallographic%252BFragment%252BScreening%252BHit%26aulast%3DMahy%26aufirst%3DWilliam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08082020%26date%3D30102020%26volume%3D63%26issue%3D21%26spage%3D12942%26epage%3D12956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carmen Esposito, Shuzhe Wang, Udo E. W. Lange, Frank Oellien, <span class="NLM_string-name hlFld-ContribAuthor">Sereina Riniker</span>. </span><span class="cited-content_cbyCitation_article-title">Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein Substrates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (10)
                                     , 4730-4749. <a href="https://doi.org/10.1021/acs.jcim.0c00525" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00525%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DCombining%252BMachine%252BLearning%252Band%252BMolecular%252BDynamics%252Bto%252BPredict%252BP-Glycoprotein%252BSubstrates%26aulast%3DEsposito%26aufirst%3DCarmen%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13052020%26date%3D21082020%26date%3D07082020%26volume%3D60%26issue%3D10%26spage%3D4730%26epage%3D4749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">William Mahy, Mikesh Patel, David Steadman, Hannah L. Woodward, Benjamin N. Atkinson, Fredrik Svensson, Nicky J. Willis, Alister Flint, Dimitra Papatheodorou, Yuguang Zhao, Luca Vecchia, Reinis R. Ruza, James Hillier, Sarah Frew, Amy Monaghan, Artur Costa, Magda Bictash, Magnus W. Walter, E. Yvonne Jones, <span class="NLM_string-name hlFld-ContribAuthor">Paul V. Fish</span>. </span><span class="cited-content_cbyCitation_article-title">Screening of a Custom-Designed Acid Fragment Library Identifies 1-Phenylpyrroles and 1-Phenylpyrrolidines as Inhibitors of Notum Carboxylesterase Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9464-9483. <a href="https://doi.org/10.1021/acs.jmedchem.0c00660" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00660%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScreening%252Bof%252Ba%252BCustom-Designed%252BAcid%252BFragment%252BLibrary%252BIdentifies%252B1-Phenylpyrroles%252Band%252B1-Phenylpyrrolidines%252Bas%252BInhibitors%252Bof%252BNotum%252BCarboxylesterase%252BActivity%26aulast%3DMahy%26aufirst%3DWilliam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D18082020%26date%3D29072020%26volume%3D63%26issue%3D17%26spage%3D9464%26epage%3D9483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David Smil, Jong Fu Wong, Eleanor P. Williams, Roslin J. Adamson, Alison Howarth, David A. McLeod, Ahmed Mamai, Soyoung Kim, Brian J. Wilson, Taira Kiyota, Ahmed Aman, Julie Owen, Gennady Poda, Kurumi Y. Horiuchi, Ekaterina Kuznetsova, Haiching Ma, J. Nicole Hamblin, Sue Cramp, Owen G. Roberts, Aled M. Edwards, David Uehling, Rima Al-awar, Alex N. Bullock, Jeff A. O’Meara, <span class="NLM_string-name hlFld-ContribAuthor">Methvin B. Isaac</span>. </span><span class="cited-content_cbyCitation_article-title">Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 10061-10085. <a href="https://doi.org/10.1021/acs.jmedchem.0c01199" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01199%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLeveraging%252Ban%252BOpen%252BScience%252BDrug%252BDiscovery%252BModel%252Bto%252BDevelop%252BCNS-Penetrant%252BALK2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BDiffuse%252BIntrinsic%252BPontine%252BGlioma%26aulast%3DSmil%26aufirst%3DDavid%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10072020%26date%3D26082020%26date%3D11082020%26volume%3D63%26issue%3D17%26spage%3D10061%26epage%3D10085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mengsi Zhang, Baojun Li, Huimin Chen, Haotian Lu, Hailong Ma, Xiaoyu Cheng, Wenbo Wang, Yue Wang, Yun Ding, <span class="NLM_string-name hlFld-ContribAuthor">Aiguo Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Triggering the Antitumor Activity of Acyclic Enediyne through Maleimide-Assisted Rearrangement and Cycloaromatization. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (15)
                                     , 9808-9819. <a href="https://doi.org/10.1021/acs.joc.0c01124" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01124%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTriggering%252Bthe%252BAntitumor%252BActivity%252Bof%252BAcyclic%252BEnediyne%252Bthrough%252BMaleimide-Assisted%252BRearrangement%252Band%252BCycloaromatization%26aulast%3DZhang%26aufirst%3DMengsi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09052020%26date%3D22072020%26date%3D13072020%26volume%3D85%26issue%3D15%26spage%3D9808%26epage%3D9819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rakesh H. Vekariya, Wei Lei, Abhisek Ray, Surendra K. Saini, Sixue Zhang, Gabriella Molnar, Deborah Barlow, Kelly L. Karlage, Edward J. Bilsky, Karen L. Houseknecht, Tally M. Largent-Milnes, John M. Streicher, <span class="NLM_string-name hlFld-ContribAuthor">Subramaniam Ananthan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7663-7694. <a href="https://doi.org/10.1021/acs.jmedchem.0c00503" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00503%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252B5%2525E2%252580%2525B2-Aryl-14-alkoxypyridomorphinans%25253A%252BIdentification%252Bof%252Ba%252B%2525CE%2525BC%252BOpioid%252BReceptor%252BAgonist%25252F%2525CE%2525B4%252BOpioid%252BReceptor%252BAntagonist%252BLigand%252Bwith%252BSystemic%252BAntinociceptive%252BActivity%252Band%252BDiminished%252BOpioid%252BSide%252BEffects%26aulast%3DVekariya%26aufirst%3DRakesh%2BH.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03042020%26date%3D30062020%26date%3D12062020%26volume%3D63%26issue%3D14%26spage%3D7663%26epage%3D7694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Payal Rana, Stephen Kogut, Xuerong Wen, Fatemeh Akhlaghi, <span class="NLM_string-name hlFld-ContribAuthor">Michael D. Aleo</span>. </span><span class="cited-content_cbyCitation_article-title">Most Influential Physicochemical and In Vitro Assay Descriptors for Hepatotoxicity and Nephrotoxicity Prediction. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2020,</strong> <em>33 </em>
                                    (7)
                                     , 1780-1790. <a href="https://doi.org/10.1021/acs.chemrestox.0c00040" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.0c00040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.0c00040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.0c00040%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DMost%252BInfluential%252BPhysicochemical%252Band%252BIn%252BVitro%252BAssay%252BDescriptors%252Bfor%252BHepatotoxicity%252Band%252BNephrotoxicity%252BPrediction%26aulast%3DRana%26aufirst%3DPayal%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02022020%26date%3D08052020%26date%3D27042020%26volume%3D33%26issue%3D7%26spage%3D1780%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Deeba Ensan, David Smil, Carlos A. Zepeda-Velázquez, Dimitrios Panagopoulos, Jong Fu Wong, Eleanor P. Williams, Roslin Adamson, Alex N. Bullock, Taira Kiyota, Ahmed Aman, Owen G. Roberts, Aled M. Edwards, Jeff A. O’Meara, Methvin B. Isaac, <span class="NLM_string-name hlFld-ContribAuthor">Rima Al-awar</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4978-4996. <a href="https://doi.org/10.1021/acs.jmedchem.0c00395" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00395%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BALK2%25253A%252BAn%252BOpen%252BScience%252BApproach%252Bto%252BDeveloping%252BTherapeutics%252Bfor%252Bthe%252BTreatment%252Bof%252BDiffuse%252BIntrinsic%252BPontine%252BGlioma%26aulast%3DEnsan%26aufirst%3DDeeba%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06032020%26date%3D05052020%26volume%3D63%26issue%3D9%26spage%3D4978%26epage%3D4996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maris A. Cinelli, Cory T. Reidl, Huiying Li, Georges Chreifi, Thomas L. Poulos, <span class="NLM_string-name hlFld-ContribAuthor">Richard B. Silverman</span>. </span><span class="cited-content_cbyCitation_article-title">First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4528-4554. <a href="https://doi.org/10.1021/acs.jmedchem.9b01573" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01573%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252BContact%25253A%252B7-Phenyl-2-Aminoquinolines%25252C%252BPotent%252Band%252BSelective%252BNeuronal%252BNitric%252BOxide%252BSynthase%252BInhibitors%252BThat%252BTarget%252Ban%252BIsoform-Specific%252BAspartate%26aulast%3DCinelli%26aufirst%3DMaris%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20092019%26date%3D17042020%26volume%3D63%26issue%3D9%26spage%3D4528%26epage%3D4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radhika Amaradhi, Avijit Banik, Shabber Mohammed, Vidyavathi Patro, Asheebo Rojas, Wenyi Wang, Damoder Reddy Motati, Ray Dingledine, <span class="NLM_string-name hlFld-ContribAuthor">Thota Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1032-1050. <a href="https://doi.org/10.1021/acs.jmedchem.9b01218" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01218%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252BWater%252BSoluble%25252C%252BBrain-Permeable%252BEP2%252BReceptor%252BAntagonist%252Bfor%252BUse%252Bin%252BCentral%252BNervous%252BSystem%252BDisease%252BModels%26aulast%3DAmaradhi%26aufirst%3DRadhika%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D14082019%26date%3D16012020%26date%3D06012020%26volume%3D63%26issue%3D3%26spage%3D1032%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jean-Marc M. Grandjean, Alexander Y. Jiu, John W. West, Atsushi Aoyagi, Daniel G. Droege, Manuel Elepano, Makoto Hirasawa, Masakazu Hirouchi, Ryo Murakami, Joanne Lee, Koji Sasaki, Shimpei Hirano, Takao Ohyama, Benjamin C. Tang, Roy J. Vaz, Masahiro Inoue, Steven H. Olson, Stanley B. Prusiner, Jay Conrad, <span class="NLM_string-name hlFld-ContribAuthor">Nick A. Paras</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     , 127-132. <a href="https://doi.org/10.1021/acsmedchemlett.9b00480" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00480%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B4-Piperazine%252BIsoquinoline%252BDerivatives%252Bas%252BPotent%252Band%252BBrain-Permeable%252BTau%252BPrion%252BInhibitors%252Bwith%252BCDK8%252BActivity%26aulast%3DGrandjean%26aufirst%3DJean-Marc%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D17102019%26date%3D14012020%26date%3D30012020%26volume%3D11%26issue%3D2%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Mengru Cao, Hongling Xiang, Wei Wang, Xing Feng, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoping Yang</span>. </span><span class="cited-content_cbyCitation_article-title">WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 4787-4799. <a href="https://doi.org/10.1021/acschemneuro.9b00409" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DWBQ5187%25252C%252Ba%252BMultitarget%252BDirected%252BAgent%25252C%252BAmeliorates%252BCognitive%252BImpairment%252Bin%252Ba%252BTransgenic%252BMouse%252BModel%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BModulates%252BCerebral%252B%2525CE%2525B2-Amyloid%25252C%252BGliosis%25252C%252BcAMP%252BLevels%25252C%252Band%252BNeurodegeneration%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D07112019%26date%3D20112019%26date%3D07112019%26volume%3D10%26issue%3D12%26spage%3D4787%26epage%3D4799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thilo Focken, Kristen Burford, Michael E. Grimwood, Alla Zenova, Jean-Christophe Andrez, Wei Gong, Michael Wilson, Matt Taron, Shannon Decker, Verner Lofstrand, Sultan Chowdhury, Noah Shuart, Sophia Lin, Samuel J. Goodchild, Clint Young, Maegan Soriano, Parisa K. Tari, Matthew Waldbrook, Karen Nelkenbrecher, Rainbow Kwan, Andrea Lindgren, Gina de Boer, Stephanie Lee, Luis Sojo, Robert J. DeVita, Charles J. Cohen, Steven S. Wesolowski, J. P. Johnson, Jr., Christoph M. Dehnhardt, <span class="NLM_string-name hlFld-ContribAuthor">James R. Empfield</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective NaV1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9618-9641. <a href="https://doi.org/10.1021/acs.jmedchem.9b01032" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BCNS-Penetrant%252BAryl%252BSulfonamides%252Bas%252BIsoform-Selective%252BNaV1.6%252BInhibitors%252Bwith%252BEfficacy%252Bin%252BMouse%252BModels%252Bof%252BEpilepsy%26aulast%3DFocken%26aufirst%3DThilo%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28062019%26date%3D03102019%26date%3D17092019%26volume%3D62%26issue%3D21%26spage%3D9618%26epage%3D9641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xin Yang, Yifei Wang, Ryan Byrne, Gisbert Schneider, <span class="NLM_string-name hlFld-ContribAuthor">Shengyong Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (18)
                                     , 10520-10594. <a href="https://doi.org/10.1021/acs.chemrev.8b00728" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00728%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DConcepts%252Bof%252BArtificial%252BIntelligence%252Bfor%252BComputer-Assisted%252BDrug%252BDiscovery%26aulast%3DYang%26aufirst%3DXin%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29112018%26date%3D11072019%26volume%3D119%26issue%3D18%26spage%3D10520%26epage%3D10594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xin Li, Zhigao Zhang, Yang Chen, Hong Wan, Jiakang Sun, Bin Wang, Bingqiang Feng, Bing Hu, Xingxing Shi, Jun Feng, Lei Zhang, Feng He, Chang Bai, Lianshan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Weikang Tao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood–Brain Barrier Penetration. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 996-1001. <a href="https://doi.org/10.1021/acsmedchemlett.9b00186" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00186%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BSHR1653%25252C%252Ba%252BHighly%252BPotent%252Band%252BSelective%252BOTR%252BAntagonist%252Bwith%252BImproved%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BPenetration%26aulast%3DLi%26aufirst%3DXin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24042019%26date%3D29052019%26date%3D31052019%26date%3D29052019%26volume%3D10%26issue%3D6%26spage%3D996%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Leticia Toledo-Sherman, Perla Breccia, Roger Cachope, Jennifer R. Bate, Ivan Angulo-Herrera, Grant Wishart, Kim L. Matthews, Sarah L. Martin, Helen C. Cox, George McAllister, Stephen D. Penrose, Huw Vater, William Esmieu, Amanda Van de Poël, Rhea Van de Bospoort, Annelieke Strijbosch, Marieke Lamers, Philip Leonard, Rebecca E. Jarvis, Wesley Blackaby, Karen Barnes, Maria Eznarriaga, Simon Dowler, Graham D. Smith, David F. Fischer, Ovadia Lazari, Dawn Yates, Mark Rose, Sung-Wook Jang, Ignacio Muñoz-Sanjuan, <span class="NLM_string-name hlFld-ContribAuthor">Celia Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington’s Disease Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2988-3008. <a href="https://doi.org/10.1021/acs.jmedchem.8b01819" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01819%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPotent%252Band%252BSelective%252BAtaxia%252BTelangiectasia-Mutated%252BInhibitors%252BSuitable%252Bfor%252Ba%252BProof-of-Concept%252BStudy%252Bin%252BHuntington%2525E2%252580%252599s%252BDisease%252BModels%26aulast%3DToledo-Sherman%26aufirst%3DLeticia%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21112018%26date%3D19032019%26date%3D06032019%26volume%3D62%26issue%3D6%26spage%3D2988%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manuela Jörg, Emma T. van der Westhuizen, Elham Khajehali, Wessel A. C. Burger, Jonathan M. White, Kwok H. C. Choy, Andrew B. Tobin, Patrick M. Sexton, Celine Valant, Ben Capuano, Arthur Christopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1099-1114. <a href="https://doi.org/10.1021/acschemneuro.8b00613" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00613%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D6-Phenylpyrimidin-4-ones%252Bas%252BPositive%252BAllosteric%252BModulators%252Bat%252Bthe%252BM1%252BmAChR%25253A%252BThe%252BDeterminants%252Bof%252BAllosteric%252BActivity%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06112018%26date%3D14122018%26date%3D28122018%26date%3D14122018%26volume%3D10%26issue%3D3%26spage%3D1099%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ha T. Do, Huiying Li, Georges Chreifi, Thomas L. Poulos, <span class="NLM_string-name hlFld-ContribAuthor">Richard B. Silverman</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Blood–Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2690-2707. <a href="https://doi.org/10.1021/acs.jmedchem.8b02032" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b02032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b02032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b02032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BPermeability%252Bwith%252BPotent%252Band%252BSelective%252BHuman%252BNeuronal%252BNitric%252BOxide%252BSynthase%252BInhibitors%252BHaving%252Ba%252B2-Aminopyridine%252BScaffold%26aulast%3DDo%26aufirst%3DHa%2BT.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29122018%26date%3D25022019%26volume%3D62%26issue%3D5%26spage%3D2690%26epage%3D2707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christofer S. Tautermann, Florian Binder, Frank H. Büttner, Christian Eickmeier, Dennis Fiegen, Ulrike Gross, Marc A. Grundl, Ralf Heilker, Scott Hobson, Stefan Hoerer, Andreas Luippold, Volker Mack, Florian Montel, Stefan Peters, Supriyo Bhattacharya, Nagarajan Vaidehi, Gisela Schnapp, Sven Thamm, <span class="NLM_string-name hlFld-ContribAuthor">Markus Zeeb</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 306-316. <a href="https://doi.org/10.1021/acs.jmedchem.8b00857" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BActivation%252Bof%252BStriatal-Enriched%252BProtein%252BTyrosine%252BPhosphatase%252B%252528STEP%25252C%252BPTPN5%252529%252Bby%252Ba%252BFragment-like%252BMolecule%26aulast%3DTautermann%26aufirst%3DChristofer%2BS.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D30052018%26date%3D12092018%26volume%3D62%26issue%3D1%26spage%3D306%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">J. Matthew Meinig, Skylar J. Ferrara, Tapasree Banerji, Tania Banerji, Hannah S. Sanford-Crane, Dennis Bourdette, <span class="NLM_string-name hlFld-ContribAuthor">Thomas S. Scanlan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Central Nervous System Penetration by Fatty Acid Amide Hydrolase (FAAH)-Targeted Thyromimetic Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 111-116. <a href="https://doi.org/10.1021/acsmedchemlett.8b00501" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00501%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BCentral%252BNervous%252BSystem%252BPenetration%252Bby%252BFatty%252BAcid%252BAmide%252BHydrolase%252B%252528FAAH%252529-Targeted%252BThyromimetic%252BProdrugs%26aulast%3DMeinig%26aufirst%3DJ.%2BMatthew%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25102018%26date%3D04122018%26date%3D07122018%26date%3D04122018%26volume%3D10%26issue%3D1%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Atwood K. Cheung, Brian Hurley, Ryan Kerrigan, Lei Shu, Donovan N. Chin, Yiping Shen, Gary O’Brien, Moo Je Sung, Ying Hou, Jake Axford, Emma Cody, Robert Sun, Aleem Fazal, Cary Fridrich, Carina
C. Sanchez, Ronald C. Tomlinson, Monish Jain, Lin Deng, Keith Hoffmaster, Cheng Song, Mailin Van Hoosear, Youngah Shin, Rebecca Servais, Christopher Towler, Marc Hild, Daniel Curtis, William F. Dietrich, Lawrence G. Hamann, Karin Briner, Karen S. Chen, Dione Kobayashi, Rajeev Sivasankaran, <span class="NLM_string-name hlFld-ContribAuthor">Natalie A. Dales</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 11021-11036. <a href="https://doi.org/10.1021/acs.jmedchem.8b01291" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01291%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSmall%252BMolecule%252BSplicing%252BModulators%252Bof%252BSurvival%252BMotor%252BNeuron-2%252B%252528SMN2%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BSpinal%252BMuscular%252BAtrophy%252B%252528SMA%252529%26aulast%3DCheung%26aufirst%3DAtwood%2BK.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15082018%26date%3D13122018%26date%3D08112018%26volume%3D61%26issue%3D24%26spage%3D11021%26epage%3D11036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yanan Hou, Shoujiao Peng, Xinming Li, Juan Yao, Jianqiang Xu, <span class="NLM_string-name hlFld-ContribAuthor">Jianguo Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Honokiol Alleviates Oxidative Stress-Induced Neurotoxicity via Activation of Nrf2. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 3108-3116. <a href="https://doi.org/10.1021/acschemneuro.8b00290" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00290%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DHonokiol%252BAlleviates%252BOxidative%252BStress-Induced%252BNeurotoxicity%252Bvia%252BActivation%252Bof%252BNrf2%26aulast%3DHou%26aufirst%3DYanan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19062018%26date%3D10072018%26date%3D19072018%26date%3D10072018%26volume%3D9%26issue%3D12%26spage%3D3108%26epage%3D3116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sonali
S. Bharate, Serge Mignani, <span class="NLM_string-name hlFld-ContribAuthor">Ram A. Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10345-10374. <a href="https://doi.org/10.1021/acs.jmedchem.7b01922" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01922%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhy%252BAre%252Bthe%252BMajority%252Bof%252BActive%252BCompounds%252Bin%252Bthe%252BCNS%252BDomain%252BNatural%252BProducts%25253F%252BA%252BCritical%252BAnalysis%26aulast%3DBharate%26aufirst%3DSonali%2BS.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30122017%26date%3D20072018%26date%3D10072018%26volume%3D61%26issue%3D23%26spage%3D10345%26epage%3D10374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ingrid Buchler, Daniel Akuma, Vinh Au, Gregory Carr, Pablo de León, Michael DePasquale, Glen Ernst, Yifang Huang, Martha Kimos, Anna Kolobova, Michael Poslusney, Huijun Wei, Dominique Swinnen, Florian Montel, Florence Moureau, Emilie Jigorel, Monika-Sarah E.
D. Schulze, Martyn Wood, <span class="NLM_string-name hlFld-ContribAuthor">James C. Barrow</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9647-9665. <a href="https://doi.org/10.1021/acs.jmedchem.8b01126" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01126%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252B8-Hydroxyquinolines%252Bas%252BInhibitors%252Bof%252BCatechol%252BO-Methyltransferase%26aulast%3DBuchler%26aufirst%3DIngrid%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17072018%26date%3D19102018%26date%3D01102018%26volume%3D61%26issue%3D21%26spage%3D9647%26epage%3D9665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jakob
S. Pallesen, Kim T. Tran, <span class="NLM_string-name hlFld-ContribAuthor">Anders Bach</span>. </span><span class="cited-content_cbyCitation_article-title">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8088-8103. <a href="https://doi.org/10.1021/acs.jmedchem.8b00358" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNon-covalent%252BSmall-Molecule%252BKelch-like%252BECH-Associated%252BProtein%252B1%2525E2%252580%252593Nuclear%252BFactor%252BErythroid%252B2-Related%252BFactor%252B2%252B%252528Keap1%2525E2%252580%252593Nrf2%252529%252BInhibitors%252Band%252BTheir%252BPotential%252Bfor%252BTargeting%252BCentral%252BNervous%252BSystem%252BDiseases%26aulast%3DPallesen%26aufirst%3DJakob%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12032018%26date%3D29052018%26date%3D11052018%26volume%3D61%26issue%3D18%26spage%3D8088%26epage%3D8103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Willi Amberg, Udo E. W. Lange, Michael Ochse, Frauke Pohlki, Berthold Behl, Ana Lucia Relo, Wilfried Hornberger, Carolin Hoft, Mario Mezler, Jens Sydor, Ying Wang, Hongyu Zhao, Jason T. Brewer, Justin Dietrich, Huanqiu Li, Irini Akritopoulou-Zanze, Yanbin Lao, Steven M. Hannick, Yi-Yin Ku, <span class="NLM_string-name hlFld-ContribAuthor">Anil Vasudevan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7503-7524. <a href="https://doi.org/10.1021/acs.jmedchem.8b00300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00300%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BAminotetralines%252Band%252BAminochromanes%252Bas%252BSelective%252Band%252BCompetitive%252BGlycine%252BTransporter%252B1%252B%252528GlyT1%252529%252BInhibitors%26aulast%3DAmberg%26aufirst%3DWilli%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22022018%26date%3D27082018%26date%3D06082018%26volume%3D61%26issue%3D17%26spage%3D7503%26epage%3D7524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7640-7656. <a href="https://doi.org/10.1021/acs.jmedchem.8b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau-Centric%252BMultitarget%252BApproach%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDevelopment%252Bof%252BFirst-in-Class%252BDual%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252Band%252BTau-Aggregation%252BInhibitors%26aulast%3DGandini%26aufirst%3DAnnachiara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17042018%26date%3D24082018%26date%3D04082018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tsung-Yun Wong, Ming-Shian Tsai, Lih-Ching Hsu, Shu-Wha Lin, <span class="NLM_string-name hlFld-ContribAuthor">Pi-Hui Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Traversal of the Blood–Brain Barrier by Cleavable l-Lysine Conjugates of Apigenin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2018,</strong> <em>66 </em>
                                    (30)
                                     , 8124-8131. <a href="https://doi.org/10.1021/acs.jafc.8b01187" title="DOI URL">https://doi.org/10.1021/acs.jafc.8b01187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.8b01187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.8b01187%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DTraversal%252Bof%252Bthe%252BBlood%2525E2%252580%252593Brain%252BBarrier%252Bby%252BCleavable%252Bl-Lysine%252BConjugates%252Bof%252BApigenin%26aulast%3DWong%26aufirst%3DTsung-Yun%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06032018%26date%3D20062018%26date%3D17062018%26date%3D20072018%26date%3D20062018%26volume%3D66%26issue%3D30%26spage%3D8124%26epage%3D8131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kenji Nakahara, Kouki Fuchino, Kazuo Komano, Naoya Asada, Genta Tadano, Tsuyoshi Hasegawa, Takahiko Yamamoto, Yusuke Sako, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5525-5546. <a href="https://doi.org/10.1021/acs.jmedchem.8b00011" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BCentrally%252BActive%252B6-Substituted%252B5-Fluoro-1%25252C3-dihydro-oxazine%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bvia%252BActive%252BConformation%252BStabilization%26aulast%3DNakahara%26aufirst%3DKenji%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04012018%26date%3D14062018%26date%3D18052018%26volume%3D61%26issue%3D13%26spage%3D5525%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jakob
W. Buecheler, Matthias Winzer, Jason Tonillo, Christian Weber, <span class="NLM_string-name hlFld-ContribAuthor">Henning Gieseler</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Payload Hydrophobicity on the Stability of Antibody–Drug Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (7)
                                     , 2656-2664. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00177" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00177%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DImpact%252Bof%252BPayload%252BHydrophobicity%252Bon%252Bthe%252BStability%252Bof%252BAntibody%2525E2%252580%252593Drug%252BConjugates%26aulast%3DBuecheler%26aufirst%3DJakob%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17022018%26date%3D29052018%26date%3D24052018%26date%3D06062018%26date%3D29052018%26volume%3D15%26issue%3D7%26spage%3D2656%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kouki Fuchino, Yasunori Mitsuoka, Moriyasu Masui, Noriyuki Kurose, Shuhei Yoshida, Kazuo Komano, Takahiko Yamamoto, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Hirofumi Miyajima, Shuichi Hiroyama, Kiyotaka Koyabu, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5122-5137. <a href="https://doi.org/10.1021/acs.jmedchem.8b00002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BNovel%252B1%25252C3-Oxazine%252BBased%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%25253A%252BIncorporation%252Bof%252Ba%252BDouble%252BBond%252BTo%252BReduce%252BP-gp%252BEfflux%252BLeading%252Bto%252BRobust%252BA%2525CE%2525B2%252BReduction%252Bin%252Bthe%252BBrain%26aulast%3DFuchino%26aufirst%3DKouki%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01012018%26date%3D23052018%26date%3D07052018%26volume%3D61%26issue%3D12%26spage%3D5122%26epage%3D5137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Austin Horton, Kevin Nash, Ethel Tackie-Yarboi, Alexander Kostrevski, Adam Novak, Aparna Raghavan, Jatin Tulsulkar, Qasim Alhadidi, Nathan Wamer, Bryn Langenderfer, Kalee Royster, Maxwell Ducharme, Katelyn Hagood, Megan Post, Zahoor A. Shah, <span class="NLM_string-name hlFld-ContribAuthor">Isaac T. Schiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4593-4607. <a href="https://doi.org/10.1021/acs.jmedchem.8b00389" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00389%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFuroxans%252B%252528Oxadiazole-4N-oxides%252529%252Bwith%252BAttenuated%252BReactivity%252Bare%252BNeuroprotective%25252C%252BCross%252Bthe%252BBlood%252BBrain%252BBarrier%25252C%252Band%252BImprove%252BPassive%252BAvoidance%252BMemory%26aulast%3DHorton%26aufirst%3DAustin%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09032018%26date%3D07052018%26date%3D23042018%26volume%3D61%26issue%3D10%26spage%3D4593%26epage%3D4607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David
A. Perrey, Ann M. Decker, <span class="NLM_string-name hlFld-ContribAuthor">Yanan Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 587-602. <a href="https://doi.org/10.1021/acschemneuro.7b00402" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00402%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BOrexin-1%252BReceptor%252BAntagonists%252Bwith%252BImproved%252BSolubility%252Band%252BCNS%252BPermeability%26aulast%3DPerrey%26aufirst%3DDavid%2BA.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25102017%26date%3D10112017%26date%3D20112017%26date%3D11112017%26volume%3D9%26issue%3D3%26spage%3D587%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Jinhui Hu, Xiaoping Yang, Xing Feng, Xingshu Li, Ling Huang, <span class="NLM_string-name hlFld-ContribAuthor">Albert S. C. Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline–Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1871-1894. <a href="https://doi.org/10.1021/acs.jmedchem.7b01417" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BOrally%252BBioavailable%252BQuinoline%2525E2%252580%252593Indole%252BDerivatives%252Bas%252BInnovative%252BMultitarget-Directed%252BLigands%25253A%252BPromotion%252Bof%252BCell%252BProliferation%252Bin%252Bthe%252BAdult%252BMurine%252BHippocampus%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D23092017%26date%3D15022018%26date%3D08022018%26volume%3D61%26issue%3D5%26spage%3D1871%26epage%3D1894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Urban  Košak</span>, <span class="hlFld-ContribAuthor ">Boris  Brus</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Simon  Žakelj</span>, <span class="hlFld-ContribAuthor ">Jurij  Trontelj</span>, <span class="hlFld-ContribAuthor ">Anja  Pišlar</span>, <span class="hlFld-ContribAuthor ">Roman  Šink</span>, <span class="hlFld-ContribAuthor ">Marko  Jukič</span>, <span class="hlFld-ContribAuthor ">Marko  Živin</span>, <span class="hlFld-ContribAuthor ">Adrian  Podkowa</span>, <span class="hlFld-ContribAuthor ">Florian  Nachon</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Jure  Stojan</span>, <span class="hlFld-ContribAuthor ">Janko  Kos</span>, <span class="hlFld-ContribAuthor ">Nicolas  Coquelle</span>, <span class="hlFld-ContribAuthor ">Kinga  Sałat</span>, <span class="hlFld-ContribAuthor ">Jacques-Philippe  Colletier</span>, and <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>  . </span><span class="cited-content_cbyCitation_article-title">The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (1)
                                     , 119-139. <a href="https://doi.org/10.1021/acs.jmedchem.7b01086" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01086%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BMagic%252Bof%252BCrystal%252BStructure-Based%252BInhibitor%252BOptimization%25253A%252BDevelopment%252Bof%252Ba%252BButyrylcholinesterase%252BInhibitor%252Bwith%252BPicomolar%252BAffinity%252Band%252Bin%252BVivo%252BActivity%26aulast%3DKo%25C5%25A1ak%26aufirst%3DUrban%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D25072017%26date%3D22122017%26date%3D11012018%26date%3D11122017%26volume%3D61%26issue%3D1%26spage%3D119%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Li</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Yang  Chen</span>, <span class="hlFld-ContribAuthor ">Guimei  Yang</span>, <span class="hlFld-ContribAuthor ">Hong  Wan</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiyue  Hu</span>, <span class="hlFld-ContribAuthor ">Jun  Feng</span>, <span class="hlFld-ContribAuthor ">Zhigao  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  He</span>, <span class="hlFld-ContribAuthor ">Chang  Bai</span>, <span class="hlFld-ContribAuthor ">Lianshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  You</span>, and <span class="hlFld-ContribAuthor ">Weikang  Tao</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2017,</strong> <em>2 </em>
                                    (12)
                                     , 9261-9267. <a href="https://doi.org/10.1021/acsomega.7b01452" title="DOI URL">https://doi.org/10.1021/acsomega.7b01452</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b01452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b01452%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiscovery%252Bof%252BSHR9352%25253A%252BA%252BHighly%252BPotent%252BG%252BProtein-Biased%252B%2525CE%2525BC-Opioid%252BReceptor%252BAgonist%26aulast%3DLi%26aufirst%3DXin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30092017%26date%3D18122017%26date%3D31122017%26volume%3D2%26issue%3D12%26spage%3D9261%26epage%3D9267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Wenwen  Liu</span>, <span class="hlFld-ContribAuthor ">Qi  Gong</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Qiu</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, and <span class="hlFld-ContribAuthor ">Jian  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Vilazodone–Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 2708-2721. <a href="https://doi.org/10.1021/acschemneuro.7b00259" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00259%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BVilazodone%2525E2%252580%252593Tacrine%252BHybrids%252Bas%252BPotential%252BMultitarget-Directed%252BLigands%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BAccompanied%252Bwith%252BDepression%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DLi%26aufirst%3DXiaokang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11072017%26date%3D05092017%26date%3D19092017%26date%3D20122017%26date%3D05092017%26volume%3D8%26issue%3D12%26spage%3D2708%26epage%3D2721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana B.  Bueno</span>, <span class="hlFld-ContribAuthor ">Javier  Agejas</span>, <span class="hlFld-ContribAuthor ">Howard  Broughton</span>, <span class="hlFld-ContribAuthor ">Robert  Dally</span>, <span class="hlFld-ContribAuthor ">Timothy B.  Durham</span>, <span class="hlFld-ContribAuthor ">Juan Félix  Espinosa</span>, <span class="hlFld-ContribAuthor ">Rosario  González</span>, <span class="hlFld-ContribAuthor ">Patric J.  Hahn</span>, <span class="hlFld-ContribAuthor ">Alicia  Marcos</span>, <span class="hlFld-ContribAuthor ">Ramón  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Gema  Sanz</span>, <span class="hlFld-ContribAuthor ">José F.  Soriano</span>, <span class="hlFld-ContribAuthor ">David  Timm</span>, <span class="hlFld-ContribAuthor ">Paloma  Vidal</span>, <span class="hlFld-ContribAuthor ">Hsiu-Chiung  Yang</span>, and <span class="hlFld-ContribAuthor ">James R.  McCarthy</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9807-9820. <a href="https://doi.org/10.1021/acs.jmedchem.7b01304" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01304%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BHydroxyethylamine%252BTransition%252BState%252BIsosteres%252Bas%252BAspartic%252BProtease%252BInhibitors%252Bby%252BExploiting%252BConformational%252BPreferences%26aulast%3DBueno%26aufirst%3DAna%2BB.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04092017%26date%3D28112017%26date%3D14122017%26date%3D31102017%26volume%3D60%26issue%3D23%26spage%3D9807%26epage%3D9820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Polishchuk</span>  . </span><span class="cited-content_cbyCitation_article-title">Interpretation of Quantitative Structure–Activity Relationship Models: Past, Present, and Future. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (11)
                                     , 2618-2639. <a href="https://doi.org/10.1021/acs.jcim.7b00274" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DInterpretation%252Bof%252BQuantitative%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BModels%25253A%252BPast%25252C%252BPresent%25252C%252Band%252BFuture%26aulast%3DPolishchuk%26aufirst%3DPavel%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17052017%26date%3D13102017%26date%3D27112017%26date%3D26092017%26volume%3D57%26issue%3D11%26spage%3D2618%26epage%3D2639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ha T.  Do</span>, <span class="hlFld-ContribAuthor ">Heng-Yen  Wang</span>, <span class="hlFld-ContribAuthor ">Huiying  Li</span>, <span class="hlFld-ContribAuthor ">Georges  Chreifi</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Poulos</span>, and <span class="hlFld-ContribAuthor ">Richard B.  Silverman</span>  . </span><span class="cited-content_cbyCitation_article-title">Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9360-9375. <a href="https://doi.org/10.1021/acs.jmedchem.7b01356" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01356%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImprovement%252Bof%252BCell%252BPermeability%252Bof%252BHuman%252BNeuronal%252BNitric%252BOxide%252BSynthase%252BInhibitors%252BUsing%252BPotent%252Band%252BSelective%252B2-Aminopyridine-Based%252BScaffolds%252Bwith%252Ba%252BFluorobenzene%252BLinker%26aulast%3DDo%26aufirst%3DHa%2BT.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12092017%26date%3D01112017%26date%3D22112017%26volume%3D60%26issue%3D22%26spage%3D9360%26epage%3D9375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thuy  Nguyen</span>, <span class="hlFld-ContribAuthor ">Ann M.  Decker</span>, <span class="hlFld-ContribAuthor ">Tiffany L.  Langston</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Mathews</span>, <span class="hlFld-ContribAuthor ">Justin N.  Siemian</span>, <span class="hlFld-ContribAuthor ">Jun-Xu  Li</span>, <span class="hlFld-ContribAuthor ">Danni L.  Harris</span>, <span class="hlFld-ContribAuthor ">Scott P.  Runyon</span>, and <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 2290-2308. <a href="https://doi.org/10.1021/acschemneuro.7b00219" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00219%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%252Bof%252BNovel%252BProline-Based%252BNeuropeptide%252BFF%252BReceptor%252BAntagonists%26aulast%3DNguyen%26aufirst%3DThuy%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15062017%26date%3D24072017%26date%3D09082017%26date%3D18102017%26date%3D24072017%26volume%3D8%26issue%3D10%26spage%3D2290%26epage%3D2308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Dmitri A.  Pissarnitski</span>, <span class="hlFld-ContribAuthor ">Xianhai  Huang</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, and <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1002-1006. <a href="https://doi.org/10.1021/acsmedchemlett.7b00178" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00178%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BTetrahydrobenzisoxazole%252BSeries%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%26aulast%3DZhao%26aufirst%3DZhiqiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23042017%26date%3D19092017%26date%3D26092017%26date%3D12102017%26date%3D19092017%26volume%3D8%26issue%3D10%26spage%3D1002%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Andrew V.  Mossine</span>, <span class="hlFld-ContribAuthor ">Simon  Lindner</span>, <span class="hlFld-ContribAuthor ">Lena  Vomacka</span>, <span class="hlFld-ContribAuthor ">Arturo  Aliaga</span>, <span class="hlFld-ContribAuthor ">Xia  Shao</span>, <span class="hlFld-ContribAuthor ">Carole A.  Quesada</span>, <span class="hlFld-ContribAuthor ">Phillip  Sherman</span>, <span class="hlFld-ContribAuthor ">Anne  Mahringer</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Marilyn  Grand’Maison</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Soucy</span>, <span class="hlFld-ContribAuthor ">Alexander  Thiel</span>, <span class="hlFld-ContribAuthor ">David R.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Gert  Fricker</span>, <span class="hlFld-ContribAuthor ">Björn  Wängler</span>, <span class="hlFld-ContribAuthor ">Peter  Bartenstein</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, and <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>  . </span><span class="cited-content_cbyCitation_article-title">A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (16)
                                     , 6897-6910. <a href="https://doi.org/10.1021/acs.jmedchem.7b00396" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00396%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BKinome-Wide%252BSelective%252BRadiolabeled%252BTrkB%25252FC%252BInhibitor%252Bfor%252Bin%252BVitro%252Band%252Bin%252BVivo%252BNeuroimaging%25253A%252BSynthesis%25252C%252BPreclinical%252BEvaluation%25252C%252Band%252BFirst-in-Human%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15032017%26date%3D21072017%26date%3D24082017%26date%3D11072017%26volume%3D60%26issue%3D16%26spage%3D6897%26epage%3D6910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Zoran Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 5943-5954. <a href="https://doi.org/10.1021/acs.jmedchem.6b01469" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01469%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCNS%252BPhysicochemical%252BProperty%252BSpace%252BShaped%252Bby%252Ba%252BDiverse%252BSet%252Bof%252BMolecules%252Bwith%252BExperimentally%252BDetermined%252BExposure%252Bin%252Bthe%252BMouse%252BBrain%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2019%26date%3D05022019%26date%3D06102016%26date%3D07042017%26volume%3D60%26issue%3D14%26spage%3D5943%26epage%3D5954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Raphaëlle  Berger</span>, <span class="hlFld-ContribAuthor ">Kristin  Goldberg</span>, <span class="hlFld-ContribAuthor ">Rachel T.  Nishimura</span>, <span class="hlFld-ContribAuthor ">John  Reilly</span>, <span class="hlFld-ContribAuthor ">Paul  Richardson</span>, <span class="hlFld-ContribAuthor ">Daniel  Richter</span>, <span class="hlFld-ContribAuthor ">Edward C.  Sherer</span>, <span class="hlFld-ContribAuthor ">Brian A.  Sparling</span>, and <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>  . </span><span class="cited-content_cbyCitation_article-title">Sustainable Practices in Medicinal Chemistry Part 2: Green by Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 5955-5968. <a href="https://doi.org/10.1021/acs.jmedchem.6b01837" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01837%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSustainable%252BPractices%252Bin%252BMedicinal%252BChemistry%252BPart%252B2%25253A%252BGreen%252Bby%252BDesign%26aulast%3DAliagas%26aufirst%3DIgnacio%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D14122016%26date%3D12042017%26date%3D27072017%26date%3D04042017%26volume%3D60%26issue%3D14%26spage%3D5955%26epage%3D5968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Paul J.  Lorello</span>, <span class="hlFld-ContribAuthor ">Barbara J.  Caldarone</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6273-6288. <a href="https://doi.org/10.1021/acs.jmedchem.7b00584" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00584%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-Substituted%252B%2525282-Phenylcyclopropyl%252529methylamines%252Bas%252BFunctionally%252BSelective%252BSerotonin%252B2C%252BReceptor%252BAgonists%252Bfor%252BPotential%252BUse%252Bas%252BAntipsychotic%252BMedications%26aulast%3DZhang%26aufirst%3DGuiping%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17042017%26date%3D18072017%26date%3D27072017%26date%3D28062017%26volume%3D60%26issue%3D14%26spage%3D6273%26epage%3D6288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saleh  Ahmed</span>, <span class="hlFld-ContribAuthor ">Andrew  Ayscough</span>, <span class="hlFld-ContribAuthor ">Greg R.  Barker</span>, <span class="hlFld-ContribAuthor ">Hannah E.  Canning</span>, <span class="hlFld-ContribAuthor ">Richard  Davenport</span>, <span class="hlFld-ContribAuthor ">Robert  Downham</span>, <span class="hlFld-ContribAuthor ">David  Harrison</span>, <span class="hlFld-ContribAuthor ">Kerry  Jenkins</span>, <span class="hlFld-ContribAuthor ">Natasha  Kinsella</span>, <span class="hlFld-ContribAuthor ">David G.  Livermore</span>, <span class="hlFld-ContribAuthor ">Susanne  Wright</span>, <span class="hlFld-ContribAuthor ">Anthony D.  Ivetac</span>, <span class="hlFld-ContribAuthor ">Robert  Skene</span>, <span class="hlFld-ContribAuthor ">Steven J.  Wilkens</span>, <span class="hlFld-ContribAuthor ">Natalie A.  Webster</span>, and <span class="hlFld-ContribAuthor ">Alan G.  Hendrick</span>  . </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5663-5672. <a href="https://doi.org/10.1021/acs.jmedchem.7b00352" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00352%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C4-Triazolo-%25255B1%25252C5-a%25255Dpyridine%252BHIF%252BProlylhydroxylase%252BDomain-1%252B%252528PHD-1%252529%252BInhibitors%252BWith%252Ba%252BNovel%252BMonodentate%252BBinding%252BInteraction%26aulast%3DAhmed%26aufirst%3DSaleh%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09032017%26date%3D24062017%26date%3D13072017%26date%3D08062017%26volume%3D60%26issue%3D13%26spage%3D5663%26epage%3D5672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span> and <span class="hlFld-ContribAuthor ">Demetri T.  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3552-3579. <a href="https://doi.org/10.1021/acs.jmedchem.6b01807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BNecessary%252BNitrogen%252BAtom%25253A%252BA%252BVersatile%252BHigh-Impact%252BDesign%252BElement%252Bfor%252BMultiparameter%252BOptimization%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D09122016%26date%3D08022017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik J. R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">José-Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Manuela  Ariza</span>, <span class="hlFld-ContribAuthor ">José Manuel  Alonso</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">Astrid  Bottelbergs</span>, <span class="hlFld-ContribAuthor ">Lu  Chen</span>, <span class="hlFld-ContribAuthor ">Vladimir  Chupakhin</span>, <span class="hlFld-ContribAuthor ">Erna  Cleiren</span>, <span class="hlFld-ContribAuthor ">Katleen  Fierens</span>, <span class="hlFld-ContribAuthor ">Alberto  Fontana</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Leenaerts</span>, <span class="hlFld-ContribAuthor ">Jonas  Mariën</span>, <span class="hlFld-ContribAuthor ">Carolina  Martínez Lamenca</span>, <span class="hlFld-ContribAuthor ">Rhys  Salter</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Paula  Te Riele</span>, <span class="hlFld-ContribAuthor ">Cindy  Wintmolders</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, and <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (4)
                                     , 1272-1291. <a href="https://doi.org/10.1021/acs.jmedchem.6b01173" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01173%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%252528Pyridin-4-yl%252529-1%25252C5-naphthyridin-2-amines%252Bas%252BPotential%252BTau%252BPathology%252BPET%252BTracers%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRombouts%26aufirst%3DFrederik%2BJ.%2BR.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D12082016%26date%3D10022017%26date%3D23022017%26date%3D20012017%26volume%3D60%26issue%3D4%26spage%3D1272%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian R.  Levell</span>, <span class="hlFld-ContribAuthor ">Thomas  Caferro</span>, <span class="hlFld-ContribAuthor ">Gregg  Chenail</span>, <span class="hlFld-ContribAuthor ">Ina  Dix</span>, <span class="hlFld-ContribAuthor ">Julia  Dooley</span>, <span class="hlFld-ContribAuthor ">Brant  Firestone</span>, <span class="hlFld-ContribAuthor ">Pascal D.  Fortin</span>, <span class="hlFld-ContribAuthor ">John  Giraldes</span>, <span class="hlFld-ContribAuthor ">Ty  Gould</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Growney</span>, <span class="hlFld-ContribAuthor ">Michael D.  Jones</span>, <span class="hlFld-ContribAuthor ">Raviraj  Kulathila</span>, <span class="hlFld-ContribAuthor ">Fallon  Lin</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Arne  Mueller</span>, <span class="hlFld-ContribAuthor ">Simon  van der Plas</span>, <span class="hlFld-ContribAuthor ">Kelly  Slocum</span>, <span class="hlFld-ContribAuthor ">Troy  Smith</span>, <span class="hlFld-ContribAuthor ">Remi  Terranova</span>, <span class="hlFld-ContribAuthor ">B. Barry  Touré</span>, <span class="hlFld-ContribAuthor ">Viraj  Tyagi</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Xie</span>, <span class="hlFld-ContribAuthor ">Ming  Xu</span>, <span class="hlFld-ContribAuthor ">Fan S.  Yang</span>, <span class="hlFld-ContribAuthor ">Liping X.  Zhou</span>, <span class="hlFld-ContribAuthor ">Raymond  Pagliarini</span>, and <span class="hlFld-ContribAuthor ">Young Shin  Cho</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 151-156. <a href="https://doi.org/10.1021/acsmedchemlett.6b00334" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00334%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252B3-Pyrimidin-4-yl-oxazolidin-2-ones%252Bas%252BAllosteric%252Band%252BMutant%252BSpecific%252BInhibitors%252Bof%252BIDH1%26aulast%3DLevell%26aufirst%3DJulian%2BR.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D20082016%26date%3D16122016%26date%3D06012017%26date%3D09022017%26date%3D16122016%26volume%3D8%26issue%3D2%26spage%3D151%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arup K.  Ghose</span>, <span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>, and <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>  . </span><span class="cited-content_cbyCitation_article-title">Technically Extended MultiParameter Optimization (TEMPO): An Advanced Robust Scoring Scheme To Calculate Central Nervous System Druggability and Monitor Lead Optimization. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 147-154. <a href="https://doi.org/10.1021/acschemneuro.6b00273" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00273%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DTechnically%252BExtended%252BMultiParameter%252BOptimization%252B%252528TEMPO%252529%25253A%252BAn%252BAdvanced%252BRobust%252BScoring%252BScheme%252BTo%252BCalculate%252BCentral%252BNervous%252BSystem%252BDruggability%252Band%252BMonitor%252BLead%252BOptimization%26aulast%3DGhose%26aufirst%3DArup%2BK.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29082016%26date%3D14102016%26date%3D26102016%26date%3D18012017%26date%3D14102016%26volume%3D8%26issue%3D1%26spage%3D147%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Je Ho  Ryu</span>, <span class="hlFld-ContribAuthor ">Jung A  Lee</span>, <span class="hlFld-ContribAuthor ">Shinae  Kim</span>, <span class="hlFld-ContribAuthor ">Young Ah  Shin</span>, <span class="hlFld-ContribAuthor ">Jewon  Yang</span>, <span class="hlFld-ContribAuthor ">Hye Young  Han</span>, <span class="hlFld-ContribAuthor ">Hyun Joo  Son</span>, <span class="hlFld-ContribAuthor ">Yong Hyuk  Kim</span>, <span class="hlFld-ContribAuthor ">Joon Ho  Sa</span>, <span class="hlFld-ContribAuthor ">Jae-Sun  Kim</span>, <span class="hlFld-ContribAuthor ">Jungeun  Lee</span>, <span class="hlFld-ContribAuthor ">Jeeyeon  Lee</span>, and <span class="hlFld-ContribAuthor ">Hyeung-geun  Park</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-((R)-4-(2-Fluoro-4-(methylsulfonyl)phenyl)-2-methylpiperazin-1-yl)-N-((1R,2s,3S,5S,7S)-5-hydroxyadamantan-2-yl)pyrimidine-4-carboxamide (SKI2852): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10176-10189. <a href="https://doi.org/10.1021/acs.jmedchem.6b01122" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01122%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%252528%252528R%252529-4-%2525282-Fluoro-4-%252528methylsulfonyl%252529phenyl%252529-2-methylpiperazin-1-yl%252529-N-%252528%2525281R%25252C2s%25252C3S%25252C5S%25252C7S%252529-5-hydroxyadamantan-2-yl%252529pyrimidine-4-carboxamide%252B%252528SKI2852%252529%25253A%252BA%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitor%252Bof%252B11%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%252BType%252B1%252B%25252811%2525CE%2525B2-HSD1%252529%26aulast%3DRyu%26aufirst%3DJe%2BHo%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05082016%26date%3D07112016%26date%3D23112016%26date%3D31102016%26volume%3D59%26issue%3D22%26spage%3D10176%26epage%3D10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Obdulia  Rabal</span>, <span class="hlFld-ContribAuthor ">Juan A.  Sánchez-Arias</span>, <span class="hlFld-ContribAuthor ">Mar  Cuadrado-Tejedor</span>, <span class="hlFld-ContribAuthor ">Irene  de Miguel</span>, <span class="hlFld-ContribAuthor ">Marta  Pérez-González</span>, <span class="hlFld-ContribAuthor ">Carolina  García-Barroso</span>, <span class="hlFld-ContribAuthor ">Ana  Ugarte</span>, <span class="hlFld-ContribAuthor ">Ander  Estella-Hermoso de Mendoza</span>, <span class="hlFld-ContribAuthor ">Elena  Sáez</span>, <span class="hlFld-ContribAuthor ">Maria  Espelosin</span>, <span class="hlFld-ContribAuthor ">Susana  Ursua</span>, <span class="hlFld-ContribAuthor ">Tan  Haizhong</span>, <span class="hlFld-ContribAuthor ">Wu  Wei</span>, <span class="hlFld-ContribAuthor ">Xu  Musheng</span>, <span class="hlFld-ContribAuthor ">Ana  Garcia-Osta</span>, and <span class="hlFld-ContribAuthor ">Julen  Oyarzabal</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8967-9004. <a href="https://doi.org/10.1021/acs.jmedchem.6b00908" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00908%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BFirst-in-Class%252BDual%252BActing%252BHistone%252BDeacetylases%252B%252528HDACs%252529%252Band%252BPhosphodiesterase%252B5%252B%252528PDE5%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRabal%26aufirst%3DObdulia%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D27092016%26date%3D13102016%26date%3D08092016%26volume%3D59%26issue%3D19%26spage%3D8967%26epage%3D9004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher L.  Cioffi</span>, <span class="hlFld-ContribAuthor ">Shuang  Liu</span>, <span class="hlFld-ContribAuthor ">Mark A.  Wolf</span>, <span class="hlFld-ContribAuthor ">Peter R.  Guzzo</span>, <span class="hlFld-ContribAuthor ">Kashinath  Sadalapure</span>, <span class="hlFld-ContribAuthor ">Visweswaran  Parthasarathy</span>, <span class="hlFld-ContribAuthor ">David T. J.  Loong</span>, <span class="hlFld-ContribAuthor ">Jun-Ho  Maeng</span>, <span class="hlFld-ContribAuthor ">Edmund  Carulli</span>, <span class="hlFld-ContribAuthor ">Xiao  Fang</span>, <span class="hlFld-ContribAuthor ">Kalesh  Karunakaran</span>, <span class="hlFld-ContribAuthor ">Lakshman  Matta</span>, <span class="hlFld-ContribAuthor ">Sok Hui  Choo</span>, <span class="hlFld-ContribAuthor ">Shailijia  Panduga</span>, <span class="hlFld-ContribAuthor ">Ronald N.  Buckle</span>, <span class="hlFld-ContribAuthor ">Randall N.  Davis</span>, <span class="hlFld-ContribAuthor ">Samuel A.  Sakwa</span>, <span class="hlFld-ContribAuthor ">Priya  Gupta</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Sargent</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Moore</span>, <span class="hlFld-ContribAuthor ">Michele M.  Luche</span>, <span class="hlFld-ContribAuthor ">Grant J.  Carr</span>, <span class="hlFld-ContribAuthor ">Yuri L.  Khmelnitsky</span>, <span class="hlFld-ContribAuthor ">Jiffry  Ismail</span>, <span class="hlFld-ContribAuthor ">Mark  Chung</span>, <span class="hlFld-ContribAuthor ">Mei  Bai</span>, <span class="hlFld-ContribAuthor ">Wei Yee  Leong</span>, <span class="hlFld-ContribAuthor ">Nidhi  Sachdev</span>, <span class="hlFld-ContribAuthor ">Srividya  Swaminathan</span>, and <span class="hlFld-ContribAuthor ">Andrew J.  Mhyre</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8473-8494. <a href="https://doi.org/10.1021/acs.jmedchem.6b00914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00914%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BN-%252528%2525281-%2525284-%252528Sulfonyl%252529piperazin-1-yl%252529cycloalkyl%252529methyl%252529benzamide%252BInhibitors%252Bof%252BGlycine%252BTransporter-1%26aulast%3DCioffi%26aufirst%3DChristopher%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D09092016%26date%3D22092016%26date%3D25082016%26volume%3D59%26issue%3D18%26spage%3D8473%26epage%3D8494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Clark</span>, <span class="hlFld-ContribAuthor ">Abraham J.  Al-Ahmad</span>, <span class="hlFld-ContribAuthor ">Tongcheng  Qian</span>, <span class="hlFld-ContribAuthor ">Ray R.  Zhang</span>, <span class="hlFld-ContribAuthor ">Hannah K.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jamey P.  Weichert</span>, <span class="hlFld-ContribAuthor ">Sean P.  Palecek</span>, <span class="hlFld-ContribAuthor ">John S.  Kuo</span>, and <span class="hlFld-ContribAuthor ">Eric V.  Shusta</span>  . </span><span class="cited-content_cbyCitation_article-title">Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood–Brain Barrier Model. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2016,</strong> <em>13 </em>
                                    (9)
                                     , 3341-3349. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b00441" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b00441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b00441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b00441%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DAnalysis%252Bof%252BCancer-Targeting%252BAlkylphosphocholine%252BAnalogue%252BPermeability%252BCharacteristics%252BUsing%252Ba%252BHuman%252BInduced%252BPluripotent%252BStem%252BCell%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BModel%26aulast%3DClark%26aufirst%3DPaul%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18052016%26date%3D15072016%26date%3D12072016%26date%3D04082016%26date%3D06092016%26date%3D15072016%26volume%3D13%26issue%3D9%26spage%3D3341%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satish N.  Dighe</span>, <span class="hlFld-ContribAuthor ">Girdhar Singh  Deora</span>, <span class="hlFld-ContribAuthor ">Eugenio  De la Mora</span>, <span class="hlFld-ContribAuthor ">Florian  Nachon</span>, <span class="hlFld-ContribAuthor ">Stephen  Chan</span>, <span class="hlFld-ContribAuthor ">Marie-Odile  Parat</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, and <span class="hlFld-ContribAuthor ">Benjamin P.  Ross</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7683-7689. <a href="https://doi.org/10.1021/acs.jmedchem.6b00356" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00356%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252Ba%252BHighly%252BSelective%252BButyrylcholinesterase%252BInhibitor%252Bby%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DDighe%26aufirst%3DSatish%2BN.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08032016%26date%3D26072016%26date%3D25082016%26date%3D13072016%26volume%3D59%26issue%3D16%26spage%3D7683%26epage%3D7689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Polishchuk</span>, <span class="hlFld-ContribAuthor ">Oleg  Tinkov</span>, <span class="hlFld-ContribAuthor ">Tatiana  Khristova</span>, <span class="hlFld-ContribAuthor ">Ludmila  Ognichenko</span>, <span class="hlFld-ContribAuthor ">Anna  Kosinskaya</span>, <span class="hlFld-ContribAuthor ">Alexandre  Varnek</span>, and <span class="hlFld-ContribAuthor ">Victor  Kuz’min</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural and Physico-Chemical Interpretation (SPCI) of QSAR Models and Its Comparison with Matched Molecular Pair Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (8)
                                     , 1455-1469. <a href="https://doi.org/10.1021/acs.jcim.6b00371" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00371%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructural%252Band%252BPhysico-Chemical%252BInterpretation%252B%252528SPCI%252529%252Bof%252BQSAR%252BModels%252Band%252BIts%252BComparison%252Bwith%252BMatched%252BMolecular%252BPair%252BAnalysis%26aulast%3DPolishchuk%26aufirst%3DPavel%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21062016%26date%3D29072016%26date%3D22082016%26date%3D15072016%26volume%3D56%26issue%3D8%26spage%3D1455%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Ramon  Soto-Otero</span>, <span class="hlFld-ContribAuthor ">Lydia  Siragusa</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>, and <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6791-6806. <a href="https://doi.org/10.1021/acs.jmedchem.6b00562" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00562%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252BBasic%252BTail%252BModifications%252Bof%252BCoumarin-Based%252BDual%252BAcetylcholinesterase-Monoamine%252BOxidase%252BB%252BInhibitors%25253A%252BIdentification%252Bof%252BWater-Soluble%25252C%252BBrain-Permeant%252BNeuroprotective%252BMultitarget%252BAgents%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13042016%26date%3D07072016%26date%3D28072016%26date%3D27062016%26volume%3D59%26issue%3D14%26spage%3D6791%26epage%3D6806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>  . </span><span class="cited-content_cbyCitation_article-title">Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (6)
                                     , 767-775. <a href="https://doi.org/10.1021/acschemneuro.6b00029" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00029%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCentral%252BNervous%252BSystem%252BMultiparameter%252BOptimization%252BDesirability%25253A%252BApplication%252Bin%252BDrug%252BDiscovery%26aulast%3DWager%26aufirst%3DTravis%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02022016%26date%3D18032016%26date%3D04042016%26date%3D15062016%26date%3D18032016%26volume%3D7%26issue%3D6%26spage%3D767%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Houfu  Liu</span>, <span class="hlFld-ContribAuthor ">Scott G.  Summerfield</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Luscombe</span>, and <span class="hlFld-ContribAuthor ">Jasminder  Sahi</span>  . </span><span class="cited-content_cbyCitation_article-title">Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2016,</strong> <em>13 </em>
                                    (5)
                                     , 1540-1550. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b00031" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b00031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b00031%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DIntegrating%252Bin%252BSilico%252Band%252Bin%252BVitro%252BApproaches%252BTo%252BPredict%252BDrug%252BAccessibility%252Bto%252Bthe%252BCentral%252BNervous%252BSystem%26aulast%3DZhang%26aufirst%3DYan-Yan%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12012016%26date%3D25032016%26date%3D17032016%26date%3D04042016%26date%3D02052016%26date%3D25032016%26volume%3D13%26issue%3D5%26spage%3D1540%26epage%3D1550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">Jan  Mollitor</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Sladjana  Dukic-Stefanovic</span>, <span class="hlFld-ContribAuthor ">Mathias  Kranz</span>, <span class="hlFld-ContribAuthor ">Chrysoula  Vraka</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Robert  Günther</span>, <span class="hlFld-ContribAuthor ">Cornelius K.  Donat</span>, <span class="hlFld-ContribAuthor ">Friedrich-Alexander  Ludwig</span>, <span class="hlFld-ContribAuthor ">Steffen  Fischer</span>, <span class="hlFld-ContribAuthor ">Rene  Smits</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Wadsak</span>, <span class="hlFld-ContribAuthor ">Markus  Mitterhauser</span>, <span class="hlFld-ContribAuthor ">Jörg  Steinbach</span>, <span class="hlFld-ContribAuthor ">Alexander  Hoepping</span>, and <span class="hlFld-ContribAuthor ">Peter  Brust</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Novel Nonpeptidic 18F-Labeled Radiotracer for in Vivo Imaging of Oxytocin Receptors with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (5)
                                     , 1800-1817. <a href="https://doi.org/10.1021/acs.jmedchem.5b01080" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01080%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BNovel%252BNonpeptidic%252B18F-Labeled%252BRadiotracer%252Bfor%252Bin%252BVivo%252BImaging%252Bof%252BOxytocin%252BReceptors%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DWenzel%26aufirst%3DBarbara%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D18082015%26date%3D03022016%26date%3D10032016%26date%3D21012016%26volume%3D59%26issue%3D5%26spage%3D1800%26epage%3D1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideyuki  Igawa</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Keiko  Kakegawa</span>, <span class="hlFld-ContribAuthor ">Asato  Kina</span>, <span class="hlFld-ContribAuthor ">Minoru  Ikoma</span>, <span class="hlFld-ContribAuthor ">Jumpei  Aida</span>, <span class="hlFld-ContribAuthor ">Tsuneo  Yasuma</span>, <span class="hlFld-ContribAuthor ">Yayoi  Kawata</span>, <span class="hlFld-ContribAuthor ">Shuntaro  Ashina</span>, <span class="hlFld-ContribAuthor ">Syunsuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Mrinalkanti  Kundu</span>, <span class="hlFld-ContribAuthor ">Uttam  Khamrai</span>, <span class="hlFld-ContribAuthor ">Hideki  Hirabayashi</span>, <span class="hlFld-ContribAuthor ">Masaharu  Nakayama</span>, <span class="hlFld-ContribAuthor ">Yasutaka  Nagisa</span>, <span class="hlFld-ContribAuthor ">Shizuo  Kasai</span>, and <span class="hlFld-ContribAuthor ">Tsuyoshi  Maekawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure–Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 1116-1139. <a href="https://doi.org/10.1021/acs.jmedchem.5b01704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMelanin-Concentrating%252BHormone%252BReceptor%252B1%252BAntagonists%252BLacking%252Ban%252BAliphatic%252BAmine%25253A%252BSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BNovel%252B1-%252528Imidazo%25255B1%25252C2-a%25255Dpyridin-6-yl%252529pyridin-2%2525281H%252529-one%252BDerivatives%26aulast%3DIgawa%26aufirst%3DHideyuki%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D01112015%26date%3D22012016%26date%3D11022016%26date%3D06012016%26volume%3D59%26issue%3D3%26spage%3D1116%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>  . </span><span class="cited-content_cbyCitation_article-title">Probabilistic Approach to Generating MPOs and Its Application as a Scoring Function for CNS Drugs. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 89-93. <a href="https://doi.org/10.1021/acsmedchemlett.5b00390" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00390%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProbabilistic%252BApproach%252Bto%252BGenerating%252BMPOs%252Band%252BIts%252BApplication%252Bas%252Ba%252BScoring%252BFunction%252Bfor%252BCNS%252BDrugs%26aulast%3DGunaydin%26aufirst%3DHakan%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06102015%26date%3D02122015%26date%3D04122015%26date%3D14012016%26date%3D02122015%26volume%3D7%26issue%3D1%26spage%3D89%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Timothy P.    Heffron </span><span class="hlFld-ContribAuthor "> Andrew    McClory </span><span class="hlFld-ContribAuthor "> Andreas    Stumpf </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Process Chemistry Development of GDC-0084, a Brain Penetrating Inhibitor of PI3K and mTOR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 147-173. <a href="https://doi.org/10.1021/bk-2016-1239.ch006" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch006%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BProcess%252BChemistry%252BDevelopment%252Bof%252BGDC-0084%25252C%252Ba%252BBrain%252BPenetrating%252BInhibitor%252Bof%252BPI3K%252Band%252BmTOR%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26spage%3D147%26epage%3D173%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Ziqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Kan  Chen</span>, <span class="hlFld-ContribAuthor ">Peter  Johnström</span>, <span class="hlFld-ContribAuthor ">Katarina  Varnäs</span>, <span class="hlFld-ContribAuthor ">David Yunzhi  Li</span>, <span class="hlFld-ContribAuthor ">Zhen Fan  Yang</span>, and <span class="hlFld-ContribAuthor ">Xiaolin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 8200-8215. <a href="https://doi.org/10.1021/acs.jmedchem.5b01073" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01073%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEvaluation%252Bof%252BClinical%252BCandidate%252BAZD3759%25252C%252Ba%252BPotent%25252C%252BOral%252BActive%25252C%252BCentral%252BNervous%252BSystem-Penetrant%25252C%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinase%252BInhibitor%26aulast%3DZeng%26aufirst%3DQingbei%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10072015%26date%3D09102015%26date%3D22102015%26date%3D27082015%26volume%3D58%26issue%3D20%26spage%3D8200%26epage%3D8215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik J. R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">Carolina  Martínez-Lamenca</span>, <span class="hlFld-ContribAuthor ">Michiel  Van Gool</span>, <span class="hlFld-ContribAuthor ">Aránzazu  García-Molina</span>, <span class="hlFld-ContribAuthor ">Sergio A.  Alonso de Diego</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hana  Prokopcova</span>, <span class="hlFld-ContribAuthor ">José Manuel  Alonso</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Sven  Van Brandt</span>, <span class="hlFld-ContribAuthor ">Michel  Surkyn</span>, <span class="hlFld-ContribAuthor ">Michel  De Cleyn</span>, <span class="hlFld-ContribAuthor ">Ann  Vos</span>, <span class="hlFld-ContribAuthor ">Richard  Alexander</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>, <span class="hlFld-ContribAuthor ">Harrie  Gijsen</span>, and <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>  . </span><span class="cited-content_cbyCitation_article-title">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 8216-8235. <a href="https://doi.org/10.1021/acs.jmedchem.5b01101" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C4-Oxazine%252B%2525CE%2525B2-Secretase%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BFrom%252BHit%252BGeneration%252Bto%252BOrally%252BBioavailable%252BBrain%252BPenetrant%252BLeads%26aulast%3DRombouts%26aufirst%3DFrederik%2BJ.%2BR.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D14072015%26date%3D10102015%26date%3D22102015%26date%3D17092015%26volume%3D58%26issue%3D20%26spage%3D8216%26epage%3D8235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xixi  Feng</span>, <span class="hlFld-ContribAuthor ">Claudia  Sippel</span>, <span class="hlFld-ContribAuthor ">Andreas  Bracher</span>, and <span class="hlFld-ContribAuthor ">Felix  Hausch</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Affinity Relationship Analysis of Selective FKBP51 Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (19)
                                     , 7796-7806. <a href="https://doi.org/10.1021/acs.jmedchem.5b00785" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00785%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Affinity%252BRelationship%252BAnalysis%252Bof%252BSelective%252BFKBP51%252BLigands%26aulast%3DFeng%26aufirst%3DXixi%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11062015%26date%3D30092015%26date%3D08102015%26volume%3D58%26issue%3D19%26spage%3D7796%26epage%3D7806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span> and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6733-6746. <a href="https://doi.org/10.1021/acs.jmedchem.5b00261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252BBiology%252Bof%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D14052015%26date%3D10092015%26date%3D27042015%26volume%3D58%26issue%3D17%26spage%3D6733%26epage%3D6746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A.  Christopher</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Aves</span>, <span class="hlFld-ContribAuthor ">Kirstie A.  Bennett</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Doré</span>, <span class="hlFld-ContribAuthor ">James C.  Errey</span>, <span class="hlFld-ContribAuthor ">Ali  Jazayeri</span>, <span class="hlFld-ContribAuthor ">Fiona H.  Marshall</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Okrasa</span>, <span class="hlFld-ContribAuthor ">Maria J.  Serrano-Vega</span>, <span class="hlFld-ContribAuthor ">Benjamin G.  Tehan</span>, <span class="hlFld-ContribAuthor ">Giselle R.  Wiggin</span>, and <span class="hlFld-ContribAuthor ">Miles  Congreve</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6653-6664. <a href="https://doi.org/10.1021/acs.jmedchem.5b00892" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00892</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00892%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment%252Band%252BStructure-Based%252BDrug%252BDiscovery%252Bfor%252Ba%252BClass%252BC%252BGPCR%25253A%252BDiscovery%252Bof%252Bthe%252BmGlu5%252BNegative%252BAllosteric%252BModulator%252BHTL14242%252B%2525283-Chloro-5-%25255B6-%2525285-fluoropyridin-2-yl%252529pyrimidin-4-yl%25255Dbenzonitrile%252529%26aulast%3DChristopher%26aufirst%3DJohn%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10062015%26date%3D12082015%26date%3D27082015%26date%3D30072015%26volume%3D58%26issue%3D16%26spage%3D6653%26epage%3D6664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>, <span class="hlFld-ContribAuthor ">Nicholas W.  Griggs</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Anand</span>, <span class="hlFld-ContribAuthor ">John R.  Traynor</span>, <span class="hlFld-ContribAuthor ">Emily M.  Jutkiewicz</span>, and <span class="hlFld-ContribAuthor ">Henry I.  Mosberg</span>  . </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis and in Vitro and in Vivo Activity of Tetrahydroquinolines Featuring a Diverse Set of Polar Substitutions at the 6 Position as Mixed-Efficacy μ Opioid Receptor/δ Opioid Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (8)
                                     , 1428-1435. <a href="https://doi.org/10.1021/acschemneuro.5b00100" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00100%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DAsymmetric%252BSynthesis%252Band%252Bin%252BVitro%252Band%252Bin%252BVivo%252BActivity%252Bof%252BTetrahydroquinolines%252BFeaturing%252Ba%252BDiverse%252BSet%252Bof%252BPolar%252BSubstitutions%252Bat%252Bthe%252B6%252BPosition%252Bas%252BMixed-Efficacy%252B%2525CE%2525BC%252BOpioid%252BReceptor%25252F%2525CE%2525B4%252BOpioid%252BReceptor%252BLigands%26aulast%3DBender%26aufirst%3DAaron%2BM.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D25032015%26date%3D01052015%26date%3D13052015%26date%3D19082015%26date%3D04052015%26volume%3D6%26issue%3D8%26spage%3D1428%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yinan  Zhang</span>, <span class="hlFld-ContribAuthor ">Kevin Tianmeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Susan G.  Fox</span>, <span class="hlFld-ContribAuthor ">Jinho  Kim</span>, <span class="hlFld-ContribAuthor ">Donald R.  Kirsch</span>, <span class="hlFld-ContribAuthor ">Robert J.  Ferrante</span>, <span class="hlFld-ContribAuthor ">Richard I.  Morimoto</span>, and <span class="hlFld-ContribAuthor ">Richard B.  Silverman</span>  . </span><span class="cited-content_cbyCitation_article-title">Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (15)
                                     , 5942-5949. <a href="https://doi.org/10.1021/acs.jmedchem.5b00561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTertiary%252BAmine%252BPyrazolones%252Band%252BTheir%252BSalts%252Bas%252BInhibitors%252Bof%252BMutant%252BSuperoxide%252BDismutase%252B1-Dependent%252BProtein%252BAggregation%252Bfor%252Bthe%252BTreatment%252Bof%252BAmyotrophic%252BLateral%252BSclerosis%26aulast%3DZhang%26aufirst%3DYinan%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09042015%26date%3D31072015%26date%3D13082015%26date%3D17072015%26volume%3D58%26issue%3D15%26spage%3D5942%26epage%3D5949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chudi O.  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Jason W.  Boggs</span>, <span class="hlFld-ContribAuthor ">Joy  Drobnick</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Rajiv  Jesudason</span>, <span class="hlFld-ContribAuthor ">Erin  McNamara</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Amy  Sambrone</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Tanya  Smyczek</span>, <span class="hlFld-ContribAuthor ">Philip  Vitorino</span>, <span class="hlFld-ContribAuthor ">Lan  Wang</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>, <span class="hlFld-ContribAuthor ">Stacey  Yeung</span>, <span class="hlFld-ContribAuthor ">Jinhua  Chen</span>, <span class="hlFld-ContribAuthor ">Kevin  Chen</span>, <span class="hlFld-ContribAuthor ">Charles Z.  Ding</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Zijin  Xu</span>, <span class="hlFld-ContribAuthor ">Stephen E.  Gould</span>, <span class="hlFld-ContribAuthor ">Lesley J.  Murray</span>, and <span class="hlFld-ContribAuthor ">Weilan  Ye</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (8)
                                     , 913-918. <a href="https://doi.org/10.1021/acsmedchemlett.5b00174" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00174%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-Based%252BDesign%252Bof%252BGNE-495%25252C%252Ba%252BPotent%252Band%252BSelective%252BMAP4K4%252BInhibitor%252Bwith%252BEfficacy%252Bin%252BRetinal%252BAngiogenesis%26aulast%3DNdubaku%26aufirst%3DChudi%2BO.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D24042015%26date%3D29062015%26date%3D01072015%26date%3D13082015%26date%3D29062015%26volume%3D6%26issue%3D8%26spage%3D913%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianyuan  Deng</span>, <span class="hlFld-ContribAuthor ">Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Xinyu  Dong</span>, <span class="hlFld-ContribAuthor ">Janos  Hajagos</span>, <span class="hlFld-ContribAuthor ">Mary  Saltz</span>, <span class="hlFld-ContribAuthor ">Joel  Saltz</span>, <span class="hlFld-ContribAuthor ">Fusheng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids. </span><span class="cited-content_cbyCitation_journal-name">Drugs - Real World Outcomes</span><span> <strong>2021,</strong> <em>8 </em>
                                    (3)
                                     , 393-406. <a href="https://doi.org/10.1007/s40801-021-00253-8" title="DOI URL">https://doi.org/10.1007/s40801-021-00253-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40801-021-00253-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40801-021-00253-8%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520-%2520Real%2520World%2520Outcomes%26atitle%3DA%252BLarge-Scale%252BObservational%252BStudy%252Bon%252Bthe%252BTemporal%252BTrends%252Band%252BRisk%252BFactors%252Bof%252BOpioid%252BOverdose%25253A%252BReal-World%252BEvidence%252Bfor%252BBetter%252BOpioids%26aulast%3DDeng%26aufirst%3DJianyuan%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D3%26spage%3D393%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohei  Kosugi</span>, <span class="hlFld-ContribAuthor ">Kunihiko  Mizuno</span>, <span class="hlFld-ContribAuthor ">Cipriano  Santos</span>, <span class="hlFld-ContribAuthor ">Sho  Sato</span>, <span class="hlFld-ContribAuthor ">Natalie  Hosea</span>, <span class="hlFld-ContribAuthor ">Michael  Zientek</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model. </span><span class="cited-content_cbyCitation_journal-name">The AAPS Journal</span><span> <strong>2021,</strong> <em>23 </em>
                                    (4)
                                     <a href="https://doi.org/10.1208/s12248-021-00604-x" title="DOI URL">https://doi.org/10.1208/s12248-021-00604-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12248-021-00604-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12248-021-00604-x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520AAPS%2520Journal%26atitle%3DDirect%252BComparison%252Bof%252Bthe%252BPrediction%252Bof%252Bthe%252BUnbound%252BBrain-to-Plasma%252BPartitioning%252BUtilizing%252BMachine%252BLearning%252BApproach%252Band%252BMechanistic%252BNeuropharmacokinetic%252BModel%26aulast%3DKosugi%26aufirst%3DYohei%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanan  Hou</span>, <span class="hlFld-ContribAuthor ">Shoujiao  Peng</span>, <span class="hlFld-ContribAuthor ">Zilong  Song</span>, <span class="hlFld-ContribAuthor ">Feifei  Bai</span>, <span class="hlFld-ContribAuthor ">Xinming  Li</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Oat polyphenol avenanthramide-2c confers protection from oxidative stress by regulating the Nrf2-ARE signaling pathway in PC12 cells. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2021,</strong> <em>706 </em>, 108857. <a href="https://doi.org/10.1016/j.abb.2021.108857" title="DOI URL">https://doi.org/10.1016/j.abb.2021.108857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2021.108857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2021.108857%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DOat%252Bpolyphenol%252Bavenanthramide-2c%252Bconfers%252Bprotection%252Bfrom%252Boxidative%252Bstress%252Bby%252Bregulating%252Bthe%252BNrf2-ARE%252Bsignaling%252Bpathway%252Bin%252BPC12%2525C2%2525A0cells%26aulast%3DHou%26aufirst%3DYanan%26date%3D2021%26volume%3D706%26spage%3D108857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sho  Sato</span>, <span class="hlFld-ContribAuthor ">Kota  Matsumiya</span>, <span class="hlFld-ContribAuthor ">Kimio  Tohyama</span>, <span class="hlFld-ContribAuthor ">Yohei  Kosugi</span>. </span><span class="cited-content_cbyCitation_article-title">Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios. </span><span class="cited-content_cbyCitation_journal-name">The AAPS Journal</span><span> <strong>2021,</strong> <em>23 </em>
                                    (4)
                                     <a href="https://doi.org/10.1208/s12248-021-00609-6" title="DOI URL">https://doi.org/10.1208/s12248-021-00609-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12248-021-00609-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12248-021-00609-6%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520AAPS%2520Journal%26atitle%3DTranslational%252BCNS%252BSteady-State%252BDrug%252BDisposition%252BModel%252Bin%252BRats%25252C%252BMonkeys%25252C%252Band%252BHumans%252Bfor%252BQuantitative%252BPrediction%252Bof%252BBrain-to-Plasma%252Band%252BCerebrospinal%252BFluid-to-Plasma%252BUnbound%252BConcentration%252BRatios%26aulast%3DSato%26aufirst%3DSho%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue  Zhou</span>, <span class="hlFld-ContribAuthor ">Quentin R.  Smith</span>, <span class="hlFld-ContribAuthor ">Xinli  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target
              CNS
              diseases. </span><span class="cited-content_cbyCitation_journal-name">WIREs Nanomedicine and Nanobiotechnology</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/wnan.1695" title="DOI URL">https://doi.org/10.1002/wnan.1695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wnan.1695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwnan.1695%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Nanomedicine%2520and%2520Nanobiotechnology%26atitle%3DBrain%252Bpenetrating%252Bpeptides%252Band%252Bpeptide%2525E2%252580%252593drug%252Bconjugates%252Bto%252Bovercome%252Bthe%252Bblood%2525E2%252580%252593brain%252Bbarrier%252Band%252Btarget%252BCNS%252Bdiseases%26aulast%3DZhou%26aufirst%3DXue%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samson Olaitan  Oselusi</span>, <span class="hlFld-ContribAuthor ">Alan  Christoffels</span>, <span class="hlFld-ContribAuthor ">Samuel Ayodele  Egieyeh</span>. </span><span class="cited-content_cbyCitation_article-title">Cheminformatic Characterization of Natural Antimicrobial Products for the Development of New Lead Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (13)
                                     , 3970. <a href="https://doi.org/10.3390/molecules26133970" title="DOI URL">https://doi.org/10.3390/molecules26133970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26133970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26133970%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCheminformatic%252BCharacterization%252Bof%252BNatural%252BAntimicrobial%252BProducts%252Bfor%252Bthe%252BDevelopment%252Bof%252BNew%252BLead%252BCompounds%26aulast%3DOselusi%26aufirst%3DSamson%2BOlaitan%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D13%26spage%3D3970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and Structural Strategies to Selectively Target mTOR Kinase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1002/cmdc.202100332" title="DOI URL">https://doi.org/10.1002/cmdc.202100332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100332%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChemical%252Band%252BStructural%252BStrategies%252Bto%252BSelectively%252BTarget%252BmTOR%252BKinase%26aulast%3DBorsari%26aufirst%3DChiara%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Berend  van der Wildt</span>, <span class="hlFld-ContribAuthor ">Madina  Nezam</span>, <span class="hlFld-ContribAuthor ">Esther J.M.  Kooijman</span>, <span class="hlFld-ContribAuthor ">Samantha T.  Reyes</span>, <span class="hlFld-ContribAuthor ">Bin  Shen</span>, <span class="hlFld-ContribAuthor ">Albert D.  Windhorst</span>, <span class="hlFld-ContribAuthor ">Frederick T.  Chin</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>42 </em>, 116245. <a href="https://doi.org/10.1016/j.bmc.2021.116245" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116245%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252Bcarbon-11%252Blabeled%252B5-%2525281-methyl-1H-pyrazol-4-yl%252529-N-%2525282-methyl-5-%2525283-%252528trifluoromethyl%252529benzamido%252529phenyl%252529nicotinamide%252Bas%252BPET%252Btracer%252Bfor%252Bimaging%252Bof%252BCSF-1R%252Bexpression%252Bin%252Bthe%252Bbrain%26aulast%3Dvan%2Bder%2BWildt%26aufirst%3DBerend%26date%3D2021%26volume%3D42%26spage%3D116245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leandro L.  Santos</span>, <span class="hlFld-ContribAuthor ">Eva L.  Wu</span>, <span class="hlFld-ContribAuthor ">Kaitlin M.  Grinias</span>, <span class="hlFld-ContribAuthor ">Michael C.  Koetting</span>, <span class="hlFld-ContribAuthor ">Piyush  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Developability profile framework for lead candidate selection in topical dermatology. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2021,</strong> <em>604 </em>, 120750. <a href="https://doi.org/10.1016/j.ijpharm.2021.120750" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2021.120750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2021.120750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2021.120750%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DDevelopability%252Bprofile%252Bframework%252Bfor%252Blead%252Bcandidate%252Bselection%252Bin%252Btopical%252Bdermatology%26aulast%3DSantos%26aufirst%3DLeandro%2BL.%26date%3D2021%26volume%3D604%26spage%3D120750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George  Lambrinidis</span>, <span class="hlFld-ContribAuthor ">Anna  Tsantili-Kakoulidou</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-objective optimization methods in novel drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 647-658. <a href="https://doi.org/10.1080/17460441.2021.1867095" title="DOI URL">https://doi.org/10.1080/17460441.2021.1867095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1867095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1867095%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DMulti-objective%252Boptimization%252Bmethods%252Bin%252Bnovel%252Bdrug%252Bdesign%26aulast%3DLambrinidis%26aufirst%3DGeorge%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D6%26spage%3D647%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jenny P.  Patel</span>, <span class="hlFld-ContribAuthor ">Susan E.  Spiller</span>, <span class="hlFld-ContribAuthor ">Elizabeth D.  Barker</span>. </span><span class="cited-content_cbyCitation_article-title">Drug penetration in pediatric brain tumors: Challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Pediatric Blood & Cancer</span><span> <strong>2021,</strong> <em>68 </em>
                                    (6)
                                     <a href="https://doi.org/10.1002/pbc.28983" title="DOI URL">https://doi.org/10.1002/pbc.28983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pbc.28983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpbc.28983%26sid%3Dliteratum%253Aachs%26jtitle%3DPediatric%2520Blood%2520%2526%2520Cancer%26atitle%3DDrug%252Bpenetration%252Bin%252Bpediatric%252Bbrain%252Btumors%25253A%252BChallenges%252Band%252Bopportunities%26aulast%3DPatel%26aufirst%3DJenny%2BP.%26date%3D2021%26date%3D2021%26volume%3D68%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Kouhi</span>, <span class="hlFld-ContribAuthor ">Vyshnavi  Pachipulusu</span>, <span class="hlFld-ContribAuthor ">Talya  Kapenstein</span>, <span class="hlFld-ContribAuthor ">Peisheng  Hu</span>, <span class="hlFld-ContribAuthor ">Alan L.  Epstein</span>, <span class="hlFld-ContribAuthor ">Leslie A.  Khawli</span>. </span><span class="cited-content_cbyCitation_article-title">Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (12)
                                     , 6442. <a href="https://doi.org/10.3390/ijms22126442" title="DOI URL">https://doi.org/10.3390/ijms22126442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22126442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22126442%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBrain%252BDisposition%252Bof%252BAntibody-Based%252BTherapeutics%25253A%252BDogma%25252C%252BApproaches%252Band%252BPerspectives%26aulast%3DKouhi%26aufirst%3DAida%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D12%26spage%3D6442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Guo</span>, <span class="hlFld-ContribAuthor ">Zixue  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Ziyi  Huang</span>, <span class="hlFld-ContribAuthor ">Qinwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianqi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113383. <a href="https://doi.org/10.1016/j.ejmech.2021.113383" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113383%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbrain%252Bpenetrant%252Bbenzazepine-based%252Bhistone%252Bdeacetylase%252B6%252Binhibitors%252Bfor%252Balleviating%252Bstroke-induced%252Bbrain%252Binfarction%26aulast%3DGuo%26aufirst%3DZheng%26date%3D2021%26volume%3D218%26spage%3D113383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivedita  Thakur</span>, <span class="hlFld-ContribAuthor ">Thomas  Klopstock</span>, <span class="hlFld-ContribAuthor ">Suzanne  Jackowski</span>, <span class="hlFld-ContribAuthor ">Enej  Kuscer</span>, <span class="hlFld-ContribAuthor ">Fernando  Tricta</span>, <span class="hlFld-ContribAuthor ">Aleksandar  Videnovic</span>, <span class="hlFld-ContribAuthor ">Hyder A.  Jinnah</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel Therapies for Pantothenate
              Kinase–Associated
              Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Movement Disorders</span><span> <strong>2021,</strong> <em>42 </em><a href="https://doi.org/10.1002/mds.28642" title="DOI URL">https://doi.org/10.1002/mds.28642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mds.28642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmds.28642%26sid%3Dliteratum%253Aachs%26jtitle%3DMovement%2520Disorders%26atitle%3DRational%252BDesign%252Bof%252BNovel%252BTherapies%252Bfor%252BPantothenate%252BKinase%2525E2%252580%252593Associated%252BNeurodegeneration%26aulast%3DThakur%26aufirst%3DNivedita%26date%3D2021%26date%3D2021%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcel  Lindemann</span>, <span class="hlFld-ContribAuthor ">Sladjana  Dukic-Stefanovic</span>, <span class="hlFld-ContribAuthor ">Sonja  Hinz</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Cathleen  Juhl</span>, <span class="hlFld-ContribAuthor ">Jörg  Steinbach</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>, <span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A2B Receptor Binding Affinity. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (5)
                                     , 485. <a href="https://doi.org/10.3390/ph14050485" title="DOI URL">https://doi.org/10.3390/ph14050485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14050485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14050485%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DSynthesis%252Bof%252BNovel%252BFluorinated%252BXanthine%252BDerivatives%252Bwith%252BHigh%252BAdenosine%252BA2B%252BReceptor%252BBinding%252BAffinity%26aulast%3DLindemann%26aufirst%3DMarcel%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D5%26spage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharmin Reza  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Jinxin  Gu</span>, <span class="hlFld-ContribAuthor ">Hu  Yixin</span>, <span class="hlFld-ContribAuthor ">Juntao  Wang</span>, <span class="hlFld-ContribAuthor ">Shuwen  Lei</span>, <span class="hlFld-ContribAuthor ">Mojdeh S.  Tavallaie</span>, <span class="hlFld-ContribAuthor ">Celine  Lam</span>, <span class="hlFld-ContribAuthor ">Dan  Lu</span>, <span class="hlFld-ContribAuthor ">Faqin  Jiang</span>, <span class="hlFld-ContribAuthor ">Lei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modeling of Benzofuran piperidine derivatives as Aβ antiaggregant. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>206 </em>, 113541. <a href="https://doi.org/10.1016/j.ejmech.2021.113541" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113541%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bof%252BBenzofuran%252Bpiperidine%252Bderivatives%252Bas%252BA%2525CE%2525B2%252Bantiaggregant%26aulast%3DChowdhury%26aufirst%3DSharmin%2BReza%26date%3D2021%26volume%3D206%26spage%3D113541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm501535r&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501535r%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=275&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Principal CNS PK parameters and concepts. (a) Schematic representation of bound and unbound drug concentration equilibrium across BBB and brain main compartments: interstitial fluid (ISF), intracellular fluid (ICF), and cerebrospinal fluid (CSF); (b) <i>K</i><sub>p,uu</sub> values significantly lower or higher than 1 indicate active transport across the BBB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Terfenadine and its main metabolite, fexofenadine.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. A structure of ALK inhibitor crizotinib, <b>42</b>, co-crystallized with the ALK kinase domain, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2">2XP2</a> (the protein is omitted for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/medium/jm-2014-01535r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Distribution of brain unbound concentrations (<i>C</i><sub>u,b</sub>) in mouse for a diverse set of 616 compounds from Eli Lilly’s collection as a function of: (a) CNS MPO score (1–6) and (b) cLogD (Chemaxon). Pie charts are colored according to <i>C</i><sub>u,b</sub> levels: red, low (<i>C</i><sub>u,b</sub> < 10 nM); green, high (<i>C</i><sub>u,b</sub> > 10 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501535r/20150320/images/large/jm-2014-01535r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501535r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 158 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Chandler, D. J.</span><span> </span><span class="NLM_article-title">Something’s got to give: psychiatric disease on the rise and novel drug development on the decline</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=202-206&author=D.+J.+Chandler&title=Something%E2%80%99s+got+to+give%3A+psychiatric+disease+on+the+rise+and+novel+drug+development+on+the+decline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChandler%26aufirst%3DD.%2BJ.%26atitle%3DSomething%25E2%2580%2599s%2520got%2520to%2520give%253A%2520psychiatric%2520disease%2520on%2520the%2520rise%2520and%2520novel%2520drug%2520development%2520on%2520the%2520decline%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D202%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>Forecasting Health Care Costs; <span class="NLM_publisher-name">National Bureau of Economic Research</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>; <a href="http://www.nber.org/aginghealth/2008no4/w14361.html" class="extLink">http://www.nber.org/aginghealth/2008no4/w14361.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Forecasting+Health+Care+Costs%3B+National+Bureau+of+Economic+Research%3A+Cambridge%2C+MA%3B+http%3A%2F%2Fwww.nber.org%2Faginghealth%2F2008no4%2Fw14361.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DForecasting%2520Health%2520Care%2520Costs%26pub%3DNational%2520Bureau%2520of%2520Economic%2520Research" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Barnholtz-Sloan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigneau, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, R. E.</span><span> </span><span class="NLM_article-title">Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1200%2FJCO.2004.12.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15254054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2865-2872&author=J.+S.+Barnholtz-Sloanauthor=A.+E.+Sloanauthor=F.+G.+Davisauthor=F.+D.+Vigneauauthor=P.+Laiauthor=R.+E.+Sawaya&title=Incidence+proportions+of+brain+metastases+in+patients+diagnosed+%281973+to+2001%29+in+the+metropolitan+detroit+cancer+surveillance+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System</span></div><div class="casAuthors">Barnholtz-Sloan Jill S; Sloan Andrew E; Davis Faith G; Vigneau Fawn D; Lai Ping; Sawaya Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2865-72</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Population-based estimates of the incidence of brain metastases are not generally available.  The purpose of this study was to calculate population-based incidence proportions (IPs) of brain metastases from single primary lung, melanoma, breast, renal, or colorectal cancer.  PATIENTS AND METHODS:  Patients diagnosed with single primary lung, melanoma, breast, renal, or colorectal cancer (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System (MDCSS) were used for analysis.  IP of brain metastases by primary site and variable of interest (race, sex, age at diagnosis of primary cancer, and Surveillance, Epidemiology, and End Results [SEER] stage of primary cancer) was calculated with 95% CIs.  RESULTS:  Total IP percentage (IP%) of brain metastases was 9.6% for all primary sites combined, and highest for lung (19.9%), followed by melanoma (6.9%), renal (6.5%), breast (5.1%), and colorectal (1.8%) cancers.  Racial differences were seen with African Americans demonstrating higher IP% of brain metastases compared with other racial groups for most primary sites.  IP% was significantly higher for female patients with lung cancer, and significantly higher for male patients with melanoma.  The highest IP% of brain metastases occurred at different ages at diagnoses: age 40 to 49 years for primary lung cancer; age 50 to 59 years for primary melanoma, renal, or colorectal cancers; and age 20 to 39 for primary breast cancer.  IP% significantly increased as SEER stage of primary cancer advanced for all primary sites.  CONCLUSION:  Total IP% of brain metastases was lower than previously reported, and it varied by primary site, race, sex, age at diagnosis of primary cancer, and SEER stage of primary cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1FltY_UquSCCEBeYuoi7AfW6udTcc2eZptKgYgSC7QLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D&md5=76fa82deca39e5aced5f3d98735be3d0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.12.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.12.149%26sid%3Dliteratum%253Aachs%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%2BS.%26aulast%3DSloan%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DF.%2BG.%26aulast%3DVigneau%26aufirst%3DF.%2BD.%26aulast%3DLai%26aufirst%3DP.%26aulast%3DSawaya%26aufirst%3DR.%2BE.%26atitle%3DIncidence%2520proportions%2520of%2520brain%2520metastases%2520in%2520patients%2520diagnosed%2520%25281973%2520to%25202001%2529%2520in%2520the%2520metropolitan%2520detroit%2520cancer%2520surveillance%2520system%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2865%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistics</span> <span class="citation_source-journal">Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><div class="note"><p class="first last">2014</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.3322%2Fcaac.21208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=24399786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=9-29&author=R.+Siegelauthor=J.+Maauthor=Z.+Zouauthor=A.+Jemal&title=Cancer+statistics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2014</span></div><div class="casAuthors">Siegel Rebecca; Ma Jiemin; Zou Zhaohui; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics.  A total of 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014.  During the most recent 5 years for which there are data (2006-2010), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.4% per year in women.  The combined cancer death rate (deaths per 100,000 population) has been continuously declining for 2 decades, from a peak of 215.1 in 1991 to 171.8 in 2010.  This 20% decline translates to the avoidance of approximately 1,340,400 cancer deaths (952,700 among men and 387,700 among women) during this time period.  The magnitude of the decline in cancer death rates from 1991 to 2010 varies substantially by age, race, and sex, ranging from no decline among white women aged 80 years and older to a 55% decline among black men aged 40 years to 49 years.  Notably, black men experienced the largest drop within every 10-year age group.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-53QNNisGn5agfuraLLzSfW6udTcc2eZptKgYgSC7QLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D&md5=2aa85d07bbfc7838e1d0e6bf94ce6c46</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21208%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%26jtitle%3DCancer%2520J.%2520Clin.%26date%3D2014%26volume%3D64%26spage%3D9%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Nguyen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, L. M.</span><span> </span><span class="NLM_article-title">Brain metastases</span> <span class="citation_source-journal">Neurol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.ncl.2007.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17964030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2snjvFygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1173-1192&author=T.+D.+Nguyenauthor=L.+M.+DeAngelis&title=Brain+metastases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metastases</span></div><div class="casAuthors">Nguyen Teri D; DeAngelis Lisa M</div><div class="citationInfo"><span class="NLM_cas:title">Neurologic clinics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1173-92, x-xi</span>
        ISSN:<span class="NLM_cas:issn">0733-8619</span>.
    </div><div class="casAbstract">Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression.  Supportive therapies include steroids and antiseizure medications.  Definitive treatments include radiation therapy, surgery, and chemotherapy.  The optimal choice of treatment and overall prognosis largely depend on patient characteristics and the extent and distribution of disease.  Delaying or decreasing neurologic cause of death and disability are important therapeutic goals for this population.  While better definitive strategies are investigated, physicians must remember to optimize the use of supportive therapies to ameliorate symptoms and maintain quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSYt-AmUO_aF1C8OJBvdfbfW6udTcc2eZVA9zYUyF-v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snjvFygtg%253D%253D&md5=a16350bd3ec9d4488bee98cd27c8cd77</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ncl.2007.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ncl.2007.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26aulast%3DDeAngelis%26aufirst%3DL.%2BM.%26atitle%3DBrain%2520metastases%26jtitle%3DNeurol.%2520Clin.%26date%3D2007%26volume%3D25%26spage%3D1173%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and cros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4720</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.-L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-Amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28metheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+cros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-Amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520cros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">The blood-brain barrier: bottleneck in brain drug development</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1602%2Fneurorx.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15717053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=3-14&author=W.+M.+Pardridge&title=The+blood-brain+barrier%3A+bottleneck+in+brain+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The blood-brain barrier: bottleneck in brain drug development</span></div><div class="casAuthors">Pardridge William M</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">The blood-brain barrier (BBB) is formed by the brain capillary endothelium and excludes from the brain approximately 100% of large-molecule neurotherapeutics and more than 98% of all small-molecule drugs.  Despite the importance of the BBB to the neurotherapeutics mission, the BBB receives insufficient attention in either academic neuroscience or industry programs.  The combination of so little effort in developing solutions to the BBB problem, and the minimal BBB transport of the majority of all potential CNS drugs, leads predictably to the present situation in neurotherapeutics, which is that there are few effective treatments for the majority of CNS disorders.  This situation can be reversed by an accelerated effort to develop a knowledge base in the fundamental transport properties of the BBB, and the molecular and cellular biology of the brain capillary endothelium.  This provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D9y3lHz94U-GfW6udTcc2eZVA9zYUyF-v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D&md5=88e326d840c4ab0f4e55da8a2ffd513c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DThe%2520blood-brain%2520barrier%253A%2520bottleneck%2520in%2520brain%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D3%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Shen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artru, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkison, K. K.</span><span> </span><span class="NLM_article-title">Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.addr.2004.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15381336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslOhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1825-1827&author=D.+D.+Shenauthor=A.+A.+Artruauthor=K.+K.+Adkison&title=Principles+and+applicability+of+CSF+sampling+for+the+assessment+of+CNS+drug+delivery+and+pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics</span></div><div class="casAuthors">Shen, Danny D.; Artru, Alan A.; Adkison, Kimberly K.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1825-1857</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Cerebrospinal fluid (CSF) concns. are used as a surrogate measure of central nervous system (CNS) availability of drugs.  Systemically administered drugs can reach CSF either directly via passage across the choroid plexus, or indirectly by passage across the blood-brain barrier (BBB) followed by diffusion/convection transport from the interstitial fluid (ISF) to CSF.  This review focuses on the physiol. and pharmacokinetic variables that must be considered in the interpretation of the CSF-to-plasma concn. gradient.  A survey of the literature suggests that the equilibrated CSF-to-unbound plasma concn. ratio reflects the balance between drug permeability across the blood-CNS barriers and the sink action of CSF turnover.  As lipophilicity and membrane permeability increase, the CSF-to-plasma unbound concn. ratio rises from well below 1 toward unity.  Deviations are noted in that lipophilic drugs highly bound to CSF proteins had ratio exceeding unity, and lipophilic drugs that were efflux transporter substrates exhibited ratios well less than unity.  Drug concn. gradients have been obsd. between drug in the ISF and CSF, the direction of which depends on the CSF sink action and drug permeability/transport across the BBB and choroid plexus.  Despite the complexity of CSF pharmacokinetics, for some drugs a rapid kinetic equil. exists between the CSF and biophase, such that CSF concn. can serve as a proximate ref. for detailed investigation of factors affecting the intrinsic pharmacodynamics of a centrally acting drug.  The applicability and limitations of CSF sampling for assessing the CNS availability and concn.-effect relationship of drug candidates with varying physicochem. properties during drug discovery and development is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Nkcnqy8t3rVg90H21EOLACvtfcHk0lgiEk_7Ht160w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslOhsrg%253D&md5=e16fbe5043d36b99261b7eea0d3972ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DArtru%26aufirst%3DA.%2BA.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26atitle%3DPrinciples%2520and%2520applicability%2520of%2520CSF%2520sampling%2520for%2520the%2520assessment%2520of%2520CNS%2520drug%2520delivery%2520and%2520pharmacodynamics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1825%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Martin, I.</span><span> </span><span class="NLM_article-title">Prediction of blood–brain barrier penetration: are we missing the point?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=161-162&author=I.+Martin&title=Prediction+of+blood%E2%80%93brain+barrier+penetration%3A+are+we+missing+the+point%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26atitle%3DPrediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%253A%2520are%2520we%2520missing%2520the%2520point%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D161%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Giacomini, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillgren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmaster, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Membrane transporters in drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=20190787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-236&author=K.+M.+Giacominiauthor=S.-M.+Huangauthor=D.+J.+Tweedieauthor=L.+Z.+Benetauthor=K.+L.+R.+Brouwerauthor=X.+Chuauthor=A.+Dahlinauthor=R.+Eversauthor=V.+Fischerauthor=K.+M.+Hillgrenauthor=K.+A.+Hoffmasterauthor=T.+Ishikawaauthor=D.+Kepplerauthor=R.+B.+Kimauthor=C.+A.+Leeauthor=M.+Niemiauthor=J.+W.+Polliauthor=Y.+Sugiyamaauthor=P.+W.+Swaanauthor=J.+A.+Wareauthor=S.+H.+Wrightauthor=S.+W.+Yeeauthor=M.+J.+Zamek-Gliszczynskiauthor=L.+Zhang&title=Membrane+transporters+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transporters in drug development</span></div><div class="casAuthors">Giacomini, Kathleen M.; Huang, Shiew-Mei; Tweedie, Donald J.; Benet, Leslie Z.; Brouwer, Kim L. R.; Chu, Xiaoyan; Dahlin, Amber; Evers, Raymond; Fischer, Volker; Hillgren, Kathleen M.; Hoffmaster, Keith A.; Ishikawa, Toshihisa; Keppler, Dietrich; Kim, Richard B.; Lee, Caroline A.; Niemi, Mikko; Polli, Joseph W.; Sugiyama, Yuicchi; Swaan, Peter W.; Ware, Joseph A.; Wright, Stephen H.; Wah Yee, Sook; Zamek-Gliszczynski, Maciej J.; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-236</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs.  This presents several key questions for drug development, including which transporters are clin. important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters.  In addn., what criteria should trigger follow-up clin. studies, and which clin. studies should be conducted if needed.  In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clin. studies on the currently recognized most important drug transporter interactions.  The recommendations are generally intended to support clin. development and filing of a new drug application.  Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clin. trial enrollment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metab. and excretion properties of the drug mol., and information required for drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiBIf0gk93W7Vg90H21EOLACvtfcHk0lgiEk_7Ht160w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D&md5=89d9ce746284c1814fb01cd9b9a72027</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3028%26sid%3Dliteratum%253Aachs%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%2BR.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DDahlin%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHillgren%26aufirst%3DK.%2BM.%26aulast%3DHoffmaster%26aufirst%3DK.%2BA.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DNiemi%26aufirst%3DM.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DWare%26aufirst%3DJ.%2BA.%26aulast%3DWright%26aufirst%3DS.%2BH.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMembrane%2520transporters%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Abbott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönnbäck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, L.</span><span> </span><span class="NLM_article-title">Astrocyte–endothelial interactions at the blood–brain barrier</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrn1824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16371949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlaktbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=41-53&author=N.+J.+Abbottauthor=L.+R%C3%B6nnb%C3%A4ckauthor=L.+Hansson&title=Astrocyte%E2%80%93endothelial+interactions+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Astrocyte-endothelial interactions at the blood-brain barrier</span></div><div class="casAuthors">Abbott, N. Joan; Roennbaeck, Lars; Hansson, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-53</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier, which is formed by the endothelial cells that line cerebral microvessels, has an important role in maintaining a precisely regulated microenvironment for reliable neuronal signaling.  At present, there is great interest in the assocn. of brain microvessels, astrocytes and neurons to form functional neurovascular units, and recent studies have highlighted the importance of brain endothelial cells in this modular organization.  Here, we explore specific interactions between the brain endothelium, astrocytes, and neurons that may regulate blood-brain barrier function.  An understanding of how these interactions are disturbed in pathol. conditions could lead to the development of new protective and restorative therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpmeWESRRQSbVg90H21EOLACvtfcHk0lgiEk_7Ht160w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlaktbjP&md5=831bcfddad8af8122f7139d525c96356</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrn1824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1824%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DR%25C3%25B6nnb%25C3%25A4ck%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DL.%26atitle%3DAstrocyte%25E2%2580%2593endothelial%2520interactions%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D41%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecker, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennernas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugano, K.</span><span> </span><span class="NLM_article-title">Evidence-based approach to assess passive diffusion and carrier-mediated drug transport</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.drudis.2012.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=22507594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlWisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=905-912&author=L.+Diauthor=P.+Arturssonauthor=A.+Avdeefauthor=G.+F.+Eckerauthor=B.+Fallerauthor=H.+Fischerauthor=J.+B.+Houstonauthor=M.+Kansyauthor=E.+H.+Kernsauthor=S.+D.+Kramerauthor=H.+Lennernasauthor=K.+Sugano&title=Evidence-based+approach+to+assess+passive+diffusion+and+carrier-mediated+drug+transport"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence-based approach to assess passive diffusion and carrier-mediated drug transport</span></div><div class="casAuthors">Di, Li; Artursson, Per; Avdeef, Alex; Ecker, Gerhard F.; Faller, Bernard; Fischer, Holger; Houston, J. Brian; Kansy, Manfred; Kerns, Edward H.; Kramer, Stefanie D.; Lennernas, Hans; Sugano, Kiyohiko</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">905-912</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Evidence supporting the action of passive diffusion and carrier-mediated (CM) transport in drug bioavailability and disposition is discussed to refute the recently proposed theory that drug transport is CM-only and that new transporters will be discovered that possess transport characteristics ascribed to passive diffusion.  Misconceptions and faulty speculations are addressed to provide reliable guidance on choosing appropriate tools for drug design and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxroQ5Hx-CarVg90H21EOLACvtfcHk0lgOki1Ql0QOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlWisrg%253D&md5=a16c61888f55b82f03c1115b95fc4b94</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DKramer%26aufirst%3DS.%2BD.%26aulast%3DLennernas%26aufirst%3DH.%26aulast%3DSugano%26aufirst%3DK.%26atitle%3DEvidence-based%2520approach%2520to%2520assess%2520passive%2520diffusion%2520and%2520carrier-mediated%2520drug%2520transport%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D905%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing CNS drugs for optimal brain exposure</span>. In  <span class="citation_source-book">Blood–Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Di, L.; Kerns, E. H.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1002%2F9781118788523.ch18" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Rankovicauthor=L.+Di&author=E.+H.+Kerns&title=Blood%E2%80%93Brain+Barrier+in+Drug+Discovery%3A+Optimizing+Brain+Exposure+of+CNS+Drugs+and+Minimizing+Brain+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F9781118788523.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118788523.ch18%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520CNS%2520drugs%2520for%2520optimal%2520brain%2520exposure%26btitle%3DBlood%25E2%2580%2593Brain%2520Barrier%2520in%2520Drug%2520Discovery%253A%2520Optimizing%2520Brain%2520Exposure%2520of%2520CNS%2520Drugs%2520and%2520Minimizing%2520Brain%2520Side%2520Effects%26aulast%3DDi%26aufirst%3DL.%26pub%3DWiley%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rankovic, Z.; Bingham, M.</span><span> </span><span class="NLM_article-title">Medicinal chemistry challenges in CNS drug discovery</span>. In  <span class="citation_source-book">Drug Discovery for Psychiatric Disorders</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Rankovic, Z.; Bingham, M.; Nestler, E.; Hargreaves, R.</span>, Eds.; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=465-509&author=Z.+Rankovic&author=M.+Binghamauthor=Z.+Rankovic&author=M.+Bingham&author=E.+Nestler&author=R.+Hargreaves&title=Drug+Discovery+for+Psychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DMedicinal%2520chemistry%2520challenges%2520in%2520CNS%2520drug%2520discovery%26btitle%3DDrug%2520Discovery%2520for%2520Psychiatric%2520Disorders%26aulast%3DRankovic%26aufirst%3DZ.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2013%26spage%3D465%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Malakoutikhah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giralt, E.</span><span> </span><span class="NLM_article-title">Shuttle-mediated drug delivery to the brain</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">7998</span><span class="NLM_x">–</span> <span class="NLM_lpage">8014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=7998-8014&author=M.+Malakoutikhahauthor=M.+Teixidauthor=E.+Giralt&title=Shuttle-mediated+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalakoutikhah%26aufirst%3DM.%26aulast%3DTeixid%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DShuttle-mediated%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D7998%26epage%3D8014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Strategies to optimize brain penetration in drug discovery</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=505-512&author=X.+Liuauthor=C.+Chen&title=Strategies+to+optimize+brain+penetration+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DStrategies%2520to%2520optimize%2520brain%2520penetration%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26spage%3D505%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deusen, J. V.</span><span> </span><span class="NLM_article-title">Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood–brain barrier permeability, plasma protein binding, and brain tissue binding</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">1254</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.104.079319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15743928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslektbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=1254-1262&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrognaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+Nelsonauthor=M.+A.+Szewcauthor=J.+V.+Deusen&title=Use+of+a+physiologically+based+pharmacokinetic+model+to+study+the+time+to+reach+brain+equilibrium%3A+an+experimental+analysis+of+the+role+of+blood%E2%80%93brain+barrier+permeability%2C+plasma+protein+binding%2C+and+brain+tissue+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: An experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffery</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1254-1262</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed (1) to examine the effects of blood-brain barrier (BBB) permeability [quantified as permeability-surface area product (PS)], unbound fraction in plasma (fu,plasma), and brain tissue (fu,brain) on the time to reach equil. between brain and plasma and (2) to investigate the drug discovery strategies to design and select compds. that can rapidly penetrate the BBB and distribute to the site of action.  The pharmacokinetics of seven model compds.: caffeine, CP-141938 (methoxy-3-[(2-phenyl-piperadinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), fluoxetine, NFPS [N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine], propranolol, theobromine, and theophylline in rat brain and plasma after s.c. administration were studied.  The in vivo log PS and log fu,brain calcd. using a physiol. based pharmacokinetic model correlates with in situ log PS (R2 = 0.83) and in vitro log fu,brain (R2 = 0.69), where the in situ PS and in vitro fu,brain was detd. using in situ brain perfusion and equil. dialysis using brain homogenate, resp.  The time to achieve brain equil. can be quantitated with a proposed parameter, intrinsic brain equil. half-life [t1/2eq,in = VbIn2/(PS · fu,brain)], where Vb is the physiol. vol. of brain.  The in vivo log t1/2eq,in does not correlate with in situ log PS (R2 < 0.01) but correlates inversely with log(PS · fu,brain) (R2 = 0.85).  The present study demonstrates that rapid brain equilibration requires a combination of high BBB permeability and low brain tissue binding.  A high BBB permeability alone cannot guarantee a rapid equilibration.  The strategy to select compds. with rapid brain equilibration in drug discovery should identify compds. with high BBB permeability and low nonspecific binding in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv5KbqnWflVbVg90H21EOLACvtfcHk0lgOki1Ql0QOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslektbs%253D&md5=544d4bff8b1460321f1941018ac8b5f5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.079319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.079319%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DDeusen%26aufirst%3DJ.%2BV.%26atitle%3DUse%2520of%2520a%2520physiologically%2520based%2520pharmacokinetic%2520model%2520to%2520study%2520the%2520time%2520to%2520reach%2520brain%2520equilibrium%253A%2520an%2520experimental%2520analysis%2520of%2520the%2520role%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%252C%2520plasma%2520protein%2520binding%252C%2520and%2520brain%2520tissue%2520binding%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D1254%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=54-61&author=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cecchelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renftel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehouck, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenart, L.</span><span> </span><span class="NLM_article-title">Modelling of the blood–brain barrier in drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=50-661&author=R.+Cecchelliauthor=V.+Berezowskiauthor=S.+Lundquistauthor=M.+Culotauthor=M.+Renftelauthor=M.-P.+Dehouckauthor=L.+Fenart&title=Modelling+of+the+blood%E2%80%93brain+barrier+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DBerezowski%26aufirst%3DV.%26aulast%3DLundquist%26aufirst%3DS.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DRenftel%26aufirst%3DM.%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DFenart%26aufirst%3DL.%26atitle%3DModelling%2520of%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D50%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+Debartoloauthor=D.+A.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0lhTJRL_FhBjhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDebartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Markus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, F.</span><span> </span><span class="NLM_article-title">Positron emission tomography in CNS drug discovery and drug monitoring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9232</span><span class="NLM_x">–</span> <span class="NLM_lpage">9258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9232-9258&author=P.+Markusauthor=I.+Vernalekenauthor=F.+Roesch&title=Positron+emission+tomography+in+CNS+drug+discovery+and+drug+monitoring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkus%26aufirst%3DP.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DRoesch%26aufirst%3DF.%26atitle%3DPositron%2520emission%2520tomography%2520in%2520CNS%2520drug%2520discovery%2520and%2520drug%2520monitoring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9232%26epage%3D9258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0lhTJRL_FhBjhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1997&pages=768-771&author=D.+Wuauthor=Y.-S.+Kangauthor=U.+Bickelauthor=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+permeability+to+morphine-6-glucuronide+is+markedly+reduced+compared+with+morphine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DY.-S.%26aulast%3DBickel%26aufirst%3DU.%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520permeability%2520to%2520morphine-6-glucuronide%2520is%2520markedly%2520reduced%2520compared%2520with%2520morphine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D26%26spage%3D768%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Frolich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dees, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paetz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaev, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenk, M. H.</span><span> </span><span class="NLM_article-title">Distinct pharmacological properties of morphine metabolites at Gi-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=1248-1254&author=N.+Frolichauthor=C.+Deesauthor=C.+Paetzauthor=X.+Renauthor=M.+J.+Lohseauthor=V.+O.+Nikolaevauthor=M.+H.+Zenk&title=Distinct+pharmacological+properties+of+morphine+metabolites+at+Gi-protein+and+%CE%B2-arrestin+signaling+pathways+activated+by+the+human+%CE%BC-opioid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolich%26aufirst%3DN.%26aulast%3DDees%26aufirst%3DC.%26aulast%3DPaetz%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DZenk%26aufirst%3DM.%2BH.%26atitle%3DDistinct%2520pharmacological%2520properties%2520of%2520morphine%2520metabolites%2520at%2520Gi-protein%2520and%2520%25CE%25B2-arrestin%2520signaling%2520pathways%2520activated%2520by%2520the%2520human%2520%25CE%25BC-opioid%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D1248%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Paul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standiffer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inturrisi, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of morphine 6-b-glucuronidase, a very potent morphine metabolite</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=477-483&author=D.+Paulauthor=K.+M.+Standifferauthor=C.+E.+Inturrisiauthor=G.+W.+Pasternak&title=Pharmacological+characterization+of+morphine+6-b-glucuronidase%2C+a+very+potent+morphine+metabolite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DStandiffer%26aufirst%3DK.%2BM.%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DPharmacological%2520characterization%2520of%2520morphine%25206-b-glucuronidase%252C%2520a%2520very%2520potent%2520morphine%2520metabolite%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D251%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Reichel, A.</span><span> </span><span class="NLM_article-title">Addressing central nervous system (CNS) penetration in drug discovery: Basics and implications of the evolving new concept</span> <span class="citation_source-journal">Chem. Biodivers.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2030</span><span class="NLM_x">–</span> <span class="NLM_lpage">2049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=2030-2049&author=A.+Reichel&title=Addressing+central+nervous+system+%28CNS%29+penetration+in+drug+discovery%3A+Basics+and+implications+of+the+evolving+new+concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DAddressing%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetration%2520in%2520drug%2520discovery%253A%2520Basics%2520and%2520implications%2520of%2520the%2520evolving%2520new%2520concept%26jtitle%3DChem.%2520Biodivers.%26date%3D2009%26volume%3D6%26spage%3D2030%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Stain-Texier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandouk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span> </span><span class="NLM_article-title">Elevated concentrations of morphine 6-beta-<span class="smallcaps smallerCapital">d</span>-glucuronide in brain extracellular fluid despite low blood–brain barrier permeability</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fsj.bjp.0702873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=10556926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXntFCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=917-924&author=F.+Stain-Texierauthor=G.+Boschiauthor=P.+Sandoukauthor=J.+M.+Scherrmann&title=Elevated+concentrations+of+morphine+6-beta-d-glucuronide+in+brain+extracellular+fluid+despite+low+blood%E2%80%93brain+barrier+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood - brain barrier permeability</span></div><div class="casAuthors">Stain-Texier, Frederique; Boschi, Gabrielle; Sandouk, Pierre; Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">917-924</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">This study was done to find out how morphine 6-beta-D-glucuronide (M6G) induces more potent central analgesia than morphine, despite its poor blood-brain barrier (BBB) permeability.  The brain uptake and disposition of these compds. were investigated in plasma and in various brain compartments: extracellular fluid (ECF), intracellular space (ICS) and cerebrospinal fluid (CSF).  Morphine or M6G was given to rats at 10 mg kg-1 s.c.  Transcortical microdialysis was used to assess their distributions in the brain ECF.  Conventional tissue homogenization was used to det. the distribution in the cortex and whole brain.  These two procedures were combined to est. drug distribution in the brain ICS.  The blood and CSF pharmacokinetics were also detd.  Plasma concn. data for M6G were much higher than those of morphine, with Cmax and AUC 4-5 times more higher, Tmax shorter, and VZf-1 (vol. of distribution) and CL f-1 (clearance) 4-6 times lower.  The concns. of the compds. in various brain compartments also differed: AUC values for M6G were lower than those of morphine in tissue and CSF and higher in brain ECF.  AUC values in brain show that morphine levels were four times higher in ICS than in ECF, whereas M6G levels were 125 higher in ECF than in ICS.  Morphine entered brain cells, whereas M6G was almost exclusively extracellular.  This high extracellular concn., coupled with extremely slow diffusion into the CSF, indicates that M6G was predominantly trapped in the extracellular fluid and therefore durably available to bind at opioid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4m4joGsaYsLVg90H21EOLACvtfcHk0ljhD5sTkX7epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFCiu7g%253D&md5=5c21b08e2b1099a8fe5b3e5b32ae0d39</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702873%26sid%3Dliteratum%253Aachs%26aulast%3DStain-Texier%26aufirst%3DF.%26aulast%3DBoschi%26aufirst%3DG.%26aulast%3DSandouk%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DElevated%2520concentrations%2520of%2520morphine%25206-beta-d-glucuronide%2520in%2520brain%2520extracellular%2520fluid%2520despite%2520low%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D917%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massingham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. N.</span><span> </span><span class="NLM_article-title">Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1002%2Fbdd.509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16791848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=291-297&author=A.+Guptaauthor=M.+Hammarlund-Udenaesauthor=P.+Chatelainauthor=R.+Massinghamauthor=E.+N.+Jonsson&title=Stereoselective+pharmacokinetics+of+cetirizine+in+the+guinea+pig%3A+role+of+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding</span></div><div class="casAuthors">Gupta, Anubha; Hammarlund-Udenaes, Margareta; Chatelain, Pierre; Massingham, Roy; Jonsson, E. Niclas</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Purpose. To characterize the pharmacokinetics of cetirizine enantiomers in the guinea pig including protein binding in both the guinea pig and human plasma.  Methods. Plasma concns. of cetirizine enantiomers in the guinea pig were detd. using a LC-MS/MS method after a short i.v. infusion (1, 2 and 4 mg/kg) of racemic cetirizine.  Protein binding was detd. using an in vitro equil. dialysis technique.  A pharmacokinetic model was developed using NONMEM and the differences in pharmacokinetic parameters of levocetirizine and dextrocetirizine were estd.  Results. The plasma concn. time data of both the enantiomers were best described by a three-compartment pharmacokinetics model.  The clearance (CL) of levocetirizine and dextrocetirizine was 1.2 and 2.7 mL/min, resp., and the vol. of distribution at steady state (Vss) was 457 mL and 996 mL, resp.  The fraction unbound (fu) in guinea pig plasma for levocetirizine and dextrocetirizine was 7-10% and 16-21% while in human plasma, it was 8% and 12%, resp.  The factor describing the difference in the pharmacokinetic parameters of the cetirizine enantiomers was estd. to be 2.26.  Conclusions. Cetirizine pharmacokinetics is stereoselective in the guinea pig.  For levocetirizine, fu, CL and Vss were half those of dextrocetirizine, indicating that protein binding is an important factor affecting the pharmacokinetics of cetirizine.  The effect of protein binding on the pharmacokinetics of the cetirizine enantiomers could be extrapolated to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGT69fkPBFHrVg90H21EOLACvtfcHk0ljhD5sTkX7epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGlsrjF&md5=5294005f5f2b7f326e2f00330e8bc18d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbdd.509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.509%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DP.%26aulast%3DMassingham%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%2BN.%26atitle%3DStereoselective%2520pharmacokinetics%2520of%2520cetirizine%2520in%2520the%2520guinea%2520pig%253A%2520role%2520of%2520protein%2520binding%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2006%26volume%3D27%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0ljhD5sTkX7epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baughman, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, K.H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mote, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salisbury, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tippin, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span> </span><span class="NLM_article-title">P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2082</span><span class="NLM_x">–</span> <span class="NLM_lpage">2089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2082-2089&author=J.+W.+Polliauthor=T.+M.+Baughmanauthor=J.+E.+Humphreysauthor=K.H.+Jordanauthor=A.+L.+Moteauthor=J.+A.+Salisburyauthor=T.+K.+Tippinauthor=C.+J.+Serabjit-Singh&title=P-glycoprotein+influences+the+brain+concentrations+of+cetirizine+%28Zyrtec%29%2C+a+second-generation+non-sedating+antihistamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBaughman%26aufirst%3DT.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DJordan%26aufirst%3DK.H.%26aulast%3DMote%26aufirst%3DA.%2BL.%26aulast%3DSalisbury%26aufirst%3DJ.%2BA.%26aulast%3DTippin%26aufirst%3DT.%2BK.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26atitle%3DP-glycoprotein%2520influences%2520the%2520brain%2520concentrations%2520of%2520cetirizine%2520%2528Zyrtec%2529%252C%2520a%2520second-generation%2520non-sedating%2520antihistamine%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2082%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Simon, F. E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, K. J.</span><span> </span><span class="NLM_article-title">H1 antihistamines: current status and future directions</span> <span class="citation_source-journal">World Allergy Organ. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1186%2F1939-4551-1-9-145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=145-155&author=F.+E.+R.+Simonauthor=K.+J.+Simons&title=H1+antihistamines%3A+current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2F1939-4551-1-9-145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1939-4551-1-9-145%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DF.%2BE.%2BR.%26aulast%3DSimons%26aufirst%3DK.%2BJ.%26atitle%3DH1%2520antihistamines%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DWorld%2520Allergy%2520Organ.%2520J.%26date%3D2008%26volume%3D1%26spage%3D145%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sadiq, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjoerkman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlundudenaes, M.</span><span> </span><span class="NLM_article-title">Diphenhydramine active uptake at the blood–brain barrier and its interaction with oxycodone <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3912</span><span class="NLM_x">–</span> <span class="NLM_lpage">3923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=3912-3923&author=M.+W.+Sadiqauthor=A.+Borgsauthor=T.+Okuraauthor=K.+Shimomuraauthor=S.+Katoauthor=Y.+Deguchiauthor=B.+Janssonauthor=S.+Bjoerkmanauthor=T.+Terasakiauthor=M.+Hammarlundudenaes&title=Diphenhydramine+active+uptake+at+the+blood%E2%80%93brain+barrier+and+its+interaction+with+oxycodone+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadiq%26aufirst%3DM.%2BW.%26aulast%3DBorgs%26aufirst%3DA.%26aulast%3DOkura%26aufirst%3DT.%26aulast%3DShimomura%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DJansson%26aufirst%3DB.%26aulast%3DBjoerkman%26aufirst%3DS.%26aulast%3DTerasaki%26aufirst%3DT.%26aulast%3DHammarlundudenaes%26aufirst%3DM.%26atitle%3DDiphenhydramine%2520active%2520uptake%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520its%2520interaction%2520with%2520oxycodone%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D3912%26epage%3D3923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kageyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimohama, S.</span><span> </span><span class="NLM_article-title">The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">879</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FS0006-8993%2800%2902758-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=11011012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslyjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=879&publication_year=2000&pages=115-121&author=T.+Kageyamaauthor=M.+Nakamuraauthor=A.+Matsuoauthor=Y.+Yamasakiauthor=Y.+Takakuraauthor=M.+Hashidaauthor=Y.+Kanaiauthor=M.+Naitoauthor=T.+Tsuruoauthor=N.+Minatoauthor=S.+Shimohama&title=The+4F2hc%2FLAT1+complex+transports+L-DOPA+across+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The 4F2hc/LAT1 complex transports l-DOPA across the blood-brain barrier</span></div><div class="casAuthors">Kageyama, T.; Nakamura, M.; Matsuo, A.; Yamasaki, Y.; Takakura, Y.; Hashida, M.; Kanai, Y.; Naito, M.; Tsuruo, T.; Minato, N.; Shimohama, S.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">879</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">115-121</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">L-DOPA is transported across the blood-brain barrier (BBB) by an amino acid transporter, system L.  Recently, it has been demonstrated that system L consists of two subunits, 4F2hc and either LAT1 or LAT2. 4F2hc/LAT1 and 4F2hc/LAT2 show different transport characteristics, while their distribution in the brain has not been detd.  To clarify whether 4F2hc/LAT1 participates in l-DOPA transport across the BBB, we first examd. the expression of 4F2hc/LAT1 in the mouse brain capillary endothelial cell line, MBEC4, as an in vitro BBB model.  Northern hybridization and immunoblotting revealed that both 4F2hc and LAT1 are expressed and form a heterodimer in MBEC4 cells.  To confirm whether 4F2hc/LAT1 acts as system L to transport l-DOPA, we characterized l-DOPA uptake into the cells.  The uptake process was time-dependent, temp.-sensitive, and Na+-independent.  Neutral amino acids with bulky side chains and a bicyclic amino acid, 2-aminobicyclo-[2,2,1]-heptane-2-carboxylic acid (BCH), inhibited l-DOPA uptake into MBEC4 cells to a great extent, while an acidic amino acid, basic amino acids, and glycine had no effect.  Other neutral amino acids, such as alanine, asparagine, glutamine, serine, and threonine inhibited l-DOPA uptake by 40-70% at most.  These characteristics are more compatible with those of 4F2hc/LAT1, rather than those of 4F2hc/LAT2.  Finally, immunohistochem. with anti-LAT1 antibody demonstrated that LAT1 is predominantly expressed in the microvessels of the central nervous system.  This is the first report showing that the 4F2hc/LAT1 complex participates in l-DOPA transport across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE3IFZUc76ybVg90H21EOLACvtfcHk0ljRGxrDHtBh7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslyjsLs%253D&md5=08b982ef604a9fe2889d94d53440c101</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902758-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902758-X%26sid%3Dliteratum%253Aachs%26aulast%3DKageyama%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMatsuo%26aufirst%3DA.%26aulast%3DYamasaki%26aufirst%3DY.%26aulast%3DTakakura%26aufirst%3DY.%26aulast%3DHashida%26aufirst%3DM.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DMinato%26aufirst%3DN.%26aulast%3DShimohama%26aufirst%3DS.%26atitle%3DThe%25204F2hc%252FLAT1%2520complex%2520transports%2520L-DOPA%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D879%26spage%3D115%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Doran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasman, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahematpura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raunig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasgar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span> </span><span class="NLM_article-title">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=165-174&author=A.+Doranauthor=R.+S.+Obachauthor=B.+J.+Smithauthor=N.+A.+Hoseaauthor=S.+Beckerauthor=E.+Callegariauthor=C.+Chenauthor=X.+Chenauthor=E.+Chooauthor=J.+Cianfrognaauthor=L.+M.+Coxauthor=J.+P.+Gibbsauthor=M.+A.+Gibbsauthor=H.+Hatchauthor=C.+E.+Hopauthor=I.+N.+Kasmanauthor=J.+LaPerleauthor=J.+Liuauthor=X.+Liuauthor=M.+Logmanauthor=D.+Maclinauthor=F.+M.+Nedzaauthor=F.+Nelsonauthor=E.+Olsonauthor=S.+Rahematpuraauthor=D.+Raunigauthor=S.+Rogersauthor=K.+Schmidtauthor=D.+K.+Spracklinauthor=M.+Szewcauthor=M.+Troutmanauthor=E.+Tsengauthor=M.+Tuauthor=J.+W.+Van+Deusenauthor=K.+Venkatakrishnanauthor=G.+Walensauthor=E.+Q.+Wangauthor=D.+Wongauthor=A.+S.+Yasgarauthor=C.+Zhang&title=The+impact+of+P-glycoprotein+on+the+disposition+of+drugs+targeted+for+indications+of+the+central+nervous+system%3A+evaluation+using+the+MDR1A%2F1B+knockout+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%2BM.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DGibbs%26aufirst%3DM.%2BA.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DKasman%26aufirst%3DI.%2BN.%26aulast%3DLaPerle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DRahematpura%26aufirst%3DS.%26aulast%3DRaunig%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DSzewc%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%2BW.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DWalens%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DYasgar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520impact%2520of%2520P-glycoprotein%2520on%2520the%2520disposition%2520of%2520drugs%2520targeted%2520for%2520indications%2520of%2520the%2520central%2520nervous%2520system%253A%2520evaluation%2520using%2520the%2520MDR1A%252F1B%2520knockout%2520mouse%2520model%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friden</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syvnen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span> </span><span class="NLM_article-title">On the rate and extent of drug delivery to the brain</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1737</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2Fs11095-007-9502-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18058202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1737-1750&author=M.+Hammarlund-Udenaesauthor=+Fridenauthor=M.+S.+Syvnenauthor=A.+Gupta&title=On+the+rate+and+extent+of+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">On The Rate and Extent of Drug Delivery to the Brain</span></div><div class="casAuthors">Hammarlund-Udenaes, Margareta; Friden, Markus; Syvaenen, Stina; Gupta, Anubha</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1737-1750</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  To define and differentiate relevant aspects of blood-brain barrier transport and distribution in order to aid research methodol. in brain drug delivery.  Pharmacokinetic parameters relative to the rate and extent of brain drug delivery are described and illustrated with relevant data, with special emphasis on the unbound, pharmacol. active drug mol.  Drug delivery to the brain can be comprehensively described using three parameters: K p,uu (concn. ratio of unbound drug in brain to blood), CLin (permeability clearance into the brain), and V u,brain (intra-brain distribution).  The permeability of the blood-brain barrier is less relevant to drug action within the CNS than the extent of drug delivery, as most drugs are administered on a continuous (repeated) basis.  K p,uu can differ between CNS-active drugs by a factor of up to 150-fold.  This range is much smaller than that for log BB ratios (K p), which can differ by up to at least 2000-fold, or for BBB permeabilities, which span an even larger range (up to at least 20,000-fold difference).  Methods that measure the three parameters K p,uu, CLin, and V u,brain can give clin. valuable ests. of brain drug delivery in early drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkysWU99T_hbVg90H21EOLACvtfcHk0lg5VQIJprlpYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D&md5=20f106a980c4949b78ead8c00cb5db41</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs11095-007-9502-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-007-9502-2%26sid%3Dliteratum%253Aachs%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DFriden%26aulast%3DSyvnen%26aufirst%3DM.%2BS.%26aulast%3DGupta%26aufirst%3DA.%26atitle%3DOn%2520the%2520rate%2520and%2520extent%2520of%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26spage%3D1737%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnaraj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patsalos, P. N.</span><span> </span><span class="NLM_article-title">The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus)</span> <span class="citation_source-journal">Seizure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">574</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.seizure.2004.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15519917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2crkvVOqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=574-581&author=X.+Wangauthor=N.+Ratnarajauthor=P.+N.+Patsalos&title=The+pharmacokinetic+inter-relationship+of+tiagabine+in+blood%2C+cerebrospinal+fluid+and+brain+extracellular+fluid+%28frontal+cortex+and+hippocampus%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus)</span></div><div class="casAuthors">Wang Xiaolan; Ratnaraj Neville; Patsalos Philip N</div><div class="citationInfo"><span class="NLM_cas:title">Seizure</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">574-81</span>
        ISSN:<span class="NLM_cas:issn">1059-1311</span>.
    </div><div class="casAbstract">PURPOSE:  Tiagabine is a unique antiepileptic drug with a novel mechanism of action.  Whilst some limited data are available as to the peripheral blood pharmacokinetics of tiagabine, data regarding the kinetics of tiagabine in the central brain compartment are very limited.  We therefore sought to investigate serum, cerebrospinal fluid (CSF) and frontal cortex and hippocampal extracellular fluid (ECF) kinetic inter-relationship of tiagabine in a freely moving rat model.  METHODS:  Adult male rats were implanted with either a jugular vein catheter and a cisterna magna catheter for blood and CSF sampling, respectively, or a blood catheter and a microdialysis probe in the hippocampus and frontal cortex (for ECF sampling).  Tiagabine was administered intraperitoneal (i.p.) at 20 or 40 mg/kg and blood, CSF and ECF were collected at timed intervals for the measurement of tiagabine concentrations by high performance liquid chromatography.  RESULTS:  Tiagabine concentrations in blood and CSF rose linearly and dose-dependently and time to maximum concentration (Tmax) was 15 and 29 min, respectively.  Mean CSF/serum tiagabine concentration ratios (range, 0.008-0.01) were much smaller than the mean free/total tiagabine concentration ratios in serum (0.045 +/- 0.003).  Entry of tiagabine into brain ECF (frontal cortex and hippocampus) was rapid with Tmax values of 31-46 min.  Distribution of tiagabine in brain was not brain region specific with values in the frontal cortex and hippocampus being indistinguishable.  Whilst elimination from CSF was comparable to that of serum, half-life (t(1/2)) values in ECF were three times longer.  CONCLUSIONS:  Tiagabine is associated with linear kinetic characteristics and with rapid brain penetration.  However, CSF concentrations are not reflective of free non-protein-bound concentrations in serum.  The observation that tiagabine elimination from the brain is threefold slower than that seen in blood, may explain as to the relatively long duration of action of tiagabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrouhM9sT0mdy3lHz94U-GfW6udTcc2eawwZz-iMcdXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crkvVOqsw%253D%253D&md5=233a864b5f0bbe2d4b2f6d87162f29a5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.seizure.2004.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.seizure.2004.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRatnaraj%26aufirst%3DN.%26aulast%3DPatsalos%26aufirst%3DP.%2BN.%26atitle%3DThe%2520pharmacokinetic%2520inter-relationship%2520of%2520tiagabine%2520in%2520blood%252C%2520cerebrospinal%2520fluid%2520and%2520brain%2520extracellular%2520fluid%2520%2528frontal%2520cortex%2520and%2520hippocampus%2529%26jtitle%3DSeizure%26date%3D2004%26volume%3D13%26spage%3D574%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerndal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6233</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901036q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6233&author=M.+Fridenauthor=S.+Winiwarterauthor=G.+Jerndalauthor=O.+Bengtssonauthor=H.+Wanauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaesauthor=M.+Antonsson&title=Structure%E2%80%93brain+exposure+relationships+in+rat+and+human+using+a+novel+data+set+of+unbound+drug+concentrations+in+brain+interstitial+and+cerebrospinal+fluids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm901036q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901036q%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DJerndal%26aufirst%3DG.%26aulast%3DBengtsson%26aufirst%3DO.%26aulast%3DWan%26aufirst%3DH.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DAntonsson%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%2520in%2520rat%2520and%2520human%2520using%2520a%2520novel%2520data%2520set%2520of%2520unbound%2520drug%2520concentrations%2520in%2520brain%2520interstitial%2520and%2520cerebrospinal%2520fluids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kodaira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusuhara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of the impact of active efflux by P-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.111.180398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21934030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=935-944&author=H.+Kodairaauthor=H.+Kusuharaauthor=T.+Fujitaauthor=J.+Ushikiauthor=E.+Fuseauthor=Y.+Sugiyama&title=Quantitative+evaluation+of+the+impact+of+active+efflux+by+P-glycoprotein+and+breast+cancer+resistance+protein+at+the+blood-brain+barrier+on+the+predictability+of+the+unbound+concentrations+of+drugs+in+the+brain+using+cerebrospinal+fluid+concentration+as+a+surrogate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of the impact of active efflux by P-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</span></div><div class="casAuthors">Kodaira, Hiroshi; Kusuhara, Hiroyuki; Fujita, Takuya; Ushiki, Junko; Fuse, Eiichi; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">935-944</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study investigated the impact of the active efflux mediated by P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp) at the blood-brain barrier (BBB) on the predictability of the unbound brain concn. (Cu,brain) by the concn. in the cerebrospinal fluid (CSF) (Cu,CSF) in rats.  Cu,brain is obtained as the product of the total brain concn. and unbound fraction in the brain (fu,brain) detd. in vitro in brain slices.  Twenty-five compds., including P-gp and/or Bcrp substrates, were given a const. i.v. infusion, and their plasma, brain, and CSF concns. were detd.  P-gp and/or Bcrp substrates, such as verapamil, loperamide, flavopiridol, genistein, quinidine, dantrolene, daidzein, cimetidine, and pefloxacin, showed a higher CSF-to-brain unbound concn. ratio (Kp,uu,CSF/brain) compared with non-P-gp and non-Bcrp substrates.  Kp,uu,CSF/brain values of P-gp-specific (quinidine and verapamil) and Bcrp-specific (daidzein and genistein) substrates were significantly decreased in Mdr1a/1b(-/-) and Bcrp(-/-) mice, resp.  Furthermore, consistent with the contribution of P-gp and Bcrp to the net efflux at the BBB, Kp,uu,CSF/brain values of the common substrates (flavopiridol and erlotinib) were markedly decreased in Mdr1a/1b(-/-)/Bcrp(-/-) mice, but only moderately or weakly in Mdr1a/1b(-/-) mice and negligibly in Bcrp(-/-) mice.  In conclusion, predictability of Cu,brain by Cu,CSF decreases along with the net transport activities by P-gp and Bcrp at the BBB.  Cu,CSF of non-P-gp and non-Bcrp substrates can be a reliable surrogate of Cu,brain for lipophilic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6e2OeGRsyrVg90H21EOLACvtfcHk0lg5VQIJprlpYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSksbo%253D&md5=36a778b164943b101534146120fc6cdf</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180398%26sid%3Dliteratum%253Aachs%26aulast%3DKodaira%26aufirst%3DH.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DQuantitative%2520evaluation%2520of%2520the%2520impact%2520of%2520active%2520efflux%2520by%2520P-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520at%2520the%2520blood-brain%2520barrier%2520on%2520the%2520predictability%2520of%2520the%2520unbound%2520concentrations%2520of%2520drugs%2520in%2520the%2520brain%2520using%2520cerebrospinal%2520fluid%2520concentration%2520as%2520a%2520surrogate%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D935%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">De Lange, E. C. M.</span><span> </span><span class="NLM_article-title">Utility of CSF in translational neuroscience</span> <span class="citation_source-journal">J. Pharmacokinet. Pharmacodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2Fs10928-013-9301-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=23400635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BC3sznsVKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=315-326&author=E.+C.+M.+De+Lange&title=Utility+of+CSF+in+translational+neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of CSF in translational neuroscience</span></div><div class="casAuthors">de Lange Elizabeth C M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacokinetics and pharmacodynamics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human cerebrospinal fluid (CSF) sampling is of high value as the only general applicable methodology to obtain information on free drug concentrations in individual human brain.  As the ultimate interest is in the free drug concentration at the CNS target site, the question is what CSF concentrations may tell us in that respect.  Studies have been performed in rats and other animals for which concentrations in brain extracellular fluid (brain ECF) as a target site for many drugs, have been compared to (cisterna magna) CSF concentrations, at presumed steady state conditions,.  The data indicated that CSF drug concentrations provided a rather good indication of, but not a reliable measure for predicting brain ECF concentrations.  Furthermore, comparing rat with human CSF concentrations, human CSF concentrations tend to be higher and display much more variability.  However, this comparison of CSF concentrations cannot be a direct one, as humans probably had a disease for which CSF was collected in the first place, while the rats were healthy.  In order to be able to more accurately predict human brain ECF concentrations, understanding of the complexity of the CNS in terms of intrabrain pharmacokinetic relationships and the influence of CNS disorders on brain pharmacokinetics needs to be increased.  This can be achieved by expanding a currently existing preclinically derived physiologically based pharmacokinetic model for brain distribution.  This model has been shown to successfully predict data obtained for human lumbar CSF concentrations of acetaminophen which renders trust in the model prediction of human brain ECF concentrations.  This model should further evolute by inclusion of influences of drug properties, fluid flows, transporter functionalities and different disease conditions.  Finally the model should include measures of target site engagement and CNS effects, to ultimately learn about concentrations that best predict particular target site concentrations, via human CSF concentrations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTi9WqlS0U7bsjl5L8hwNX0fW6udTcc2eaKALC5CveDKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sznsVKlug%253D%253D&md5=283a3121ccb261617d4d2896012e0dc7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs10928-013-9301-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10928-013-9301-9%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLange%26aufirst%3DE.%2BC.%2BM.%26atitle%3DUtility%2520of%2520CSF%2520in%2520translational%2520neuroscience%26jtitle%3DJ.%2520Pharmacokinet.%2520Pharmacodyn.%26date%3D2013%26volume%3D40%26spage%3D315%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Westerhout, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danhof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lange, E. C. M.</span><span> </span><span class="NLM_article-title">Preclinical prediction of human brain target site concentrations: Considerations and extrapolating to the clinical setting</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3577</span><span class="NLM_x">–</span> <span class="NLM_lpage">3593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=3577-3593&author=J.+Westerhoutauthor=M.+Danhofauthor=E.+C.+M.+De+Lange&title=Preclinical+prediction+of+human+brain+target+site+concentrations%3A+Considerations+and+extrapolating+to+the+clinical+setting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWesterhout%26aufirst%3DJ.%26aulast%3DDanhof%26aufirst%3DM.%26aulast%3DDe%2BLange%26aufirst%3DE.%2BC.%2BM.%26atitle%3DPreclinical%2520prediction%2520of%2520human%2520brain%2520target%2520site%2520concentrations%253A%2520Considerations%2520and%2520extrapolating%2520to%2520the%2520clinical%2520setting%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D3577%26epage%3D3593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehngren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrçm, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunek, A.</span><span> </span><span class="NLM_article-title">High-throughput screening of drug–brain tissue binding and in silico prediction for assessment of central nervous system drug delivery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070375w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4606-4615&author=H.+Wanauthor=M.+Rehngrenauthor=F.+Giordanettoauthor=F.+Bergstr%C3%A7mauthor=A.+Tunek&title=High-throughput+screening+of+drug%E2%80%93brain+tissue+binding+and+in+silico+prediction+for+assessment+of+central+nervous+system+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm070375w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070375w%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DRehngren%26aufirst%3DM.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DBergstr%25C3%25A7m%26aufirst%3DF.%26aulast%3DTunek%26aufirst%3DA.%26atitle%3DHigh-throughput%2520screening%2520of%2520drug%25E2%2580%2593brain%2520tissue%2520binding%2520and%2520in%2520silico%2520prediction%2520for%2520assessment%2520of%2520central%2520nervous%2520system%2520drug%2520delivery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1711</span><span class="NLM_x">–</span> <span class="NLM_lpage">1719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1711-1719&author=M.+Fridenauthor=A.+Guptaauthor=M.+Antonssonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=In+vitro+methods+for+estimating+unbound+drug+concentrations+in+the+brain+interstitial+and+intracellular+fluids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520methods%2520for%2520estimating%2520unbound%2520drug%2520concentrations%2520in%2520the%2520brain%2520interstitial%2520and%2520intracellular%2520fluids%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1711%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Nattaauthor=H.+van+Yeoauthor=O.+Vilenskiauthor=P.+Wellerauthor=P.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0lhMSx6UdVs3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNatta%26aufirst%3DK.%26aulast%3Dvan%2BYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DWorboys%26aufirst%3DP.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Debruyne, D.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.2165%2F00003088-199733010-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9250423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXltlShsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1997&pages=52-77&author=D.+Debruyne&title=Clinical+pharmacokinetics+of+fluconazole+in+superficial+and+systemic+mycoses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses</span></div><div class="casAuthors">Debruyne, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-77</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis</span>)
        </div><div class="casAbstract">The bis triazole agent fluconazole is used widely in the treatment of superficial and deep mycoses.  A single oral dose of fluconazole 150mg gives a mean long term clin. cure rate of 84±5% and is considered a valuable alternative to other topical antifungal drugs for vaginal candidiasis.  A clin. cure rate of 90.4% for oropharyngeal candidiasis was obtained with 100mg daily for a min. of 14 days; however, as for the other azoles the rate of relapse was large (40%) in immunocompromised patients.  A daily dose of 100mg for at last 3 wk gave satisfying outcomes for esophageal candidiasis.  Most patients (71 to 86%) with signs and symptoms of urinary tract candidiasis show beneficial clin. results when given oral fluconazole 50mg for several weeks.  Fluconazole 50 to 150mg given for weeks or months results in over 90% clin. cure or improvement for cutaneous mycosis including tinea, pityriasis, cryptococcosis and candidiasis.  Prolonged (6 to 12 mo) fluconazole 150mg once a week is needed to treat onychomycosis successfully.  Higher oral doses (200 to 400mg daily) for long periods are generally used to treat deep mycoses such as meningitis, ophthalmitis, pneumonia, hepatosplenic mycosis and endocarditis.  Fluconazole is effective for treating the fungal peritonitis which can complicate continuous ambulatory peritoneal dialysis (CAPD).  A regimen of 50mg i.p. or 100mg orally was used in these patients with impaired renal function.  The dosage schedules used to treat disseminated fungal infections due to systemic mycoses with different or multiple foci of infections vary widely, with doses of 50 to 400mg given orally or i.v. for between 1 wk and several months.  The most recent clin. reports have investigated the use of prophylaxis with fluconazole 100 to 400mg daily, in immunocompromised patients.  Fluconazole is found in body fluids such as vaginal secretions, breast milk, saliva, sputum and cerebrospinal fluid at concns. comparable with those detd. in blood after single or multiple doses.  There is an excellent linear plasma concn.-dose relationship, but the mycol. and clin. responses do not appear to be well correlated with the dose.  A total max. daily dose of 1600mg is recommended to avoid neurol. toxicity.  Data from pharmacokinetic studies conducted in patients, mainly those with AIDS, and using a 1-compartment model give very const. parameters similar to those obtained in healthy individuals.  Bioavailability, measured in HIV-pos. patients and those with AIDS, exceeded 93% for tablets, suspension and suppositories.  The time to reach peak plasma concns. (tmax) was 2.4 to 3.7 h.  The peak plasma drug concn. (Cmax) obtained after a 100mg oral dose was 2 mg/L.  Areas under the concn.-time curve (AUC) obtained in different studies all correlate well with the dose (r = 0.926).  The AUC detd. after 200 and 25mg suppositories were similarly well correlated.  Hypochlorhydria does not affect the absorption of fluconazole, neither does food intake, race (Japanese or Caucasian) or gastrointestinal resection.  Binding to plasma protein is low (11.14%) and is increased to 23% in cancer patients.  Fluconazole is rapidly distributed to the tissue, where it accumulates.  Tissues fall into 1 of 4 groups of increasing drug concn.: blood, bone and brain have the lowest concns., and spleen has the highest.  The vol. of distribution (Vd) remains stable at 46.3±7.9L and is considered to be an "invariant" parameter across species.  Fluconazole is poorly metabolized and is mainly eliminated unchanged in the urine.  The percentage of the dose recovered in the urine in 48 h is close to 60%.  Concns. in the urine are high and the half-life (t 1/2) is long (37.2±5.5h) in patients, mainly those with AIDS, which is not significantly different from the t 1/2 (31.4±4.7 h) in healthy individuals.  The mean total clearance is 1.073±0.473 L/h and renal clearance is 72% of the total clearance.  The pharmacokinetics of fluconazole are different in infants (larger Vd and shorter t 1/2) so that the fluconazole dosage must be adjusted accordingly.  Absorption is rapid and nearly complete, but i.v. administration is preferred for neonates.  The Cmax and AUC0→∞ vary linearly with the dose, and tmax is 1 to 2 h.  The mean Vd is 1.15±0.52 L/kg; it is largest in neonates and decreases in young adult to a value similar to that in adults.  The mean t 1/2 is very long (71±417 h) in premature and neonates and is correlated with age during the first weeks of life.  It stabilizes to around 21.2±5.1 h during the first years of life, shorter than in adults.  Renal clearance is 65±5% of total clearance.  T 1/2 increases with decreasing renal function in renal disease.  It is 124.6 to 98.1 h in patients with end-stage renal failure and the dose must be decreased by 50% or the interval between doses extended 2- to 3-fold.  In patients on CAPD the t 1/2 (79±7 h) is intermediate between those reported in patients with or without renal disease and a 150mg dose is needed in a single dialyzate bag every 48 h.  The t 1/2 does not change in hemodialysis purification mode and the dose given at the end of dialysis need not be changed.  Fluconazole increases the concns. of glipizide, glyburide, midazolam, nortriptyline, phenytoin, rifabutin, tacrolimus, tolbutamide and cyclosporin at doses over 200mg daily.  Cimetidine and rifampicin (rifampin) decrease the concns. of fluconazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-RWZ8YrWnXLVg90H21EOLACvtfcHk0lhXNSI9pqYkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltlShsbg%253D&md5=3f62b9b5ea79c4d8ca6b28ba26da215f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2165%2F00003088-199733010-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199733010-00005%26sid%3Dliteratum%253Aachs%26aulast%3DDebruyne%26aufirst%3DD.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520fluconazole%2520in%2520superficial%2520and%2520systemic%2520mycoses%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1997%26volume%3D33%26spage%3D52%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Summerfield, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osuna, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffo, A. D.</span><span> </span><span class="NLM_article-title">Toward an improved prediction of human <i>in vivo</i> brain penetration</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">–</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1518-1535&author=S.+G.+Summerfieldauthor=A.+J.+Lucasauthor=R.+A.+Porterauthor=P.+Jeffreyauthor=R.+N.+Gunnauthor=K.+R.+Readauthor=A.+J.+Stevensauthor=A.+C.+Metcalfauthor=M.+C.+Osunaauthor=P.+J.+Kilfordauthor=J.+Passchierauthor=A.+D.+Ruffo&title=Toward+an+improved+prediction+of+human+in+vivo+brain+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DLucas%26aufirst%3DA.%2BJ.%26aulast%3DPorter%26aufirst%3DR.%2BA.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRead%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DMetcalf%26aufirst%3DA.%2BC.%26aulast%3DOsuna%26aufirst%3DM.%2BC.%26aulast%3DKilford%26aufirst%3DP.%2BJ.%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DRuffo%26aufirst%3DA.%2BD.%26atitle%3DToward%2520an%2520improved%2520prediction%2520of%2520human%2520in%2520vivo%2520brain%2520penetration%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D1518%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lhXNSI9pqYkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summerfield, S. G.</span><span> </span><span class="NLM_article-title">Challenges for blood–brain barrier (BBB) screening</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=1135-1151&author=P.+Jeffreyauthor=S.+G.+Summerfield&title=Challenges+for+blood%E2%80%93brain+barrier+%28BBB%29+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26atitle%3DChallenges%2520for%2520blood%25E2%2580%2593brain%2520barrier%2520%2528BBB%2529%2520screening%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26spage%3D1135%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0lhXNSI9pqYkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Garberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindmark, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabondzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanimirovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeberg, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oesterberg, T.</span><span> </span><span class="NLM_article-title"><i>In-vitro</i> models for the blood brain barrier</span> <span class="citation_source-journal">Toxicol. In Vitro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=299-334&author=P.+Garbergauthor=M.+Ballauthor=N.+Borgauthor=R.+Cecchelliauthor=L.+Fenartauthor=R.+D.+Hurstauthor=T.+Lindmarkauthor=A.+Mabondzoauthor=J.+E.+Nilssonauthor=T.+J.+Raubauthor=D.+Stanimirovicauthor=T.+Terasakiauthor=J.+O.+Oebergauthor=T.+Oesterberg&title=In-vitro+models+for+the+blood+brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarberg%26aufirst%3DP.%26aulast%3DBall%26aufirst%3DM.%26aulast%3DBorg%26aufirst%3DN.%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DFenart%26aufirst%3DL.%26aulast%3DHurst%26aufirst%3DR.%2BD.%26aulast%3DLindmark%26aufirst%3DT.%26aulast%3DMabondzo%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DJ.%2BE.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DStanimirovic%26aufirst%3DD.%26aulast%3DTerasaki%26aufirst%3DT.%26aulast%3DOeberg%26aufirst%3DJ.%2BO.%26aulast%3DOesterberg%26aufirst%3DT.%26atitle%3DIn-vitro%2520models%2520for%2520the%2520blood%2520brain%2520barrier%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2005%26volume%3D19%26spage%3D299%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lgmwbHCweeydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chenauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lgmwbHCweeydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DChen%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Giacomini, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillgren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmaster, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Membrane transporters in drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=20190787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-236&author=K.+M.+Giacominiauthor=S.-M.+Huangauthor=D.+J.+Tweedieauthor=L.+Z.+Benetauthor=K.+L.+R.+Brouwerauthor=X.+Chuauthor=A.+Dahlinauthor=R.+Eversauthor=V.+Fischerauthor=K.+M.+Hillgrenauthor=K.+A.+Hoffmasterauthor=T.+Ishikawaauthor=D.+Kepplerauthor=R.+B.+Kimauthor=C.+A.+Leeauthor=M.+Niemiauthor=J.+W.+Polliauthor=Y.+Sugiyamaauthor=P.+W.+Swaanauthor=J.+A.+Wareauthor=S.+H.+Wrightauthor=S.+W.+Yeeauthor=M.+J.+Zamek-Gliszczynskiauthor=L.+Zhang&title=Membrane+transporters+in+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transporters in drug development</span></div><div class="casAuthors">Giacomini, Kathleen M.; Huang, Shiew-Mei; Tweedie, Donald J.; Benet, Leslie Z.; Brouwer, Kim L. R.; Chu, Xiaoyan; Dahlin, Amber; Evers, Raymond; Fischer, Volker; Hillgren, Kathleen M.; Hoffmaster, Keith A.; Ishikawa, Toshihisa; Keppler, Dietrich; Kim, Richard B.; Lee, Caroline A.; Niemi, Mikko; Polli, Joseph W.; Sugiyama, Yuicchi; Swaan, Peter W.; Ware, Joseph A.; Wright, Stephen H.; Wah Yee, Sook; Zamek-Gliszczynski, Maciej J.; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-236</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs.  This presents several key questions for drug development, including which transporters are clin. important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters.  In addn., what criteria should trigger follow-up clin. studies, and which clin. studies should be conducted if needed.  In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clin. studies on the currently recognized most important drug transporter interactions.  The recommendations are generally intended to support clin. development and filing of a new drug application.  Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clin. trial enrollment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metab. and excretion properties of the drug mol., and information required for drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiBIf0gk93W7Vg90H21EOLACvtfcHk0lgmwbHCweeydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D&md5=89d9ce746284c1814fb01cd9b9a72027</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnrd3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3028%26sid%3Dliteratum%253Aachs%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%2BR.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DDahlin%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHillgren%26aufirst%3DK.%2BM.%26aulast%3DHoffmaster%26aufirst%3DK.%2BA.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DNiemi%26aufirst%3DM.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DWare%26aufirst%3DJ.%2BA.%26aulast%3DWright%26aufirst%3DS.%2BH.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMembrane%2520transporters%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">The P-glycoprotein efflux pump: how does it transport drugs?</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2Fs002329900305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9425600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1997&pages=161-175&author=F.+J.+Sharom&title=The+P-glycoprotein+efflux+pump%3A+how+does+it+transport+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The P-glycoprotein efflux pump: how does it transport drugs?</span></div><div class="casAuthors">Sharom, F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-175</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">A review, with 118 refs.  P-glycoprotein (Pgp) is an atypical translocating ATPase, with low affinity for ATP and high constitutive ATPase activity.  Pgp also has an unusually broad specificity for hydrophobic substrates, including many chemotherapeutic drugs.  Transport studies in reconstituted systems indicate that drug transport requires ATP hydrolysis and is active, generating a drug concn. gradient.  Binding of drugs and ATP to Pgp induces conformational changes in the protein, and the drug binding site is conformationally coupled to nucleotide-binding domains.  Evidence accumulated to date suggest that the transporter interact directly with nonpolar substrate within the membrane environment, and may act as drug flippase, moving drug from the inner to outer leaflet of the bilayer.  Chemosensitizers that block the action of Pgp are proposed to act as alternative substrates, but their high rate of spontaneous flip-flop across the membrane results in futile cycling of the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpduTsyKNWuPrVg90H21EOLACvtfcHk0ljvueuJwDWRHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotV2isb4%253D&md5=52fb1ef5b0a0772eeda2ee1c474ae374</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs002329900305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900305%26sid%3Dliteratum%253Aachs%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520P-glycoprotein%2520efflux%2520pump%253A%2520how%2520does%2520it%2520transport%2520drugs%253F%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1997%26volume%3D160%26spage%3D161%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casals, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittman-Grauer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biedler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertino, J. R.</span><span> </span><span class="NLM_article-title">Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=695-698&author=C.+Cordon-Cardoauthor=J.+P.+O%E2%80%99Brienauthor=D.+Casalsauthor=L.+Rittman-Grauerauthor=J.+L.+Biedlerauthor=M.+R.+Melamedauthor=J.+R.+Bertino&title=Multidrug-resistance+gene+%28P-glycoprotein%29+is+expressed+by+endothelial+cells+at+blood-brain+barrier+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BP.%26aulast%3DCasals%26aufirst%3DD.%26aulast%3DRittman-Grauer%26aufirst%3DL.%26aulast%3DBiedler%26aufirst%3DJ.%2BL.%26aulast%3DMelamed%26aufirst%3DM.%2BR.%26aulast%3DBertino%26aufirst%3DJ.%2BR.%26atitle%3DMultidrug-resistance%2520gene%2520%2528P-glycoprotein%2529%2520is%2520expressed%2520by%2520endothelial%2520cells%2520at%2520blood-brain%2520barrier%2520sites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D695%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Doan, M. K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=M.+K.+M.+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein-mediated+efflux+differentiate+central+nervous+system+%28CNS%29+and+non-CNS+marketed+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Doan, Kelly M. Mahar; Humphreys, Joan E.; Webster, Lindsey O.; Wring, Stephen A.; Shampine, Larry J.; Serabjit-Singh, Cosette J.; Adkison, Kimberly K.; Polli, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-1037</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to det. whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochem. properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compds. for drug development.  Apparent permeability (Papp) and Pgp substrate profiles for 93 CNS and non-CNS drugs were detd. by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were pos. in the calcein-AM assay when tested at 100 μM.  The CNS drug set (of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (of 45, 42.2%).  Anal. of 18 physicochem. properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer pos. charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group, properties that enhance membrane permeability.  This study on a large, diverse set of marketed compds. clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochem. properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B → A/A → B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2qUc-kS0MC7Vg90H21EOLACvtfcHk0lhqfSkTu3F9pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlamtLg%253D&md5=bcac11a02278360d6d6ad48718f0d5be</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DM.%2BK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein-mediated%2520efflux%2520differentiate%2520central%2520nervous%2520system%2520%2528CNS%2529%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jodoin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagenais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghrabi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Drug transport to the brain: Key roles for the efflux pump P-glycoprotein in the blood–brain barrier</span> <span class="citation_source-journal">Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2002&pages=339-348&author=M.+Demeuleauthor=A.+Reginaauthor=J.+Jodoinauthor=A.+Laplanteauthor=C.+Dagenaisauthor=F.+Bertheletauthor=A.+Moghrabiauthor=R.+Beliveau&title=Drug+transport+to+the+brain%3A+Key+roles+for+the+efflux+pump+P-glycoprotein+in+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DJodoin%26aufirst%3DJ.%26aulast%3DLaplante%26aufirst%3DA.%26aulast%3DDagenais%26aufirst%3DC.%26aulast%3DBerthelet%26aufirst%3DF.%26aulast%3DMoghrabi%26aufirst%3DA.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DDrug%2520transport%2520to%2520the%2520brain%253A%2520Key%2520roles%2520for%2520the%2520efflux%2520pump%2520P-glycoprotein%2520in%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2002%26volume%3D38%26spage%3D339%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lhqfSkTu3F9pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Hsiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasongko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankoff, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Verapamil P-glycoprotein transport across the rat blood–brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.105.097931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16415090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=704-710&author=P.+Hsiaoauthor=L.+Sasongkoauthor=J.+M.+Linkauthor=D.+A.+Mankoffauthor=M.+Muziauthor=A.+C.+Collierauthor=J.+D.+Unadkat&title=Verapamil+P-glycoprotein+transport+across+the+rat+blood%E2%80%93brain+barrier%3A+cyclosporine%2C+a+concentration+inhibition+analysis%2C+and+comparison+with+human+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Verapamil p-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data</span></div><div class="casAuthors">Hsiao, Peng; Sasongko, Lucy; Link, Jeanne M.; Mankoff, David A.; Muzi, Mark; Collier, Ann C.; Unadkat, Jashvant D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">704-710</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">To predict the magnitude of P-glycoprotein (P-gp)-based drug interactions at the human blood-brain barrier (BBB), rodent studies are routinely conducted where P-gp is chem. inhibited.  For such studies to be predictive of interactions at the human BBB, the plasma concn. of the P-gp inhibitor must be comparable with that obsd. in the clinic.  Therefore, we detd. the in vivo EC50 of P-gp inhibition at the rat BBB using verapamil as a model P-gp substrate and cyclosporine A (CsA) as the model P-gp inhibitor.  Under isoflurane anesthesia, male Sprague-Dawley rats were administered i.v. CsA to achieve pseudo steady-state CsA blood concns. ranging from 0 to ∼12 μM.  Then, an i.v. tracer dose of [3H]verapamil was administered, and 20 min after verapamil administration, the animals were sacrificed for detn. of blood, plasma, and brain 3H radioactivity by scintillation counting.  The percentage increase in the brain/blood 3H radioactivity (relative to 0 μM CsA) was described by the Hill equation with Emax, 1290%; EC50, 7.2 μM; and γ, 3.8.  Previously, using [11C]verapamil, we have shown that the human brain/blood 11C radioactivity was increased by 79% at 2.8 μM CsA blood concn.  At an equiv. CsA blood concn., the rat brain/blood 3H radioactivity was increased by a remarkably similar extent of 75%.  This is the first time that an in vivo CsA EC50 of P-gp inhibition at the rat BBB has been detd. and the magnitude of such inhibition was compared between the rat and the human BBB at the same blood CsA concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZB-ViPTeAabVg90H21EOLACvtfcHk0lhqfSkTu3F9pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamurg%253D&md5=a61944c26815e07bdbd08a5bd94927ed</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097931%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DP.%26aulast%3DSasongko%26aufirst%3DL.%26aulast%3DLink%26aufirst%3DJ.%2BM.%26aulast%3DMankoff%26aufirst%3DD.%2BA.%26aulast%3DMuzi%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DVerapamil%2520P-glycoprotein%2520transport%2520across%2520the%2520rat%2520blood%25E2%2580%2593brain%2520barrier%253A%2520cyclosporine%252C%2520a%2520concentration%2520inhibition%2520analysis%252C%2520and%2520comparison%2520with%2520human%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D704%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Aller, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittaboina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbatsch, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span> </span><span class="NLM_article-title">Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">1718</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1126%2Fscience.1168750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19325113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1718-1722&author=S.+G.+Allerauthor=J.+Yuauthor=A.+Wardauthor=Y.+Wengauthor=S.+Chittaboinaauthor=R.+Zhuoauthor=P.+M.+Harrellauthor=Y.+T.+Trinhauthor=Q.+Zhangauthor=I.+L.+Urbatschauthor=G.+Chang&title=Structure+of+P-glycoprotein+reveals+a+molecular+basis+for+poly-specific+drug+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span></div><div class="casAuthors">Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5922</span>),
    <span class="NLM_cas:pages">1718-1722</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chem. unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers.  Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors.  The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of ~6000 angstroms cubed with a 30 angstrom sepn. of the two nucleotide-binding domains.  Two addnl. P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and arom. interactions.  Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry.  The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2EUmR-iQyaLVg90H21EOLACvtfcHk0lgSQ6vn2ysbMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D&md5=66c7398b0257e6c05161a1afbecdafb1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168750%26sid%3Dliteratum%253Aachs%26aulast%3DAller%26aufirst%3DS.%2BG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChittaboina%26aufirst%3DS.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DP.%2BM.%26aulast%3DTrinh%26aufirst%3DY.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DChang%26aufirst%3DG.%26atitle%3DStructure%2520of%2520P-glycoprotein%2520reveals%2520a%2520molecular%2520basis%2520for%2520poly-specific%2520drug%2520binding%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D1718%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Desai, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, M.-J.</span><span> </span><span class="NLM_article-title">How hydrogen bonds impact P-glycoprotein transport and permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6540</span><span class="NLM_x">–</span> <span class="NLM_lpage">6548</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.bmcl.2012.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=23006604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6540-6548&author=P.+V.+Desaiauthor=T.+J.+Raubauthor=M.-J.+Blanco&title=How+hydrogen+bonds+impact+P-glycoprotein+transport+and+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">How hydrogen bonds impact P-glycoprotein transport and permeability</span></div><div class="casAuthors">Desai, Prashant V.; Raub, Thomas J.; Blanco, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6540-6548</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The requirement to cross a biol. membrane can be a complex process esp. if multidrug transporters such as P-gp must be considered.  Drug partitioning into the lipid membrane and efflux by P-gp are tightly coupled processes wherein H-bonding interactions play a key role.  All H-bond donors and acceptors are not equal in terms of the strength of the H-bonds that they form, hence it is important to consider their relative strength.  Using various examples from literature, we illustrate the benefits of considering the relative strengths of individual H-bonds and introducing intramol. H-bonds to increase membrane permeability and/or decrease P-gp efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxB3oN1ILz7LVg90H21EOLACvtfcHk0lgSQ6vn2ysbMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSjsr%252FO&md5=a27f286d4349eec6f76b745b19ccf84f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DP.%2BV.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DBlanco%26aufirst%3DM.-J.%26atitle%3DHow%2520hydrogen%2520bonds%2520impact%2520P-glycoprotein%2520transport%2520and%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6540%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Raub, T. J.; Lutzke, B. S.; Andrus, P. K.; Sawada, G. A.; Staton, B. A.</span><span> </span><span class="NLM_article-title">Early preclinical evaluation of brain exposure in support of hit identification and lead optimization</span>. In  <span class="citation_source-book">Optimizing the ‘Drug-Like’ Properties of Leads in Drug Discovery</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Borchardt, R. T.; Kerns, E. H.; Hageman, M. J.; Thakker, D. R.; Stevens, J. L.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1007%2F978-0-387-44961-6_16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=355-410&author=T.+J.+Raub&author=B.+S.+Lutzke&author=P.+K.+Andrus&author=G.+A.+Sawada&author=B.+A.+Statonauthor=R.+T.+Borchardt&author=E.+H.+Kerns&author=M.+J.+Hageman&author=D.+R.+Thakker&author=J.+L.+Stevens&title=Optimizing+the+%E2%80%98Drug-Like%E2%80%99+Properties+of+Leads+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-44961-6_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-44961-6_16%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DEarly%2520preclinical%2520evaluation%2520of%2520brain%2520exposure%2520in%2520support%2520of%2520hit%2520identification%2520and%2520lead%2520optimization%26btitle%3DOptimizing%2520the%2520%25E2%2580%2598Drug-Like%25E2%2580%2599%2520Properties%2520of%2520Leads%2520in%2520Drug%2520Discovery%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26pub%3DSpringer%26date%3D2006%26spage%3D355%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Doyle, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abruzzo, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span> </span><span class="NLM_article-title">A multidrug resistance transporter from human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15665</span><span class="NLM_x">–</span> <span class="NLM_lpage">15670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+multidrug+resistance+transporter+from+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0lhJNvTDTnk_Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520multidrug%2520resistance%2520transporter%2520from%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Eisenblatter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galla, H. J.</span><span> </span><span class="NLM_article-title">A new multidrug resistance protein at the blood-brain barrier</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2002&pages=1273-1278&author=T.+Eisenblatterauthor=H.+J.+Galla&title=A+new+multidrug+resistance+protein+at+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisenblatter%26aufirst%3DT.%26aulast%3DGalla%26aufirst%3DH.%2BJ.%26atitle%3DA%2520new%2520multidrug%2520resistance%2520protein%2520at%2520the%2520blood-brain%2520barrier%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D293%26spage%3D1273%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, W. F.</span><span> </span><span class="NLM_article-title">P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fjpet.109.154781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19491323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyitL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=956-63&author=Y.+Chenauthor=S.+Agarwalauthor=N.+M.+Shaikauthor=C.+Chenauthor=Z.+Yangauthor=W.+F.+Elmquist&title=P-glycoprotein+and+breast+cancer+resistance+protein+influence+brain+distribution+of+dasatinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib</span></div><div class="casAuthors">Chen, Ying; Agarwal, Sagar; Shaik, Naveed M.; Chen, Cliff; Yang, Zheng; Elmquist, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">956-963</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The novel tyrosine kinase inhibitor dasatinib (Sprycel; BMS-354825) is approved for use in imatinib (Gleevec; STI 571)-resistant or -intolerant chronic myelogenous leukemia and may be useful for other tumors in the central nervous system (CNS).  The objective of this study was to investigate the role of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in modulating the CNS penetration of dasatinib.  Results from the in vitro studies indicate that cellular delivery of dasatinib is significantly limited by active efflux due to both P-gp and BCRP.  Permeability studies indicated greater permeability in the basolateral-to-apical direction than in the apical-to-basolateral direction due to active efflux by P-gp or BCRP.  Selective inhibitors of P-gp and BCRP, such as (R)-4-((1aR,6R,10bS)-1,2-difluoro-1,1a,6,10b-tetrahydrodibenzo-(a,e)cyclopropa(c) cycloheptan-6-yl)-α-((5-quinoloyloxy)methyl)-1-piperazineethanol, trihydrochloride (zosuquidar; LY335979) and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12α-octahydropyrazino1',2':1,6pryrido3,4-bindol-3-yl)-propionic acid tert-Bu ester (Ko143), were able to restore the intracellular accumulation and abolish the directionality in net flux of dasatinib.  In vivo brain distribution studies showed that the CNS distribution of dasatinib is limited, with the brain-to-plasma concn. ratios less than 0.12 in wild-type mice, which increased approx. 8-fold in Mdr1a/b(-/-) Bcrp1(-/-) mice.  Dasatinib brain distribution was significantly increased in Mdr1a/b(-/-) mice and when wild-type mice were pretreated with LY335979.  Simultaneous inhibition of P-gp and BCRP by elacridar [N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide] (GF120918) resulted in a 5-fold increase in brain concn.  These in vitro and in vivo studies demonstrate that dasatinib is a substrate for the important efflux transporters p-glycoprotein and BCRP.  These transport systems play a significant role in limiting the CNS delivery of dasatinib and may have direct implications in the treatment of primary and metastatic brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7uWzd3Qm6q7Vg90H21EOLACvtfcHk0lhJNvTDTnk_Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyitL3F&md5=2b43bf0468e6fea3a5aae1f84b3fb69d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.154781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.154781%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DShaik%26aufirst%3DN.%2BM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DP-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520influence%2520brain%2520distribution%2520of%2520dasatinib%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D956%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Tang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lankheet, N. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrand, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijnen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1002%2Fijc.26000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=21351087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOmsrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2012&pages=223-233&author=S.+C.+Tangauthor=J.+C.+Lagasauthor=N.+A.+G.+Lankheetauthor=B.+Pollerauthor=M.+J.+Hillebrandauthor=H.+Rosingauthor=J.+H.+Beijnenauthor=A.+H.+Schinkel&title=Brain+accumulation+of+sunitinib+is+restricted+by+P-glycoprotein+%28ABCB1%29+and+breast+cancer+resistance+protein+%28ABCG2%29+and+can+be+enhanced+by+oral+elacridar+and+sunitinib+coadministration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration</span></div><div class="casAuthors">Tang, Seng Chuan; Lagas, Jurjen S.; Lankheet, Nienke A. G.; Poller, Birk; Hillebrand, Michel J.; Rosing, Hilde; Beijnen, Jos H.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-233</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Sunitinib is an orally active, multitargeted tyrosine kinase inhibitor which has been used for the treatment of metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors.  We aimed to investigate the in vivo roles of the ATP-binding cassette drug efflux transporters ABCB1 and ABCG2 in plasma pharmacokinetics and brain accumulation of oral sunitinib, and the feasibility of improving sunitinib kinetics using oral coadministration of the dual ABCB1/ABCG2 inhibitor elacridar.  We used in vitro transport assays and Abcb1a/1b-/-, Abcg2-/- and Abcb1a/1b/Abcg2-/- mice to study the roles of ABCB1 and ABCG2 in sunitinib disposition.  In vitro, sunitinib was a good substrate of murine (mu)ABCG2 and a moderate substrate of human (hu)ABCB1 and huABCG2.  In vivo, the systemic exposure of sunitinib after oral dosing (10 mg kg-1) was unchanged when muABCB1 and/or muABCG2 were absent.  Brain accumulation of sunitinib was markedly (23-fold) increased in Abcb1a/b/Abcg2-/- mice, but only slightly (2.3-fold) in Abcb1a/b-/- mice, and not in Abcg2-/- mice.  Importantly, a clin. realistic coadministration of oral elacridar and oral sunitinib to wild-type mice resulted in markedly increased sunitinib brain accumulation, equaling levels in Abcb1a/1b/Abcg2-/- mice.  This indicates complete inhibition of the blood-brain barrier (BBB) transporters.  High-dose i.v. sunitinib could sat. BBB muABCG2, but not muABCB1A, illustrating a dose-dependent relative impact of the BBB transporters.  Brain accumulation of sunitinib is effectively restricted by both muABCB1 and muABCG2 activity.  Complete inhibition of both transporters, leading to markedly increased brain accumulation of sunitinib, is feasible and safe with a clin. realistic oral elacridar/sunitinib coadministration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9Na4B5yH0LVg90H21EOLACvtfcHk0lhJNvTDTnk_Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOmsrjP&md5=47fee810fd84296c9b1598fd8e80acf7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fijc.26000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.26000%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%2BC.%26aulast%3DLagas%26aufirst%3DJ.%2BC.%26aulast%3DLankheet%26aufirst%3DN.%2BA.%2BG.%26aulast%3DPoller%26aufirst%3DB.%26aulast%3DHillebrand%26aufirst%3DM.%2BJ.%26aulast%3DRosing%26aufirst%3DH.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DBrain%2520accumulation%2520of%2520sunitinib%2520is%2520restricted%2520by%2520P-glycoprotein%2520%2528ABCB1%2529%2520and%2520breast%2520cancer%2520resistance%2520protein%2520%2528ABCG2%2529%2520and%2520can%2520be%2520enhanced%2520by%2520oral%2520elacridar%2520and%2520sunitinib%2520coadministration%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D130%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span> </span><span class="NLM_article-title">Breast cancer resistance protein interacts with various compounds <i>in vitro</i>, but plays a minor role in substrate efflux at the blood–brain barrier</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1251-1258&author=R.+Zhaoauthor=T.+J.+Raubauthor=G.+A.+Sawadaauthor=S.+C.+Kasperauthor=J.+A.+Baconauthor=A.+S.+Bridgesauthor=G.+M.+Pollack&title=Breast+cancer+resistance+protein+interacts+with+various+compounds+in+vitro%2C+but+plays+a+minor+role+in+substrate+efflux+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DSawada%26aufirst%3DG.%2BA.%26aulast%3DKasper%26aufirst%3DS.%2BC.%26aulast%3DBacon%26aufirst%3DJ.%2BA.%26aulast%3DBridges%26aufirst%3DA.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DBreast%2520cancer%2520resistance%2520protein%2520interacts%2520with%2520various%2520compounds%2520in%2520vitro%252C%2520but%2520plays%2520a%2520minor%2520role%2520in%2520substrate%2520efflux%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1251%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Giri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakoshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, W. F.</span><span> </span><span class="NLM_article-title">Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1476</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=1476-1484&author=N.+Giriauthor=N.+Shaikauthor=G.+Panauthor=T.+Terasakiauthor=C.+Mukaiauthor=S.+Kitagakiauthor=N.+Miyakoshiauthor=W.+F.+Elmquist&title=Investigation+of+the+role+of+breast+cancer+resistance+protein+%28Bcrp%2FAbcg2%29+on+pharmacokinetics+and+central+nervous+system+penetration+of+abacavir+and+zidovudine+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiri%26aufirst%3DN.%26aulast%3DShaik%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DTerasaki%26aufirst%3DT.%26aulast%3DMukai%26aufirst%3DC.%26aulast%3DKitagaki%26aufirst%3DS.%26aulast%3DMiyakoshi%26aufirst%3DN.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DInvestigation%2520of%2520the%2520role%2520of%2520breast%2520cancer%2520resistance%2520protein%2520%2528Bcrp%252FAbcg2%2529%2520on%2520pharmacokinetics%2520and%2520central%2520nervous%2520system%2520penetration%2520of%2520abacavir%2520and%2520zidovudine%2520in%2520the%2520mouse%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D1476%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Ball, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzom, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decleves, X.</span><span> </span><span class="NLM_article-title">Physiologically based pharmacokinetic modelling of drug penetration across the blood–brain barrier—Towards a mechanistic IVIVE-based approach</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=913-932&author=K.+Ballauthor=F.+Bouzomauthor=J.-M.+Scherrmannauthor=B.+Waltherauthor=X.+Decleves&title=Physiologically+based+pharmacokinetic+modelling+of+drug+penetration+across+the+blood%E2%80%93brain+barrier%E2%80%94Towards+a+mechanistic+IVIVE-based+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBall%26aufirst%3DK.%26aulast%3DBouzom%26aufirst%3DF.%26aulast%3DScherrmann%26aufirst%3DJ.-M.%26aulast%3DWalther%26aufirst%3DB.%26aulast%3DDecleves%26aufirst%3DX.%26atitle%3DPhysiologically%2520based%2520pharmacokinetic%2520modelling%2520of%2520drug%2520penetration%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%25E2%2580%2594Towards%2520a%2520mechanistic%2520IVIVE-based%2520approach%26jtitle%3DAAPS%2520J.%26date%3D2013%26volume%3D15%26spage%3D913%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Ball, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzom, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decleves, X.</span><span> </span><span class="NLM_article-title">Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an <i>in vitro</i>–<i>in vivo</i> scaling methodology for the blood–brain barrier permeability of two transporter substrates, morphine and oxycodone</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">4277</span><span class="NLM_x">–</span> <span class="NLM_lpage">4292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=4277-4292&author=K.+Ballauthor=F.+Bouzomauthor=J.-M.+Scherrmannauthor=B.+Waltherauthor=X.+Decleves&title=Development+of+a+physiologically+based+pharmacokinetic+model+for+the+rat+central+nervous+system+and+determination+of+an+in+vitro%E2%80%93in+vivo+scaling+methodology+for+the+blood%E2%80%93brain+barrier+permeability+of+two+transporter+substrates%2C+morphine+and+oxycodone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBall%26aufirst%3DK.%26aulast%3DBouzom%26aufirst%3DF.%26aulast%3DScherrmann%26aufirst%3DJ.-M.%26aulast%3DWalther%26aufirst%3DB.%26aulast%3DDecleves%26aufirst%3DX.%26atitle%3DDevelopment%2520of%2520a%2520physiologically%2520based%2520pharmacokinetic%2520model%2520for%2520the%2520rat%2520central%2520nervous%2520system%2520and%2520determination%2520of%2520an%2520in%2520vitro%25E2%2580%2593in%2520vivo%2520scaling%2520methodology%2520for%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%2520of%2520two%2520transporter%2520substrates%252C%2520morphine%2520and%2520oxycodone%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D4277%26epage%3D4292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Eyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Drug interactions at the blood–brain barrier: fact or fantasy?</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.pharmthera.2009.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19393264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ahsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=80-104&author=S.+Eyalauthor=P.+Hsiaoauthor=J.+D.+Unadkat&title=Drug+interactions+at+the+blood%E2%80%93brain+barrier%3A+fact+or+fantasy%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interactions at the blood-brain barrier: Fact or fantasy?</span></div><div class="casAuthors">Eyal, Sara; Hsiao, Peng; Unadkat, Jashvant D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-104</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  There is considerable interest in the therapeutic and adverse outcomes of drug interactions at the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB).  These include altered efficacy of drugs used in the treatment of CNS disorders, such as AIDS dementia and malignant tumors, and enhanced neurotoxicity of drugs that normally penetrate poorly into the brain.  BBB- and BCSFB-mediated interactions are possible because these interfaces are not only passive anatomical barriers, but are also dynamic in that they express a variety of influx and efflux transporters and drug metabolizing enzymes.  Based on studies in rodents, it has been widely postulated that efflux transporters play an important role at the human BBB in terms of drug delivery.  Furthermore, it is assumed that chem. inhibition of transporters or their genetic ablation in rodents is predictive of the magnitude of interaction to be expected at the human BBB.  However, studies in humans challenge this well-established paradigm and claim that such drug interactions will be lesser in magnitude but yet may be clin. significant.  This review focuses on current known mechanisms of drug interactions at the blood-brain and blood-CSF barriers and the potential impact of such interactions in humans.  We also explore whether such drug interactions can be predicted from preclin. studies.  Defining the mechanisms and the impact of drug-drug interactions at the BBB is important for improving efficacy of drugs used in the treatment of CNS disorders while minimizing their toxicity as well as minimizing neurotoxicity of non-CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotLboooAs_BrVg90H21EOLACvtfcHk0lhrbNvMXUnHWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ahsb0%253D&md5=29866ee9b51e99a5fd1833ef680ea7d8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2009.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2009.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DEyal%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DP.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DDrug%2520interactions%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%253A%2520fact%2520or%2520fantasy%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2009%26volume%3D123%26spage%3D80%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdet, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span> </span><span class="NLM_article-title">Why clinical modulation of efflux transport at the human blood–brain barrier is unlikely: the ITC evidence-based position</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fclpt.2013.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=23588303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVOrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=80-94&author=J.+C.+Kalvassauthor=J.+W.+Polliauthor=D.+L.+Bourdetauthor=B.+Fengauthor=S.-M.+Huangauthor=X.+Liuauthor=Q.+R.+Smithauthor=L.+K.+Zhangauthor=M.+J.+Zamek-Gliszczynski&title=Why+clinical+modulation+of+efflux+transport+at+the+human+blood%E2%80%93brain+barrier+is+unlikely%3A+the+ITC+evidence-based+position"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Why Clinical Modulation of Efflux Transport at the Human Blood-Brain Barrier Is Unlikely: The ITC Evidence-Based Position</span></div><div class="casAuthors">Kalvass, J. C.; Polli, J. W.; Bourdet, D. L.; Feng, B.; Huang, S.-M.; Liu, X.; Smith, Q. R.; Zhang, L. K.; Zamek-Gliszczynski, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-94</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Drug interactions due to efflux transport inhibition at the blood-brain barrier (BBB) have been receiving increasing scrutiny because of the theor. possibility of adverse central nervous system (CNS) effects identified in preclin. studies.  In this review, evidence from pharmacokinetic, pharmacodynamic, imaging, pharmacogenetic, and pharmacovigilance studies, along with drug safety reports, is presented supporting a low probability of modulating transporters at the human BBB by currently marketed drugs.  Clin. Pharmacol. & Therapeutics (2013); 94 1, 80-94. doi:10.1038/clpt.2013.34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfxdzZMTG6_7Vg90H21EOLACvtfcHk0lgtuMZbwtWlng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVOrtbY%253D&md5=c106f689e1c83f58eb6d0dbc527cf0fa</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2013.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2013.34%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBourdet%26aufirst%3DD.%2BL.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26aulast%3DZhang%26aufirst%3DL.%2BK.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26atitle%3DWhy%2520clinical%2520modulation%2520of%2520efflux%2520transport%2520at%2520the%2520human%2520blood%25E2%2580%2593brain%2520barrier%2520is%2520unlikely%253A%2520the%2520ITC%2520evidence-based%2520position%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2013%26volume%3D94%26spage%3D80%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deemter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voordouw, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spits, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlmans, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fibbe, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span> </span><span class="NLM_article-title">Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">4028</span><span class="NLM_x">–</span> <span class="NLM_lpage">4033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1073%2Fpnas.94.8.4028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9108099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXis1akurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4028-4033&author=A.+H.+Schinkelauthor=U.+Mayerauthor=E.+Wagenaarauthor=C.+A.+A.+M.+Molauthor=L.+van+Deemterauthor=J.+J.+M.+Smitauthor=M.+A.+van+der+Valkauthor=A.+C.+Voordouwauthor=H.+Spitsauthor=O.+van+Tellingenauthor=J.+M.+Zijlmansauthor=W.+E.+Fibbeauthor=P.+Borst&title=Normal+viability+and+altered+pharmacokinetics+in+mice+lacking+mdr1-type+%28drug-transporting%29+P-glycoproteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins</span></div><div class="casAuthors">Schinkel, Alfred H.; Mayer, Ulrich; Wagenaar, Els; Mol, Carla A. A. M.; van Deemter, Liesbeth; Smit, Jaap J. M.; van der Valk, Martin A.; Voordouw, Arie C.; Spits, Hergen; van Tellingen, Olaf; Zijlmans, J. Mark J. M.; Fibbe, Willem E.; Borst, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4028-4033</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mdr1-type P-glycoproteins (P-gps) confer multidrug resistance to cancer cells by active extrusion of a wide range of drugs from the cell.  To study their physiol. roles, the authors have generated mice genetically deficient in the mdr1b gene [mdr1b (-/-) mice] and in both the mdr1a and mdr1b genes [mdr1a/1b (-/-) mice].  In spite of the host of functions speculatively attributed to the mdr1-type P-gps, the authors found no physiol. abnormalities in either strain.  Viability, fertility, and a range of histol., hematol., serum-chem., and immunol. parameters were not abnormal in mdr1a/1b (-/-) mice.  The high level of mdr1b P-gp normally present in the pregnant uterus did not protect fetuses from a drug (digoxin) in the bloodstream of the mother, although the protein did reduce drug accumulation in the mother, although the protein did reduce drug accumulation in the adrenal gland and ovaries.  Pharmacol., mdr1a/1b (-/-) mice behaved similarly to the previously analyzed mdr1a (-/-) mice, displaying, for instance, increased brain penetration and reduced elimination of digoxin.  However, both mdr1a and mdr1b P-gps contributed to the extrusion of rhodamine from hematopoietic progenitor cells, suggesting a potential role for the endogenous mdr1-type P-gps in protection of bone marrow against cytotoxic anticancer drugs.  This, and the normal viability of mdr1a/1b (-/-) mice, has implications for the use of P-gp-blocking agents in cancer and other chemotherapy.  Mdr1a/1b (-/-) mice should provide a useful model system to further test the pharmacol. roles of the drug-transporting P-gps and to analyze the specificity and effectivity of P-gp-blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtwe5hHz5m7Vg90H21EOLACvtfcHk0lgtuMZbwtWlng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1akurk%253D&md5=37f9d88768c8eab633618eabb7f19eee</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.8.4028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.8.4028%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DMayer%26aufirst%3DU.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DMol%26aufirst%3DC.%2BA.%2BA.%2BM.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DSmit%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DM.%2BA.%26aulast%3DVoordouw%26aufirst%3DA.%2BC.%26aulast%3DSpits%26aufirst%3DH.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DZijlmans%26aufirst%3DJ.%2BM.%26aulast%3DFibbe%26aufirst%3DW.%2BE.%26aulast%3DBorst%26aufirst%3DP.%26atitle%3DNormal%2520viability%2520and%2520altered%2520pharmacokinetics%2520in%2520mice%2520lacking%2520mdr1-type%2520%2528drug-transporting%2529%2520P-glycoproteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D4028%26epage%3D4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span> </span><span class="NLM_article-title">Development of a P-glycoprotein knockout model in rodents to define species differences in its functional effect at the blood–brain barrier</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1944</span><span class="NLM_x">–</span> <span class="NLM_lpage">1953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1944-1953&author=L.+Cutlerauthor=C.+Howesauthor=N.+J.+Deeksauthor=T.+L.+Buckauthor=P.+Jeffrey&title=Development+of+a+P-glycoprotein+knockout+model+in+rodents+to+define+species+differences+in+its+functional+effect+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DBuck%26aufirst%3DT.%2BL.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520a%2520P-glycoprotein%2520knockout%2520model%2520in%2520rodents%2520to%2520define%2520species%2520differences%2520in%2520its%2520functional%2520effect%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D1944%26epage%3D1953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Syvanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornum, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langstrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Species differences in blood–brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=635-643&author=S.+Syvanenauthor=O.+Lindheauthor=M.+Palnerauthor=B.+R.+Kornumauthor=O.+Rahmanauthor=B.+Langstromauthor=G.+M.+Knudsenauthor=M.+Hammarlund-Udenaes&title=Species+differences+in+blood%E2%80%93brain+barrier+transport+of+three+positron+emission+tomography+radioligands+with+emphasis+on+P-glycoprotein+transport"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSyvanen%26aufirst%3DS.%26aulast%3DLindhe%26aufirst%3DO.%26aulast%3DPalner%26aufirst%3DM.%26aulast%3DKornum%26aufirst%3DB.%2BR.%26aulast%3DRahman%26aufirst%3DO.%26aulast%3DLangstrom%26aufirst%3DB.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DSpecies%2520differences%2520in%2520blood%25E2%2580%2593brain%2520barrier%2520transport%2520of%2520three%2520positron%2520emission%2520tomography%2520radioligands%2520with%2520emphasis%2520on%2520P-glycoprotein%2520transport%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D635%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Desai, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span> </span><span class="NLM_article-title">Integration of <i>in silico</i> and <i>in vitro</i> tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1249</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp300555n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1249-1261&author=P.+V.+Desaiauthor=G.+A.+Sawadaauthor=I.+A.+Watsonauthor=T.+J.+Raub&title=Integration+of+in+silico+and+in+vitro+tools+for+scaffold+optimization+during+drug+discovery%3A+predicting+P-glycoprotein+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Integration of in Silico and in Vitro Tools for Scaffold Optimization during Drug Discovery: Predicting P-Glycoprotein Efflux</span></div><div class="casAuthors">Desai, Prashant V.; Sawada, Geri A.; Watson, Ian A.; Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1249-1261</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In silico tools are regularly utilized for designing and prioritizing compds. to address challenges related to drug metab. and pharmacokinetics (DMPK) during the process of drug discovery.  P-Glycoprotein (P-gp) is a member of the ATP-binding cassette (ABC) transporters with broad substrate specificity that plays a significant role in absorption and distribution of drugs that are P-gp substrates.  As a result, screening for P-gp transport has now become routine in the drug discovery process.  Typically, bidirectional permeability assays are employed to assess in vitro P-gp efflux.  In this article, we use P-gp as an example to illustrate a well-validated methodol. to effectively integrate in silico and in vitro tools to identify and resolve key barriers during the early stages of drug discovery.  A detailed account of development and application of in silico tools such as simple guidelines based on physicochem. properties and more complex quant. structure-activity relationship (QSAR) models is provided.  The tools were developed based on structurally diverse data for more than 2000 compds. generated using a robust P-gp substrate assay over the past several years.  Anal. of physicochem. properties revealed a significantly lower proportion (<10%) of P-gp substrates among the compds. with topol. polar surface area (TPSA) <60 Å2 and the most basic cpKa <8.  In contrast, this proportion of substrates was greater than 75% for compds. with TPSA >60 Å2 and the most basic cpKa >8.  Among the various QSAR models evaluated to predict P-gp efflux, the Bagging model provided optimum prediction performance for prospective validation based on chronol. test sets.  Four sequential versions of the model were built with increasing nos. of compds. to train the models as new data became available.  Except for the first version with the smallest training set, the QSAR models exhibited robust prediction profiles with pos. prediction values (PPV) and neg. prediction values (NPV) exceeding 80%.  The QSAR model demonstrated better concordance with the manual P-gp substrate assay than an automated P-gp substrate screen.  The in silico and the in vitro tools have been effectively integrated during early stages of drug discovery to resolve P-gp-related challenges exemplified by several case studies.  Key learning based on our experience with P-gp can be widely applicable across other DMPK-related challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Q5Y8HssxH7Vg90H21EOLACvtfcHk0lgAgDmzd5_nkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aju7o%253D&md5=3bd5239b80270c0f4ed85dffb86704ed</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fmp300555n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300555n%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DP.%2BV.%26aulast%3DSawada%26aufirst%3DG.%2BA.%26aulast%3DWatson%26aufirst%3DI.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DIntegration%2520of%2520in%2520silico%2520and%2520in%2520vitro%2520tools%2520for%2520scaffold%2520optimization%2520during%2520drug%2520discovery%253A%2520predicting%2520P-glycoprotein%2520efflux%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1249%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Didziapetris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Japertas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrauskas, A.</span><span> </span><span class="NLM_article-title">Classification analysis of P-glycoprotein substrate specificity</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1080%2F10611860310001648248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15203928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=391-406&author=R.+Didziapetrisauthor=P.+Japertasauthor=A.+Avdeefauthor=A.+Petrauskas&title=Classification+analysis+of+P-glycoprotein+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Classification Analysis of P-Glycoprotein Substrate Specificity</span></div><div class="casAuthors">Didziapetris, Remigijus; Japertas, Pranas; Avdeef, Alex; Petrauskas, Alanas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">391-406</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Prediction of P-glycoprotein substrate specificity (SPGP) can be viewed as a constituent part of a compd.'s "pharmaceutical profiling" in drug design.  This task is difficult to achieve due to several factors that raised many contradictory opinions: (i) the disparity between the SPGP values obtained in different assays, (ii) the confusion between Pgp substrates and inhibitors, (iii) the confusion between lipophilicity and amphiphilicity of Pgp substrates, and (iv) the dilemma of describing class-specific relationships when Pgp has no binding sites of high ligand specificity.  In this work, the authors compiled SPGP data for 1000 compds.  All data were represented in a binary format, assigning SPGP = 1 for substrates and SPGP = 0 for nonsubstrates.  Each value was ranked according to the reliability of exptl. assay.  Two data sets were considered.  Set 1 included 220 compds. with SPGP from polarized transport across MDR1 transfected cell monolayers.  Set 2 included the entire list of 1000 compds., with SPGP values of generally lower reliability.  Both sets were analyzed using a stepwise classification structure-activity relationship (C-SAR) method, leading to derivation of simple rules for crude estn. of SPGP values.  The obtained rules are based on the following factors: (i) compd.'s size expressed through molar wt. or vol., (ii) H-accepting given by the Abraham's β (that can be crudely approximated by the sum of O and N atoms), and (iii) ionization given by the acid and base pKa values.  Very roughly, SPGP can be estd. by the "rule of fours".  Compds. with (N + O) ≥ 8, MW > 400 and acid pKa > 4 are likely to be Pgp substrates, whereas compds. with (N+O) ≤ 4, MW < 400 and base pKa < 8 are likely to be nonsubstrates.  The obtained results support the view that Pgp functioning can be compared to a complex "mini-pharmacokinetic" system with fuzzy specificity.  This system can be described by a probabilistic version of Abraham's solvation equation, suggesting a certain similarity between Pgp transport and chromatog. retention.  The chromatog. model does not work in the case of "marginal" compds. with properties close to the "global" physicochem. cut-offs.  In the latter case various class-specific rules must be considered.  These can be assocd. with the "amphiphilicity" and "biol. similarity" of compds.  The definition of class-specific effects entails construction of the knowledge base that can be very useful in ADME profiling of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsvKJmruZ7RLVg90H21EOLACvtfcHk0lgAgDmzd5_nkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D&md5=5b7ea95eb2d9faded5645481c1330f03</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1080%2F10611860310001648248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860310001648248%26sid%3Dliteratum%253Aachs%26aulast%3DDidziapetris%26aufirst%3DR.%26aulast%3DJapertas%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DPetrauskas%26aufirst%3DA.%26atitle%3DClassification%2520analysis%2520of%2520P-glycoprotein%2520substrate%2520specificity%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2003%26volume%3D11%26spage%3D391%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Del Amo, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yliperttula, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.ejps.2008.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18656534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyltrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=161-174&author=E.+M.+Del+Amoauthor=A.+Urttiauthor=M.+Yliperttula&title=Pharmacokinetic+role+of+L-type+amino+acid+transporters+LAT1+and+LAT2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2</span></div><div class="casAuthors">del Amo, Eva M.; Urtti, Arto; Yliperttula, Marjo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  LAT1 and LAT2 are heterodimeric large amino acid transporters that are expressed in various tissues, including the intestinal wall, blood-brain barrier, and kidney.  These transporters consist of membrane spanning light chain and heavy chain, and they act as 1:1 exchangers in concert with other amino acid transporters.  Only a few drugs (less than 10) are substrates of LAT1 and LAT2, including -DOPA, alpha-methyldopa, melphalan, and gabapentin.  The mechanisms and substrates have been mostly elucidated using mammalian cells and Xenopus oocytes.  The in vivo relevance of LAT1 and LAT2 in pharmacokinetics is obscure, because contradictory findings have been reported.  It is difficult to make quant. pharmacokinetic conclusions about LAT1 and LAT2.  This is due to the possible involvement of other transporters (including cross-linked heterodimers of light chain with different heavy chains, other overlapping transporters, for example TAT1), competing endogenous amino acids, and satn. phenomena.  This review presents the current functional knowledge on LAT1 and LAT2 with emphasis on their potential involvement in pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvc4C-d6d6X7Vg90H21EOLACvtfcHk0lgzvxJTkkkILw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyltrzP&md5=31f6073e1bc3ff74b78773373ba6a9e9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2008.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2008.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BAmo%26aufirst%3DE.%2BM.%26aulast%3DUrtti%26aufirst%3DA.%26aulast%3DYliperttula%26aufirst%3DM.%26atitle%3DPharmacokinetic%2520role%2520of%2520L-type%2520amino%2520acid%2520transporters%2520LAT1%2520and%2520LAT2%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D35%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Del. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lgzvxJTkkkILw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Del.%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0lhKEsjrOg6MFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, <i>in vitro</i> ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lhKEsjrOg6MFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-439&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhKEsjrOg6MFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Defining optimum lipophilicity and molecular weight ranges for drug candidates—molecular weight dependent lower logD limits based on permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2844</span><span class="NLM_x">–</span> <span class="NLM_lpage">2851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2844-2851&author=M.+J.+Waring&title=Defining+optimum+lipophilicity+and+molecular+weight+ranges+for+drug+candidates%E2%80%94molecular+weight+dependent+lower+logD+limits+based+on+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DDefining%2520optimum%2520lipophilicity%2520and%2520molecular%2520weight%2520ranges%2520for%2520drug%2520candidates%25E2%2580%2594molecular%2520weight%2520dependent%2520lower%2520logD%2520limits%2520based%2520on%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2844%26epage%3D2851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0liDKyQOOVoF5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eYPwHT33cU_Bbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span> </span><span class="NLM_article-title">Time-related differences in the physical property profiles of oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6338</span><span class="NLM_x">–</span> <span class="NLM_lpage">6348</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049717d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6338-6348&author=P.+D.+Leesonauthor=A.+M.+Davis&title=Time-related+differences+in+the+physical+property+profiles+of+oral+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Time-Related Differences in the Physical Property Profiles of Oral Drugs</span></div><div class="casAuthors">Leeson, Paul D.; Davis, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6338-6348</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparisons of the calcd. physicochem. properties of oral drugs launched prior to 1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of lipophilicity, percent polar surface area and H-bond donor count are the same, suggesting that these are the most important oral drug-like phys. properties.  In contrast, mean values of mol. wt. and the nos. of O + N atoms, H-bond acceptors, and rotatable bonds and rings have increased in 1983-2002 drugs (by 13-29%).  Anal. of the 1983-2002 oral drugs by therapy area shows that anti-infectives and nervous system drugs have the most extreme phys. property profiles.  Cardiovascular drugs show increasing mol. wt. with year of publication, primarily a consequence of focusing on clin. proven mechanisms, with limited chem. diversity.  Drug classes other than anti-infectives show comparable distributions of lipophilicity, suggesting that this property in oral drugs is important irresp. of the drug's target.  The results suggest that the balance between polar and nonpolar drug properties is an important, unchanging feature of oral drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtNkiWH6Bl6bVg90H21EOLACvtfcHk0liDKyQOOVoF5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D&md5=edd5cceab1ccfe3542cb4df180e3c160</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm049717d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049717d%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26atitle%3DTime-related%2520differences%2520in%2520the%2520physical%2520property%2520profiles%2520of%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6338%26epage%3D6348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Norinder, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeberlein, M.</span><span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood–brain distribution</span> <span class="citation_source-journal">Adv. Drug Deliv. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood%E2%80%93brain+distribution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood%25E2%2580%2593brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayada, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbressine, L. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploemen, J.-P.</span><span> </span><span class="NLM_article-title">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1514</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1023%2FA%3A1015040217741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=10554091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=1514-1519&author=J.+Kelderauthor=P.+D.+J.+Grootenhuisauthor=D.+M.+Bayadaauthor=L.+P.+C.+Delbressineauthor=J.-P.+Ploemen&title=Polar+molecular+surface+as+a+dominating+determinant+for+oral+absorption+and+brain+penetration+of+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span></div><div class="casAuthors">Kelder, Jan; Grootenhuis, Peter D. J.; Bayada, Denis M.; Delbressine, Leon P. C.; Ploemen, Jan-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Purpose: To study oral absorption and brain penetration as a function of polar mol. surface area.  Methods: Measured brain penetration data of 45 drug mols. were investigated.  The dynamic polar surface areas were calcd. and correlated with the brain penetration data.  Also the static polar surface areas of 776 orally administered CNS drugs that have reached at least Phase II efficacy studies were calcd.  The same was done for a series of 1590 orally administered non-CNS drugs that have reached at least Phase II efficacy studies.  Results: A linear relationship between brain penetration and dynamic polar surface area (A2) was found (n = 45, R = 0.917, F1,43 = 229).  Brain penetration decreases with increasing polar surface area.  A clear difference between the distribution of the polar surface area of the 776 CNS and 1590 non-CNS drugs was found.  It was deduced that orally active drugs that are transported passively by the transcellular route should not exceed a polar surface area of about 120 A2.  They can be tailored to brain penetration by decreasing the polar surface to <60-70 A2.  This conclusion is supported by the inverse linear relationship between exptl. brain penetration data and the dynamic polar surface area of 45 drug mols.  Conclusions: The polar mol. surface area is a dominating determinant for oral absorption and brain penetration of drugs that are transported by the transcellular route.  This property should be considered in the early phase of drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmc3v7TzWM4LVg90H21EOLACvtfcHk0liDKyQOOVoF5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D&md5=868fe1e9491dd3b8b92b326d28ee48f9</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015040217741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015040217741%26sid%3Dliteratum%253Aachs%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26aulast%3DBayada%26aufirst%3DD.%2BM.%26aulast%3DDelbressine%26aufirst%3DL.%2BP.%2BC.%26aulast%3DPloemen%26aufirst%3DJ.-P.%26atitle%3DPolar%2520molecular%2520surface%2520as%2520a%2520dominating%2520determinant%2520for%2520oral%2520absorption%2520and%2520brain%2520penetration%2520of%2520drugs%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D1514%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camenisch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chretien, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raevsky, O. A.</span><span> </span><span class="NLM_article-title">Estimation of blood–brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.3109%2F10611869808997889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9886238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=151-165&author=H.+Van+de+Waterbeemdauthor=G.+Camenischauthor=G.+Folkersauthor=J.+R.+Chretienauthor=O.+A.+Raevsky&title=Estimation+of+blood%E2%80%93brain+barrier+crossing+of+drugs+using+molecular+size+and+shape%2C+and+H-bonding+descriptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span></div><div class="casAuthors">Van de Waterbeemd, Han; Camenisch, Gian; Folkers, Gerd; Chretien, Jacques R.; Raevsky, Oleg A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-165</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The influence of physicochem. properties, including lipophilicity, H-bonding capacity and mol. size and shape descriptors on brain uptake has been investigated using a selection of marketed CNS and CNS-inactive drugs.  It is demonstrated that the polar surface area of a drug can be used as a suitable descriptor for the drugs' H-bonding potential.  A combination of a H-bonding and a mol. size descriptor, i.e., the major components of lipophilicity and permeability, avoiding knowledge of distribution coeffs., is proposed to est. brain penetration potential of new drug candidates.  Previously reported exptl. surface activity data appear to be strongly correlated to mol. size of the drug compds.  Present anal. offers a modern basis for property-based design and targeting of CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0yCKmlzsa37Vg90H21EOLACvtfcHk0ljl43fkK8OE6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D&md5=9106ff6aa0755ff76fd0634822857d4a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3109%2F10611869808997889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611869808997889%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DChretien%26aufirst%3DJ.%2BR.%26aulast%3DRaevsky%26aufirst%3DO.%2BA.%26atitle%3DEstimation%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520crossing%2520of%2520drugs%2520using%2520molecular%2520size%2520and%2520shape%252C%2520and%2520H-bonding%2520descriptors%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D1998%26volume%3D6%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span> </span><span class="NLM_article-title">Hydrogen-bonding capacity and brain penetration</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1992&pages=299-303&author=H.+Van+de+Waterbeemdauthor=M.+Kansy&title=Hydrogen-bonding+capacity+and+brain+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DKansy%26aufirst%3DM.%26atitle%3DHydrogen-bonding%2520capacity%2520and%2520brain%2520penetration%26jtitle%3DChimia%26date%3D1992%26volume%3D46%26spage%3D299%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Young, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sore, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, T. J.</span><span> </span><span class="NLM_article-title">Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H<sub>2</sub> receptor histamine antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00398a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaL1cXpsVChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=656-671&author=R.+C.+Youngauthor=R.+C.+Mitchellauthor=T.+H.+Brownauthor=C.+R.+Ganellinauthor=R.+Griffithsauthor=M.+Jonesauthor=K.+K.+Ranaauthor=D.+Saundersauthor=I.+R.+Smithauthor=N.+E.+Soreauthor=T.+J.+Wilks&title=Development+of+a+new+physicochemical+model+for+brain+penetration+and+its+application+to+the+design+of+centrally+acting+H2+receptor+histamine+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists</span></div><div class="casAuthors">Young, Rodney C.; Mitchell, Robert C.; Brown, Thomas H.; Ganellin, C. Robin; Griffiths, Robin; Jones, Martin; Rana, Kishore K.; Saunders, David; Smith, Ian R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-71</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A rational approach to the design of centrally acting agents is presented, based initially upon a comparison of the physicochem. properties of three typical histamine H2 receptor antagonists which do not readily cross the blood-brain barrier with those of the three brain-penetrating drugs clonidine, mepyramine, and imipramine.  A good correlation was found between the logarithms of the equil. brain/blood concn. ratios in the rat and the partition parameter, Δ log P, defined as log P (1-octanol/water) - log P (cyclohexane/water), which suggests that brain penetration might be improved by reducing overall hydrogen-bonding ability.  This model has been employed as a guide in the design of novel brain-penetrating H2 antagonists by the systematic structural modification of representatives of different structural types of H2 antagonists.  Although marked increases in brain penetration among congeners of cimetidine, ranitidine, and tiotidine were achieved, no compd. was found with an acceptable combination of H2 antagonist activity (-log KB in the guinea pig atrium > 7.0) and brain penetration (steady-state brain/blood concn. ratio > 1.0).  Conversely, structural modification of N-[3-[m-(piperidinylmethyl)phenoxy]propyl]acetamide led to several potent, novel compds. which readily cross the blood-brain barrier.  One of these, zolantidine (SK&F 95282), whose -log KB is 7.46 and steady-state brain/blood ratio is 1.4, has been identified for use in studying histaminergic H2 receptor mechanisms in brain.  Comparison of Δ log P values with the logarithms of the brain/blood ratios for 20 structurally diverse compds. for which data became available confirms a highly significant correlation and supports the general validity of this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6PLz9CeYbs7Vg90H21EOLACvtfcHk0ljl43fkK8OE6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXpsVChtA%253D%253D&md5=668f7ad2d17fc57312ed5753f6f9c40a</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm00398a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00398a028%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BC.%26aulast%3DMitchell%26aufirst%3DR.%2BC.%26aulast%3DBrown%26aufirst%3DT.%2BH.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DGriffiths%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DRana%26aufirst%3DK.%2BK.%26aulast%3DSaunders%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DI.%2BR.%26aulast%3DSore%26aufirst%3DN.%2BE.%26aulast%3DWilks%26aufirst%3DT.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520new%2520physicochemical%2520model%2520for%2520brain%2520penetration%2520and%2520its%2520application%2520to%2520the%2520design%2520of%2520centrally%2520acting%2520H2%2520receptor%2520histamine%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D656%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, D. L.</span><span> </span><span class="NLM_article-title">Parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1968&pages=1-11&author=C.+Hanschauthor=A.+R.+Stewardauthor=S.+M.+Andersonauthor=D.+L.+Bentley&title=Parabolic+dependence+of+drug+action+upon+lipophilic+character+as+revealed+by+a+study+of+hypnotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DSteward%26aufirst%3DA.%2BR.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DBentley%26aufirst%3DD.%2BL.%26atitle%3DParabolic%2520dependence%2520of%2520drug%2520action%2520upon%2520lipophilic%2520character%2520as%2520revealed%2520by%2520a%2520study%2520of%2520hypnotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1968%26volume%3D1%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhg0yi4aKA0Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Leo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, D.</span><span> </span><span class="NLM_article-title">Partition coefficients and their uses</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60274a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaE38XivVansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1971&pages=525-616&author=A.+Leoauthor=C.+Hanschauthor=D.+Elkins&title=Partition+coefficients+and+their+uses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Partition coefficients and their uses</span></div><div class="casAuthors">Leo, Albert; Hansch, Corwin; Elkins, David</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-616</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with 519 refs. includes discussion of:  thermodynamics of partitioning systems, energy requirements for phase transfer, exptl. methods, linear free-energy relations among systems, and uses of partition measurements (countercurrent distribution, equil. detns., dissoln. and partitioning rate of drugs, liq. ion-exchange media and ion-selective electrodes, emulsion systems, hydrophobic bonding ability).  An extensive tabulation of partitioning data is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ7MM8VxGt8LVg90H21EOLACvtfcHk0lhg0yi4aKA0Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XivVansw%253D%253D&md5=7dc3aa11e7b4feb2f6087842b251f809</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fcr60274a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60274a001%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DElkins%26aufirst%3DD.%26atitle%3DPartition%2520coefficients%2520and%2520their%2520uses%26jtitle%3DChem.%2520Rev.%26date%3D1971%26volume%3D71%26spage%3D525%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Johnson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzya, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudhar, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murkitt, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartlon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, F.</span><span> </span><span class="NLM_article-title">The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5434</span><span class="NLM_x">–</span> <span class="NLM_lpage">5438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5434-5438&author=D.+J.+Johnsonauthor=I.+T.+Forbesauthor=S.+P.+Watsonauthor=V.+Garzyaauthor=G.+I.+Stevensonauthor=G.+R.+Walkerauthor=H.+S.+Mudharauthor=S.+J.+Flynnauthor=P.+A.+Wymanauthor=P.+W.+Smithauthor=G.+S.+Murkittauthor=A.+J.+Lucasauthor=C.+R.+Mookherjeeauthor=J.+M.+Watsonauthor=J.+E.+Gartlonauthor=A.+M.+Bradfordauthor=F.+Brown&title=The+discovery+of+a+series+of+N-substituted+3-%284-piperidinyl%29-1%2C3-benzoxazolinones+and+oxindoles+as+highly+brain+penetrant%2C+selective+muscarinic+M1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BJ.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26aulast%3DGarzya%26aufirst%3DV.%26aulast%3DStevenson%26aufirst%3DG.%2BI.%26aulast%3DWalker%26aufirst%3DG.%2BR.%26aulast%3DMudhar%26aufirst%3DH.%2BS.%26aulast%3DFlynn%26aufirst%3DS.%2BJ.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DMurkitt%26aufirst%3DG.%2BS.%26aulast%3DLucas%26aufirst%3DA.%2BJ.%26aulast%3DMookherjee%26aufirst%3DC.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DGartlon%26aufirst%3DJ.%2BE.%26aulast%3DBradford%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DF.%26atitle%3DThe%2520discovery%2520of%2520a%2520series%2520of%2520N-substituted%25203-%25284-piperidinyl%2529-1%252C3-benzoxazolinones%2520and%2520oxindoles%2520as%2520highly%2520brain%2520penetrant%252C%2520selective%2520muscarinic%2520M1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5434%26epage%3D5438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafinowska, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coggon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murkitt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Searle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">New quinoline NK3 receptor antagonists with CNS activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=837-840&author=P.+W.+Smithauthor=P.+A.+Wymanauthor=P.+Lovellauthor=C.+Goodacreauthor=H.+T.+Serafinowskaauthor=A.+Vongauthor=F.+Harringtonauthor=S.+Flynnauthor=D.+M.+Bradleyauthor=R.+Porterauthor=S.+Coggonauthor=G.+Murkittauthor=K.+Searleauthor=D.+R.+Thomasauthor=J.+M.+Watsonauthor=W.+Martinauthor=Z.+Wuauthor=L.+A.+Dawson&title=New+quinoline+NK3+receptor+antagonists+with+CNS+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26aulast%3DLovell%26aufirst%3DP.%26aulast%3DGoodacre%26aufirst%3DC.%26aulast%3DSerafinowska%26aufirst%3DH.%2BT.%26aulast%3DVong%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DF.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBradley%26aufirst%3DD.%2BM.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DCoggon%26aufirst%3DS.%26aulast%3DMurkitt%26aufirst%3DG.%26aulast%3DSearle%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DNew%2520quinoline%2520NK3%2520receptor%2520antagonists%2520with%2520CNS%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D837%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Martin, Y. C.</span><span> </span><span class="NLM_article-title">A bioavailability score</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3164</span><span class="NLM_x">–</span> <span class="NLM_lpage">3170</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2nt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3164-3170&author=Y.+C.+Martin&title=A+bioavailability+score"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A Bioavailability Score</span></div><div class="casAuthors">Martin, Yvonne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3164-3170</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Responding to a demonstrated need for scientists to forecast the permeability and bioavailability (F) properties of compds. before their purchase, synthesis, or advanced testing, the authors have developed a score that assigns the probability that a compd. will have F > 10% in the rat.  Neither the rule-of-five, log P, log D, nor the combination of the no. of rotatable bonds and polar surface area successfully categorized compds.  Instead, different properties govern the bioavailability of compds. depending on their predominant charge at biol. pH.  The fraction of anions with >10% F falls from 85% if the polar surface area (PSA) is ≤ 75 Å2, to 56% if 75 < PSA < 150 Å2, to 11% if PSA is ≥ 150 Å2.  On the other hand, whereas 55% of the neutral, zwitterionic, or cationic compds. that pass the rule-of-five have >10% F, only 17% of those that fail have > 10% F.  This same categorization distinguishes compds. that are poorly permeable from those that are permeable in Caco-2 cells.  Further validation is provided with human bioavailability values from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXWIgR8hRzC7Vg90H21EOLACvtfcHk0lhg0yi4aKA0Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2nt7k%253D&md5=aeed812cf4ab717896170c232e170c46</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm0492002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492002%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DY.%2BC.%26atitle%3DA%2520bioavailability%2520score%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3164%26epage%3D3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Abraham, M. H.</span><span> </span><span class="NLM_article-title">Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1039%2Fcs9932200073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK3sXktlGjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=73-83&author=M.+H.+Abraham&title=Scales+of+solute+hydrogen-bonding%3A+their+construction+and+application+to+physicochemical+and+biochemical+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes</span></div><div class="casAuthors">Abraham, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    </div><div class="casAbstract">A review with no refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptfSZN252ExLVg90H21EOLACvtfcHk0lhQ5PjtNp7Adg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktlGjt7s%253D&md5=bdeb33e66746bc875a6765f685bbc6fb</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1039%2Fcs9932200073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcs9932200073%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26atitle%3DScales%2520of%2520solute%2520hydrogen-bonding%253A%2520their%2520construction%2520and%2520application%2520to%2520physicochemical%2520and%2520biochemical%2520processes%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D1993%26volume%3D22%26spage%3D73%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirripa, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span> </span><span class="NLM_article-title">Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061094b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=272-282&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=R.+K.+Changauthor=M.+R.+Woodauthor=K.+M.+Schirripaauthor=J.+J.+Kimauthor=J.+M.+Waiauthor=R.+M.+DiPardoauthor=K.+L.+Murphyauthor=R.+W.+Ransomauthor=C.+M.+Harrellauthor=D.+R.+Reissauthor=M.+A.+Holahanauthor=J.+Cookauthor=J.+F.+Hessauthor=N.+Sainauthor=M.+O.+Urbanauthor=C.+Tangauthor=T.+Prueksaritanontauthor=D.+J.+Pettiboneauthor=M.+G.+Bock&title=Development+of+orally+bioavailable+and+CNS+penetrant+biphenylaminocyclopropane+carboxamide+bradykinin+B1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm061094b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061094b%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DSchirripa%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DWai%26aufirst%3DJ.%2BM.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26aulast%3DSain%26aufirst%3DN.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DBock%26aufirst%3DM.%2BG.%26atitle%3DDevelopment%2520of%2520orally%2520bioavailable%2520and%2520CNS%2520penetrant%2520biphenylaminocyclopropane%2520carboxamide%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D272%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmait, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester-Zeiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biorn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span> </span><span class="NLM_article-title">Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8781</span><span class="NLM_x">–</span> <span class="NLM_lpage">8792</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401234w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8781-8792&author=E.+Huauthor=R.+K.+Kunzauthor=N.+Chenauthor=S.+Rumfeltauthor=A.+Siegmundauthor=K.+Andrewsauthor=S.+Chmaitauthor=S.+Zhaoauthor=C.+Davisauthor=H.+Chenauthor=D.+Lester-Zeinerauthor=J.+Maauthor=C.+Biornauthor=J.+Shiauthor=A.+Porterauthor=J.+Treanorauthor=J.+R.+Allen&title=Design%2C+optimization%2C+and+biological+evaluation+of+novel+keto-benzimidazoles+as+potent+and+selective+inhibitors+of+phosphodiesterase+10A+%28PDE10A%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm401234w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401234w%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DAndrews%26aufirst%3DK.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DBiorn%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DDesign%252C%2520optimization%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520keto-benzimidazoles%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8781%26epage%3D8792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lhQ5PjtNp7Adg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Rafi, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hearn, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedantham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Predicting and improving the membrane permeability of peptidic small molecules</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3163</span><span class="NLM_x">–</span> <span class="NLM_lpage">3169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201634q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Ogtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3163-3169&author=S.+B.+Rafiauthor=B.+R.+Hearnauthor=P.+Vedanthamauthor=M.+P.+Jacobsonauthor=A.+R.+Renslo&title=Predicting+and+improving+the+membrane+permeability+of+peptidic+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and Improving the Membrane Permeability of Peptidic Small Molecules</span></div><div class="casAuthors">Rafi, Salma B.; Hearn, Brian R.; Vedantham, Punitha; Jacobson, Matthew P.; Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3163-3169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluate exptl. and computationally the membrane permeability of matched sets of peptidic small mols. bearing natural or bioisosteric unnatural amino acids.  We find that the intentional introduction of hydrogen bond acceptor-donor pairs in such mols. can improve membrane permeability while retaining or improving other favorable drug-like properties.  We employ an all-atom force field based method to calc. changes in free energy assocd. with the transfer of the peptidic mols. from water to membrane.  This computational method correctly predicts rank order exptl. permeability trends within congeneric series and is much more predictive than calcns. (e.g., clogP) that do not consider three-dimensional conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAMuvF4vQFrVg90H21EOLACvtfcHk0liw59XObIsByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Ogtrg%253D&md5=a517000b38fb76198d38beac165d2d99</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm201634q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201634q%26sid%3Dliteratum%253Aachs%26aulast%3DRafi%26aufirst%3DS.%2BB.%26aulast%3DHearn%26aufirst%3DB.%2BR.%26aulast%3DVedantham%26aufirst%3DP.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DPredicting%2520and%2520improving%2520the%2520membrane%2520permeability%2520of%2520peptidic%2520small%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3163%26epage%3D3169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien-Larose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span> </span><span class="NLM_article-title">Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK1 receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2276</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010825z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2276-2285&author=V.+A.+Ashwoodauthor=M.+J.+Fieldauthor=D.+C.+Horwellauthor=C.+Julien-Laroseauthor=R.+A.+Lewthwaiteauthor=S.+McClearyauthor=M.+C.+Pritchardauthor=J.+Raphyauthor=L.+Singh&title=Utilization+of+an+intramolecular+hydrogen+bond+to+increase+the+CNS+penetration+of+an+NK1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fjm010825z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010825z%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DField%26aufirst%3DM.%2BJ.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DJulien-Larose%26aufirst%3DC.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DPritchard%26aufirst%3DM.%2BC.%26aulast%3DRaphy%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26atitle%3DUtilization%2520of%2520an%2520intramolecular%2520hydrogen%2520bond%2520to%2520increase%2520the%2520CNS%2520penetration%2520of%2520an%2520NK1%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2276%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Over, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grönberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgendorf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellisson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M. W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvall, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span> </span><span class="NLM_article-title">Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2746</span><span class="NLM_x">–</span> <span class="NLM_lpage">2754</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500059t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2746-2754&author=B.+Overauthor=P.+McCarrenauthor=P.+Arturssonauthor=M.+Foleyauthor=F.+Giordanettoauthor=G.+Gr%C3%B6nbergauthor=C.+Hilgendorfauthor=M.+D.+Leeauthor=P.+Matssonauthor=G.+Muncipintoauthor=M.+Pellissonauthor=M.+W.+D.+Perryauthor=R.+Svenssonauthor=J.+R.+Duvallauthor=J.+Kihlberg&title=Impact+of+stereospecific+intramolecular+hydrogen+bonding+on+cell+permeability+and+physicochemical+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Stereospecific Intramolecular Hydrogen Bonding on Cell Permeability and Physicochemical Properties</span></div><div class="casAuthors">Over, Bjoern; McCarren, Patrick; Artursson, Per; Foley, Michael; Giordanetto, Fabrizio; Groenberg, Gunnar; Hilgendorf, Constanze; Lee, Maurice D.; Matsson, Paer; Muncipinto, Giovanni; Pellisson, Melanie; Perry, Matthew W. D.; Svensson, Richard; Duvall, Jeremy R.; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2746-2754</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Profiling of eight stereoisomeric T. cruzi growth inhibitors revealed vastly different in vitro properties such as soly., lipophilicity, pKa, and cell permeability for two sets of four stereoisomers.  Using computational chem. and NMR spectroscopy, we identified the formation of an intramol. NH→NR3 hydrogen bond in the set of stereoisomers displaying lower soly., higher lipophilicity, and higher cell permeability.  The intramol. hydrogen bond resulted in a significant pKa difference that accounts for the other structure-property relationships.  Application of this knowledge could be of particular value to maintain the delicate balance of size, soly., and lipophilicity required for cell penetration and oral administration for chem. probes or therapeutics with properties at, or beyond, Lipinski's rule of 5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR_VAbJqqxirVg90H21EOLACvtfcHk0liw59XObIsByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKiurg%253D&md5=4227f825b82f5d17fab3f0de43806a5d</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm500059t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500059t%26sid%3Dliteratum%253Aachs%26aulast%3DOver%26aufirst%3DB.%26aulast%3DMcCarren%26aufirst%3DP.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DFoley%26aufirst%3DM.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DGr%25C3%25B6nberg%26aufirst%3DG.%26aulast%3DHilgendorf%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BD.%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DPellisson%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DSvensson%26aufirst%3DR.%26aulast%3DDuvall%26aufirst%3DJ.%2BR.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520stereospecific%2520intramolecular%2520hydrogen%2520bonding%2520on%2520cell%2520permeability%2520and%2520physicochemical%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2746%26epage%3D2754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Hennig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Leon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Cornejo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, L.</span><span> </span><span class="NLM_article-title">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.jfluchem.2009.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2009&pages=453-460&author=L.+Hennigauthor=K.+Ayala-Leonauthor=J.+Angulo-Cornejoauthor=R.+Richterauthor=L.+Beyer&title=Fluorine+hydrogen+short+contacts+and+hydrogen+bonds+in+substituted+benzamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span></div><div class="casAuthors">Hennig, Lothar; Ayala-Leon, Ketty; Angulo-Cornejo, Jorge; Richter, Rainer; Beyer, Lothar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ten Fluorine substituted benzamides were synthesized and studied by spectroscopic methods (NMR, IR, MS) and x-ray structure anal.  The configuration of these compds. strongly depends on solvent, temp. and substitution pattern.  Unexpectedly, some of these compds. form weak intramol. hydrogen bonds/short N-H···F-C contacts in CDCl3 soln. and in the solid state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO1miRde9jnbVg90H21EOLACvtfcHk0liw59XObIsByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D&md5=2abb3e0d14e81fe2adda68b51bd6b6b8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2009.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2009.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DAyala-Leon%26aufirst%3DK.%26aulast%3DAngulo-Cornejo%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DL.%26atitle%3DFluorine%2520hydrogen%2520short%2520contacts%2520and%2520hydrogen%2520bonds%2520in%2520substituted%2520benzamides%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2009%26volume%3D130%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9009</span><span class="NLM_x">–</span> <span class="NLM_lpage">9024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9009-9024&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+hydroxyethylamine+containing+%CE%B2-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+%CE%B2-amyloid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520hydroxyethylamine%2520containing%2520%25CE%25B2-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9009%26epage%3D9024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4156</span><span class="NLM_x">–</span> <span class="NLM_lpage">4180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Alex, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Baxter, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, M. P.</span><span> </span><span class="NLM_article-title">Temperature dependence of <sup>1</sup>H chemical shifts in proteins</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1023%2FA%3A1018334207887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=9255942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2sXltFCktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=359-369&author=N.+J.+Baxterauthor=M.+P.+Williamson&title=Temperature+dependence+of+1H+chemical+shifts+in+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Temperature dependence of 1H chemical shifts in proteins</span></div><div class="casAuthors">Baxter, Nicola J.; Williamson, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer</span>)
        </div><div class="casAbstract">Temp. coeffs. have been measured by 2D NMR methods for the amide and CαH proton chem. shifts in two globular proteins, bovine pancreatic trypsin inhibitor and hen egg-white lysozyme.  The temp.-dependent changes in chem. shift are generally linear up to about 15° below the global denaturation temp., and the derived coeffs. span a range of roughly -16 to +2 ppb/K for amide protons and -4 to +3 ppb/K for CαH.  The temp. coeffs. can be rationalized by the assumption that heating causes increases in thermal motion in the protein.  Precise calcns. of temp. coeffs. derived from protein coordinates are not possible, since chem. shifts are sensitive to small changes in at. coordinates.  Amide temp. coeffs. correlate well with the location of hydrogen bonds as detd. by crystallog.  It is concluded that a combined use of both temp. coeffs. and exchange rates produces a far more reliable indicator of hydrogen bonding than either alone.  If an amide proton exchanges slowly and has a temp. coeff. more pos. than -4.5 ppb/K, it is hydrogen bonded, while if it exchanges rapidly and has a temp. coeff. more neg. than -4.5 ppb/K, it is not hydrogen bonded.  The previously obsd. unreliability of temp. coeffs. as measures of hydrogen bonding in peptides may arise from losses of peptide secondary structure on heating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr05sDHtiqi5LVg90H21EOLACvtfcHk0lgbmrmoAjoO4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltFCktbo%253D&md5=3e6a19a161d0172703abde67a908774c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018334207887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018334207887%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DN.%2BJ.%26aulast%3DWilliamson%26aufirst%3DM.%2BP.%26atitle%3DTemperature%2520dependence%2520of%25201H%2520chemical%2520shifts%2520in%2520proteins%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1997%26volume%3D9%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Tardia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolfa, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiatordi, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DAlberga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzariti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span> </span><span class="NLM_article-title">Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6403</span><span class="NLM_x">–</span> <span class="NLM_lpage">6418</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500697c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6403-6418&author=P.+Tardiaauthor=A.+Stefanachiauthor=M.+Nisoauthor=D.+A.+Stolfaauthor=G.+F.+Mangiatordiauthor=D.+DAlbergaauthor=O.+Nicolottiauthor=G.+Lattanziauthor=A.+Carottiauthor=F.+Leonettiauthor=R.+Perroneauthor=F.+Berardiauthor=A.+Azzaritiauthor=N.+A.+Colabufoauthor=S.+Cellamare&title=Trimethoxybenzanilide-based+P-glycoprotein+modulators%3A+an+interesting+case+of+lipophilicity+tuning+by+intramolecular+hydrogen+bonding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm500697c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500697c%26sid%3Dliteratum%253Aachs%26aulast%3DTardia%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DDAlberga%26aufirst%3DD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLattanzi%26aufirst%3DG.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DAzzariti%26aufirst%3DA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DCellamare%26aufirst%3DS.%26atitle%3DTrimethoxybenzanilide-based%2520P-glycoprotein%2520modulators%253A%2520an%2520interesting%2520case%2520of%2520lipophilicity%2520tuning%2520by%2520intramolecular%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6403%26epage%3D6418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Shalaeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalamanchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. J.</span><span> </span><span class="NLM_article-title">Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4870</span><span class="NLM_x">–</span> <span class="NLM_lpage">4879</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301850m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4870-4879&author=M.+Shalaevaauthor=G.+Caronauthor=Y.+A.+Abramovauthor=T.+N.+O%E2%80%99Connellauthor=M.+S.+Plummerauthor=G.+Yalamanchiauthor=K.+A.+Farleyauthor=G.+H.+Goetzauthor=L.+Philippeauthor=M.+J.+Shapiro&title=Integrating+intramolecular+hydrogen+bonding+%28IMHB%29+considerations+in+drug+discovery+using+%CE%94logP+as+a+tool"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm301850m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301850m%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DT.%2BN.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DYalamanchi%26aufirst%3DG.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3DIntegrating%2520intramolecular%2520hydrogen%2520bonding%2520%2528IMHB%2529%2520considerations%2520in%2520drug%2520discovery%2520using%2520%25CE%2594logP%2520as%2520a%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4870%26epage%3D4879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Goetz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciabola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. J.</span><span> </span><span class="NLM_article-title">High throughput method for the indirect detection of intramolecular hydrogen bonding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2920</span><span class="NLM_x">–</span> <span class="NLM_lpage">2929</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401859b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2iurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2920-2929&author=H.+Goetzauthor=W.+Farrellauthor=M.+Shalaevaauthor=S.+Sciabolaauthor=D.+Andersonauthor=J.+Yanauthor=L.+Philippeauthor=M.+J.+Shapiro&title=High+throughput+method+for+the+indirect+detection+of+intramolecular+hydrogen+bonding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">High Throughput Method for the Indirect Detection of Intramolecular Hydrogen Bonding</span></div><div class="casAuthors">Goetz, Gilles H.; Farrell, William; Shalaeva, Marina; Sciabola, Simone; Anderson, Dennis; Yan, Jiangli; Philippe, Laurence; Shapiro, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2920-2929</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A supercrit. fluid chromatog. method was developed for the detection of intramol. hydrogen bonds in pharmaceutically relevant mols.  The identification of compds. likely to form intramol. hydrogen bonds is an important drug design consideration given the correlation of intramol. hydrogen bonding with increased membrane permeability.  The technique described here correlates chromatog. retention with the exposed polarity of a mol.  Mols. that can form an intramol. hydrogen bond can hide their polarity and therefore exhibit lower retention than similar compds. that cannot.  By use of a pairwise anal. strategy, intramol. hydrogen bonds are identified within a test set of compds. with diverse topologies.  The chromatog. results are confirmed by NMR chem. shift and temp. coeff. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmIBznjNPRbVg90H21EOLACvtfcHk0liPDoc478nGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2iurY%253D&md5=14eb39ae2abe2830c634ff1e642af520</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm401859b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401859b%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DH.%26aulast%3DFarrell%26aufirst%3DW.%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3DHigh%2520throughput%2520method%2520for%2520the%2520indirect%2520detection%2520of%2520intramolecular%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2920%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0liPDoc478nGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Palm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungell, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strandlund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Correlation of drug absorption with molecular surface properties</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1021%2Fjs950285r" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=8926580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=32-39&author=K.+Palmauthor=K.+Luthmanauthor=A.+L.+Ungellauthor=G.+Strandlundauthor=P.+Artursson&title=Correlation+of+drug+absorption+with+molecular+surface+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Drug Absorption with Molecular Surface Properties</span></div><div class="casAuthors">Palm, Katrin; Luthman, Kristina; Ungell, Anna-Lena; Strandlund, Gert; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-9</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The correlation between dynamic surface properties of drug mols. and drug absorption in two common in vitro models of the intestinal wall (Caco-2 monolayers and rat intestinal segments) has been investigated.  A homologous series of β-adrenoreceptor antagonists were used as model compds.  Dynamic mol. surface properties, considering all low-energy conformations, of the compds. were calcd.  The flexibility of the mols. was studied by mol. mechanics calcns. (MM2) and the van der Waals' (vdW) and water accessible surface areas were calcd. and averaged according to a Boltzmann distribution.  Excellent correlations were obtained between the dynamic polar vdW surface areas and cell permeabilities in Caco-2 cells and rat ileum (r2 = 0.99 and 0.92, resp.).  These correlations were stronger than those between calcd. octanol/buffer partition coeffs. (log Doct,7.4) and permeability (r2 = 0.80 and 0.73, resp.).  Moreover, the calcd. log Doct,7.4 values failed to rank the permeability coeffs. through Caco-2 monolayers and rat ileum in the correct order.  The results indicate that dynamic polar surface area is a promising alternative model for the prediction of oral drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLOYEAamFQdrVg90H21EOLACvtfcHk0liPDoc478nGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGkt7Y%253D&md5=ed1c2dc15492941a8084653907c57d0c</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjs950285r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs950285r%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DUngell%26aufirst%3DA.%2BL.%26aulast%3DStrandlund%26aufirst%3DG.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DCorrelation%2520of%2520drug%2520absorption%2520with%2520molecular%2520surface%2520properties%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1996%26volume%3D85%26spage%3D32%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Richmond, T. J. T.</span><span> </span><span class="NLM_article-title">Solvent accessible surface area and excluded volume in proteins</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=1984&pages=63-89&author=T.+J.+T.+Richmond&title=Solvent+accessible+surface+area+and+excluded+volume+in+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DT.%2BJ.%2BT.%26atitle%3DSolvent%2520accessible%2520surface%2520area%2520and%2520excluded%2520volume%2520in%2520proteins%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1984%26volume%3D178%26spage%3D63%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Goldberg, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Schoolmeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swales, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, M. J.</span><span> </span><span class="NLM_article-title">Optimization of brain penetrant 11β-hydroxysteroid dehydrogenase type I inhibitors and <i>in vivo</i> testing in diet-induced obese mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4016729" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=970-986&author=F.+W.+Goldbergauthor=A.+G.+Dossetterauthor=J.+S.+Scottauthor=R.+Robbauthor=S.+Boydauthor=S.+D.+Groombridgeauthor=P.+D.+Kemmittauthor=T.+Sjogrenauthor=P.+M.+Gutierrezauthor=J.+De+Schoolmeesterauthor=J.+G.+Swalesauthor=A.+W.+Turnbullauthor=M.+J.+Wild&title=Optimization+of+brain+penetrant+11%CE%B2-hydroxysteroid+dehydrogenase+type+I+inhibitors+and+in+vivo+testing+in+diet-induced+obese+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm4016729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4016729%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DRobb%26aufirst%3DR.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DDe%2BSchoolmeester%26aufirst%3DJ.%26aulast%3DSwales%26aufirst%3DJ.%2BG.%26aulast%3DTurnbull%26aufirst%3DA.%2BW.%26aulast%3DWild%26aufirst%3DM.%2BJ.%26atitle%3DOptimization%2520of%2520brain%2520penetrant%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%2520I%2520inhibitors%2520and%2520in%2520vivo%2520testing%2520in%2520diet-induced%2520obese%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D970%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1<i>H</i>-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5801</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5801-5812&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=D.+Andreottiauthor=S.+Ballantineauthor=B.+D.+Baxauthor=A.+J.+Harrisauthor=A.+J.+Harkerauthor=J.+Lundauthor=R.+Melarangeauthor=A.+Mingardiauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=M.+Neveauthor=B.+Oliosiauthor=R.+Profetaauthor=K.+J.+Smithauthor=P.+W.+Smithauthor=S.+Spadaauthor=K.+M.+Thewlisauthor=S.+P.+Yusaf&title=Discovery+of+N-%5B%282S%29-5-%286-fluoro-3-pyridinyl%29-2%2C3-dihydro-1H-inden-2-yl%5D-2-propanesulfonamide%2C+a+novel+clinical+AMPA+receptor+positive+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm1005429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005429%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarker%26aufirst%3DA.%2BJ.%26aulast%3DLund%26aufirst%3DJ.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNeve%26aufirst%3DM.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DProfeta%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DSpada%26aufirst%3DS.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25282S%2529-5-%25286-fluoro-3-pyridinyl%2529-2%252C3-dihydro-1H-inden-2-yl%255D-2-propanesulfonamide%252C%2520a%2520novel%2520clinical%2520AMPA%2520receptor%2520positive%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5801%26epage%3D5812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">McDonald, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zusi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post-Munson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertekap, R. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworetzky, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1684</span><span class="NLM_x">–</span> <span class="NLM_lpage">1688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1684-1688&author=I.+M.+McDonaldauthor=R.+A.+Mateauthor=F.+C.+Zusiauthor=H.+Huangauthor=D.+J.+Post-Munsonauthor=M.+A.+Ferranteauthor=L.+Gallagherauthor=R.+L.+Bertekapauthor=R.+J.+Knoxauthor=B.+J.+Robertsonauthor=D.+G.+Hardenauthor=D.+G.+Morganauthor=N.+J.+Lodgeauthor=S.+I.+Dworetzkyauthor=R.+E.+Olsonauthor=J.+E.+Macor&title=Discovery+of+a+novel+series+of+quinolone+%CE%B17+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DI.%2BM.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DZusi%26aufirst%3DF.%2BC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DFerrante%26aufirst%3DM.%2BA.%26aulast%3DGallagher%26aufirst%3DL.%26aulast%3DBertekap%26aufirst%3DR.%2BL.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DRobertson%26aufirst%3DB.%2BJ.%26aulast%3DHarden%26aufirst%3DD.%2BG.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DDworetzky%26aufirst%3DS.%2BI.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520quinolone%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1684%26epage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Lerchner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintelnot-Blomley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaton, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paganetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span> </span><span class="NLM_article-title">Macrocyclic BACE-1 inhibitors acutely reduce Aβ in brain after po application</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=603-607&author=A.+Lerchnerauthor=R.+Machauerauthor=C.+Betschartauthor=S.+Veenstraauthor=H.+Rueegerauthor=C.+McCarthyauthor=M.+Tintelnot-Blomleyauthor=A.-L.+Jatonauthor=S.+Rabeauthor=S.+Desrayaudauthor=A.+Enzauthor=M.+Staufenbielauthor=P.+Paganettiauthor=J.-M.+Rondeauauthor=U.+Neumann&title=Macrocyclic+BACE-1+inhibitors+acutely+reduce+A%CE%B2+in+brain+after+po+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerchner%26aufirst%3DA.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBetschart%26aufirst%3DC.%26aulast%3DVeenstra%26aufirst%3DS.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DJaton%26aufirst%3DA.-L.%26aulast%3DRabe%26aufirst%3DS.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DPaganetti%26aufirst%3DP.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DMacrocyclic%2520BACE-1%2520inhibitors%2520acutely%2520reduce%2520A%25CE%25B2%2520in%2520brain%2520after%2520po%2520application%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D603%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Rampe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wible, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dage, R. C.</span><span> </span><span class="NLM_article-title">Effects of terfenadine and its metabolites on a delayed rectifier K1 channel cloned from human heart</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=1240-1245&author=D.+Rampeauthor=B.+Wibleauthor=A.+M.+Brownauthor=R.+C.+Dage&title=Effects+of+terfenadine+and+its+metabolites+on+a+delayed+rectifier+K1+channel+cloned+from+human+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRampe%26aufirst%3DD.%26aulast%3DWible%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DDage%26aufirst%3DR.%2BC.%26atitle%3DEffects%2520of%2520terfenadine%2520and%2520its%2520metabolites%2520on%2520a%2520delayed%2520rectifier%2520K1%2520channel%2520cloned%2520from%2520human%2520heart%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D44%26spage%3D1240%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Doan, M. K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkison, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2004&pages=92-98&author=M.+K.+M.+Doanauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=K.+H.+Jordanauthor=J.+P.+Bishopauthor=J.+Kratzauthor=E.+Yangauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkisonauthor=J.+W.+Polli&title=Steady-state+brain+concentrations+of+antihistamines+in+rats%3A+interplay+of+membrane+permeability%2C+P-glycoprotein+efflux+and+plasma+protein+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DM.%2BK.%2BM.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DJordan%26aufirst%3DK.%2BH.%26aulast%3DBishop%26aufirst%3DJ.%2BP.%26aulast%3DKratz%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DSteady-state%2520brain%2520concentrations%2520of%2520antihistamines%2520in%2520rats%253A%2520interplay%2520of%2520membrane%2520permeability%252C%2520P-glycoprotein%2520efflux%2520and%2520plasma%2520protein%2520binding%26jtitle%3DPharmacology%26date%3D2004%26volume%3D72%26spage%3D92%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanni, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span> </span><span class="NLM_article-title">Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=529-535&author=R.+Zhaoauthor=J.+C.+Kalvassauthor=S.+B.+Yanniauthor=A.+S.+Bridgesauthor=G.+M.+Pollack&title=Fexofenadine+brain+exposure+and+the+influence+of+blood-brain+barrier+P-glycoprotein+after+fexofenadine+and+terfenadine+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DYanni%26aufirst%3DS.%2BB.%26aulast%3DBridges%26aufirst%3DA.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DFexofenadine%2520brain%2520exposure%2520and%2520the%2520influence%2520of%2520blood-brain%2520barrier%2520P-glycoprotein%2520after%2520fexofenadine%2520and%2520terfenadine%2520administration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D529%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Mihalic, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3781-3785&author=J.+T.+Mihalicauthor=F.+Fanauthor=X.+Chenauthor=X.+Chenauthor=Y.+Fuauthor=A.+Motaniauthor=L.+Liangauthor=M.+Lindstromauthor=L.+Tangauthor=L.-L.+Chenauthor=J.+Jaenauthor=K.+Daiauthor=L.+Li&title=Discovery+of+a+novel+melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonist+with+reduced+hERG+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalic%26aufirst%3DJ.%2BT.%26aulast%3DFan%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DMotani%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.-L.%26aulast%3DJaen%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonist%2520with%2520reduced%2520hERG%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3781%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Hogberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasmal, P. K.</span><span> </span><span class="NLM_article-title">Melanin concentrating hormone receptor 1 (MCHR1) antagonists—still a viable approach for obesity treatment?</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6039</span><span class="NLM_x">–</span> <span class="NLM_lpage">6047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6039-6047&author=T.+Hogbergauthor=T.+Frimurerauthor=P.+K.+Sasmal&title=Melanin+concentrating+hormone+receptor+1+%28MCHR1%29+antagonists%E2%80%94still+a+viable+approach+for+obesity+treatment%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHogberg%26aufirst%3DT.%26aulast%3DFrimurer%26aufirst%3DT.%26aulast%3DSasmal%26aufirst%3DP.%2BK.%26atitle%3DMelanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCHR1%2529%2520antagonists%25E2%2580%2594still%2520a%2520viable%2520approach%2520for%2520obesity%2520treatment%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6039%26epage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5050</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5050&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0ljzR6VRwH9vuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Gianotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglioni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal-Cin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fratte, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korajac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovric, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rast, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roscic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smehil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togninelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigglesworth, M. J.</span><span> </span><span class="NLM_article-title">Novel spirotetracyclic zwitterionic dual H1/5-HT2A receptor antagonists for the treatment of sleep disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7778</span><span class="NLM_x">–</span> <span class="NLM_lpage">7795</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100856p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7778-7795&author=M.+Gianottiauthor=M.+Bottaauthor=S.+Broughauthor=R.+Carlettiauthor=E.+Castiglioniauthor=C.+Cortiauthor=M.+Dal-Cinauthor=S.+D.+Fratteauthor=D.+Korajacauthor=M.+Lovricauthor=G.+Merloauthor=M.+Mesicauthor=F.+Pavoneauthor=L.+Piccoliauthor=S.+Rastauthor=M.+Roscicauthor=A.+Savaauthor=M.+Smehilauthor=L.+Stasiauthor=A.+Togninelliauthor=M.+J.+Wigglesworth&title=Novel+spirotetracyclic+zwitterionic+dual+H1%2F5-HT2A+receptor+antagonists+for+the+treatment+of+sleep+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm100856p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100856p%26sid%3Dliteratum%253Aachs%26aulast%3DGianotti%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBrough%26aufirst%3DS.%26aulast%3DCarletti%26aufirst%3DR.%26aulast%3DCastiglioni%26aufirst%3DE.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DDal-Cin%26aufirst%3DM.%26aulast%3DFratte%26aufirst%3DS.%2BD.%26aulast%3DKorajac%26aufirst%3DD.%26aulast%3DLovric%26aufirst%3DM.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DMesic%26aufirst%3DM.%26aulast%3DPavone%26aufirst%3DF.%26aulast%3DPiccoli%26aufirst%3DL.%26aulast%3DRast%26aufirst%3DS.%26aulast%3DRoscic%26aufirst%3DM.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DSmehil%26aufirst%3DM.%26aulast%3DStasi%26aufirst%3DL.%26aulast%3DTogninelli%26aufirst%3DA.%26aulast%3DWigglesworth%26aufirst%3DM.%2BJ.%26atitle%3DNovel%2520spirotetracyclic%2520zwitterionic%2520dual%2520H1%252F5-HT2A%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520sleep%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7778%26epage%3D7795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span> </span><span class="NLM_article-title">Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6128</span><span class="NLM_x">–</span> <span class="NLM_lpage">6140</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500610n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6128-6140&author=W.+McCoullauthor=P.+Bartonauthor=A.+J.+H.+Brownauthor=S.+S.+Bowkerauthor=J.+Cameronauthor=D.+S.+Clarkeauthor=R.+D.+M.+Daviesauthor=A.+G.+Dossetterauthor=A.+Ertanauthor=M.+Fenwickauthor=C.+Greenauthor=J.+L.+Holmesauthor=N.+Martinauthor=D.+Mastersauthor=J.+E.+Mooreauthor=N.+J.+Newcombeauthor=C.+Newtonauthor=H.+Pointonauthor=G.+R.+Robbauthor=C.+Sheldonauthor=S.+Stokesauthor=D.+Morgan&title=Identification%2C+optimization%2C+and+pharmacology+of+acylurea+GHS-R1a+inverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm500610n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500610n%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DBowker%26aufirst%3DS.%2BS.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavies%26aufirst%3DR.%2BD.%2BM.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DFenwick%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSheldon%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DIdentification%252C%2520optimization%252C%2520and%2520pharmacology%2520of%2520acylurea%2520GHS-R1a%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6128%26epage%3D6140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span> </span><span class="NLM_article-title">CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1200%2FJCO.2010.34.1313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=443-445&author=D.+B.+Costaauthor=S.+Kobayashiauthor=S.+S.+Pandyaauthor=W.+L.+Yeoauthor=Z.+Shenauthor=W.+Tanauthor=K.+D.+Wilner&title=CSF+concentration+of+the+anaplastic+lymphoma+kinase+inhibitor+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.34.1313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.34.1313%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DS.%2BS.%26aulast%3DYeo%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26atitle%3DCSF%2520concentration%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520inhibitor%2520crizotinib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D443%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Marsault, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span> </span><span class="NLM_article-title">Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lgFKjNtMNT14A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Levin, V. A.</span><span> </span><span class="NLM_article-title">Relationship of octanol/water partition coefficients to rat brain capillary permeability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00180a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=682-684&author=V.+A.+Levin&title=Relationship+of+octanol%2Fwater+partition+coefficients+to+rat+brain+capillary+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm00180a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00180a022%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DV.%2BA.%26atitle%3DRelationship%2520of%2520octanol%252Fwater%2520partition%2520coefficients%2520to%2520rat%2520brain%2520capillary%2520permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D682%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZq05iUKuOddbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Bergstrom, C. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strafford, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazorova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Absorption classification of oral drugs based on molecular surface properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020986i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=558-570&author=C.+A.+S.+Bergstromauthor=M.+Straffordauthor=L.+Lazorovaauthor=A.+Avdeefauthor=K.+Luthmanauthor=P.+Artursson&title=Absorption+classification+of+oral+drugs+based+on+molecular+surface+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm020986i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020986i%26sid%3Dliteratum%253Aachs%26aulast%3DBergstrom%26aufirst%3DC.%2BA.%2BS.%26aulast%3DStrafford%26aufirst%3DM.%26aulast%3DLazorova%26aufirst%3DL.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DAbsorption%2520classification%2520of%2520oral%2520drugs%2520based%2520on%2520molecular%2520surface%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D558%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Tantishaiyakul, V.</span><span> </span><span class="NLM_article-title">Prediction of Caco-2 cell permeability using partial least square multivariate analysis</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=407-411&author=V.+Tantishaiyakul&title=Prediction+of+Caco-2+cell+permeability+using+partial+least+square+multivariate+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTantishaiyakul%26aufirst%3DV.%26atitle%3DPrediction%2520of%2520Caco-2%2520cell%2520permeability%2520using%2520partial%2520least%2520square%2520multivariate%2520analysis%26jtitle%3DPharmazie%26date%3D2001%26volume%3D56%26spage%3D407%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Egan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span> </span><span class="NLM_article-title">Prediction of drug absorption using multivariate statistics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3867</span><span class="NLM_x">–</span> <span class="NLM_lpage">3877</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000292e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3867-3877&author=W.+J.+Eganauthor=K.+M.+Merzauthor=J.+J.+Baldwin&title=Prediction+of+drug+absorption+using+multivariate+statistics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Absorption Using Multivariate Statistics</span></div><div class="casAuthors">Egan, William J.; Merz, Kenneth M. Jr.; Baldwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3867-3877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Literature data on compds. both well- and poorly-absorbed in humans were used to build a statistical pattern recognition model of passive intestinal absorption.  Robust outlier detection was utilized to analyze the well-absorbed compds., some of which were intermingled with the poorly-absorbed compds. in the model space.  Outliers were identified as being actively transported.  The descriptors chosen for inclusion in the model were PSA and AlogP98, based on consideration of the phys. processes involved in membrane permeability and the interrelationships and redundancies between available descriptors.  These descriptors are quite straightforward for a medicinal chemist to interpret, enhancing the utility of the model.  Mol. wt., while often used in passive absorption models, was shown to be superfluous, as it is already a component of both PSA and AlogP98.  Extensive validation of the model on hundreds of known orally delivered drugs, "drug-like" mols., and Pharmacopeia, Inc. compds., which had been assayed for Caco-2 cell permeability, demonstrated a good rate of successful predictions (74-92%, depending on the dataset and exact criterion used).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZF9e_GNz8LVg90H21EOLACvtfcHk0lgFKjNtMNT14A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitLk%253D&md5=44f909ad1fd6187840921e7f07497b4e</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm000292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000292e%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DW.%2BJ.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520drug%2520absorption%2520using%2520multivariate%2520statistics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3867%26epage%3D3877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2eYZLQWsDGrYlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Tarcsay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0liz931fcc_kOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Nicolaou, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span> </span><span class="NLM_article-title">Multi-objective optimization methods in drug design</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=427-435&author=C.+A.+Nicolaouauthor=N.+Brown&title=Multi-objective+optimization+methods+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DC.%2BA.%26aulast%3DBrown%26aufirst%3DN.%26atitle%3DMulti-objective%2520optimization%2520methods%2520in%2520drug%2520design%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2013%26volume%3D10%26spage%3D427%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span> </span><span class="NLM_article-title">Estimation of ADME properties with substructure pattern recognition</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100104j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFektLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1034-1041&author=J.+Shenauthor=F.+Chengauthor=Y.+Xuauthor=W.+Liauthor=Y.+Tang&title=Estimation+of+ADME+properties+with+substructure+pattern+recognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of ADME Properties with Substructure Pattern Recognition</span></div><div class="casAuthors">Shen, Jie; Cheng, Feixiong; Xu, You; Li, Weihua; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1034-1041</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past decade, absorption, distribution, metab., and excretion (ADME) property evaluation has become one of the most important issues in the process of drug discovery and development.  Since in vivo and in vitro evaluations are costly and laborious, in silico techniques had been widely used to est. ADME properties of chem. compds.  Traditional prediction methods usually try to build a functional relationship between a set of mol. descriptors and a given ADME property.  Although traditional methods have been successfully used in many cases, the accuracy and efficiency of mol. descriptors must be concerned.  Herein, we report a new classification method based on substructure pattern recognition, in which each mol. is represented as a substructure pattern fingerprint based on a predefined substructure dictionary, and then a support vector machine (SVM) algorithm is applied to build the prediction model.  Therefore, a direct connection between substructures and mol. properties is built.  The most important substructure patterns can be identified via the information gain anal., which could help to interpret the models from a medicinal chem. perspective.  Afterward, this method was verified with two data sets, one for blood-brain barrier (BBB) penetration and the other for human intestinal absorption (HIA).  The results demonstrated that the overall predictive accuracies of the best HIA model for the training and test sets were 98.5 and 98.8%, and the overall predictive accuracies of the best BBB model for the training and test sets were 98.8 and 98.4%, which confirmed the reliability of our method.  In the addnl. validations, the predictive accuracies were 94 and 69.5% for the HIA and the BBB models, resp.  Moreover, some of the representative key substructure patterns which significantly correlated with the HIA and BBB penetration properties were also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEzrJIPuAKLrVg90H21EOLACvtfcHk0liz931fcc_kOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFektLs%253D&md5=db97701246ad6ffa35915307bf101e44</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fci100104j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100104j%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DEstimation%2520of%2520ADME%2520properties%2520with%2520substructure%2520pattern%2520recognition%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1034%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Chernet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Need, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phebus, L. A.</span><span> </span><span class="NLM_article-title">Use of LC/MS to assess brain tracer distribution in preclinical, <i>in vivo</i> receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2005&pages=340-346&author=E.+Chernetauthor=L.+J.+Martinauthor=D.+Liauthor=A.+B.+Needauthor=V.+N.+Barthauthor=K.+S.+Rashauthor=L.+A.+Phebus&title=Use+of+LC%2FMS+to+assess+brain+tracer+distribution+in+preclinical%2C+in+vivo+receptor+occupancy+studies%3A+dopamine+D2%2C+serotonin+2A+and+NK-1+receptors+as+examples"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChernet%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DNeed%26aufirst%3DA.%2BB.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26atitle%3DUse%2520of%2520LC%252FMS%2520to%2520assess%2520brain%2520tracer%2520distribution%2520in%2520preclinical%252C%2520in%2520vivo%2520receptor%2520occupancy%2520studies%253A%2520dopamine%2520D2%252C%2520serotonin%25202A%2520and%2520NK-1%2520receptors%2520as%2520examples%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D78%26spage%3D340%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Need, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitch, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phebus, L. A.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=1389-1396&author=A.+B.+Needauthor=J.+H.+McKinzieauthor=C.+H.+Mitchauthor=M.+A.+Statnickauthor=L.+A.+Phebus&title=In+vivo+rat+brain+opioid+receptor+binding+of+LY255582+assessed+with+a+novel+method+using+LC%2FMS%2FMS+and+the+administration+of+three+tracers+simultaneously"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeed%26aufirst%3DA.%2BB.%26aulast%3DMcKinzie%26aufirst%3DJ.%2BH.%26aulast%3DMitch%26aufirst%3DC.%2BH.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26atitle%3DIn%2520vivo%2520rat%2520brain%2520opioid%2520receptor%2520binding%2520of%2520LY255582%2520assessed%2520with%2520a%2520novel%2520method%2520using%2520LC%252FMS%252FMS%2520and%2520the%2520administration%2520of%2520three%2520tracers%2520simultaneously%26jtitle%3DLife%2520Sci.%26date%3D2007%26volume%3D81%26spage%3D1389%26epage%3D1396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Hawkins, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">The blood–brain barrier/neurovascular unit in health and disease</span> <span class="citation_source-journal">Am. Soc. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=173-185&author=B.+T.+Hawkinsauthor=T.+P.+Davis&title=The+blood%E2%80%93brain+barrier%2Fneurovascular+unit+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DB.%2BT.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%252Fneurovascular%2520unit%2520in%2520health%2520and%2520disease%26jtitle%3DAm.%2520Soc.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D57%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Seelbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egleton, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1111%2Fj.1471-4159.2007.04644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=17697052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1677-1690&author=M.+J.+Seelbachauthor=T.+A.+Brooksauthor=R.+D.+Egletonauthor=T.+P.+Davis&title=Peripheral+inflammatory+hyperalgesia+modulates+morphine+delivery+to+the+brain%3A+a+role+for+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein</span></div><div class="casAuthors">Seelbach, Melissa J.; Brooks, Tracy A.; Egleton, Richard D.; Davis, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1677-1690</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">P-glycoprotein (Pgp, ABCB1) is a crit. efflux transporter at the blood-brain barrier (BBB) where its luminal location and substrate promiscuity limit the brain distribution of numerous therapeutics.  Moreover, Pgp is known to confer multi-drug resistance in cancer chemotherapy and brain diseases, such as epilepsy, and is highly regulated by inflammatory mediators.  The involvement of inflammatory processes in neuropathol. states has led us to investigate the effects of peripheral inflammatory hyperalgesia on transport properties at the BBB.  In the present study, we examd. the effects of λ-carrageenan-induced inflammatory pain (CIP) on brain endothelium regulation of Pgp.  Western blot anal. of enriched brain microvessel fractions showed increased Pgp expression 3 h post-CIP.  In situ brain perfusion studies paralleled these findings with decreased brain uptake of the Pgp substrate and opiate analgesic, [3H] morphine.  Cyclosporin A-mediated inhibition of Pgp enhanced the uptake of morphine in λ-carrageenan and control animals.  This indicates that the CIP induced decrease in morphine transport was the result of an increase in Pgp activity at the BBB.  Furthermore, antinociception studies showed decreased morphine analgesia following CIP.  The observation that CIP modulates Pgp at the BBB in vivo is crit. to understanding BBB regulation during inflammatory disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgcmw0KrITRrVg90H21EOLACvtfcHk0lhAXfewaKB75g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7jM&md5=119fd4b1d49f1c3e69f4a59d346a3ddf</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04644.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeelbach%26aufirst%3DM.%2BJ.%26aulast%3DBrooks%26aufirst%3DT.%2BA.%26aulast%3DEgleton%26aufirst%3DR.%2BD.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DPeripheral%2520inflammatory%2520hyperalgesia%2520modulates%2520morphine%2520delivery%2520to%2520the%2520brain%253A%2520a%2520role%2520for%2520P-glycoprotein%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D102%26spage%3D1677%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Vieth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durst, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hipskind, P. A.</span><span> </span><span class="NLM_article-title">Characteristic physical properties and structural fragments of marketed oral drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030267j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=224-232&author=M.+Viethauthor=M.+G.+Siegelauthor=R.+E.+Higgsauthor=I.+A.+Watsonauthor=D.+H.+Robertsonauthor=K.+A.+Savinauthor=G.+L.+Durstauthor=P.+A.+Hipskind&title=Characteristic+physical+properties+and+structural+fragments+of+marketed+oral+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjm030267j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030267j%26sid%3Dliteratum%253Aachs%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DM.%2BG.%26aulast%3DHiggs%26aufirst%3DR.%2BE.%26aulast%3DWatson%26aufirst%3DI.%2BA.%26aulast%3DRobertson%26aufirst%3DD.%2BH.%26aulast%3DSavin%26aufirst%3DK.%2BA.%26aulast%3DDurst%26aufirst%3DG.%2BL.%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26atitle%3DCharacteristic%2520physical%2520properties%2520and%2520structural%2520fragments%2520of%2520marketed%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D224%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2969</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0512185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2969-2978&author=R.+Morphy&title=The+influence+of+target+family+and+functional+activity+on+the+physicochemical+properties+of+pre-clinical+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">The Influence of Target Family and Functional Activity on the Physicochemical Properties of Pre-Clinical Compounds</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2969-2978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The target families of greatest interest in drug discovery can be differentiated on the basis of the physicochem. properties of their preclin. ligands.  The ligands for peptidergic targets, such as peptide G protein-coupled receptors (GPCRs) and integrin receptors, possess significantly higher median property values than those for aminergic targets, such as monoamine transporters and GPCRs.  The ligands for peptide GPCRs were found to be less efficient, in terms of their binding energy per unit of mol. wt. or lipophilicity, than ligands for monoamine GPCRs.  The changes in the property values during the optimization process were found to vary only slightly across the target families, with the main determinant of the drug-likeness of the optimized compds. being the profile of the starting compds.  Agonists for monoamine GPCRs, opioid receptors and ion channels were typically smaller and less lipophilic than the antagonists, but there was no difference between the agonists and the antagonists for peptide GPCRs and nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EegclZUHNbVg90H21EOLACvtfcHk0lhAXfewaKB75g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D&md5=fcf63bff570d58d56492b46ddecb5eb1</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm0512185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512185%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%2520target%2520family%2520and%2520functional%2520activity%2520on%2520the%2520physicochemical%2520properties%2520of%2520pre-clinical%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2969%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, R. V. D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, E. H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with <i>in vivo</i> toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+D.+E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+H.+T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lhXmDr3WRLbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DEllsworth%26aufirst%3DR.%2BV.%2BD.%2BE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DKrieger-Burke%26aufirst%3DE.%2BH.%2BT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhXmDr3WRLbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Ritchie1, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchie1author=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie1%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Alelyunas, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empfield, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi-Kilby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span> </span><span class="NLM_article-title">Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7312</span><span class="NLM_x">–</span> <span class="NLM_lpage">7316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7312-7316&author=Y.+W.+Alelyunasauthor=J.+R.+Empfieldauthor=D.+McCarthyauthor=R.+C.+Spreenauthor=K.+Buiauthor=L.+Pelosi-Kilbyauthor=C.+Shen&title=Experimental+solubility+profiling+of+marketed+CNS+drugs%2C+exploring+solubility+limit+of+CNS+discovery+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlelyunas%26aufirst%3DY.%2BW.%26aulast%3DEmpfield%26aufirst%3DJ.%2BR.%26aulast%3DMcCarthy%26aufirst%3DD.%26aulast%3DSpreen%26aufirst%3DR.%2BC.%26aulast%3DBui%26aufirst%3DK.%26aulast%3DPelosi-Kilby%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26atitle%3DExperimental%2520solubility%2520profiling%2520of%2520marketed%2520CNS%2520drugs%252C%2520exploring%2520solubility%2520limit%2520of%2520CNS%2520discovery%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7312%26epage%3D7316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Noe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span> </span><span class="NLM_article-title">Targeted covalent enzyme inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1016%2FB978-0-12-396492-2.00027-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=413-439&author=M.+C.+Noeauthor=A.+M.+Gilbert&title=Targeted+covalent+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted covalent enzyme inhibitors</span></div><div class="casAuthors">Noe, Mark C.; Gilbert, Adam M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">413-439</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Selective covalent modification of a biomol. target can offer several important advantages in drug discovery.  The purpose of this report is to broadly detail targeted covalent inhibitor approaches across a variety of enzyme families which were published over the past 5 years.  Covalent modification of essential enzyme cofactors as a design strategy and the development of covalent probes to enable chem. biol. studies are beyond the scope of this review.  Tis review will be divided into several sections based on reactivity of the electrophilic species (producing functionally irreversible or reversible covalent assocn. with the target protein), and type of nucleophile with which the electrophile is known to assoc. in its biol. context (sulfur, oxygen, or nitrogen).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp04K2rcDR5rVg90H21EOLACvtfcHk0lhXmDr3WRLbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eju7jK&md5=4957a32f394ad591702a4316ffe9c8df</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00027-8%26sid%3Dliteratum%253Aachs%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26atitle%3DTargeted%2520covalent%2520enzyme%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D413%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Dounay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechle, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evdokimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salafia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuyten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Discovery of brain-penetrant, irreversible kynurenine aminotransferase II inhibitors for schizophrenia</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200204m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=187-192&author=A.+B.+Dounayauthor=M.+Andersonauthor=B.+M.+Bechleauthor=B.+M.+Campbellauthor=M.+M.+Claffeyauthor=A.+Evdokimovauthor=E.+Evrardauthor=K.+R.+Fonsecaauthor=X.+Ganauthor=S.+Ghoshauthor=M.+M.+Haywardauthor=W.+Hornerauthor=J.-Y.+Kimauthor=L.+A.+McAllisterauthor=J.+Panditauthor=V.+Paradisauthor=V.+D.+Parikhauthor=M.+R.+Reeseauthor=S.+Rongauthor=M.+A.+Salafiaauthor=K.+Schuytenauthor=C.+A.+Strickauthor=J.+B.+Tuttleauthor=J.+Valentineauthor=H.+Wangauthor=L.+E.+Zawadzkeauthor=P.+R.+Verhoest&title=Discovery+of+brain-penetrant%2C+irreversible+kynurenine+aminotransferase+II+inhibitors+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fml200204m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200204m%26sid%3Dliteratum%253Aachs%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DCampbell%26aufirst%3DB.%2BM.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DEvdokimov%26aufirst%3DA.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGan%26aufirst%3DX.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DHorner%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DParadis%26aufirst%3DV.%26aulast%3DParikh%26aufirst%3DV.%2BD.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DRong%26aufirst%3DS.%26aulast%3DSalafia%26aufirst%3DM.%2BA.%26aulast%3DSchuyten%26aufirst%3DK.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DValentine%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDiscovery%2520of%2520brain-penetrant%252C%2520irreversible%2520kynurenine%2520aminotransferase%2520II%2520inhibitors%2520for%2520schizophrenia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0liGaOgehezlig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Covalent modifiers: an orthogonal approach to drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1231-1246&author=M.+H.+Potashmanauthor=M.+E.+Duggan&title=Covalent+modifiers%3A+an+orthogonal+approach+to+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: An Orthogonal Approach to Drug Design</span></div><div class="casAuthors">Potashman, Michele H.; Duggan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1231-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this article we review a variety of examples in which therapeutic targets are covalently bound by small-mol. drugs or by compds. in advanced clin. development.  The covalent interactions can be either reversible or irreversible, depending on the reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BO6g9_F717Vg90H21EOLACvtfcHk0liGaOgehezlig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D&md5=f8380d5a1cdd8638ad2a1e0405d25267</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008597%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DCovalent%2520modifiers%253A%2520an%2520orthogonal%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1231%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Moghaddam, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apuy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span> </span><span class="NLM_article-title">A proposed screening paradigm for discovery of covalent inhibitor drugs</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.2174%2F1872312808666140317151735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=24628405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGqur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=19-30&author=M.+F.+Moghaddamauthor=Y.+Tangauthor=Z.+O%E2%80%99Brienauthor=S.+J.+Richardsonauthor=M.+Bacoldauthor=P.+Chaturvediauthor=J.+Apuyauthor=A.+Kulkarni&title=A+proposed+screening+paradigm+for+discovery+of+covalent+inhibitor+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs</span></div><div class="casAuthors">Moghaddam, Mehran F.; Tang, Yang; O'Brien, Zhihong; Richardson, Samantha J.; Bacolod, Maria; Chaturedi, Prasoon; Apuy, Julius; Kulkarni, Ashutosh</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-30</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The in vitro and in vivo preclin. ADME properties of 10 clin. late stage or marketed covalent inhibitors were evaluated in order to define advancement criteria for discovery of future drugs in this arena.  Our studies revealed the following: After incubating with S9 fractions for 30 min, the rat and human in vitro stability for these compds. ranged from 1% to 100%.  The blood stability ranged from 30% to 100%.  There was a broad range of CYP inhibition with prevalence for time-dependent inhibition of at least one enzyme.  The Caco-2 permeability (A→B) ranged from negligible (0.6 x 10-6 cm/s) to highly permeable (31 x 10-6 cm/s) and the efflux ratio also varied widely (0.2-30).  Most of the compds. were highly protein bound in both rat and human with binding ≥ 90%.  Rat plasma clearance for the 10 compds. ranged from slow (11 mL/min/kg) to very rapid (350 mL/min/kg).  The Vss ranged from low (0.67 L/kg) to very high (115 L/kg).  MRT's also ranged from short (0.5 h) to long (7.4 h).  The oral exposures also showed a very broad range with Cmax's ranging from 0.01-77 μM and exposure levels ranging from 0.03-106 μM.hr.  In conclusion, the wide range in in vitro and in vivo ADME data makes these particular ADME assays non-discriminatory in the selection of promising compds.  In our opinion, non-traditional assays such as target mass modification, target confirmation by amino acid sequencing, cellular target occupancy, and target turnover rate data in combination with the pharmacokinetic profiles are the crit. considerations for progression of irreversible compds. in early discovery. ; <b>Biog.</b>: Mehran Moghaddam, PhD, is.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobrQbTwxt6f7Vg90H21EOLACvtfcHk0liGaOgehezlig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGqur%252FF&md5=97ff5ba47e9547cbae3e5d10ec35112e</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.2174%2F1872312808666140317151735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1872312808666140317151735%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DBacold%26aufirst%3DM.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DApuy%26aufirst%3DJ.%26aulast%3DKulkarni%26aufirst%3DA.%26atitle%3DA%2520proposed%2520screening%2520paradigm%2520for%2520discovery%2520of%2520covalent%2520inhibitor%2520drugs%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2014%26volume%3D8%26spage%3D19%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Johansson, M. H.</span><span> </span><span class="NLM_article-title">Reversible michael additions: covalent inhibitors and prodrugs</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=22625413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1330-1344&author=M.+H.+Johansson&title=Reversible+michael+additions%3A+covalent+inhibitors+and+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible Michael additions: covalent inhibitors and prodrugs</span></div><div class="casAuthors">Johansson, Martin H.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1330-1344</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Covalent inhibition is an efficient mol. mechanism for inhibiting enzymes or modulating the function of proteins and is found in the action of many drugs and biol. active natural products.  However, it is has been less appreciated that the formation of covalent bonds can be reversible or irreversible.  This review focuses on biol. active compds. that are Michael acceptors and how the reversible nature of the Michael addn. reaction influences biol. activity and how this can be exploited in designing prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9X1yh9k4q-7Vg90H21EOLACvtfcHk0liiW_4TAgrDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jJ&md5=f90694162e39fe57915e888bbadbd2bb</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DM.%2BH.%26atitle%3DReversible%2520michael%2520additions%253A%2520covalent%2520inhibitors%2520and%2520prodrugs%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1330%26epage%3D1344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Uetrecht, J. P.</span><span> </span><span class="NLM_article-title">New concepts in immunology relevant to idiosyncratic drug reactions: the “danger hypothesis” and innate immune system</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx980249i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=387-395&author=J.+P.+Uetrecht&title=New+concepts+in+immunology+relevant+to+idiosyncratic+drug+reactions%3A+the+%E2%80%9Cdanger+hypothesis%E2%80%9D+and+innate+immune+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Ftx980249i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx980249i%26sid%3Dliteratum%253Aachs%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26atitle%3DNew%2520concepts%2520in%2520immunology%2520relevant%2520to%2520idiosyncratic%2520drug%2520reactions%253A%2520the%2520%25E2%2580%259Cdanger%2520hypothesis%25E2%2580%259D%2520and%2520innate%2520immune%2520system%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1999%26volume%3D12%26spage%3D387%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, O.</span><span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0liiW_4TAgrDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span> </span><span class="NLM_article-title">Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm501535r&amp;key=10.1038%2Fbjp.2008.260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm501535r&amp;key=18574456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm501535r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=185-197&author=A.+Reginaauthor=M.+Demeuleauthor=C.+Cheauthor=I.+Lavalleeauthor=J.+Poirierauthor=R.+Gabathulerauthor=R.+Beliveauauthor=J.+P.+Castaigne&title=Antitumour+activity+of+ANG1005%2C+a+conjugate+between+paclitaxel+and+the+new+brain+delivery+vector+Angiopep-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2</span></div><div class="casAuthors">Regina, A.; Demeule, M.; Che, C.; Lavallee, I.; Poirier, J.; Gabathuler, R.; Beliveau, R.; Castaigne, J-P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-197</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Paclitaxel is highly efficacious in the treatment of breast, head and neck, non-small cell lung cancers and ovarian carcinoma.  For malignant gliomas, paclitaxel is prevented from reaching its target by the presence of the efflux pump P-glycoprotein (P-gp) at the blood-brain barrier.  We investigated the utilization of a new drug delivery system to increase brain delivery of paclitaxel.  Exptl. approach: Paclitaxel mols. were conjugated to a brain peptide vector, Angiopep-2, to provide a paclitaxel-Angiopep-2 conjugate named ANG1005.  We detd. the brain uptake capacity, intracellular effects and antitumor properties of ANG1005 in vitro against human tumor cell lines and in vivo in human xenografts.  We then detd. ANG1005 activity on brain tumors with intracerebral human tumor models in nude mice.  Key results: We show by in situ brain perfusion that ANG1005 enters the brain to a greater extent than paclitaxel and bypasses the P-gp.  ANG1005 has an antineoplastic potency similar to that of paclitaxel against human cancer cell lines.  We also demonstrate that ANG1005 caused a more potent inhibition of human tumor xenografts than paclitaxel.  Finally, ANG1005 administration led to a significant increase in the survival of mice with intracerebral implantation of U87 MG glioblastoma cells or NCI-H460 lung carcinoma cells.  Conclusions and implications: These results demonstrate the antitumor potential of a new drug, ANG1005, and establish that conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf7gdI2T8jHbVg90H21EOLACvtfcHk0liiW_4TAgrDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N&md5=3c86b5d1a64c5754d439dfa787f16637</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.260%26sid%3Dliteratum%253Aachs%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DLavallee%26aufirst%3DI.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26atitle%3DAntitumour%2520activity%2520of%2520ANG1005%252C%2520a%2520conjugate%2520between%2520paclitaxel%2520and%2520the%2520new%2520brain%2520delivery%2520vector%2520Angiopep-2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D185%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2','PDB','2XP2'); return false;">PDB: 2XP2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a href="/doi/suppl/10.1021/jm501535r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_25124"></div></div></div></div></div><hr /></hr><p class="last">Calculated physicochemical properties and CNS MPO scores for a diverse set of compounds with experimentally obtained <i>C</i><sub>u,b</sub> values (Figure <a id="rightTab-" class=" internalNav" href="#fig4">4</a>). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501535r/suppl_file/jm501535r_si_001.pdf">jm501535r_si_001.pdf (735.3 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501535r&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501535r%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501535r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6798f83ddeca3c94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
